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Structure–activity relationships (SARs) in the disorazole family have been revealed 
through the biological testing of natural disorazoles and their synthetic analogues, 
but little is known about the contribution of the oxazole to the anti-tubulin activity of 
disorazole C1 I. The development of a novel Evans–Tishchenko/alkyne metathesis 
(ET–AM) route towards the synthesis of disorazole C1 will provide straightforward 
access to disorazole C1 and its heterocyclic analogues, thus allowing the contribution 
of the oxazole to the natural product’s bioactivity to be elucidated. 
 
Our ET–AM approach offers a highly diastereoselective and convergent means of 
constructing heterocyclic analogues of the disorazole C1 scaffold Het-II. It is 
envisaged that ET coupling of C(1)–C(9) aldehydes Het-IV to the C(10)–C(19)       
β-hydroxyketone V will give the key, requisite, 1,3-anti diol monoester bis-alkynes 
Het-III for dimerisation via an alkyne cross-metathesis/ring-closing alkyne 
metathesis (ACM–RCAM) reaction. 
 
Further diversification may be achieved through the synthesis of C(6)-heteroatom 
analogues of the C(1)–C(9) fragment Het-IV. Chapter 2 outlines efforts towards the 
synthesis of C(6)-amino analogues Het-VI of the C(1)–C(9) fragment IV. 
Elaboration of Garner’s aldehyde VIII allowed the synthesis of the N-protected       





A scalable route towards the synthesis of the C(10)–C(19) fragment V and 
investigations into its reactivity under ET coupling conditions are critical to the 
success of our ET–AM approach. Chapter 3 details convergent approaches towards 
the synthesis of the C(10)–C(19) β-hydroxyketone V, which centred around: (i) an 
olefin cross-metathesis reaction [C(11)–C(12) disconnection]; (ii) an epoxide ring-
opening reaction [C(12)–C(13) disconnection]; and (iii) a Mukaiyama aldol reaction 
[C(14)–C(15) disconnection]. Chapter 4 describes our successful linear synthesis of 
the β-hydroxyketone V. 
 
Gram-scale preparation of the C(10)–C(19) fragment V permitted investigation into 
the viability of the ET reaction as a fragment coupling strategy, the results of which 
are reported in Chapter 5. Although many (hetero)aryl aldehydes failed to react, the 
successful coupling of electron-deficient substrates allowed a contingency strategy to 
be explored through preparation of the mono-protected diol IX. Esterification of IX 
with the carboxylic acid derivative of the C(1)–C(9) oxazole has allowed generation 





TITLE PAGE                      I 
DECLARATION                     II 
ACKNOWLEDGEMENTS                 III 
ABSTRACT                       V 
CONTENTS                       VII 
 
1. INTRODUCTION                    1 
 1.1 The Disorazoles: Background               1 
  1.1.1 Discovery and Isolation               1 
  1.1.2 Biological Activity                 3 
  1.1.3 Key Challenges in the Synthesis of the Disorazoles      6 
 1.2 Synthesis of the Disorazoles                7 
  1.2.1 C(1)–C(19) Monomer Synthesis (Meyers, 2000)       7 
  1.2.2 C(11)–C(12) Tetradehydro-Disorazole C1 (Meyers, 2001)    9 
  1.2.3 C(9)–C(10) Tetradehydro-Disorazole C1 (Hoffmann, 2002–2006) 11 
  1.2.4 The First Total Synthesis of Disorazole C1 (Wipf. 2004)     14 
 1.3 Synthesis of Disorazole Analogues             17 
  1.3.1 Disorazole C1 Analogues (Graham, 2006)         17 
  1.3.2 The Simplified Disorazoles (Kalesse, 2010)         19 
  1.3.3 (–)-CP2-Disorazole C1 (Wipf, 2011)           21 
 1.4 Structure–Activity Relationships in the Disorazoles        24 
 1.5 The Hulme Group Strategy towards the Synthesis of Disorazole C1   28 
 1.6 Thesis Overview and Research Aims             30 
 
2. RESULTS AND DISCUSSION 1               32 
Studies towards the Synthesis of a C(6)-Amino Analogue of the C(1)–C(9)  
Fragment of Disorazole C1 
 2.1 Overview, Previous Work and Retrosynthesis          32 
 2.2 Synthesis of the 1,3-Enyne Garner Aldehyde Derivative      36 
  2.2.1 Direct Synthesis Using a Propargylic Phosphonium Salt     36 
  2.2.2 Indirect Synthesis                 38  
   2.2.2.1 Approach A: Takai Olefination           39 
VIII 
 
   2.2.2.2 Approach B: Hydrostannylation/Iododestannylation    41 
   2.2.2.3 Completion of the C(7)–C(9) (E)-Enyne Moiety      43 
 2.3 Oxazolidine Deprotection and O-Tosylation          44 
  2.3.1 Overview, Deprotection and Approach A: Direct O-Tosylation  44 
  2.3.2 Approach B: Protected Alcohol Approach         47 
  2.3.3 Attempted Tosylation of the C(5)–C(9) Alcohol       48 
 2.4 Alteration of the C(6) N-Protecting Group           51 
  2.4.1 Synthesis of the N-Protected C(5)–C(9) Amino Alcohols    51 
  2.4.2 Completion of the C(6)-Amino C(5)–C(9) Fragment Analogue  55 
 2.5 Conclusions and Future Work               59 
  2.5.1 The N-Protecting Group               61 
  2.5.2 Streamlining the Synthetic Pathway           63 
  2.5.3 Further C(6) C(1)–C(9) Fragment Analogues        64 
 2.6 Summary                      65 
 
3. RESULTS AND DISCUSSION 2               66 
Convergent Approaches towards the Synthesis of the C(10)–C(19) Fragment 
of Disorazole C1 
 3.1 Overview, Previous Work and Retrosynthesis          66 
 3.2 Approach A: Cross-Metathesis               69 
  3.2.1 Synthesis of the C(10)–C(11) Enyne           70 
  3.2.2 Synthesis of the C(12)–C(16) Olefin           71 
  3.2.3 Cross-Metathesis Reactions              73 
 3.3 Approach B: Epoxide Ring-Opening             76 
  3.3.1 Synthesis of the C(13)–C(16) Epoxide           77 
  3.3.2 Synthesis of the C(10)–C(12) Vinyl Bromide        81 
 3.4 Approach C: Mukaiyama Aldol Reaction           82 
  3.4.1 Synthesis of the Silyl Ketene Acetal and N-Ts-D-Valine     84 
  3.4.2 Synthesis of the C(10)–C(14) Alcohol           85 
  3.4.3 The Mukaiyama Aldol Reaction: C(11)–C(14) Vinyl Iodide   86 
  3.4.4 The Mukaiyama Aldol Reaction: C(10)–C(14) Enyne     88 
 3.5 Fragment Completion from the C(10)–C(16) β-Hydroxyester     91 
 3.6 Summary                      92 
IX 
 
4. RESULTS AND DISCUSSION 3               93 
Linear Approaches towards the Synthesis of the C(10)–C(19) Fragment of 
Disorazole C1 
 4.1 Overview, Previous Work and Retrosynthesis          93 
 4.2 Synthesis of the C(12)–C(16) β-Hydroxyester Scaffold       95 
  4.2.1 Synthesis of the C(12)–C(14) Aldehyde          95 
  4.2.2 The Mukaiyama Aldol Reaction             96 
  4.2.3 Synthesis of the C(12)–C(16) Aldehyde          97 
 4.3 Installation of the C(10)–C(12) (Z)-Enyne           98 
  4.3.1 Approach A: Direct Synthesis Using a Wittig Olefination    99 
  4.3.2 Approach B: Synthesis via Iodo-olefination/Negishi Coupling   103 
 4.4 Fragment Completion                  105 
  4.4.1 Weinreb Amide Synthesis               105
  4.4.2 Installation of the C(16)–C(19) Propene Group        109 
   4.4.2.1 Reaction with 1-Propenylmagnesium Bromide      110 
   4.4.2.2 Reaction with Allylmagnesium Bromide        112 
  4.4.3 Early-Stage Deprotection and Grignard Reaction       115 
 4.5 Conclusions and Future Work               117 
  4.5.1 Early Installation of the Weinreb Amide          118 
  4.5.2 Improvements to the Synthetic Route           121 
 4.6 Summary                      122 
 
5. RESULTS AND DISCUSSION 4               124 
Evans–Tishchenko Coupling of Model Heterocycles 
 5.1 Introduction                     124 
  5.1.1 Applications of Evans–Tishchenko Coupling        125 
  5.1.2 The Heteroaryl Evans–Tishchenko Reaction         127 
  5.1.3 Retrosynthesis: C(1)–C(9)/C(10′)–C(19′) Fragment Analogues  129 
 5.2 Synthesis of Model N-Heterocycles             130 
  5.2.1 Introduction                   130 
  5.2.2 Pyrrole and Indole Heterocycles             132 
  5.2.3 Pyrazole Heterocycles                133 
  5.2.4 Triazole Heterocycles                136 
X 
 
  5.2.5 N-Alkylation of 1H-N-Heterocycles           137 
  5.2.6 Completion of the Series of Model Heterocycles       141 
 5.3 Evans–Tishchenko Coupling: the C(10)–C(19) β-Hydroxyketone   143 
 5.4 Esterification Approach                 151 
  5.4.1 Synthesis of the C(10)–C(19) Mono-Protected Diol      152 
  5.4.2 Esterification Reactions               155 
   5.4.2.1 Pyrazole Esterification              155 
   5.4.2.2 Oxazole Esterification              157 
 5.5 Conclusions and Future Work               162 
  5.5.1 The Evans–Tishchenko Reaction            163 
  5.5.2 Synthesis of Further C(1)–C(9) Analogues         164 
 5.6 Summary                      166 
 
6. FUTURE WORK                    167 
 6.1 Overview: Alkyne Metathesis Dimerisation          167 
 6.2 Preliminary Alkyne Metathesis Dimerisation Results       169 
 6.3 Implications for Future Work               171 
 6.4 Concluding Remarks                  173 
 
7. EXPERIMENTAL                    174 
 7.1 General Experimental                  174 
  7.1.1 Index for General Procedures              177 
 7.2 Experimental for Chapter 2                178 
 7.3 Experimental for Chapter 3                196 
 7.4 Experimental for Chapter 4                211 
 7.5 Experimental for Chapter 5                232 
  7.5.1 Preparation of Model Heterocycles            232 
   7.5.1.1 Pyrroles                   233 
   7.5.1.2 Indoles                   236 
   7.5.1.3 Pyrazoles                   240 
   7.5.1.4 Triazoles                   248 
  7.5.2 Evans–Tishchenko Reactions              250 
  7.5.3 Completion of the C(1)–C(9)/C(10′)–C(19′) Fragment     256 
XI 
 
                       
ABBREVIATIONS                    263 
REFERENCES                      266 




Chapter 1         Introduction 
1.1 The Disorazoles: Background 
1.1.1 Discovery and Isolation 
The disorazoles
1
 are a class of 31 polyketide natural products, 29 of which were 
isolated from a portion of the neutral extracts of a fermentation broth of the 
myxobacterium Sorangium cellulosum in 1994;
2a
 while the final disorazoles – 
disorazole Z and disorazole Z-epoxide – were discovered 13 years later.
2b
 Figure 1.1 
shows the structure of 12 of the 31 disorazoles and their relative abundance with 
respect to their isolated mass. As can be ascribed from Figure 1.1, all disorazoles are 
(pseudo)dimeric large-ring (28 to 32 atom) macrocyclic dilactones that each contain 
the oxazole heterocycle; a number of double bonds, many of which are conjugated 
and sometimes have internal vinylic epoxides, alcohols or ethers; and a number of 
stereogenic alcohol (or derivative) groups. Disorazole variants are typically 
distinguished by the presence (or absence) of epoxides and hydroxyl groups, and 
differences in their double bond stereochemistry.  
Of their relative isolation mass, disorazole A1 2 is by far the most abundant 
component, accounting for 69.8% of the isolated (disorazole) mass from the neutral 
extracts; followed by disorazoles E1 7 (8.7%), F1 9 (3.7%) and B1 4 (3.3%). The 
remaining mass accounts for a total of 14.5%, with disorazole C1 1 representing only 
0.3% of the mass of the metabolites. However, the soluble organic extracts from 
which the majority of the disorazole family were discovered represents only a small 
fraction of the isolates: further disorazole A1 and E1 (ratio 3:1) were obtained from 
other sources of the broth and therefore the percentage by mass for these metabolites, 
in reality, represents more than 69.8% and 8.7%.  
Interest in the disorazoles stems from their pronounced cytotoxic activity, whereby 
all tested disorazoles (A1, C1, D1, E1 and Z) have shown at least nanomolar activity, 
with some displaying cytotoxicity at picomolar levels.
2b,3–5
 Studies examining the 
mechanism of action of the disorazoles have concluded that their cytotoxicity stems 
from their ability to act as tubulin inhibitors.
3,4
 Because tubulin is essential during the 
cell cycle, their anti-tubulin activity makes the disorazoles strong candidates for 






Figure 1.1 Selected members of the disorazole family of natural products and their relative 
abundance from the initial Sorangium cellulosum fermentation broth. Note 1: no data was 
reported for the disorazole Z variants 11/12 in the initial isolation study
2a
 and so their 
abundance is not indicated). Note 2: not all stereocentres have been assigned in the 
literature, and disorazole D1 and D2, and disorazole E1 and E2 differ in the relative 
stereochemistry at C(9)–C(10) (and their transposes in the case of the disorazole E class) 
but the absolute stereochemistry is yet to be defined. Other variants (not shown), typically 
show differences from those above in double bond stereochemistry or have diols as opposed 
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 Microtubule disruption by an inactive control and disorazole C1 1 at the (a) 
interphase; and (b) mitosis stages of the cell cycle. Microtubules are shown in orange-red, 





 and indeed in silico docking studies
9
 have shown an affinity of the 
disorazoles for the (microtubule destabilising) vinblastine binding site; although the 
same study identified some affinity of the disorazoles for the (microtubule 
stabilising) paclitaxel binding site, and so it is possible that the disorazoles have 
further, unknown modes of action.
9
 Regardless, as can be seen from Figure 1.3, 
disorazole C1 disrupts microtubules at both the interphase (Figure 1.3a) and mitosis 
(Figure 1.3b) stages of the cell cycle at nanomolar concentrations in the range of 5 
to 100 nM.
4a
 This is particularly clear on comparison of the images obtained for the 
differentially treated cells during mitosis, whereby the classically depicted structure 
of the mitotic spindle connected to the aligned chromosomes at the spindle equator 
(clearly shown in the control conditions) is greatly perturbed as a result of the 
presence of the active agent (Dis. C1 conditions). As a result, the division event is  
*
Figure 1.3 is adapted from ‘Fig. 4’ of: “Microtubule Binding and Disruption and Induction of 
Premature Senescence by Disorazole C1”, The Journal of Pharmacology and Experimental 
Therapeutics, Tierno et al. (2009),4a and is included with the authors’ and publisher’s kind permission. 
Concentration (nM) 
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believed to fail spindle checkpointing and the cell enters controlled senescence,
4a
 
thus impeding cell replication and proliferation. Disorazole A1 and other disorazoles 
are believed to act in a similar manner and inhibit cells via the same mechanism of 
action.
2b,3–5





 are also believed to inhibit cell growth by causing microtubule disruption, 
and therefore it is plausible that the disorazoles could also be developed as anti-
cancer agents, because they show a similar level of cytotoxic activity. 
 
Most studies that have examined the anti-proliferative activity of the disorazoles 
have focussed on disorazole A1 and C1, with some data available regarding the 
activity of disorazoles D1, E1 and Z. Against cancer cell lines, disorazole A1 was 
exhibited a mean IC50 of 0.012 nM (number of cell lines N = 10),
3
 while disorazole 
C1 displayed a mean IC50 of 1.66 nM (N = 12).
4a
 Disorazoles D1, E1 and Z showed 
cytotoxicity against cancer cell lines in the picogram range, with measured activities 
of 19 and 7 pg/cm
3
 (EC50; N = 5);
5
 and 30 pg/cm
3
 (IC50; N = 1),
2b
 respectively.  
These data are further discussed with respect to structure–activity relationships 
(SARs) in Section 1.4, but there are a number of noteworthy points that centre 
around these studies in relation to the potential for development of the disorazoles as 
anti-cancer agents. Firstly, disorazoles A1 and C1 displayed comparable or higher in 
vitro potency to the clinically approved anti-cancer drug vinblastine,
3,4a
 implying that 
the natural products are sufficiently active for development as anti-cancer drugs. 
Secondly, disorazole C1 exhibited some selectivity for cancer cells, with wild-type 
confluent fibroblasts displaying an IC50 some 15 to 384 times greater than the cancer 
cell lines, which is promising given that poor malignant-cell selectivity is a major 
problem associated with chemotherapy.
4a
 Finally, disorazole A1 was shown to be 
active against a multidrug resistant (KB-V1) cell line,
3
 which again, is promising, 
because drug resistance is also a problem in chemotherapy.
12
 However, this activity 
implies that cancers may not possess (or have developed) mechanisms to cope with 
the drug’s mode of action, and may also imply (albeit speculatively) that the 
disorazoles have the capability to act against cellular mechanisms of drug resistance. 
Indeed, the generation of cells resistant to the disorazoles has been met with great 
difficulty,
13




1.1.3 Key Challenges in the Synthesis of the Disorazoles 
In order to establish SARs in the disorazoles, a route towards their laboratory 
syntheses would be highly desirable. On the basis of biological activity, the synthesis 
of disorazole A1, D1, E1 or Z would perhaps appear to be most attractive owing to 
their increased potency over disorazole C1. However, it has been suggested that the 
picomolar cytotoxicity displayed by disorazole A1 would be too potent for clinical 
use as an anti-cancer agent;
14a
 and disorazole A1 accounts for over 70% of the mass 
of the isolated disorazoles, and therefore could perhaps be obtained more 
economically through use of the organism’s fermentation broth.
15
 Conversely, 
disorazole C1 is a minor component, and therefore obtaining this disorazole in 
appreciable quantity would be more suited to laboratory synthesis.  
The synthesis of all disorazole variants is highly demanding owing to the size of their 
structures, the multiple stereocentres present, and the known lability of conjugated 
double bond systems. In addition, divinyl epoxides and divinyl diols are reactive 
functional groups, and therefore the syntheses of disorazole variants containing these 
moieties would be especially difficult, from both a preparation and handling 
perspective (Figure 1.4).  
Aside from possessing an acceptable level of cytotoxicity (and some selectivity for 
cancer cells), the symmetrical, homodimeric structure of disorazole C1 lends itself to 
a modular approach towards its synthesis, and the installation of potentially labile  
  
 
Figure 1.4 Key challenges in the synthesis of the disorazoles. 
1,2-Divinyl oxirane or 1,2-divinyl diol              
Reactive 
Multiple Stereocentres 
Conjugated double bonds  
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divinyl epoxides need not be carried out. In addition, the disorazole C1 monomer is 
present in 17 of the 31 disorazoles, and therefore successful synthesis of this subunit 
provides access to other members of the series. Finally, the synthesis of disorazole C1 
will assist in establishing strategies for synthesising other disorazoles. 
The following section outlines the efforts towards the synthesis of the disorazoles. 
For reasons of brevity, this section will focus primarily on methods used to assemble 
the macrocyclic framework of the disorazoles; more comprehensive reviews that 




1.2 Synthesis of the Disorazoles 
1.2.1 C(1)–C(19) Monomer Synthesis (Meyers, 2000) 
 
Scheme 1.1 Meyers’ first generation strategy towards the synthesis of disorazole C1, as 
exemplified for racemic disorazole C1 (±)-1.
17 
 
The first attempted synthesis
17
 of disorazole C1 aimed to both construct the 
macrocycle, and to elucidate the stereochemistry of each chiral centre [at C(6), C(14) 
and C(16) and their transposes, which were unknown at the time] through application 
of conditions used according to a test-route with fragments of different, known 
stereochemistry. If successful, this approach was predicted to produce a library of 
stereochemically distinct disorazoles through which the optical rotation of the 
synthetic products could be compared to that of the literature value for the natural 
product as a means of identifying the correct stereochemistry. In addition, the 




disorazoles owing to the presence of this monomer in 17 of the natural disorazoles. 
Meyers’ retrosynthesis (Scheme 1.1) targeted the C(1)–C(19) monomer 13, which it 
was believed would give access to disorazole C1 by a cyclodimerisation at C(1) and 
C(14); with a Stille coupling
18
 reaction between the C(11)–C(19) stannane 14 and the 
C(1)–C(10) vinyl iodide 15 used to construct the monomer at C(10)–C(11) (Scheme 
1.1). The C(11)–C(19) stannane 14 was prepared in 13 steps and 10% yield from                 
(E)-crotonaldehyde 16 (Scheme 1.2a), while the C(1)–C(10) vinyl iodide 15 was 
synthesised in 11 steps and 13% yield from the readily prepared ester 17 (Scheme 
1.2b). Monomer 13 completion was achieved using a Stille coupling reaction 
between the stannane 14 and the vinyl iodide 15, which proceeded in very good yield 
(76%; Scheme 1.2c). However, successful cyclodimerisation was not reported, and it 
was stated in a follow-up study that the triene system was too unstable to undergo the 
required double lactonisation reaction following saponification of the C(1) ester on 
monomer 13.
19
 In addition, the monomer was reported
17
 to have undergone gradual 
decomposition (by double-bond isomerisation) under standard low-temperature 
storage conditions (–20 °C), and thus implied that a route that uses a protected triene 
would perhaps be required for reasons of both lability and storage. The use of a 
protected triene would prove to be an important strategy in all subsequent disorazole 
C1 syntheses. 
 
Reagents and conditions: (a) PdCl2(MeCN)2, DMF, rt, 76%. 
Scheme 1.2 Synthesis of the (a) C(11)–C(19) stannane 14; and (b) C(1)–C(10) vinyl iodide 
15 fragments. (c) Synthesis of the C(1)–C(19) disorazole C1 monomer 13 by Stille coupling 







1.2.2 C(11)–C(12) Tetradehydro-Disorazole C1 (Meyers, 2001) 
 





 synthesis of disorazole C1 (Scheme 1.3) envisaged 
masking the C(11)–C(12) alkene unit as an alkyne before performing a 
dilactonisation between two C(1)–C(19) monomers 19. The assembly of the 
monomer 19 would be carried out a using Sonogashira coupling
20
 between the 
C(10)–C(19) alkyne 20 and the C(1)–C(10) vinyl iodide 15, and like its predecessor, 
this synthesis also aimed to reveal disorazole stereochemistry; therefore the             
di-epimeric disorazole C1 epi-1 was targeted arbitrarily as a proof of concept. 
The C(11)–C(19) alkyne 20 and C(1)–C(10) vinyl iodide 15 were synthesised in 8 
and 10 steps in 16 and 12% overall yield, respectively, and coupled via a 
Sonogashira reaction to give the protected monomer 19 (Scheme 1.4a). 
Unfortunately, ester hydrolysis and attempted dilactonisation (DPTC)
21
 led only to 
intramolecular reaction and thus the isolation of the cyclised monomer 22 in 46% 
yield, with none of the dimer 21 detected spectroscopically (Scheme 1.4b). 
Fortunately however, an obvious linear contingency strategy was devised that 
involved esterification of the C(16)-mono-protected diol 19 with a doubly protected 





Reagents and conditions: (a) PdCl2(PPh3)2, CuI, Et3N, MeCN, –20 °C to rt, 2 h, 87%; (b) LiOH, THF/H2O, rt, 7 h; 
(c) DPTC, DMAP, PhMe, reflux, 12 h, epi-21 0%, 22 46% (2 steps); (d) TESOTf, 2,6-lutidine, DCM, 0 °C to rt, 4.5 h, 
69%; (e) LiOH, THF/H2O, rt, 2 h; (f) 19, DPTC, DMAP, PhMe, reflux, 48 h, 65% (2 steps); (g) TFA, THF/H2O, rt, 1 h, 
65%; (h) LiOH, THF/H2O, rt, 48 h; (i) 2,4,6-TCBC, Et3N, DMAP, 48 h, rt, 24% (2 steps). 
Scheme 1.4 (a) Synthesis of the C(1)–C(19) monomer 19 by Sonogashira coupling; and (b) 
attempted C(1)–C(14) dilactonisation. (c) Successful linear strategy towards the generation 





hydrolysis and a lactonisation reaction to generate the desired protected dimer epi-21 
(Scheme 1.4c). Accordingly, the C(14) hydroxyl group of the monomer 19 was 
protected as its TES-ether, and the C(1) ester was hydrolysed to give the carboxylic 
acid 23 which was then esterified with the C(14) hydroxyl group of fragment 19 to 
afford the open chain dimer 24. Selective TES deprotection and hydrolysis of the 






 step affording the desired protected tetradehydro-disorazole C1 
scaffold epi-21 in 24% yield (Scheme 1.4c). 
Despite this promising result, early attempts to either deprotect the TBS-ethers to 
give the tetradehydro-disorazole epi-18; or to selectively reduce the alkyne bonds to 
their corresponding (E)-alkenes, and hence generate the bis-silyl-protected disorazole 
epi-26 (Scheme 1.4c), were unsuccessful; and unfortunately no further work towards 
the synthesis of disorazole C1 was conducted by the Meyers group in order to find 
suitable conditions. In spite of these disappointing results, the synthesis of the 
protected tetradehydro-disorazole C1 scaffold 21 identified an important strategy 
through use of stable, dienynyl fragments as protected trienes. The study was also a 
large step towards the synthesis of disorazole C1, because this was, at the time, the 
only published example of the synthesis of a disorazole-like macrocyclic framework. 
 
1.2.3 C(9)–C(10) Tetradehydro-Disorazole C1 (Hoffmann, 2002–2006) 
In their early studies (2002/2003),
14,23
 the Hoffmann group focussed their efforts 
towards the synthesis of the northern and southern fragments of disorazole A1 27/28; 
the latter of which would also allow the total synthesis of disorazole C1, because the 
southern fragment of disorazole A1 is the disorazole C1 C(1)–C(19) monomer (and is 
present in 15 other disorazoles, and would therefore potentially have further 
synthetic value).
24
 Like Meyers’ second generation approach, Hoffmann chose to 
mask one olefin in the triene system as an alkyne for each of the fragments. 
However, on the basis of computational studies,
14
 the central C(9)–C(10) alkene unit 
in the disorazole C1 monomer was chosen as the site of the alkyne, as opposed to the 
C(11)–C(12) unit as carried out previously.
19
  
To achieve the synthesis of disorazoles, it was hoped that a two-step esterification 
and lactonisation sequence (for disorazoles A1 and C1, Scheme 1.5a) – in a 
procedure akin to that eventually utilised by Meyers in their synthesis of the              
C(11)–C(12) tetradehydro-disorazole C1 derivative epi-21 – could be adopted to 
synthesise the C(9)–C(10) isomer 29 (or the protected derivative 30); or 
























disorazole A1 northern fragment 27


















C(9)–C(10) tetradehydro-disorazole C1 29 (P = H)


















Scheme 1.5 Hoffmann’s retrosyntheses of (a) disorazole A1 and (b) disorazole C1.
14,23,25 
acid derivative) of the southern disorazole monomer 28 could be utilised (Scheme 
1.5b).  
The total synthesis of disorazole A1 was never reported by the Hoffmann group, but, 
in 2006, the synthesis of a protected C(9)–C(10) tetradehydro-disorazole C1 30 was 
described.
25
 In order to pursue their retrosynthetic analysis (Scheme 1.5b) in a 
forward sense, the southern fragment 28 and a free alcohol derivative 33, were 
synthesised using a Sonogashira coupling reaction between the C(1)–C(8) vinyl 
iodide 32 and the appropriate C(9)–C(19) alkyne 31 (Scheme 1.6a). For the purposes 
of esterification or lactonisation, the fragment was further derivatised by 
saponification of the methyl esters 28/33 with aqueous LiOH in THF. 
The monomeric C(1)–C(19) fragment 35 was initially subjected to attempted 
cyclodimerisation under a range of standard lactonisation conditions (Scheme 1.6b), 
but this was to no avail with respect to the preparation of protected                      
tetradehydro-disorazole C1 30 and consistently led to only the isolation of unreacted 



















31a P = TBS (11 steps, 18% yield)
31b P = H (12 steps, 17% yield)
35
28 P = TBS, R = Me
33 P = H, R = Me
34 P = TBS, R = H















34 P = TBS




37 P = TBS, R = Me
38 P = TES, R = Me
39 P = H, R = Me































Reagents and conditions: Synthesis of the C(1)–C(19) monomers 34 and 35: (a) PdCl2(PPh3)2, CuI, Et3N, DMF, rt, 
6 h, 28 77%, 33 89%; (b) LiOH, THF/H2O, rt, 4 h, quant; Completion of protected C(1)–C(9) tetradehydro-disorazole 
C1 30: (c) 33, DPTC, DMAP, PhMe, reflux, 36 h, 45%; (d) (i) 36 (20% of total mass to be used), 2,4,6-TCBC, Et3N, 
PhMe, rt, 45 min; (ii) Addition of mixture from (i) over 45 min to 33, DMAP, PhMe, 40 °C; (iii) 4 further iterations of 
steps (i) and (ii); (iv) 40 °C, 2 h, 69%; (e) TBAF, AcOH, H2O, THF, rt, 3 d, 87%; (f) Ba(OH)2, THF/MeOH/H2O, 0 °C 
to rt, 3 h, quant; (g) (i) 2,4,6-TCBC, Et3N, PhMe, rt, 1 h; (ii) Addition of mixture from (i) over 5 h to DMAP, 40 °C; (iii) 
40 °C, 24 h, 31%. 





reaction between the C(1) carboxylic acid 34 with the free alcohol 33 would be 
followed by C(14) silyl deprotection, C(1′) ester hydrolysis and a lactonisation 
reaction between the alcohol and carboxylic acid moieties thus revealed to give the 




Although the initial esterification between alcohol 33 and the carboxylic acid 34 to 
generate the open-chain dimer 37 was successful, silyl deprotection of the             
TBS-protected seco-ester 37 could not be achieved, and therefore the route could not 
be pursued further. To overcome this problematic deprotection step, the sequence 
was repeated using the analogous TES-protected monomer 36, and this proved to be 
a successful means of generating the desired macrocycle. Esterification of the 




implemented Yamaguchi esterification conditions. Silyl cleavage of the more labile 
TES-ether 38 and selective methyl ester hydrolysis of 39 revealed the C(14) 
hydroxyl and C(1′) carboxylic acid moieties, respectively, to give the seco-acid 40 in 
excellent yield (87%, 2 steps). This seco-acid 40 underwent lactonisation in 31% 
yield to give the target protected tetradehydro-disorazole C1 30 (Scheme 1.6c). No 
further work was done to complete the natural product, because the preparation of 
this tetradehydro-disorazole C1 30 would represent a formal total synthesis of 
disorazole C1; the Wipf group had since published the synthesis of a similar 
protected variant during their total synthesis of disorazole C1, and this synthesis is 
detailed in the following section. 
 
1.2.4 The First Total Synthesis of Disorazole C1 (Wipf, 2004) 
 
Scheme 1.7 Wipf retrosynthesis of disorazole C1.
26
 
The first total synthesis of disorazole C1 was achieved in 2004 by Wipf and 
Graham,
26
 and this approach took advantage of discoveries relating to stability and 
macrocycle construction from previous attempted syntheses. Firstly, given that the 
triene unit was unstable, Wipf chose to adopt the somewhat successful                       
alkyne-masking approach as investigated previously (and independently) by Meyers 
and Hoffmann. Secondly, since Meyers had reported difficulty in reducing the triple 
bond on masking of the C(11)–C(12) olefin as an alkyne; and because Hoffmann had 




in terms of steric strain,
14
 Hoffmann’s approach to the masking of the triene unit was 
adopted. However, in order to completely negate issues of monomer formation, the 
lactone ring system would be formed in two distinct esterification steps in a similar 
fashion to that which led to successful completion of the disorazole derivative 
macrocycles epi-21 in Meyers’ efforts
19
 and 30 in Hoffmann’s efforts.
25
 The use of 
silyl groups to protect the C(16) hydroxyl group was also avoided in favour of            
PMB-ethers owing to previous failures in Meyers’ approach to achieve desilylation 
without concomitant product decomposition.
19
 
Wipf’s approach anticipated preparation of the natural product 1 using a deprotection 
and selective alkyne reduction of the alkyne-masked and C(16)/C(16′)                           
bis-O-protected macrocyclic disorazole C1 derivative 41. To assemble the 
macrocycle 41, four distinct disconnections in the macrodiolide’s retrosynthesis were 
envisaged, as opposed to targeting a monomer representative of half of the structure 
and assembling the dimeric macrocycle 41 through direct dilactonisation (Scheme 
1.7). Each of the C(9)–C(10) alkyne units would be introduced using a Sonogashira 
coupling reaction between the terminal alkyne of the protected diol 43 and the vinyl 
iodide moiety of the oxazole fragment 32. Separate esterification and lactonisation 
reactions involving the C(14) hydroxyl group of the C(16)-protected diol 43 and 
oxazolyl carboxylic acids and would allow construction of the dilactone.  
Although slightly less direct than previous approaches, the route had two key 
advantages: (1) despite the four-step nature of the synthesis, only three fragments 
were required, one of which (acid 42) was easily derived from another (ester 32) in a 
single step; and (2) the use of a potentially unselective, capricious, and inefficient 
dilactonisation was avoided in favour of using predictable, well-precedented, 
reactions. The C(1)–C(9) oxazole fragments 32/42 were synthesised in 11/12 steps 
and 13% overall yield from 3-hydroxypropionitrile 44; synthesis of the C(9)–C(19) 
alkyne fragment 43 was achieved in 8% yield, 13 steps and 92 %ee from the 
homoallylic alcohol 45 (Scheme 1.8a and b, respectively). Construction of the 
macrolactone (Scheme 1.8c) commenced with a Sonogashira coupling reaction 
between the vinyl iodide 32 and the alkyne 43 to give the tetradehydro-disorazole 
monomer 46. Steglich esterification
27





Reagents and conditions: (a) PdCl2(PPh3)2, CuI, Et3N, MeCN, –20 °C to rt, 75 min, 94%; (b) 42, DCC, DMAP, 
DCM, 0 °C to rt, 14 h, 80%; (c) 43, PdCl2(PPh3)2, CuI, Et3N, DCM, –20 °C to rt, 75 min, 94%; (d) LiOH, THF/H2O, rt, 
13.5 h, 98%; (e) (i) 2,4,6-TCBC, Et3N, THF, rt, 2 h; (ii) DMAP, PhMe, rt, 16 h, 79%; (f) DDQ, phosphate buffer, 
DCM, rt, 15 min, 61%; (g) H2, Lindlar’s catalyst, quinoline, EtOAc, rt, 1 h, 57%. 
Scheme 1.8 Synthesis of the (a) C(1)–C(8) vinyl iodide fragments 32/42; and (b)                 





the oxazole carboxylic acid 42 gave the ‘three-quarter’ disorazole 47. A second 
Sonogashira reaction (with 43), selective hydrolysis of the methyl ester 48a and 
Yamaguchi lactonisation of the seco-acid 48b allowed completion of the synthesis of 
the protected tetradehydro-disorazole C1 derivative 41. The synthesis of the natural 
product 1 was concluded by deprotection of the C(16)/C(16′) PMB-ethers to give                     
tetradehydro-disorazole C1 29, and Lindlar hydrogenation of the alkynes; the 
endgame sequence thus furnishing disorazole C1 1 in a respectable 19% yield over 
the 7 key steps (Scheme 1.8c). Overall, Wipf and Graham’s approach allowed access 





1.3 Synthesis of Disorazole Analogues 
1.3.1 Disorazole C1 Analogues (Graham, 2006) 
In addition to describing the synthesis of natural disorazole C1, in his thesis,
26b
 
Graham reports – for reasons of investigating SARs – the synthesis of a number of 
analogues. Analogues included both those that were synthesised according to 
multistep procedures, and straightforward derivatisations of disorazole C1. Unlike the 
synthesis of the natural product, the analogues were assembled using a 
dilactonisation from a C(1)-carboxylic acid/C(14)-hydroxy monomer. Graham did 
not speculate on the reasons for this deviation from the highly successful stepwise 
approach; however, from a biological testing point of view, it was presumably 
carried out for increased expediency; and from a synthetic perspective, it would 
allow a comparison between the direct dimerisation and stepwise metal 
coupling/esterification approaches towards the disorazole C1 scaffold to be made. 
To synthesise the C(16)-methyl analogue 52, homoenynyl alcohol 49 (obtained in 6 
steps and 18% yield from pivaldehyde) was subjected to Sonogashira coupling with 
the C(1)–C(8) vinyl iodide 32 to give the monomer 50a. Methyl ester hydrolysis and 
cyclodimerisation under Yamaguchi conditions gave the dimer 51 in 26% yield; and 
from this, subsequent Lindlar hydrogenation afforded the desired C(16)-methyl 
analogue 52 in 43% yield. The C(17)–C(18) cyclopropane analogue 54 was 
synthesised in an analogous fashion from the hydroxyalkyne 53 in 5% yield over 5 
steps. Unfortunately, routes investigated towards the synthesis of the desmethoxy 
analogue 57 from vinyl iodide 55 were unsuccessful. Both direct cyclodimerisation 
(of the 55→43 Sonogashira coupled monomer, not shown), and stepwise macrocycle 
construction (cf. disorazole C1, Section 1.2.4, Scheme 1.8), led to a poor isolation 
(11 to 20%) of the dimeric product 56 in unsatisfactory purity, and therefore attempts 
to synthesise the analogue 57 were abandoned due to a lack of material. 
The final disorazole C1 analogues synthesised by Graham were more 
straightforwardly obtained: the C(16)-didehydro “diketone” analogue 58 was 
prepared in 91% yield using Dess–Martin oxidation
28
 of disorazole C1 1, while the 
hexadecahydro “alkyl” analogue 59 was obtained by hydrogenation of an                    




















50a R = Me, X = tBu



































































































Reagents and conditions: Synthesis of the C(16)–C(19) methyl analogue 52: (a) 32, PdCl2(PPh3)2, CuI, Et3N, 
MeCN, 0 °C, 2 h, 94%; (b) LiOH, THF/H2O, 20 h, rt, 97%; (c) (i) 2,4,6-TCBC, Et3N, THF, rt, 2 h; (ii) DMAP, PhMe, rt, 
2 h, 26%; (d) H2, 5% Pd/BaSO4, quinoline, EtOAc, rt, 30 min, 43%; Synthesis of the C(17)–C(18) cyclopropane 
analogue 54: (e) 32, PdCl2(PPh3)2, CuI, Et3N, MeCN, 0 °C to rt, 1.5 h, 94%; (f) LiOH, THF/H2O, rt, 12 h, quant; (g) (i) 
2,4,6-TCBC, Et3N, THF, rt, 1 h; (ii) DMAP, PhMe, rt, 4 h, 27%; (h) DDQ, phosphate buffer, DCM, 0 °C to rt, 30 min, 
91%; (i) H2, 5% Pd/BaSO4, quinoline, EtOAc, rt, 1.5 h, 22%. 
Scheme 1.9 Graham’s disorazole C1 analogues.
26b
 
disorazole C1’s total synthesis. All of the newly synthesised disorazoles were later 
tested for their activity against a range of cell lines and would provide important 




1.3.2 The Simplified Disorazoles (Kalesse, 2010) 
 
Scheme 1.10 Retrosynthesis of Kalesse’s simplified disorazoles 60.
29
 
The Kalesse group synthesised so-called “simplified” disorazoles
29
 whereby the 
disorazoles were smaller – lacking a CH2CHOMe unit in each monomer and hence 
two stereocentres – when compared to the structure of disorazole C1; and where the 
C(13) methyl ester group is absent in comparison to disorazole Z (which their 
structures most closely represent). The synthetic process was also simplified: Wipf’s 
total synthesis employed a multistep process of consecutive palladium coupling and 
esterification reactions between three fragments to construct the macrocycle and 
required 21 steps for the longest linear sequence. Kalesse regressed somewhat 
(Scheme 1.10), and anticipated the preparation of both simplified disorazole 
stereoisomers 60 by a dilactonisation reaction between C(1)–C(17) monomers 61, 
which were to be prepared via a Wittig reaction
30
 between the C(1)–C(5) oxazole 
Wittig reagent 62, and the C(6)–C(17) aldehydes 63. It was hoped that a route could 
be established that would provide access to disorazole frameworks that were more 
rapidly synthesised (cf. Wipf’s approach) but were equipotent as cytotoxic agents. 
Synthesis of the C(1)–C(5) oxazole Wittig reagent 62 was achieved in 14% yield 
over 4 steps via an initial condensation reaction between methyl acetimidate 64 and 
serine methyl ester (±)-65 (commencing from their hydrochloride salts; Scheme 
1.11a), while the (Z)-C(6)–C(17) aldehyde 63a and its (E)-stereoisomer 63b were 
synthesised in 15% yield over 8 and 10 steps, respectively. It is worth noting that the 
formation of two products at a key (vinologous Mukaiyama aldol reaction)
31





Reagents and conditions: Synthesis of the C(6)–C(17) aldehydes 63: (a) (i) Cu(OTf)2, (S)-Tol-BINAP, THF rt, 20 
min; (ii) TBAT, 20 min; (iii) 66, 67, 24 h, 68 30% yield, 5:1 dr (separable), 69 25% yield, 3:1 dr (separable at a later 
step); Synthesis of the simplified disorazoles 60: (b) (i) 62, 
t
BuOK, THF, –78 to 0 °C, 1 h; (ii) 63, –78 to 0 °C, 3 h, 
70a 85%, 70b 75%; (c) HF•Py, Py, THF, 0 °C to rt, 20 min; (d) LiOH, THF/H2O, 0 °C to rt, 15 h, absence of light, 
61a 75% (2 steps), 61b 60% (2 steps); (e) MNBA, DMAP, 4 Å MS, absence of light, 71a PhMe, 6 d, 26%; 71b 
PhMe/THF, 3 d, 18%; (f) HF, MeCN/H2O, –20 °C, 3 d, absence of light, 60a 22%, 60b 34%. 
Scheme 1.11 Synthesis of the (a) C(1)–C(5) oxazole Wittig reagent fragment 62; and (b) 




allowed the synthesis of both (E)- and (Z)-stereoisomers of the aldehydes 63 
(Scheme 1.11b) from aldehyde 66. Lactone 68 (a precursor of aldehyde 63a) was 
obtained in 30% yield and 5:1 dr, with the desired anti-isomer separable 
chromatograpically. Vinylic ester 69 (a precursor of aldehyde 63b) was obtained in 
25% yield as a 3:1 mixture of anti:syn diastereomers, which were separable 
following TMS-ether hydrolysis at a later stage in the synthesis of 63b.  
The structural similarity of the aldehyde isomers 63 allowed pursuit of an identical 
endgame strategy for completion of the simplified disorazoles 60 (Scheme 1.11c). 




C(6)–C(17) fragments 62/63 was accomplished using a Wittig olefination, which 
proceeded in high yield (>75%) for both aldehyde precursors. Selective TMS 
deprotection followed by ester hydrolysis gave the hydroxyacids 61 in good yield. 
Cyclodimerisation of the fragments 61 with MNBA
32
 proceeded in manageable 
yields of 18 and 26%. Completion of the disorazoles 60 was achieved by treatment of 
the TBS-protected derivatives 71 with HF in MeCN. 
 
1.3.3 (–)-CP2-Disorazole C1 (Wipf, 2011) 
 
Scheme 1.12 Retrosynthesis of (–)-CP2-disorazole C1 72.
33 
The Wipf group followed up their total synthesis of disorazole C1 with the synthesis 
of a disorazole C1 analogue 72, in which the central C(9)–C(10) alkene unit of 
disorazole C1 was replaced with a cyclopropane moiety.
33
 Aside from the 
cyclopropane group being a common isostere of the double bond,
34
 this moiety was 
intended to mimic the shape of the epoxide functionality present in disorazole A1 and 
other epoxide-containing analogues and probe for reactivity of the epoxide in the 
binding site. For this reason, the stereochemistry of the cyclopropane group was 
chosen such that it matched that present in disorazole A1.  
The retrosynthesis of (–)-CP2-disorazole C1 72 (Scheme 1.12) was not far removed 
from that used by Wipf in the synthesis of disorazole C1, in that it involved four key 
retrosynthetic disconnections that centred around two important and reliable types of 
reaction. Esterification/lactonisation was anticipated for formation of the C(1)–C(14) 


































80a R = CH2OPMB













81a P = TES, R = Me












TBS-protected (–)-CP2-disorazole C1 79
j
77 P = TES














74a R = CH2OPMB (7 steps, 16% yield)















































Reagents and conditions: Synthesis of the monomer 78 and attempted dilactonisation: (a) (i) 75, KHMDS, THF,   
–78 °C, 30 min; (ii) 74b, 0 °C, 24 h, 84%; (b) PPTS, MeOH, 0 °C, 23 h, 65%; Synthesis of (–)-CP2-disorazole C1 72: 
(c) LiOH, THF/H2O, rt, 20 h, quant; (d) 78, DCC, DMAP, rt, 22 h, 89%; (e) DDQ, DCM/phosphate buffer, 1.5 h, 81%; 
(f) Dess–Martin periodinane, NaHCO3, DCM, 0 °C, 6.5 h, 99%; (g) (i) 75, KHMDS, THF, –78 °C, 30 min; (ii) 80b,              
–78 to 0 °C, 17 h, 74%; (h) PPTS, MeOH, 23.5 h, 63%; (i) Ba(OH)2, THF/H2O, rt, 26 h; (j) MNBA, Et3N, DMAP, 
PhMe, rt, 29 h, 55%; (k) HF•Py, THF, 0 °C to rt, 22 h, 64%. 
Scheme 1.13 Endgame strategy towards the synthesis of (–)-CP2-disorazole C1. 
double bonds, as opposed to reliance on transition metal catalysis which 
understandably could not be so predictably relied upon given the alkyl substitution at 
C(11)–C(12). Initially, a dilactonisation was anticipated with the monomer 73, 
although this was later revised to a stepwise approach akin to that used for the 
synthesis of the natural product. The fragments required for both of these routes 
included the C(1)–C(11) oxazole 74 and the C(12)–C(19) Wittig reagent 75. 
The C(1)–C(11) oxazole PMB-ether 74a and its aldehyde derivative 74b were 




from the easily accessed aldehyde 76 (Scheme 1.13a). A Wittig olefination of the 
aldehyde 74b with the C(12)–C(19) fragment Wittig reagent 75 [which was 
synthesised from (E)-crotonaldehyde 16 in 20% yield over 12 steps; Scheme 1.13a] 
proceeded in good yield to give the C(1)–C(19) monomer 78. Unfortunately, 
attempted dimerisation [with the C(1)-carboxylic acid derivative of 78, monomer 73] 
to give the protected disorazole C1 analogue 79 failed, and therefore a stepwise 
approach was investigated. 
The stepwise route was performed in the vein of that seen in Wipf’s disorazole C1 
total synthesis: the monomer 78 was esterified with the C(1)-carboxylic acid 
derivative of 74a to give the ‘three-quarter’ disorazole 80a. Two-stage conversion of 
the PMB-ether 80a to the aldehyde 80b followed by a second Wittig reaction 
furnished the protected disorazole C1 seco-ester 81a. Selective TES deprotection 
followed by ester hydrolysis, and lactonisation of the seco-acid 81b thus obtained 
gave the protected disorazole C1 analogue 79. A final TBS deprotection with 
HF•pyridine completed the synthesis of (–)-CP2-disorazole C1 72 in 1.1% yield and 
23 steps longest linear sequence.  
It is worth noting that the final deprotection step was remarkably efficient, giving the 
product 72 in 64% yield. This stands up very well against previous efforts whereby 
comparably diminished yields were typical, and shows the effect of removing the 
conjugation associated with the unsaturated C(7)–C(12) unit can have over the 
success of silyl deprotection steps (cf. Meyers’ and Kalesse’s syntheses, Section 
1.2.2, Scheme 1.4 and Section 1.3.2, Scheme 1.11, respectively). It also implies that 
greater than expected success might be obtained in (silyl) deprotection of                   
C(11)–C(12)-epoxide-based natural product derivatives, should a suitably mild set of 
conditions compatible with epoxides be found for generation of the required 
macrocycle. This is because the epoxide functionality interferes with the conjugation 







1.4 Structure–Activity Relationships in the Disorazoles 
All studies carried out towards the synthesis of disorazole C1 and related analogues 
were followed up with biological testing, and an examination of the cytotoxic 
potency of the various disorazoles allows determination of the SARs that may be 
present within the family of natural products. Table 1.1 indicates the level of 
cytotoxicity (IC50 or EC50) of a range of disorazoles (in descending order of potency) 
against cancer cell lines, along with a broad statement describing the difference in 
chemical structure on comparison to the structure of disorazole C1. The disorazoles 
in Figure 1.5 (to which Table 1.1 refers) were either naturally obtained, are 
synthetic analogues or (in the case of disorazoles 82 and 83) were obtained by 
methanolysis of disorazole A1.
35
 
As can be seen from Table 1.1 Entry 1, the most potent variant is disorazole E1 7, 
followed by disorazoles D1 5 and A1 2 (Table 1.1, Entries 2 and 3).
3,5
 All three 
structures contain the divinyl epoxide (or -diol) moiety, which suggests that these 
isosteres give the most potent cytotoxicity. However, given that disorazoles D1 and 
A1 show almost equipotent activity, a diol at the C(9)–C(10) position may be 
sufficient for high potency; and indeed the methanolysis product KOS 1903 82 
(Table 1.1, Entry 5) – which is effectively a monomethylated disorazole D1 analogue 
– still shows activity at sub-nanomolar concentrations.
35 
After the C(9)–C(10) epoxide and diol containing disorazoles, disorazole Z 11 is the 
most potent analogue (Table 1.1, Entry 4).
2b
 This is particularly interesting, because 
it lacks both a C(9)–C(10) epoxide/diol and a C(5)–C(6) methylenemethoxy group; 
although like the most potent disorazoles, at least one triene framework exists in 
conjugation with the oxazole. Kalesse’s (Z,E,E)-simplified disorazole 60a is also 
highly potent (Table 1.1, Entry 6),
29
 however, the stereochemistry at C(9)–C(10) is 
important, because the (E,E,E)-triene configured simplified disorazole 60b (Table 
1.1, Entry 10) is some 46 times less potent than this analogue.
29
 These data imply 
that high activity can be achieved without the epoxide or diol moiety, but that the 
double bond configurations in the triene are very important. The increased activity of 
disorazole Z 11 over disorazole 60a probably relates to the presence of the C(13) 


















1 E1 7 — 0.09 (5) Two C(9)–C(10) epoxides; one C(6) 
OCH3 group absent. 
 
5 




3 A1 2 0.012 (12) 
 




4 Z 11 0.40 (1) — No C(5)–C(6) CH2OCH3 groups. Has 
an ester at C(15) and C(15′). 
 
2b 
5 KOS 1903  
82 




6 (Z,E,E)  
60a 




7 C1 1 1.66 (10) 14.6 (1) Dimeric. No epoxides or diols within 
the double bond framework. 
 
4 
8 KOS 2296  
83 
6.20 (5) — One triene disrupted; OCH3 at C(7), 
and OH group at C(10). 
 
35 
9 (–)-CP2  
72 




10 (E,E,E)  
60b 






— 3912 (1) C(9)–C(10) olefin replaced with an 


















13 Cyclopropyl  
54 




14 Diketone  
58 
— >5000 (1) C(16) OH groups replaced with 
carbonyl (ketone) groups. 
 
26b 
15 C(16)-Methyl  
52 
— >5000 (1) C(16)–C(19) propenyl alcohol removed 




Structures are shown in Figure 1.5; 
b
Refers to the average IC50 or EC50 obtained when tested over a number of 
cancer cell lines (non-cancer cell line values have been omitted from calculation). 
c
IC50 and EC50 measure the drug 
concentrations at which 50% cell growth inhibition is achieved, and the concentration of the drug required to cause  
50% cell death, respectively; 
d
The number of cell lines to which the IC50 or EC50 value refers is indicated in 
parentheses; 
e
In some cases, nanomolar concentrations (nmol/dm
3
) were calculated from the corresponding drug 































disorazole A1 2 [A–B = epoxide, X–Y = (Z)-HC=CH] (0.012, 0.27 nM)
disorazole D1 5 [A–B = 1,2-diol, X–Y = (Z)-HC=CH] (0.24 nM)













































































disorazole Z 11 [R = CO2Me, (Z)-C(9)–C(10)] (0.04 nM)
(Z,E,E)-simplified disorazole 60a [R = Me, (Z)-C(9)–C(10)] (0.96 nM)














C(9)–C(10) tetradehydro-disorazole C1 29 (3912 nM)
10
9
cyclopropyl 54 [A–B = cyclopropyl, X–Y = (Z)-HC=CH] (>5000 nM)










Figure 1.5 Biologically tested disorazole structural variants and analogues (potencies are 




potent than its synthetic analogue. 
Disorazole C1 (Table 1.1, Entry 7) is the next most potent disorazole, displaying an 
IC50 of 1.66 nM
4a
 and an EC50 of 14.6 nM.
4b
 Compared to most of the more potent 
variants, disorazole C1 lacks oxygen functionality within its two triene systems, and 
has methoxy groups at C(6). Conjugation of the olefin system with the heterocycle is 
no longer present, and it could be argued that this to some extent decreases activity 
and therefore the removal of the methoxy group in favour of conjugation with the 
oxazole is likely to augment activity. However, it should be noted that the methoxy 
group probably reduces triene lability, because Graham’s efforts to synthesise the 
desmethoxy analogue 57 were met with great difficulty;
26b
 and therefore the group 
may be required to maintain structural stability.  
After disorazole C1, the methanolysis product KOS 2296 83 is the most potent 
(Table 1.1, Entry 8).
35
 Notably, the conjugation within one ‘half’ of the disorazole 
has been completely abolished, and this perhaps has implications for binding activity 
to the natural product’s target. Wipf’s (–)-CP2-disorazole C1 analogue 72 (which, 
incidentally, also lacks triene conjugation) is approximately 21 times less potent than 
disorazole C1 (Table 1.1, Entry 9),
33
 and therefore this information indicates that a 
cyclopropane group at C(9)–C(10) is not a good isostere for the olefin or the epoxide. 
After the (E,E,E)-simplified disorazole 60b (Table 1.1, Entry 10),
29
 cytotoxicity 
rapidly declines towards micromolar levels of potency: tetradehydro-disorazole C1 
29 (Table 1.1, Entry 11) displays an EC50 of approximately 4 µM, whilst the 
saturated alkyl analogue 59 (Table 1.1, Entry 12) has an even higher EC50 value           
(>5 µM).
26b
 These two changes in particular are representative of large changes in 
disorazole conformation,
4b
 and therefore highlight the importance of the                     
three-dimensional structure on the activity of the disorazoles. The remaining 
disorazoles (Table 1.1, Entries 13 to 15) also showed potency greater than 5 µM.
26b
 
These data are important, because they identify moieties of the disorazoles which are 
of critical importance with respect to bioactivity: the C(17)–C(18) olefin of 





A summary of the above discussion is shown in Figure 1.6. As can be seen from 
Figure 1.6, variations in structure with respect to disorazole C1 mainly include 
modifications to the polyene system and changes to the C(15)–C(19) group, while 
removal of the C(5)–C(6) methylenemethoxy group and the C(15) methyl group are 
apparent in a range of the natural disorazoles and disorazole Z. A change to the 
identity of the C(2)–C(4) heterocycle has never been explored, and it is the 
modification of this group that the Hulme group wishes to achieve. In addition, 
replacement of the methoxy group with an alternative functionality, save for its 
removal, has never been investigated. These modifications have been reflected in our 






Figure 1.6 Summary of SARs in the disorazole family. Numerical values refer to the increase 
or decrease in cytotoxic potency observed when compared to disorazole C1. 
 
1.5 The Hulme Group Strategy towards the Synthesis of Disorazole C1 
Although the synthesis of disorazole C1 1 and a variety of analogues has been 
achieved previously, the most direct route – which requires a dilactonisation reaction 
– has often been unsuccessful, low yielding (typically less than 30% yield) and in 
some cases lacks chemoselectivity. Furthermore, the synthetic sequences are 
generally long (~20 steps longest linear sequence) and the approach relies on 
protecting group strategies owing to the multiple hydroxyl groups present in the 
synthetic intermediates. Our strategy towards the synthesis of disorazole C1 1 focuses  
Removal tolerated with 
triene–oxazole conjugation, 
but desmethoxy analogues 
are unstable 
Essential 




Replacement with a methyl 
ester likely to increase activity 
Two C(9)–C(10) epoxides greatly increases activity (~168×) 
Single epoxide or diol increases activity (~51 to 61×) 
Cyclopropane decreases activity (~0.05×) 
Essential 
Methyl isostere inactive 
Polyene essential 
(E,E,Z)-triene most potent (~1.7×) 
 
Less potent: 
Unconjugated triene (~0.27×) 
(E,E,Z)-triene (~0.04×) 






Scheme 1.14 The Hulme group strategy towards the synthesis of disorazole C1. 
on a novel Evans–Tishchenko/alkyne metathesis
36,37
 (ET–AM) approach towards the 
synthesis of the large-ring dilactone (Scheme 1.14). We believe that this 
methodology will be higher yielding, and more atom-economical than previous 
efforts due to reduced reliance on protecting groups; and more chemoselective 
because of the avoidance of lactonisation protocols. We also believe that this will 
allow access to a number of disorazole C1 heterocyclic analogues Het-1, which have 
not as yet been synthesised. 
Our retrosynthesis of disorazole C1 1 (Scheme 1.14) requires the synthesis of the      
C(9)–C(10)/C(9′)–C(10′) dialkynyl macrocyclic dilactone 29, from which it is 
already known that the natural product can be derived.
26
 The synthesis of the 
disorazole precursor 29 will be achieved through use of an alkyne                                 
cross-metathesis/ring-closing alkyne metathesis dimerisation
38
 (ACM–RCAM) 
reaction between two C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol monoesters 84 to 
generate the C(9)–C(10)/C(9′)–C(10′) alkyne bonds. An ET reaction between the 
C(1)–C(9) oxazolyl aldehyde 85 and the C(10)–C(19) β-hydroxyketone 86, will 
permit the generation of the key C(1)–C(9)/C(10′)–C(19′) bis-alkyne intermediate 84 
in a highly diastereoselective fashion (Scheme 1.14).  





Scheme 1.15 Adaptation of the ET–AM approach towards the synthesis of heterocyclic 
analogues Het-1, C(6)-amino (‘N’) analogue 87 and ‘mixed’ C(6)-amino/hetereocyclic 
analogues Het-87 (ox. = 2,5-oxazole cf. structures from Scheme 1.14). 
 
be achieved through synthesis of C(1)–C(9) aldehydes Het-85 derived from 
alternative heterocycles, thus providing novel heterocyclic disorazole C1 analogues 
for future SAR studies (Scheme 1.15). Similarly, elaboration the C(6)-amino              
C(1)–C(9) analogue 89 will permit the synthesis of a C(6)-amino disorazole analogue 
87, and mixed C(6)-amino/heterocyclic variants Het-87 thereof (Scheme 1.15). In 
order to investigate our ET–AM approach, the syntheses of the aldehyde 85 and                               
β-hydroxyketone 86 fragments, is required.  
 
1.6 Thesis Overview and Research Aims 
The Hulme group approach towards the total synthesis of disorazole C1 and its 
analogues revolves around the implementation of an ET–AM sequence to generate 
the disorazole C1 macrocyclic scaffold 29, from which it is known that the natural 
product can be accessed. As was also alluded to, it is likely that this method may be 
readily applied to the synthesis of C(6) analogues whereby the C(6) methoxy group 
is replaced by an alternative methylated heteroatom; and hetereocyclic analogues 
whereby the C(2)–C(4) oxazole is replaced with an alternative heterocycle.  
So far in our efforts towards the synthesis of disorazole C1, the Hulme group has 
successfully developed a reliable route towards the preparation of the C(1)–C(9) 
fragment 85, and therefore an obvious step forward would be to assess the viability 
of synthesising analogues. Towards this end, the first research chapter (Chapter 2) 





Scheme 1.16 Overview of the work described in Chapters 2 to 5 (Results and Discussion). 
bears a methylamino group at the C(6) position as opposed to the methoxy group 
present in the natural product (Scheme 1.16a).  
Perhaps more important than achieving analogue syntheses, however, is the synthesis 
of the C(10)–C(19) β-hydroxyketone fragment of disorazole C1 86. A route to the 
synthesis of 86 has so far remained elusive, and it is critical that a reliable means of 
preparing this key intermediate is devised. Accordingly, the two subsequent chapters 
address research efforts towards the synthesis of the C(10)–C(19) fragment 86 in 
both a convergent (Chapter 3) and linear (Chapter 4) sense (Scheme 1.16b). 
Following on from the synthesis of the C(10)–C(19) fragment 86, it was predicted 
that an ET reaction between this fragment and various C(1)–C(9) heterocyclic 
aldehydes Het-85 would permit the synthesis of C(1)–C(9)/C(10′)–C(19′) 1,3-anti 
diol monoester bis-alkynes Het-84 for investigations into the generation of the                
alkyne-masked disorazole macrocycle 29 via an ACM–RCAM dimerisation reaction. 
Chapter 5 discusses the synthesis of a number of model heterocyclic aldehydes, and 
their reactivity under ET coupling conditions with the C(10)–C(19) fragment; and 
presents the strategy that was used towards the synthesis of (an O-protected variant 
P-84 of) the key C(1)–C(9)/C(10′)–C(19′) bis-alkyne 84. 
Chapter 6 presents the results of some preliminary ACM–RCAM reactions (as 
performed by other members of the Hulme group) along with concluding remarks 
and a brief discussion of the future direction required to be explored towards the 




Chapter 2      Results and Discussion 1 
Studies towards the Synthesis of a C(6)-Amino Analogue of 
the C(1)–C(9) Fragment of  Disorazole C1 
2.1 Overview, Previous Work and Retrosynthesis 
Although removal of the C(6) methoxy group from synthetic intermediates led to 
difficulty in synthesising a C(6)-desmethoxy analogue (see: Chapter 1, Section 
1.3.1), no studies exist that explore the synthesis or biological activity of other           
C(6)-heteroatom analogues. The most obvious modification involves exchange of the 
methoxy group with an alternative functionality, such a methylamino group; and 
replacement of the methoxy group with this functionality was the basis of the 
synthesis discussed in the current chapter.  
It is important, prior to a discussion of the synthesis of potential analogues, to discuss 
previous syntheses of the ‘natural’ disorazole C1 C(1)–C(9) aldehyde fragment 85. 
The foundations for the synthesis of this fragment were laid by Niblock, a former 
PhD student in the Hulme group.
16 
Although a route to the optically pure fragment 85 
was not established in her studies, the racemic C(1)–C(9) fragment (±)-85 was 
successfully synthesised via a highly convergent approach which centred around a 
lateral lithiation
39
 of the 2-methyloxazole 91, followed by reaction with aldehyde 92 
in order to generate the C(1)–C(9) alcohol (±)-93 (Scheme 2.1a). The proposed 
lithiation/carbonyl addition reaction was achieved in 40% yield (Scheme 2.1a), and 
elaboration of the alcohol (±)-93 thus obtained to the desired fragment (±)-85 was 
then accomplished in three steps: alcohol (±)-93 was C(6)-O-methylated, the C(1) 
MOM group was cleaved under acidic conditions, and the free alcohol thus revealed 
was oxidised using Dess–Martin periodinane (Scheme 2.1a). The overall sequence 
furnished the fragment (±)-85 in 9 steps longest linear sequence and 1.6% yield 
(Scheme 2.1a). Unfortunately, problems associated with poor overall yield and the 
difficulties associated with handling the volatile aldehyde 92 discouraged the 
development of an asymmetric variant of a route commencing from 92, and instead 
an alternative approach was pursued. 
Niblock’s most promising route to the enantiopure C(1)–C(9) fragment 85 revolved 
around activation of the oxazole 94 2-position followed by reaction with the 




Reagents and conditions: Synthesis of the racemic C(1)–C(9) fragment (±)-85: (a) (i) 91 
n
BuLi, THF, –78 °C, 45 
min; (ii) Et2NH, 45 min; (iii) 92, 45 min, 40%; (b) MeI, NaH, THF, 0 °C to rt, 18 h, 29%; (c) HCl, MeOH, rt, 18 h, 74%; 
(d) Dess–Martin periodinane, NaHCO3, DCM, 0 °C, 2 h, 43%; Synthesis of the C(5)–C(9) tosylate 95: (e) TsCl, Py, 0 
°C to rt, quant; (f) DOWEX-H
+
, MeOH, rt, 18 h, 87%; (g) 4-methoxybenzaldehyde dimethyl acetal, TsOH•H2O, DMF, 
rt, 18 h, 80%; (h) DIBAL, DCM, –78 °C, 1 h, quant; (i) MeI, Ag2O, MeCN, 60 °C, 18 h, 85%; (j) DDQ, DCM/H2O, 30 
min, rt, 79%; (k) Dess–Martin periodinane, NaHCO3, DCM, rt, 2 h; (l) CrCl2, CHI3, dioxane/THF, rt, 18 h, 45% (2 
steps), 5:1 E:Z; (m) (i) 1-propynylmagnesium bromide, ZnCl2, PhMe, rt, 15 min; (ii) 101, PdCl2(PPh3)2, rt, 18 h, 85%; 
Synthesis of heterocyclic C(1)–C(9) analogues 102/103: (n) Ethyl pyrazole-4-carboxylate, K2CO3, DMF, rt, 48 h, 
58%; (o) (i) NaN3, DMSO, reflux, 2 h; (ii) Methyl propiolate, CuSO4, sodium ascorbate, TBTA, 
t
BuOH/H2O, rt, 18 h, 
58% (2 steps). 
Scheme 2.1 Niblock’s work on the synthesis of the C(1)–C(9) fragment and analogues: (a) 
synthesis of the racemic C(1)–C(9) fragment (±)-85; (b) retrosynthesis of the enantiopure 




C(5)–C(9) tosylate 95 or iodide 96 (Scheme 2.1b). Synthesis of the key tosylate 95 
(Scheme 2.1c) commenced with O-tosylation of the commercially available alcohol 
97 followed by acetonide hydrolysis and reprotection of the diol as its PMP-acetal 
98. DIBAL reduction selectively (and somewhat surprisingly) gave the secondary 
alcohol 99, which was O-methylated, and the primary alcohol deprotected to yield 
alcohol 100. Dess–Martin oxidation, Takai olefination
40
 and Negishi coupling
41
 
completed the synthesis of the tosylate 95 as a 5:1 mixture of E:Z stereoisomers in 9 
steps and 18% yield overall (Scheme 2.1c). Although all attempts to achieve 
coupling between the oxazole 94 and tosylate 95 (or its iodide derivative 96) under 
lithiation/nucleophilic substitution or C–H activation/C–C cross-coupling
42
 
conditions were unsuccessful, tosylate 95 would allow the synthesis of two 
analogues 102/103 as their C(1) ester derivatives by nucleophilic substitution 
Results and Discussion 1 
34 
 
(pyrazole 102), and two-stage elaboration via the CuAAC reaction
43
 (triazole 103; 
Scheme 2.1d). 
Concurrent with the work described herein, Ramstadius, a former postdoctoral 
researcher in the Hulme group, completed the synthesis of the C(1)–C(9) oxazole 
ester 110 (Scheme 2.2).
44
 A revised preparation of tosylate 95 was devised from                    
D-mannitol bis-acetonide 104, which was converted to aldehyde 105 using a sodium 
periodate-mediated diol cleavage. Seyferth–Gilbert alkynylation of 105 with the 
Ohira–Bestmann reagent
45
 and acidic hydrolysis of the volatile product gave alkynyl 
diol 106. Hydrostannylation of the alkyne, followed by iododestannylation
46
 then 
gave vinyl iodide 107 as a single (E)-stereoisomer (>40:1 E:Z). Negishi coupling, 





 and a final O-methylation completed the synthesis of tosylate 95 
in 8 steps and 14% yield overall (Scheme 2.2). 
From this key intermediate 95, a standard cyanide displacement afforded the nitrile 
108, which was hydrolysed to give carboxylic acid 109. Synthesis of the oxazole was 
completed by condensation of acid 109 with serine methyl ester and subsequent 
cyclodehydration, giving oxazole methyl ester 110 in 5 steps and 39% yield from 
tosylate 95 (Scheme 2.2). From ester 110, aldehyde 85 (for ET coupling) and acid 
111 (for esterification) can be derived; semi-reduction of ester 110 to aldehyde 85 
has yet to be accomplished, but synthesis of acid 111 was achieved by base  
 
Reagents and conditions: (a) (i) NaIO4, NaHCO3, DCM/H2O, 0 °C, 2.5 h; (ii) MgSO4, 40 min, 87%; (b)                       
Ohira–Bestmann reagent, K2CO3, MeOH, 0 °C to rt, 17 h; (c) HCl, Et2O/MeOH/THF, rt, 6.25 h, 66% (2 steps); (d) 
n
Bu3SnH, PhCl2(PPh3)2, Et2O, –30 °C, 30 min, 60%; (e) I2, Et2O, 0 °C, 5 min, 92%; (f) (i) 1-propynylmagnesium 
bromide, ZnCl2, THF, 0 °C 15 min; (ii) 107, PdCl2(PPh3)2, 25 h; (g) TsCl, 
n
Bu2SnO, Et3N, DCM, 0°C, absence of 
light, 60% (2 steps); (h) Me3OBF4, proton sponge, DCM, rt, 140 min, 76%; (i) KCN, NaHCO3, TBAI, 60 to 70°C, 4 h, 
83%; (j) H2O2, LiOH, EtOH/H2O, rt, 34 h, 75%; (k) L-serine methyl ester hydrochloride, HBTU, DIPEA, MeCN, 0 °C 
to rt, 82%; (l) (i) XtalFluor, DCM, –78 °C, 30 min; (ii) K2CO3, –78 to 0 °C, 40 min; (m) BrCCl3, DBU, DCM, –15 °C to 
rt, 5 h, 76% (2 steps); (n) LiOH, THF/H2O, rt, 8 h, 96%.  
Scheme 2.2 Ramstadius’ route towards the synthesis of the C(1)–C(9) oxazole ester 110.
44 
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hydrolysis of 110 (Scheme 2.2). 
Ramstadius achieved the synthesis of the C(5)–C(9) tosylate 95 using a seven-step 
sequence, but he had initially anticipated the synthesis of this fragment via a more 
direct means (Scheme 2.3a).
44
 His retrosynthesis had envisaged that a Wittig 
reaction between the aldehyde 105 and the phosphonium ylide generated from the 
propargylic phosphonium salt 113, followed by acetonide deprotection would furnish 
the key diol 112; selective tosylation and methylation of 112 would then afford the 
C(1)–C(9) tosylate 95 (Scheme 2.3a). For the synthesis of a C(6)-amino analogue 
114 of the C(5)–C(9) tosylate 95, it was anticipated that a similar set of 
transformations could be carried out with Garner’s aldehyde 116,
48
 which bears 
obvious structural similarities to glyceraldehyde acetonide 105.  
Thus, our retrosynthesis for the preparation of C(6)-amino C(1)–C(9) fragments of 
disorazole C1 is as follows: a Wittig reaction with Garner’s aldehyde 116 and 
subsequent oxazolidine deprotection would be used to install the C(7)–C(9) enyne 
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Scheme 2.3 (a) Ramstadius’ early retrosynthesis of the C(5)–C(9) tosylate 95 for synthesis 
of the natural [C(6)-methoxy] disorazole C(1)–C(9) fragment and heterocyclic analogues. (b) 
Retrosynthesis of a C(6)-methylamino C(5)–C(9) tosylate analogue 114; and (c) synthesis of           
C(6)-amino C(1)–C(9) analogues 117/Het-117 and the synthesis of disorazole C1 analogues 
87/Het-87. 
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then complete the synthesis of the N-protected C(6)-amino C(5)–C(9) fragment 
analogue 114 (Scheme 2.3b). Elaboration of this structure to heterocyclic derivatives 
using similar methodologies to those used with the ‘natural’ C(5)–C(9) tosylate 95 
(Schemes 2.1d and 2.2)
16,44
 would then permit the synthesis of N-protected             
C(6)-amino C(1)–C(9) fragment analogues 117/Het-117. Subsequent application of 
our ET–AM methodology gives access to C(6)-amino disorazole analogues 87 or 
Het-87 (Scheme 2.3c). 
 
2.2 Synthesis of the 1,3-Enyne Garner Aldehyde Derivative (126) 
2.2.1 Direct Synthesis Using a Propargylic Phosphonium Salt 
Our retrosynthesis (Scheme 2.3b) relied upon the synthesis of a 1,3-enyne derivative 
of Garner’s aldehyde 116, and it was anticipated that this could be synthesised 
directly using a Wittig reaction between Garner’s aldehyde and a Wittig reagent 
derived from a propargylic phosphonium salt 113. Erdsack and Krause
49
 used 
Garner’s aldehyde ent-116 as a substrate for an enyne-forming Wittig reaction in 
their efforts towards the synthesis of (+)-furanomycin 120 derivatives, and 
successfully generated (E)-enynyl Garner aldehyde derivatives 119 in good yield (62 
to 68%) and with good (E)-selectivity (~9:1 E:Z, Scheme 2.4). Their protocol 
involved reaction of the propargylphosphonium salts 118 with KHMDS in THF, 
followed by reaction of the phosphorane thus generated with aldehyde ent-116 at      
–78 °C; this protocol would provide the basis for our synthesis of the enyne 126. 
The (S)-enantiomer of Garner’s aldehyde 116 was synthesised in 4 steps and 64% 
yield overall from D-serine, according to literature procedure (Scheme 2.5a).
50
 
Phosphonium salt 113 was prepared from 2-butyn-1-ol 124 by bromination
51
 and  
 









Reagents and conditions: (a) SOCl2 (1.3 eq), MeOH, 0 °C to rt, 18 h, 94%; (b) Boc2O (1.2 eq), Et3N (2.5 eq), 
DCM, 0 °C to rt, 16 h, 76%; (c) 2,2-dimethoxypropane (15 eq), TsOH•H2O (10 mol%), DCM, 0 °C to rt, 16 h, 95%; 
(d) DIBAL (1.7 eq), PhMe/hexane (~2:1), –78 °C, 3h, 94%; (e) PBr3 (0.4 eq), Py (0.1 eq), Et2O, –30 °C to reflux, 2.5 
h, 73%; (f) PPh3 (1.0 eq), PhMe, 70 °C, 24 h, 90%; (g) 113 (2.5 eq), NaHMDS (2.5 eq), THF, –78 °C, 4 h, 49%, ~5:1 
E:Z 
Scheme 2.5 Preparation of (a) Garner’s aldehyde 116; and (b) propargyl phosphonium salt 
113. (c) Reaction of Garner’s aldehyde 116 with the phosphonium ylide derived from 
phosphonium salt 113 to generate 1,3-enyne Garner aldehyde derivative 126. 
 
subsequent reaction of the volatile propargylic bromide 125 thus obtained with PPh3 
(Scheme 2.5b).
16
 KHMDS was then added to the phosphonium salt 113 to generate 
the required phosphonium ylide, and a THF solution of the aldehyde 116 was added 
at –78 °C, according to conditions reported by Erdsack and Krause.
49
 After 6 h at the 
same temperature, aqueous workup and flash chromatography gave, disappointingly, 
only a 5:1 ratio of inseparable (E/Z)-stereoisomers 126 in poor yield (37%). 
In an attempt to increase the yield and stereoselectivity, the use of an an alternative 
base was investigated. NaHMDS seemed to be a good choice because a previous 
study had reported only the isolation of (E)-enynes on use of this base,
52
 and the use 
of an HMDS base does not deviate far from that used in the successful enyne 
syntheses from Garner’s aldehyde as reported previously.
49
 Unfortunately, NaHMDS 
gave the same level of stereoselectivity (~5:1 E:Z), albeit with a marginal 
improvement in isolated yield (49%, Scheme 2.5c). Although perhaps premature 
given the narrow range of conditions screened, the one-step route to the synthesis of 
the product 126 was abandoned because yields were poor and more importantly, the 
stereoisomers were not readily separable by flash chromatography which implied 
that even modest stereoselectivity improvements would lead to an impure product. 
This decision was also in-part a consequence of comparative advancement in an 
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alternative two-step methodology (discussed vide infra); and because the results 
obtained with Wittig salt 113 were consistently poor in both Ramstadius’ work 
towards the synthesis of the C(1)–C(9) fragment,
44
 and work described herein 
towards the synthesis of the C(10)–C(19) fragment (see: Chapter 4, Section 4.3.1).  
 
2.2.2 Indirect Synthesis 
Having quickly identified problems using a direct Wittig approach, we embarked 
upon a two-stage route towards the incorporation of the C(7)–C(9) (E)-enyne through 
generation of a vinyl iodide derivative of Garner’s aldehyde, followed by Negishi 
coupling. Fortunately, literature preparations exist for the vinyl iodide 127, which 
either require a single step from Garner’s aldehyde using the Takai olefination 
(Approach A, Scheme 2.6a);
53
 or hydrostannylation and iododestannylation
54
 of the 
known alkyne 129,
54–56
 potentially generating the iodide in three steps (Approach B, 
Scheme 2.6a). Although the latter approach, on inspection, would appear to be 
appreciably more laborious (requiring four steps overall), synthesis of alkynes using 
the Ohira–Bestmann reagent 128 can be carried out in one pot from esters,
56
 and the 











































Approach A (two steps to 126)












Scheme 2.6 Proposed synthesis of the 1,3-enyne 126, commencing from aldehyde 116, 
using (a) a two-stage Takai olefination/Negishi coupling sequence (Approach A); or a 
hydrostannylation/iododestannylation of alkyne 129 followed by Negishi coupling (Approach 
B). (b) Potential streamlining of Approach B using a one-pot route to alkyne 129 from ester 
123 followed by one-pot hydrostannylation/iododestannylation/Negishi coupling. 





 Furthermore, alkyne hydrometallation procedures (or analogous 
organoreductive processes) can be performed in one pot with palladium-mediated 
cross-coupling
58
 and so the transformation might be achieved with same number of 
purification steps as the Takai olefination, would avoid the use of toxic CrCl2, and 
would provide an interesting entry into multistep one-pot syntheses (Scheme 2.6b).
 
 
2.2.2.1 Approach A: Takai Olefination 
The synthesis of the antipode of the vinyl iodide 127 using anhydrous CrCl2 is 
reported by Taylor et al.,
53b
 but a detailed procedure is not described. Thus, screening 
was commenced by the reaction of aldehyde 116 with a large excess
59
 of CHI3 and 
CrCl2 in THF.
60
 These conditions led to a 37% isolated yield of 127 as a single         
(E)-stereoisomer after chromatography, which improved marginally (to 45%) on 
scale-up (~1.5 g; Table 2.1, Entry 1). It is worth noting that flame drying of the 
CrCl2 was essential, because failure to do so led to complete inhibition of reaction 
under otherwise air- and moisture-free conditions. Given that the yield was 
somewhat low, it would perhaps be worth investigating changes in temperature, 
solvent, or reagent stoichiometry, but for reasons described below, a more rigorous 
optimisation using commercially obtained CrCl2 was not performed.  
For reasons of cost, we wished to adapt the procedure in order to generate the active 
species from the comparatively inexpensive CrCl3. Two protocols were investigated 
towards this end, and these involved generation of CrCl2 by the in situ reduction of 
anhydrous CrCl3 with (i) zinc
53a
 (Scheme 2.7a); and (ii) LiAlH4
61
 (Scheme 2.7b). 






















1 CrCl2 18 — — 6 45 >99:1 
2 CrCl3 10 Zn 6 6 0
 
— 
3 CrCl3•6H2O 20 LiAlH4 8 6 33 >99:1 
a





As determined by 
1
H NMR analysis of the purified product. 
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2CrCl3 + Zn 2CrCl2 + ZnCl2
4CrCl3 + LiAlH4 4CrCl2 + LiCl + AlCl3 + 2H2
CrCl3 6H2O CrCl3 4H2O














Scheme 2.7 Reduction of anhydrous CrCl3 with (a) zinc; and (b) LiAlH4. (c) Thermal 




Attempted Takai olefination by way of using zinc for the generation of CrCl2 (by 
pre-heating of anhydrous CrCl3 in vacuo at 100 °C with zinc powder),
53a
 followed by 
addition of the aldehyde 116 and CHI3 in THF proved to be unsuccessful, and none 
of the desired product was isolated following flash chromatography (Table 2.1, 
Entry 2). This was surprising considering Augé et al.
53a
 employed this method with 
Garner’s aldehyde, albeit obtaining only moderate yield (56%) and stereoselectivity 
(4:1 E:Z). In retrospect, the most likely explanation probably relates to the purity of 
the zinc powder, which may have partially oxidised and despite using an excess 
[relative to the CrCl3] to account for this possibility, no attempts were made to 
activate it.
62
 It is therefore possible that repetition of the reaction with pre-activation 
of the zinc may give positive results. 
The alternative and ultimately most cost-effective Takai olefination for the synthesis 
of the vinyl iodide 127 involved using CrCl2 generated from CrCl3 by reduction with 
LiAlH4 (Table 2.1, Entry 3).
61
 CrCl3•6H2O was first dehydrated by heating under 
high-vacuum (~10 Torr, 120 to 250 °C, ~1 h), with the course of the reaction easily 
followed according to the colour of the solid (Scheme 2.7c).
53a
 The CrCl3 thus 
obtained was cooled (0 °C), suspended in THF, and reacted with LiAlH4 (~2 h). 
After addition of CHI3 and Garner’s aldehyde 116 and overnight stirring in the 
absence of light, aqueous workup and flash chromatography gave the product 127 in 
33% yield as a single (E)-stereoisomer (Table 2.1, Entry 3).  
Although poor yielding, the main advantage of this protocol is that the most 
inexpensive form of the chromium chlorides is used alongside the cheap LiAlH4 
reductant. The scale of the reaction is however, limited: large excesses are used, 
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requiring large solvent volumes and additional safety precautions, and the reaction 
mixture can coagulate at the reduction stage, thus necessitating brief mechanical 
stirring. Purification also occasionally required a second chromatographic step to 
remove residual CHI3. Nevertheless, the yield was reproducible and only slightly 
diminished compared to that obtained using commercially purchased anhydrous 
CrCl2 with no loss of stereoselectivity, and thus represented the best option for the 
synthesis of the vinyl iodide 127 via the Takai reaction. 
 
2.2.2.2 Approach B: Hydrostannylation/Iododestannylation 
 
Reagents and conditions: (b) Bu3SnH (1.3 eq), PdCl2(PPh3)2 (5 mol%), Et2O, –30 °C, 30 min, 60%; (b) I2 (1.3 eq), 
Et2O, ultrasound, 5 min, 92%. 
Scheme 2.8 Hydrostannylation/iododestannylation of alkyne 106 in Ramstadius’ synthesis of 
the C(1)–C(9) fragment of disorazole C1.
44 
 
Despite successfully obtaining the vinyl iodide 127, the disadvantages outlined above 
merited an investigation into alternative olefination procedures. In parallel with the 
studies discussed herein, marked progress was being made towards the synthesis of 
vinyl iodide 107 – a key intermediate in the synthesis of the natural disorazole C1 
C(1)–C(9) fragment; and the optimal conditions for generating this compound called 
for the hydrostannylation/iododestannylation an alkyne precursor 106 (Scheme 
2.8).
44
 Thus, to potentially improve the protocol for the synthesis of vinyl iodide 127, 
and, furthermore, for reasons of complementarity between the two synthetic routes, it 
seemed sensible to briefly investigate hydrostannylation/iododestannylation.  
To prepare the alkyne 129, Garner’s aldehyde 116 was reacted overnight with the 
Ohira–Bestmann reagent (1.4 eq) in MeOH using K2CO3 (2.0 eq) as the base.
55
 
Unfortunately, these conditions gave only a 45% yield of the product, and an 
increase in the stoichiometry of the reagents led to only a marginal improvement 
(50% yield; Scheme 2.9a). An alternative approach from Garner’s ester 123 was 
therefore investigated according to work by Hinkle et al.,
56
 who successfully 
synthesised alkyne 129 in 71% yield in a one-pot procedure using a DIBAL  




Reagents and conditions: (a) 128 (4.1 eq), K2CO3 (10 eq), MeOH, 18 h, 50%; (b) (i) DIBAL (1.7 eq), 
PhMe/Hexane (1:1), –78 °C, 3 h; (ii) MeOH (124 eq), –78 to 0 °C; (c) 128 (2.7 eq), K2CO3 (6.0 eq), 
PhMe/Hexane/MeOH (~1:1:5), 0 °C to rt, 18 h, 32% (2 steps, one pot). 
Scheme 2.9 (a) Reaction of Garner’s aldehyde 116 with the Ohira–Bestmann Reagent 128; 
(b) attempted one-pot DIBAL reduction/alkynylation of Garner’s ester 123. 
 
reduction/Seyferth–Gilbert homologation. In hope of improving the yield in the 
current study, the one-pot method was attempted; that is, Garner’s ester 123 was 
treated with DIBAL at –78 °C, followed by quenching and dilution with MeOH and 
addition of the Ohira–Bestmann reagent 128 and K2CO3 at 0 °C. However, after 
overnight stirring; quenching, workup and flash chromatography indicated that this 
modified Seyferth–Gilbert alkynylation protocol had also been poorly efficient, 
because only a 32% yield of the alkyne 129 was obtained. The reason for this 
diminished yield in comparison to the literature value could perhaps be attributed to 
inefficient quenching of the ester–DIBAL complex generated in situ leading to poor 
conversion of the ester to the intermediate aldehyde 116, the latter of which is 
required for formation of the alkyne. Alternatively, the result (and indeed the 
previous, single-step results) may have been detrimentally influenced by the low 
purity of the Ohira–Bestmann reagent 128, which was later determined by 
1
H NMR 
to be only of 67% purity and contaminated with residual tosyl azide and dimethyl             
2-oxopropylphosphonate and from preparation; future experiments should aim to 
ensure that a higher purity reagent is used.
63
 
Nevertheless, these reactions provided sufficient quantities of material to progress to 
the next stage of the synthetic route towards vinyl iodide 127, and alkyne 129 was 
submitted to hydrostannylation/iododestannylation conditions. Reaction of alkyne 
129 with 
n
Bu3SnH under PdCl2(PPh3)2 catalysis (1 mol%) at –30 °C (to form the 
intermediate stannane 131), followed by the addition of I2 to the reaction mixture 
(Scheme 2.10) gave the desired vinyl iodide 127 as a single (E)-stereoisomer in 39% 
yield. Although not far removed from that obtained by Ramstadius (55%, 2 steps),
44
 
this yield was somewhat disappointing; and because the yield for the route towards 
vinyl iodide 127 from the alkyne 129 was comparable to that obtained for the direct  




Reagents and conditions: (a) 
n
Bu3SnH (2.0 eq), PdCl2(PPh3)2 (1 mol%), THF, –30 °C, 1 h; (b) I2 (2.2 eq), THF,       
–30 °C to rt, 1 h, 39% (2 steps, one-pot), E:Z >99:1. 
Scheme 2.10 One-pot hydrostannylation/iododestannylation of Garner alkyne 129. 
Takai iodo-olefination of aldehyde 116, and offered no advantage with respect to the 
number of steps, no further efforts to optimise the reaction sequence were taken. As 
such, the single-step Takai olefination was deemed the best route towards the 
synthesis of vinyl iodide 127, and a Negishi coupling would complete the installation 
of the key (E)-enyne moiety of the C(1)–C(9) fragment analogue. 
 
2.2.2.3 Completion of the C(7)–C(9) (E)-Enyne Moiety 
Negishi coupling of the vinyl iodide 127 to generate the enyne 126 (Scheme 2.11) 
was performed according to the established procedure,
41
 which involves 
transmetallation of an organomagnesium or -lithium reagent with a zinc dihalide 
followed by reaction of the organozinc reagent thus generated with the organohalide 
substrate in the presence of catalytic palladium. Thus, freshly vacuum-dried ZnCl2 
was reacted with 1-propynylmagnesium bromide at 0 °C in THF with subsequent 
addition of the vinyl iodide 127 and PdCl2(PPh3)2. Reaction at room temperature for 
2 h gave an 89% yield of the product 126, and concluded the installation of the   
C(7)–C(9) (E)-enyne and thus the synthesis of the required C(5)–C(9) 1,3-enyne 
Garner aldehyde derivative 126. 
A one-pot iodination/Negishi coupling from alkyne 129 was also investigated, as 
previously alluded to (see: Section 2.2.2). Initially, iodination conditions from 
Scheme 2.10 were applied with an increased catalyst loading (5 mol%) to ensure 
 
Reagents and conditions: (i) 1-propynylmagnesium bromide (4.0 eq), ZnCl2 (4.4 eq), THF, 0 °C, 30 min; (ii) 127, 
PdCl2(PPh3)2 (5 mol%), 0 °C to rt, 2 h, 89%. 
Scheme 2.11 Negishi coupling of vinyl iodide 127 to generate the enyne 126. 




Reagents and conditions: (a) (i) 
n
Bu3SnH (2.0 eq), PdCl2(PPh3)2 (1 mol%), THF, –30 °C, 1 h; (ii) I2 (2.2 eq), –30 °C 
to rt, 1 h; (iii) Na2S2O3 (6.0 eq), 0 °C, 20 min; (b) 1-propynylzinc chloride (5.0 eq), PdCl2(PPh3)2 (5 mol%), THF, 0 °C 
to rt, 18 h, 126 0%, 127 50%. 
Scheme 2.12 Attempted one-pot hydrostannylation/iododestannylation/Negishi coupling. 
active palladium (0) species remained for cross-coupling. Freshly prepared                      
1-propynylzinc chloride was then added and the mixture was stirred overnight. 
Unfortunately, none of the product 126 was detected by 
1
H NMR of the crude 
material. Speculating that residual I2 in the reaction mixture had poisoned the active 
catalyst,
64
 solid Na2S2O3 was added in an attempt to quench residual I2 after 
iododestannylation; and the addition of the catalyst was staggered (1 mol% for 
hydrostannylation, 5 mol% for Negishi coupling) to account for any loss of activity. 
However, these modifications had no influence over the results, and iodide 127 was 
the only product isolated (50%) on purification (Scheme 2.12). No further work was 
done to optimise this one-pot procedure, and instead efforts were focussed towards 
completion of the fragment. 
 
2.3 Oxazolidine Deprotection and O-Tosylation 
2.3.1 Overview, Deprotection and Approach A: Direct O-Tosylation 
With the best route towards the synthesis of the (E)-enyne 126 identified as a Takai 
olefination and Negishi coupling, steps towards the completion of the tosylate 114 
could be taken. This was anticipated to be straightforward: deprotection of the 
oxazolidine would reveal the key amino alcohol 115, which would undergo              
O-tosylation and N-methylation to complete the C(5)–C(9) analogue tosylate 114 
(Approach A, Scheme 2.13). Any problems relating to reactivity of the amine with 
the leaving group during N-alkylation could be allieviated by protection of the 
hydroxyl group (to give, for example, TBS-ether 133) followed by N-methylation, 
deprotection, and O-tosylation (Approach B, Scheme 2.13).  
Deprotection of the oxazolidine initially invoked the use of the sulfonic acid-based  




Scheme 2.13 Proposed protecting group-free synthesis of tosylate 114 (Approach A); and 




 according to the protocol reported by Bittmann,
66
 which 
seemed an attractive option because the procedure is operationally simple and 
purification involves only filtration, removal of the solvent, and chromatography. 
However, use of this reagent (Table 2.2, Entry 1) led to only a 23% yield of the 
product 115. Unfortunately, the fate of the remainder of the material is not clear, 
because no starting material was recovered, and a crude NMR spectrum was not 
recorded. It is very likely however that concomitant Boc deprotection occurred, 
leading to either irreversible substrate–resin (amine–sulfonic acid) binding; or the 
isolation of an ammonium salt that was too polar to elute on silica gel.
67
 
Deprotection using the more standard reagent PPTS (20 mol%) in MeOH at reflux 
led to an improved but only moderate yield (52%; Table 2.2, Entry 2). Increasing the  




















 MeOH 25 48 23 
2 PPTS 0.2 MeOH 70 18 52
e 
3 PPTS 0.5 MeOH 70 18 63 
4 PPTS 0.5 EtOH 83 48 nd 




Isolated yield unless otherwise stated; 
b
Yields determined by 
1
H NMR of the crude material are indicated in 
parentheses; 
c
Run was performed using a 5:1 E:Z mixture of 126 stereoisomers; 
d
1 g per 100 mg 126 was 
used cf. Ref. 66; 
e
74% BORSM (30% recovery of 126); 
f
Isolated yield obtained on scale-up. 
 




Scheme 2.14 Mechanism of CuCl2•2H2O-mediated deprotection of the oxazolidine moiety. 
loading of PPTS gave only 63% yield (Table 2.2, Entry 3), while changing the 
solvent to EtOH and heating to a higher temperature also led to incomplete reaction 
according to TLC (Table 2.2, Entry 4, yield not determined). However, a third 
change of reagent to CuCl2•2H2O
68
 led to quantitative conversion to the desired 
amino alcohol 115 and would prove be the procedure of choice for scaling up (~2 g), 
where an 87% isolated yield was realised (Table 2.2, Entry 5).  
The mechanism of the reaction (Scheme 2.14)
69
 is likely to involve CuCl2 acting as a 
Lewis acid and coordinating to the oxygen atom of 126. Displacement of an H2O 
ligand by the oxazolidine oxygen atom is followed by hydrolysis of the intermediate 
iminium ion Int-134 and proton transfer, thus generating the product 115 and acetone 
as a byproduct. The liberation of acetone would mean that the reverse reaction is less 
facile, and explains the inferior yields obtained with PPTS, whereby MeOH is the 
primary nucleophile (as opposed to H2O) and dimethoxypropane – which is more 
reactive than acetone in condensation reactions – would be the side product. 
Having revealed the free alcohol and carbamate nitrogen atom, an O-tosylation 
followed by N-methylation would complete the key C(5)–C(9) analogue fragment 
114. Tosylation was initially attempted by the reaction of the alcohol 115 with TsCl 
(1.05 eq) and pyridine (2.00 eq) in DCM at room temperature, but this led to only a 
13% conversion to the product 132 by 
1
H NMR, which was identified in the crude 
spectrum according to the appearance of a (-n additional) CH3 peak at δ = 2.48 ppm 
and aryl CH peaks at δ = 7.82–7.79 and 7.39–7.36 ppm. However, a slight increase 
in TsCl stoichiometry and the use of pyridine as the solvent led to 63% conversion  




Reagents and conditions: TsCl (1.2 eq), Py (25 eq), 0 °C to rt, 18 h, 47%. 
Scheme 2.15 O-Tosylation of amino alcohol 115. 
and represented a marked improvement. 
Unfortunately, although the tosylate product 135 was subsequently isolated in 47% 
yield (Scheme 2.15), it underwent rapid decomposition,
70
 which precluded a full 
characterisation. This instability rendered the direct approach (Approach A) towards 
the synthesis of the C(5)–C(9) fragment analogue 114 impractical on the basis of the 
storage and handling difficulties associated with its precursor 132; and probably 
impossible, given that tosylate 132 would most likely be unstable to the basic 
conditions required for N-methylation. As a result, efforts were focussed towards our 
alternative approach (Approach B, Scheme 2.13), which would involve the 
installation of a C(5) hydroxyl protecting group followed by N-methylation, hydroxyl 
deprotection and C(5) O-tosylation. 
 
2.3.2 Approach B: Protected Alcohol Approach 
In order to investigate Approach B, the free alcohol (which could be used either 
chromatographically pure or telescoped directly from the previous deprotection step) 
was first protected as its TBS-ether under standard TBSCl protection conditions 
(imidazole, DMF) which gave the product in 96% yield following overnight stirring 
(Scheme 2.16). The choice of solvent proved to be an important factor in the success 
of the reaction, because the use of DCM led to a sluggish and capricious conversion 
to the desired product 135.
71
 
N-Methylation of 135 was effected using large excesses of NaH and MeI in a 10:1  
 
Reagents and conditions: (a) TBSCl (1.5 eq), Im (3.0 eq), DMF, rt, 18 h, 96%; (b) MeI (20 eq), NaH (6.0 eq), 
THF/DMF (10:1), 35 °C, 18 h, quant; (c) TBAF (1.5 eq), THF, rt, 30 min, 93%. 
Scheme 2.16 Synthesis of the C(5)–C(9) alcohol 136 via O-TBS protection, N-methylation 
and silyl deprotection. 





 at 35 °C to give, after 18 h, the product 133 in quantitative 
yield (Scheme 2.16). The conditions, although somewhat harsh, were found to be a 
requirement, because reaction under the same conditions of solvent and reagent 
loading at room temperature led to incomplete reaction, even after two days (68% 
conversion by 
1
H NMR); while reaction at room temperature with reduced reagent 
stoichiometry (NaH, 1.3 eq; MeI, 10 eq) in the absence of the DMF co-solvent led 
only to 7% conversion. It is worth noting that achieving a high conversion was 
particularly important in this step, because the product and starting material have 
close TLC Rf values on silica, and so purification is simplified. Following                
N-methylation, the free alcohol was revealed by silyl deprotection with TBAF in 
THF, which proceeded rapidly (30 min) in 93% yield and concluded the synthesis of 
the key precursor 136 for the generation of the C(5)–C(9) tosylate (Scheme 2.16). 
 
2.3.3 Attempted Tosylation of the C(5)–C(9) Alcohol (136) 
Reaction of the primary alcohol 136 to give the C(5)–C(9) analogue tosylate 114 was 
expected to proceed smoothly using standard tosylation conditions, which typically 
involve the use of TsCl and (usually) an auxiliary amine base. Unfortunately and – at 
the time – rather unexpectedly, after investigating a number of conditions, the only 
product identified was oxazolidinone 137, which was generally obtained in modest to 
quantitative yield (as determined by 
1
H NMR spectroscopy; Table 2.3). Believing at 
the time that a competing intramolecular cyclisation by attack of the alcohol on the 
carbonyl group was occurring (later refuted vide infra), in an attempt to force the 
intermolecular reaction, screening conditions were carried out which involved using 
large and modest excesses of pyridine (Table 2.3, Entries 1 to 3); pre-generation of 
the active pyridinium sulfonylating species prior addition of the alcohol 136 (Table 
2.3, Entry 4);
 
the use of a vast excess of TsCl and a second base (DMAP; which it 
was thought may force addition rather than cyclisation, Table 2.3, Entry 5); and use 
of the alternative bases Et3N, and imidazole (Table 2.3, Entries 7 and 8). Application 
of conditions involving the use of 4-pyrrolidinopyridine (4-PPy) – which was used in 
the only published example of tosylation of a β-N-Boc-N-methylamino alcohol
73a
 – 
was also attempted; but this too proved futile, and led only to the conversion of the 
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1 1.1 Py 120 — — Base 18 0 — 
2 2.0 Py 120 — — Base 18 23 0:100 
3 1.5 Py 12 — — Base 18 100 0:100 
4
c
 1.1 Py 12 — — Base 48 Trace nd 
5 10 Py 120 DMAP 1.0 Base 1.5 55 0:100 
6 10 Py 120 DMAP 2.0 Base 1.5 100 0:100 
7
d
 3.0 Et3N 6.0 — — DCM 22 100 0:100 
8
d
 6.0 Im 12 — — DMF 72 Trace nd 
9 1.1 Py 9.1 4-PPy 0.1 DCM 18 17 0:100 
a
“Base” indicates that the base used in the reaction was also the solvent; 
b
As determined by 
1
H NMR of the 
crude material; 
c
TsCl was pre-activated by addition to boiling pyridine and cooling to 0 °C; 
d
Reagent quantities 
started with up to 50% of the stated value but were increased after 18 h due to a lack of reactivity (TLC analysis) 
 
starting material 136 to the cyclised product 137 in poor yield (Table 2.3, Entry 9). 
Because the synthesis of the tosylate ester 114 was not possible under the conditions 
screened, the use of alternative leaving groups was briefly investigated. Attempted 
conversion of the alcohol 136 to the 2-nitrobenzenesulfonate ester was initially 
chosen because the reagent sulfonyl chloride (NsCl) was expected to be more 
electrophilic than TsCl (and hence more reactive with the alcohol 136), but at least 
equally effective as a substrate for subsequent nucleophilic substitution reactions. 
Hence, synthesis of the nosylate ester 138 was attempted using similar conditions as 
shown in Table 2.3, Entry 6 (with NsCl in place of TsCl); but like attempted 
generation of the tosylate 114, these conditions led only to the formation of the 
oxazolidine 137 product as determined by examination of the crude 
1
H NMR 
spectrum (Scheme 2.17a). Conversion of the alcohol 136 under Appel conditions
74
 
to the iodide 139 was also investigated, but as with the tosylate and nosylate esters, 
this gave quantitative conversion (NMR) to the cyclised product 137, with an 
isolated yield of 70% (Scheme 2.17b). 
Before investigating the use of alternative leaving groups any further, we felt it was 
necessary to examine the viability of installing any group at this position under basic 


























Reagents and conditions: (a) NsCl (10 eq), DMAP (2.0 eq), Py (120 eq), 0 °C to rt, 18 h, 138 0%, 137 quant 
conv.; (b) I2 (6.0 eq), PPh3 (6.0 eq), Im (12 eq), MeCN, 0 °C to reflux, 18 h, absence of light, 139 0%, 137 70%; (c) 
TBSCl (1.5 eq), Im (3.0 eq), DMF, rt, 18 h, 133 89%, 137 0%. 
Scheme 2.17 Attempted (a) nosylation; (b) iodination; and (c) silylation of alcohol 136. 
conditions, because it was unclear whether the failure to install the leaving group was 
due to: (i) preferential reaction of the alcohol with the neighbouring (Boc) carbonyl 
group in a 5-exo-trig type cyclisation, rather than intermolecular reaction with the 
somewhat sterically hindered electrophiles; or (ii) formation of the product tosylate, 
nosylate or iodide, which reacts further to form the oxazolidinone 137 in a 5-exo-tet 
fashion. To investigate this, we attempted to reprotect the alcohol 136 as its               
TBS-ether using conditions as previously employed in the synthesis of its 
demethylated precursor 135 (see: Scheme 2.16). Remarkably, TBS protection of this 
alcohol 136 was achieved in excellent yield (89%, Scheme 2.17c) with no side 
product observed. 
On the basis of these results, rather than proceeding via the 5-exo-trig type 
cyclisation (Scheme 2.18a) as initially speculated, the mechanism of the reaction
75
 
(Scheme 2.18b) is likely to involve initial formation of the tosylate, nosylate or 
iodide, followed by cyclisation by displacement of the leaving group by the 
carbamate oxygen atom in a 5-exo-tet manner. Base abstraction of a proton from the 
tert-butyl group of the cationic intermediate Int-140 would then liberate the 
oxazolidinone 137 and the byproduct isobutylene 141. The rate determining step in 
the reaction must be the formation of the leaving group, with the cyclisation 
comparatively rapid, because none of the desired products were observed by NMR 
spectroscopy, even in reactions which did not proceed to completion. The product 
sulfonate ester or iodide must therefore be consumed immediately after formation, 
making isolation of the desired synthetic intermediate impossible in this study. 




Scheme 2.18 (a) Single-step; and (b) two-step
75
 mechanisms for the formation of the 
oxazolidinone 137 from the alcohol 136. 
 
It is unfortunate that the conversion of the alcohol 136 to a suitable C(5)–C(9) 
analogue electrophile could not be achieved. In hindsight it is perhaps unsurprising, 
because although a small number of studies indicate that installation of a leaving 
group at an oxygen atom which neighbours an N-alkylated-N-Boc amine is 
plausible,
73
 there also exists literature precedent for similar cyclisations of                      
2-N-Boc-amino tosylates on treatment with amine bases;
75
 and indeed Lee et al.
75a
 
took advantage of this reaction in a one-pot synthesis of oxazolidinones from 
alcohols using TsCl and MsCl. Therefore conditions which involve the use of the 
free alcohol as an alkylating agent, such as the Mitsunobu reaction,
76
 could be 
performed, and may provide some success in the synthesis of C(1)–C(9) heterocyclic 
analogues.
77
 However, to keep the synthetic route concordant with the synthesis of 
the natural disorazole C1 C(5)–C(9) side chain, attention was instead focussed on the 
use of an alternative nitrogen protecting group. 
 
2.4. Alteration of the C(6) N-Protecting Group 
2.4.1 Synthesis of the N-Protected C(5)–C(9) Amino Alcohols 
Owing to its high electron-withdrawing capacity and inert nature, we believed that        
N-tosylation would provide a means of stifling (or at least slowing down) deleterious 
side reactions of the nitrogen atom (cf. Section 2.3.1) or the protecting group (cf. 
Section 2.3.3) with a newly installed leaving group.
78
 However, since our endgame 
strategy may require deprotection of a PMB-ether following RCAM cyclisation (see: 
Chapter 5, Section 5.1.4 for a full synopsis, or Section 2.5.1 for a brief summary), it 
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Scheme 2.19 Strategy for replacing the Boc group with alternative N-protecting groups. 
was preferred that the Boc group be exchanged for a PMB group, because this would 
allow global deprotection at the latter stages of the natural product synthesis, thus 
shortening the synthetic sequence and simplifying deprotection. Therefore, although 
perhaps somewhat ambitious given the previous problems of leaving group lability, 
PMB protection was investigated as a primary objective.  
Rather than attempt to repeat the synthesis of the new C(6)-N-protected C(5)–C(9) 
alcohols from the appropriate N-protected analogue of Garner’s aldehyde, it was 
decided that the best strategy would be to alter the protecting group from an 
advanced synthetic intermediate already available. A suitable substrate for this 
purpose was carbamate 133, from which amine 142 could be derived by selective 
deprotection of the Boc group and subsequent submission of the product to various 
N-protection conditions. Silyl deprotection would then yield N-protected amino 
alcohols 145/146 whereby the alcohol could be converted to a leaving group 
(Scheme 2.19).  
Because standard acidic Boc deprotection conditions could diminish the yield of the 
desired amine owing to the potential for the concomitant silyl cleavage, deprotection 
was attempted using TMSOTf/2,6-lutidine.
79
 To our delight, amine 142 was obtained 
in 92% yield under these conditions (Scheme 2.20). This transformation is highly 
favourable because it is entropically driven as a result of gas formation. The 
mechanism (Scheme 2.21) involves a transesterification of the tert-butyl group with 
with the TMS group, which is initiated by reaction of the carbonyl oxygen with the 
TMSOTf followed by abstraction of a proton from the cationic intermediate Int-147 
by 2,6-lutidine. To generate the final product 142, the nitrogen atom of Int-148 is 
 
Reagents and conditions: TMSOTf (3.0 eq), 2,6-lutidine (3.5 eq), DCM, 0 °C, 45 min, 92%. 
Scheme 2.20 Boc deprotection of the carbamate 133 to form amine 142. 




Scheme 2.21 Mechanism of the TMSOTf/2,6-lutidine–mediated Boc deprotection of 133.
80
 
protonated by the 2,6-lutidinium triflate 149 thus generated, and the cation Int-150 
undergoes decarboxylation with concomitant regeneration of TMSOTf.
80 
It is worth noting that removal of residual 2,6-lutidine by evaporation is essential to 
obtain the product in high purity, because the product amine co-elutes with the 
auxiliary base on silica using both EtOAc/hexane and DCM/MeOH eluents. In 
hindsight 2,6-lutidine was a poor (albeit standard) choice of base, and should this 
procedure be repeated, an alternative base should be sought which is either of lower 
boiling point and thus more easily removed (e.g. Et3N), or more polar such that 
purity of the product product is less easily compromised by coelution on silica gel 
(e.g. imidazole). 
Subsequent steps required N-Ts and N-PMB protection. Tosylation was achieved 
straightforwardly by reaction of the amine 142 with TsCl, Et3N and catalytic DMAP 
in DCM to give the product sulfonamide 143 in 85% yield (Scheme 2.22). N-PMB 
protection by use of NaH in conjunction with catalytic TBAI was initially attempted 
at room temperature with a modest (Table 2.4, Entry 1) and large (Table 2.4, Entry 
2) excess of PMBCl, but both conditions led to unsatisfactory yields of the desired 
 
Reagents and conditions: TsCl (1.5 eq), Et3N (3.0 eq), DMAP (11 mol%), DCM, rt, 18 h, 85%. 
Scheme 2.22 Tosylation of the amine 142. 
Results and Discussion 1 
54 
 





















1 1.2 NaH 1.1 20 DMF 25 48 29 
2 5.0 NaH 2.0 20 DMF 25
 
18 Trace 
3 2.0 NaH 2.0 20 THF/DMF (10:1) 72 18 22 
4 1.2 K2CO3 2.2 20 THF 72 18 68 
5 1.4 K2CO3 2.5 23 THF 72 48 91 
a




product 144; while elevated temperature also gave poor results (Table 2.4, Entry 3). 
Since all three conditions (Table 2.4, Entries 1 to 3) involved pre-generation of a 
sodium amide (by stirring of the amine 142 with NaH for 1 h at 0 °C before addition 
of PMBCl), it was speculated that this intermediate formed on reaction at room 
temperature was unstable, and so NaH was replaced with K2CO3 and the mixture was 
heated to reflux in THF (Table 2.4, Entries 4 and 5). Gratifyingly, the yield of the 
product 144 greatly increased, albeit requiring 2 days of reaction for isolated yields 
close to quantitative levels (Table 2.4. Entry 5). 
With both O-TBS-protected N-Ts- and N-PMB-derived C(5)–C(9) analogue 
frameworks 143/144 synthesised, the final step toward the alcohols required for the 
installation of a leaving group would involve deprotection of the silyl groups. This 
was easily achieved in both cases by reaction of the silyl ethers 143/144 with TBAF 
in THF, followed by quenching with aqueous NH4Cl (Scheme 2.23), which 
concluded the synthesis of the required alcohols 145/146. 
 
Reagents and conditions: (a) TBAF (6.0 eq), 0 °C, 1 h; 94%; (b) TBAF (6.0 eq), 0 °C to rt, 1 h, quant. 
Scheme 2.23 Silyl deprotection of (a) β-N-Ts silyl ether 143 and (b) β-N-PMB silyl ether 144. 
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2.4.2 Completion of the C(6)-Amino C(5)–C(9) Fragment Analogue 
Having successfully achieved the synthesis of both the N-Ts- and N-PMB-derived 
amino alcohols 145/146, the final step involved conversion of the primary alcohol to 
a leaving group. Because the macrocyclic dialkynyl dilactone disorazole precursor 41 
has been shown previously to be stable to standard PMB deprotection
26
 (see: 
Chapter 1, Section 1.2.4), the preferred outcome involved the installation of a C(5) 
leaving group on the N-PMB-protected amino alcohol 146. Unfortunately, efforts to 
convert alcohol 146 to a C(5)–C(9) electrophile 151 with this substrate were on the 
whole, unsuccessful, and are summarised in Table 2.5. Tosylation of the primary 
alcohol 146 using Et3N (with or without DMAP) or pyridine/DMAP led to no 
reaction of the substrate with the TsCl and the recovery of the starting material 
(Table 2.5, Entries 1 to 3). The only exception was in the case whereby heating was 
applied, where a complex mixture of components (as observed by 
1
H NMR) was 
obtained after aqueous workup (Table 2.5, Entry 4). Results were similar on 
attempted mesylation of the alcohol 146 with MsCl in DCM (Table 2.5, Entries 5 to 
9), or upon utilising Appel conditions to convert the primary alcohol 146 to an alkyl  






















1 OTs 1.2 Et3N 14.3 0 Base 0 to 25 18 NR 
2 OTs 2.0 Et3N 14.3 20 Base 0 to 25 18 NR 
3 OTs 2.0 Py 11.0 100 Base 0 to 25 18 NR 
4 OTs 2.0 Et3N 14.3 20 Base 95 1 cm 
5 OMs 4.0 DIPEA 10.0 0 DCM 25 4 NR 
6 OMs 4.0 Et3N 10.0 0 DCM 25 4 NR 
7 OMs 10 Et3N 35.8 20 DCM 0 to 25 18 cm 
8 OMs 4.0 Et3N 35.8 20 DCM 0 to 25 2.5 cm 
9 OMs 2.0 Et3N 35.8 20 DCM 0 to 25 3 cm 
10 Br 1.3 — — 0 DCM 0 to 25 18 cm 
11 I 3.0 Im 6.0 0 THF/MeCN
d
 0 to 25 18 cm 
a
Values in parentheses indicate the reagent used for the generation of group X: OTs (TsCl), OMs (MsCl), Br 
(CBr4/PPh3, 1:1), I (I2/PPh3, 1:1); 
b





H NMR of the crude material; 
d
Ratio THF:MeCN, 3:1. 
 




Scheme 2.24 Mechanism for potential formation of aziridinium salts 152 from PMB-protected 
amino alcohol derivatives 151. 
 
bromide (Table 2.5, Entry 10) or iodide (Table 2.5, Entry 11). In these cases, the 
substrate either failed to react (Table 2.5, Entries 5 and 6), or led only to the 
formation of a complex mixture of products (Table 2.5, Entries 7 to 11) after 
aqueous workup and subsequent analysis of the crude 
1
H NMR spectrum. 
Although purification of the material would perhaps provide insight into the reasons 
for the failure of the reaction, this was not attempted for number of reasons. Firstly, it 
was hoped and expected that such a reaction, in particular tosylation and mesylation 
would proceed unperturbed and therefore failure to do so cleanly in at least moderate 
conversion (~40%) was deemed unacceptable for such a theoretically straightforward 
transformation. Secondly, the reactions were typically performed with only a small 
quantity of material (typically ~20 mg) which would make isolation and 
characterisation of the multiple products in the mixtures particularly difficult. The 
most likely reason for failure of the reactions attempted in Table 2.5, on the basis of 
precedent,
81
 would involve the nucleophilic substitution of the leaving group thus 
formed by the adjacent nitrogen atom, giving rise to the aziridinium salts 152 
(Scheme 2.24). However, since the reactions consistently gave complex mixtures 
whereby identification of a single product was too difficult, the presence of the 
products 152 (or decomposition derivatives) was never confirmed. Such a process 
could perhaps be validated by addition of a nucleophile to the reaction mixture, but 
unfortunately this was never attempted, and efforts to install a leaving group on the 
N-PMB-protected C(5)–C(9) analogue 146 were discontinued. However, before the 
installation of a leaving group on the N-Ts-protected derivative 145 was carried out, 
two final, alternative uses of the alcohol as a precursor for heterocyclic C(1)–C(9) 
fragments were briefly explored. 
It was suggested in Section 2.3.3 that a Mitsunobu reaction with a heterocycle and a 
C(5)–C(9) alcohol could potentially bypass the requirement for derivatisation of the 
alcohol as a tosylate (or other) leaving group, and the N-PMB protected C(5)–C(9)  




Scheme 2.25 Proposed (a) Mitsunobu; and (b) condensation approaches towards the 
synthesis of the C(6)-amino disorazole C1 C(1)–C(9) analogues; and (c) synthesis of the 
carboxylic acid intermediate 154 required for the condensation approach. 
 
alcohol 146 probably represented the best substrate for testing this theory (Scheme 
2.25a). Another less convergent use of the alcohol 146 towards the synthesis of 
heterocycles would involve conversion to the carboxylic acid 154 and subsequent 
generation of the heterocycle by condensation with the methyl ester derivatives of 
serine 155 or cysteine 156, or diamine analogue 157 (or their hydrochloride salts; 
Scheme 2.25b). Synthesis of the carboxylic acid 154 would be achieved by oxidation 
of the alcohol 146 to the aldehyde 159 followed by conversion to the nitrile 160
82
 
with subsequent hydrolysis to the carboxylic acid (Scheme 2.25c).  
However, in a forward sense, both approaches were unsuccessful, because a 
Mitusunobu reaction between the alcohol 146 and the pyrazole 162 (Scheme 2.26a) 
under mild conditions (0 °C) and more forcing conditions (ultrasounic vibration)
83
 
gave only trace conversion (
1

























Reagents and conditions: (a) 162 (1.2 eq), PPh3 (1.3 eq), DIAD (1.3 eq), THF, 0 °C or ultrasonic vibration, 4 h, 
trace conv.; (b) Dess–Martin periodinane (1.3 eq), NaHCO3 (10 eq), DCM, 0 °C to rt, 3 h, 0%; 
Scheme 2.26 Attempted (a) Mitsunobu reaction between alcohol 146 and pyrazole 162; and 
(b) synthesis of aldehyde 159 by Dess–Martin oxidation of alcohol 146. 
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Dess–Martin oxidation of the alcohol to the aldehyde 159 gave only unreacted 
starting material and therefore the synthesis of nitrile 160 could not be pursued 
further (Scheme 2.26b). Unfortunately, further investigation into the optimisation of 
the Mitsunobu reaction, or use of alternative oxidation conditions optimisation of the 
Mitsunobu reaction, or use of alternative oxidation conditions could not be 
performed for reasons of time, and instead we opted to examine the use of the safer 
N-Ts-protected alcohol 145 as precursor for the synthesis of a C(5)–C(9) analogue 
side chain donor. 
Conversion of the hydroxyl group to a leaving group on the N-Ts-protected amino 
alcohol 145 was predicted to be far more straightforward than with the                            
N-PMB-protected amino alcohol 146, because the electron-withdrawing effect of the 
sulfonamide would reduce the propensity for reaction of the nitrogen atom with the 
leaving group; and indeed this proved to be the case, to at least some extent. 
Attempted tosylation of alcohol 145 with TsCl and pyridine/DMAP (to give tosylate 
163; Scheme 2.27) was however, unsuccessful, and can probably be attributed to the 
energetic demands of placing the large tosyl group in the vicinity of the sterically 
crowded β-nitrogen atom. Fortunately, conversion of the alcohol 145 to the 
methanesulfonate ester 164 (Scheme 2.27) was achieved almost quantitatively (95%) 
by treatment of the alcohol 145 in DCM with MsCl in the presence of Et3N and 
catalytic DMAP, and concluded the synthesis of a C(6)-amino C(5)–C(9) fragment 
analogue of disorazole C1.  
Time constraints and a lack of material prevented derivatisation of the mesylate ester 
164 to fully elaborated, heterocyclic C(1)–C(9) fragment analogues; however, a 
number of derivatives of the C(6)-amino C(5)–C(9) mesylate may be envisaged 
(Scheme 2.28). Azide displacement (NaN3) followed by application of the CuAAC 
reaction with a suitable alkyne (e.g. methyl propiolate), would allow the synthesis of 
 
Reagents and conditions: (a) TsCl (2.0 eq), Py (124 eq), DMAP (20 mol%), rt, 18 h, 0%; (b) MsCl (4.0 eq), Et3N 
(35.8 eq), DMAP (20 mol%), DCM, 0 °C to rt, 3.5 h, 95%. 
Scheme 2.27 Attempted C(5) O-tosylation and -mesylation of N-tosyl amino alcohol 145. 
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168 (X = O)
169 (X = S)














































155 (X = O)
156 (X = S)





Scheme 2.28 Proposed syntheses of C(6)-amino C(1)–C(9) fragment analogues using the 
C(5)–C(9) mesylate 164. 
 
a C(1)–C(9) triazole analogue 165.
16
 Synthesis of the oxazole analogue 168 would be 
achieved by cyanide substitution of the mesylate, followed by hydrolysis of the 
nitrile 166, and a final three-stage cyclodehydration of the acid 167 thus obtained 
with serine methyl ester 155;
44
 with thiazole 169 and imidazole 170 analogues made 
available through replacement of serine methyl ester in this sequence with its 
appropriate analogue 156/157. Finally, C(6)-amino C(1)–C(9) N-heterocyclic 
analogues Het-168 of oxazole 168 would be generated by application of our 
established N-alkylation conditions, which involve nucleophilic substitution of the 
leaving group with 1H-N-heterocycles in the presence of Cs2CO3 (see: Chapter 5, 
Section 5.2.5). 
 
2.5 Conclusions and Future Work 
Although the synthesis of a full C(6)-amino C(1)–C(9) analogue fragment was 
unsuccessful, we were able to generate the key C(5)–C(9) intermediate 164, which 
was achieved in 11% yield in 13 steps from D-serine; and a summary of the relevant 
synthetic transformations is shown in Scheme 2.29. Despite the low overall yield and 
long synthetic sequence, in the face of the numerous problems encountered, the 
synthesis can be considered a success and will provide access to C(6)-amino 
analogues of disorazole C1 and heterocyclic analogues thereof. The main weaknesses  




Scheme 2.29 Overall synthesis of the C(6)-amino C(5)–C(9) fragment analogue 164 of 
disorazole C1. 
 
of the synthetic route primarily revolve around: (1) the use of a low-yielding, 
inefficient Takai olefination in the stereoselective, two-stage synthesis of the             
C(5)–C(9) (E)-1,3-enyne 126; (2) the use of an N-tosyl protecting group, which will 
present difficulties at the deprotection stage; and (3) the rather large number of steps 
required for the synthesis of such a small fragment. Fortunately, being only a first 
generation synthesis of a C(6)-amino C(1)–C(9) fragment analogue, there remains 
great scope for enhancing the synthetic route. Improving the yield of the (E)-vinyl 
iodide 127 could probably be achieved by careful optimisation of the Takai 
conditions, or through use of an alternative iodo-olefination protocol, and therefore 
for reasons of brevity this aspect of the synthetic route will not be discussed in depth. 
However, the remaining two points will be addressed in the following section, along 
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2.5.1 The N-Protecting Group 
It became apparent during the key stage of installing the leaving group at the C(5) 
position of C(6)-amino C(5)–C(9) alcohols such as 136 and 146 that the nature of the 
C(6) N-protecting group was particularly important. Findings indicated that the group 
had to be sufficiently electron withdrawing to inhibit reactions of the nitrogen lone 
pair with the leaving group, but must not contain a reactive functional group which 
could eliminate the leaving group by acting as a nucleophile. On these bases, the 
most obvious remedy involved protection of the amine as a toluenesulfonamide, and 
indeed this proved to be the only successful N-protecting group used in our studies. 
Aside from potential global PMB deprotection
*
 that may have been carried out in the 
event that use of the N-PMB protecting group was successful, so far in our discussion 
nothing has been mentioned about deprotection of the N-tosyl (or N-Boc) group to 
reveal the free amine. It is (was) anticipated that this step would be carried out at one 
Het-174a (P = H)
Het-174b (P = PMB)
Het-88 (P = H)













Het-172a (P = H)













Het-175a (P = H)





























Scheme 2.30 Potential N-Ts deprotection stages. 
*The PMB-protected compounds 172b to 175b are encompassed in our strategy towards the             
C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol monoester bis-alkynes, as discussed in Chapter 5, Section 
5.1.4. In brief, it was anticipated that ET coupling of e.g. Het-171 with the C(10)–C(19) fragment 86 
would give the bis-alkyne (e.g. 172a), but that if ET coupling failed, C(1)→C(14′) esterification of 
C(1)–C(9) carboxylic acids with a C(10)–C(19) C(16)-O-protected diol fragment would provide 
contingency. C(16) O-protection may also be required to overcome incompatibilities of the AM 
catalyst with the free hydroxyl group; a PMB protecting group was chosen on the basis of precedent.26 
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of three stages: (1) following incorporation of the alkyl group into a full length,  
C(1)–C(9) heterocyclic fragment Het-171 (Scheme 2.30a); (2) following generation 
of the AM precursor bis-alkynes Het-172 by reaction of the C(1)–C(9) fragment with 
the C(10)–C(19) fragment (Scheme 2.30b); (3) following AM (Scheme 2.30c), to 
negate any problems associated with interaction of free amino group with the catalyst 
used during this reaction. Unfortunately, the disadvantage of using the tosyl group is 
the difficulty associated with its deprotection, which is normally performed by 









 or by thermal cleavage under harshly acidic 
conditions (phenol/AcOH/HBr);
84e
 and all of these modes of deprotection have some 
potential for damaging one or all of: (1) ester/lactone frameworks; (2) conjugated 
enyne systems; or (3) the integrity of heterocycles. Perhaps the most practical 
method of deprotection would involve the use of TMSCl/NaI in MeCN,
84f
 but it 
would be preferable not to rely on a single deprotection protocol because if this was 
unsuccessful, removal of the tosyl group would present a significant problem. 
Given the restrictions in the method of deprotection, the choice of the tosyl group 
was perhaps an aberration, but was nonetheless useful as it indicated that the 
sulfonamide group would allow the neighbouring alcohol to be successfully 
converted to a leaving group. However, to improve the fragment synthesis, an 
alternative sulfonamide should be chosen which would be more easily deprotected. 
The best alternatives would be the 2- or 4-nitrobenzenesulfonyl groups (Figure 2.1; 
henceforth in this chapter, Ns = 2- or 4-nitrobenzenesulfonyl), which are installed as 
straightforwardly as the tosyl group (NsCl, amine base), but are rapidly and 
selectively deprotected under mild conditions with the thiolate anion derived from 
reagents such as PhSH and mercaptoacetic acid.
85
 As such, on repetition of the          
C(5)–C(9) analogue synthesis, it would be worthwhile investigating these 
sulfonamide groups as alternative N-protecting groups. 
 
Figure 2.1 The nosyl group as a more labile alternative to the tosyl group. 
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2.5.2 Streamlining the Synthetic Pathway 
Another issue that requires to be addressed is the length of the synthetic route to the 
C(5)–C(9) analogue fragment 164, which currently stands at 13 steps and is therefore 
very atom inefficient. On examination of the points noted above in regards to 
modification of the N-protecting group, one potential method of shortening the 
sequence would be to use an N-nosyl Garner aldehyde derivative 178,
86
 which would 
be synthesised by installation of the group at the methyl ester 65 stage (Scheme 
2.31a) and would negate the requirement for Boc protection and deprotection, thus 
shortening the sequence by two synthetic steps. However, the use of the 
isopropylidene group may be unnecessary, which would shorten the sequence by a 
further two (protection/deprotection) steps (Scheme 2.31b). 
The hydroxyl group in serine methyl ester hydrochloride 65 would be protected as its 
TBS-ether, and the free amine subsequently nosyl-protected and methylated 
(Scheme 2.31b). DIBAL reduction of the resulting functionalised serine methyl ester 
derivative 179 to the aldehyde 180
87
 would give a product suitable for subsequent 
conversion to the enyne 182 via the Takai/Negishi coupling protocol; or preferably, a 
single-step method, for example (and as shown) a cobalt-mediated synthesis
88a
 from 
the zinc reagent 181 derived from 1-butynyl iodide.
88b–d
 Subsequent silyl 












































































Scheme 2.31 Alternative strategies towards the synthesis of a C(5)–C(9) fragment analogue 
via (a) the use of an N-nosyl Garner aldehyde analogue 178; and (b) avoidance of 
installation of the acetonide protecting group. (c) Alternative approach towards the synthesis 
of the N-PMB-protected fragment 146 for use in Mitsunobu reactions. 
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steps (Scheme 2.31b), which would represent a marked improvement over the 
protocol reported herein. Of course, conversion of C(6)-N-protected C(5)–C(9) 
alcohols (such as 145) to their mesylate esters could be avoided should useful 
Mitsunobu conditions be found for reaction of a C(5)–C(9) alcohol with                         
N-heterocycles (or derivative functional groups), and optimisation of Mitsunobu 
conditions to levels of conversion beyond trace quantities would certainly be worthy 
of further investigation. This would be preferably carried out with the                       
N-PMB-protected amino alcohol 146 and so the synthesis of this alcohol could 





2.5.3 Further C(6) C(1)–C(9) Fragment Analogues 
Once routes to fully elaborated C(6)-amino C(1)–C(9) fragment analogues are 
established, the synthesis of alternative C(6) analogues could be investigated. 
Perhaps the most straightforward route to such analogues would involve the use of an 
intermediate for which a synthetic route is already well established, and which would 
be readily converted to a number of functional groups at a late stage of the fragment 
synthesis; Ramstadius’ C(5)–C(9) diol intermediate 112 perhaps represents the best 
substrate for this purpose. The diol 112 would be converted to its C(5) tosylate ester 
(cf. Scheme 2.2) and the secondary alcohol would be silyl protected to give tosylate 
184 (Scheme 2.32). The heterocyclic portion of the molecule would then be 
introduced and the silyl protecting group would be cleaved to afford the secondary 












X = Cl, Br, I, OC(O)R






























Scheme 2.32 Synthesis of C(6)-functional-group analogues of the C(1)–C(9) fragment of 
disorazole C1 Het-186 from Ramstadius’ C(5)–C(9) diol intermediate 112 or ent-112.  
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reaction with a sacrificial carboxylic acid, followed by ester hydrolysis (Scheme 
2.32). With the key alcohol ent-Het-185, a Mitsunobu reaction or an alternative 
reaction that proceeds with inversion of stereochemistry such as the Appel reaction 
would provide access to a range of C(6) heteroatom or functional group analogues 
Het-186 of the C(1)–C(9) fragment (Scheme 2.32). Alternatively, this sequence 
could be performed with the antipode of Ramstadius’ diol 112, ent-112, and would 
negate the requirement for the use of the two-stage (Mitsunobu/hydrolysis) alcohol 
inversion step. Application of this Mitsunobu/Appel reaction-based methodology 
will permit expansion of the scope of the disorazole C1 analogue family. 
 
2.6 Summary 
The synthesis of a C(6)-amino C(5)–C(9) fragment analogue of disorazole C1 164 
was achieved in 13 steps and 11% yield from commercially available D-serine. The 
key steps involved a Takai olefination, starting from an inexpensive chromium 
source (CrCl3•6H2O), to selectively (>99:1 E:Z) synthesise an (E)-vinyl iodide 
derivative of Garner’s aldehyde 127; with a subsequent Negishi coupling used to 
complete the installation of the C(7)–C(9) enyne. The main problems encountered 
during the synthesis were concerned with the installation of the required C(5) leaving 
group to the C(5)–C(9) alcohol in the presence of the neighbouring C(6) nitrogen 
atom. A survey of C(6) N-protecting groups identified the tosyl group as the most 
viable option, and although N-tosyl protection did not permit the installation of our 
preferred O-tosyl leaving group, installation of an O-mesyl group proceeded 
successfully. Use of mesylate 164 will allow the synthesis of C(6)-amino C(1)–C(9) 
fragment analogues and if used successfully as part of our ET–AM methodology, 
will greatly expand the family of disorazole analogues. Aside from the completion of 
heterocyclic analogues, future work should involve identification of a more labile       
N-protecting group, optimisation of key steps and shortening of the synthetic 
sequence. As a longer-term target, synthesis of further C(6)-modified C(5)–C(9) 
analogues could be performed, and this will expand the family of disorazole C1 
analogues upon elaboration to full C(1)–C(9) analogues and use as intermediates as 




Chapter 3       Results and Discussion 2 
       Convergent Approaches towards the Synthesis of the                                             
  C(10)–C(19) Fragment of Disorazole C1 
3.1 Overview, Previous Work and Retrosynthesis 
Unlike the synthesis of the C(1)–C(9) fragment, whereby both the racemate and 
optically pure forms have been synthesised in either their C(1)-formyl or                  
C(1)-carboxylic acid form (see: Chapter 2, Section 2.1), a reliable route to either the 
C(10)–C(19) β-hydroxyketone fragment 86 itself or a suitable advanced derivative 
has yet to be established. Previous work towards the synthesis of the C(10)–C(19) 
fragment 86 was carried out by Dorgan,
90
 who, during his PhD studies within the 
Hulme group, investigated three routes towards the synthesis of this key intermediate 
(Scheme 3.1). The first route (Route A) relied on the generation of bromide 187 
from the boronate 188 following an olefin cross-metathesis (CM)
91
 reaction between 
the homoallylic alcohol 189 and vinyl boronic acid pinacol ester 190. The second 
route (Route B) required a Reformatsky reaction
92
 between bromoacyl 
oxazolidinone 192
93
 and aldehyde 193. The third route (Route C) was predicted to 
give the product 86 after Grignard addition to the Weinreb amide 194, which would 
be obtained via a Barbier reaction
94
 between aldehyde 195 and allylic bromide 196. 
In the case of Route A and Route C, the C(14) stereocentre would be introduced by 
use of an asymmetric allylation and an asymmetric Barbier addition protocol, 
 
Scheme 3.1 Dorgan’s retrosynthetic analysis of the C(10)–C(19) fragment 86.
90
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respectively; whilst Route B would take advantage of the diastereoselectivity 
provided by the use of an enantiopure amino acid-derived bromoacyl oxazolidinone 
192.  
Unfortunately, in a forward sense, all three of these approaches were unsuccessful 
(Scheme 3.2). Despite achieving the synthesis of the homoallylic alcohol (±)-189 
required for the investigation of Route A, CM with vinyl boronic acid pinacol ester 
190 was unsuccessful and therefore no product (±)-188 could be obtained for 
elaboration to the bromide derivative (±)-187 for transformation to the desired 
fragment (±)-86.
90
 Route B was unsuccessful owing to difficulties in handling and 
synthesising the aldehyde 193, which was volatile and difficult to obtain in high 
purity despite observing quantitative conversion (from alcohol 197) by 
1
H NMR 
spectroscopy. As such, this precluded attempted reaction of aldehyde 193 with either 
enantiomer of the oxazolidinone 192, thus preventing synthesis of the key               
C(10)–C(16) intermediate 191.
90
 Finally, although both coupling partners for the 
Barbier addition reaction were synthesised successfully,
90
 Route C failed owing to 
problems of regioselectivity in their combination using a Barbier addition.
95
 The 
desired α-adduct Barbier addition product (±)-194 – required for Grignard addition in 
order to complete the fragment 86 – was not obtained, and instead the γ-adduct           



































































Reagents and conditions: (a) Grubbs II, DCM, reflux, 12 h, 0%; (b) Dess–Martin periodinane, DCM, rt, 3 h, 99% 
conv.; (c) 195, 196, In, H2O, rt, 48 h, (±)-194 0%, (±)-198 22%. 
Scheme 3.2 Unsuccessful previous attempted syntheses of the C(10)–C(19) fragment.
90,95 
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the aldehyde 195 and the allylic bromide 196.
95
 As such, no advanced synthetic 
intermediate could be obtained from any of the three Routes A to C for completion 
of the C(10)–C(19) fragment 86, and a novel protocol for its generation is therefore 
still required. 
Route C in Dorgan’s retrosynthesis (Scheme 3.1) identified a potentially useful 
strategy for introducing the C(17)–C(19) propene group, which was anticipated to 
involve a Grignard addition reaction between the C(10)–C(16) Weinreb amide 194 
and 1-propenylmagnesium bromide (Scheme 3.3).
90
 Not only would this strategy 
permit the installation of the C(17)–C(19) propene group in our C(10)–(19) fragment 
86, but reaction of 194 with alternative organometallic reagents would allow access 
to a number of C(16) analogues of 86; targeting of the C(10)–C(16) Weinreb amide 
194 was therefore performed in our retrosynthestic analysis (Scheme 3.3). Synthetic 
routes to Weinreb amide 194 and thus β-hydroxyketone 86 were designed to 
encompass a range of bond disconnections, and these included: (1) an olefin                
cross-metathesis reaction between homoallylic alcohol 199 and enyne 200                  
[C(11)–C(12) disconnection, Approach A]; (2) an epoxide ring-opening route which 
would involve metallation of the vinyl bromide 202 and addition onto the epoxide 
201 [C(12)–C(13) disconnection, Approach B]; and (3) a Mukaiyama aldol reaction 
between the silyl ketene acetal 203 and the aldehyde 193 [C(14)–C(15) 

















Approach A Olefin Cross-Metathesis




































Scheme 3.3 Retrosynthetic analysis of the C(10)–C(19) β-hydroxyketone 86. 
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3.2 Approach A: Cross-Metathesis 
 
Scheme 3.4 Cross-metathesis approach towards the synthesis of the C(10)–C(19) fragment 
86. 
The first approach towards the synthesis of key Weinreb amide 194 focussed on an 
olefin cross-metathesis (CM) reaction between the C(12)–C(16) alkene 199 and the 
C(10)–C(11) enyne 200 (Scheme 3.4). Although CM with a similar homoallylic 
alcohol substrate was previously unsuccessful (See: Scheme 3.2),
90
 we were 
nonetheless interested in investigating the route owing to the perceived simplicity 
involved in synthesising the CM partners, and due to the recent advances in                
enyne–olefin CM which have indicated a preference for (Z)-selectivity in such 
reactions.
96
 Both enyne 200 and olefin (±)-199 had been synthesised previously, and 
therefore their retrosyntheses are straightforward: enyne 200 was to be synthesised 
from 3-pentyn-1-ol 205 through base elimination from tosylate 204 (Scheme 
3.5a);
16,97
 while alkene (±)-199 was to be synthesised from aldehyde 195,
90
 which 
may be derived from methyl hydroxypivalate 206 (Scheme 3.5b). The required                        
(S)-stereochemistry at C(14) would be introduced using one of a multitude of the 
asymmetric allylation methods available for the enantioselective synthesis of 
homoallylic alcohols from aldehydes.
98 
 
Scheme 3.5 Retrosynthesis of the (a) C(10)–C(11) enyne 200; and (b) C(12)–C(16) olefin 
199 for implementation of the cross-metathesis approach towards the synthesis of the 
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3.2.1 Synthesis of the C(10)–C(11) Enyne (200) 
Synthesis of the enyne 200 has been achieved previously
16,97a
 using base hydrolysis 
of the precursor tosylate 204 and subsequent fractional distillation of the volatile 
product. Thus, tosylate 204 was synthesised from 3-pentyn-1-ol 205 in excellent 
yield by reaction with TsCl in pyridine (94%; see Scheme in Table 3.1). 
Subsequently, tosylate 204 was treated with KOH (1.2 eq) in EtOH in the presence 
of a trace of detergent (as a solubilising agent) and the volatile product 200 (boiling 
point 57–59 °C)
97
 was collected over a period of 2 h. Unfortunately, use of these 
conditions (Table 3.1, Entry 1) led to a poor yield (trace), and co-elution of EtOH 
and H2O with the product as indicated by 
1
H NMR. The poor result was probably 





 column as described previously, and the restriction 
placed on the maximum reaction temperature by the use of EtOH, which boils at only 
18 to 21 °C higher than the product enyne 200.
 
To prevent solvent co-distillation, the use of higher-boiling-point solvents was 
investigated, along with the use of a larger base stoichiometry (to drive the 
apparently sluggish reaction to completion). Disappointingly, the use of 
n
BuOH 
(Table 3.1, Entry 2) gave similar results to that for EtOH, whereby the distillate was 
contaminated with the reaction solvent and H2O. The use of a 
t
BuOK/DMSO base 
and solvent system – which has also been shown to be useful in the generation of 
conjugated olefins
99
 – led to decomposition of the starting material as indicated by 
the formation of a black tarry residue and no formation of a distillate. However, more 
Table 3.1 Synthesis of enyne 200 by base elimination of tosylate 204. 
 
Reagents and conditions: (a) (i) TsCl (1.1 eq), Py (1.3 eq), 120 to 0 °C; (ii) 205, 0°C to rt, 18 h, 




















1 KOH 1.2 EtOH 78 65 2 Trace 
2 KOH 2.0 
n
BuOH 117 90 4 nd 
3 
t
BuOK 2.0 DMSO 189 120 2 0 
4 KOH 6.0 1-Octanol 195 135 4 65 
a
A trace of detergent (~2 µL per mmol 204) was added to all reactions with the exception of Entry 
3; 
b
As specified by the manufacturer; 
c
Reaction was conducted until the product ceased to distil, or 
for 2 h in cases where no product was readily collected; 
d
Isolated yield. 
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positive results were achieved through use of KOH in 1-octanol, giving the                
C(10)–C(11) enyne 200 in good yield (65%) without problems of solvent                        
co-distillation (Table 3.1, Entry 4). 
 
3.2.2 Synthesis of the C(12)–C(16) Olefin [(±)-199] 
 
Reagents and conditions: (a) (i) 
n
BuLi (6.0 eq), HNMe(OMe)•HCl (3.0 eq), –78 °C to rt, THF/hexane (1:1), 1 h; (ii) 
206, –78 °C to rt, 2 h, 95%; (b) (i) (COCl)2 (1.5 eq), DMSO (4.5 eq), DCM, –78 °C, (ii) 207, 1 h; (iii) Et3N (6.0 eq),      
–78 °C to rt, 0.5 h, 95%. 
Scheme 3.6 Synthesis of aldehyde 195 from methyl hydroxypivalate 206. 
It was envisaged that asymmetric allylation of aldehyde 195 would give the required 
enantiopure olefin 199 for CM. However, for the purpose of screening CM reactions, 
the racemate (±)-199 would be sufficient; and its precursor aldehyde 195 was 
synthesised in two steps from methyl hydroxypivalate (Scheme 3.6). Conversion of 
ester 206 to its Weinreb amide 207 was achieved in 95% yield using 3 equivalents
100
 
of the lithium amide generated by the reaction of 
n
BuLi with hydrochloride salt of                                          
N,O-dimethylhydroxylamine in THF. Subsequent Swern oxidation
101
 gave the target 
aldehyde 195 in 95% yield on a gram scale (Scheme 3.6). 
Our initial efforts towards the synthesis of (known)
90
 homoallylic alcohol (±)-199 
focussed on the use of a Barbier reaction using indium as the metal catalyst, as we 
believed that this may be easily adapted towards an enantioselective synthesis
102
 of 
the (S)-enantiomer should CM be successful. Thus, aldehyde 195 was allowed to 
react with allyl bromide in the presence of indium powder in THF. We were 
delighted to discover that the reaction proceeded to give the product (±)-199 in near 
quantitative yield (97%, Scheme 3.7). 
Because indium is somewhat expensive, use of an alternative metal in this reaction 
was investigated for reasons of cost. Malvestiti et al.
103
 report the use of tin powder 
(activated by HCl) in Barbier addition reactions, which proceed quickly (<1 h), and 
are environmentally friendly owing to the use of an (acidic or basic) aqueous solvent. 




Reagents and conditions: (a) Allyl bromide (6.0 eq), In (2.0 eq), THF, rt, 24 h, 97%; (b) (i) Sn (2.5 eq), HCl (16 
eq), H2O, rt, 45 min; (ii) 195, allyl bromide (3.7 eq), 2.5 h, 85%. 
Scheme 3.7 Alternative Barbier syntheses of the cross-metathesis precursor (±)-199. 
Thus, aldehyde 195 was added to a solution of allyl bromide and tin powder in HCl 
(1.0 M aq), which had been pre-stirred for 5 to 10 minutes. Purification of the crude 
product thus obtained gave a good yield (67%) of the C(12)–C(16) homoallylic 
alcohol (±)-199 after only 15 minutes. On scaling up (50 mg to 1 g), an improved 
yield was obtained (85%; Scheme 3.7), albeit after a reaction time of 2.5 h; probably 
as a result of the tin powder – now used in gram quantities – requiring a longer time 
period (45 min) to undergo dissolution.  
The mechanism of the reaction is likely, by analogy to that proposed by Malvestiti et 
al.
103
 for the crotylation of ortho-substituted benzaldehydes, to proceed via a              
[6,6]-cyclic transition state owing to the presence of the neighbouring β-amide 
oxygen atom in aldehyde 195 (Scheme 3.8). Coordination of the in situ generated 
allyltin species 208 to both oxygen atoms is followed by transfer of the allyl group to 
the aldehyde carbonyl group via transition state TS-209 (Scheme 3.8). Protonation of 
the oxygen atom – which would be rapid because the reaction is performed in acidic 
media – then yields the homoallylic alcohol product (±)-199. 
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3.2.3 Cross-Metathesis Reactions 
 
Reagents and conditions: (a) 210 (1.0 eq), 211 (3.0 eq), 214 (5 mol%), PhH, 10 h, 50% yield, >25:1 Z:E; (b) (i)             
3-Bromopyridine (10 eq), 5 min; (ii) Pentane, 4 °C, 18 h, 88%. 
Scheme 3.9 (a) Exemplar enyne–olefin cross-metathesis reaction with catalyst 214;
96c
 (b) 
synthesis of modified Grubbs’ second generation catalyst 214. 
 
We had envisaged the use of a modified Grubbs’ II catalyst 214, which has been 
shown to be an exceptional catalyst for the CM of alkenes with enynes, has excellent 
functional group tolerance, and, crucially, is predominantly (Z)-selective.
96a,c;105
 For 
example, Chang et al.
96c
 demonstrated that enyne 210 and olefin 211 may undergo 
CM to give enyne 212 as the product with excellent (Z)-selectivity (>25:1 Z:E; 
Scheme 3.9a). To perform CM reactions in the current study, the catalyst 214 was 
prepared by treatment of Grubbs’ II 213 with an excess of 3-bromopyridine followed 
by trituration of the crude residue with pentane and filtration of the insoluble green 
solid, according to literature procedure
104
 (Scheme 3.9b). 
With the required catalyst in hand, the CM reaction between alkene (±)-199 and 
enyne 200 was attempted in an effort to synthesise the product (±)-194 (Table 3.2, 
Entries 1 to 4). Disappointingly, regardless of catalyst loading (5 to 20 mol%), 
solvent (DCM, toluene, or no solvent), or temperature (room temperature, or 45 to    
55 °C), only unreacted starting material was observed in the crude 
1
H NMR 
spectrum, or isolated after flash chromatography. A change of catalyst to the 
standard, unmodified Grubbs’ II 213 was also unsuccessful under our conditions, and 
led to no reaction in both cases (Table 3.2, Entries 5 and 6), although in the case of 
Entry 5, this may have been a consequence of substrate 200 evaporation. 
In order to investigate the compatibility of the homoallylic alcohol (±)-199 in CM, 
reaction of the olefin with 1-hexene
106
 in the presence of the modified Grubbs’ II 
catalyst 214 (5 mol%) was attempted. This reaction led to no conversion to the CM 
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 1 1 6 20 DCM 45 72 0  
 2 1 6 20 PhMe 25 60 (0)  
 3 1 6 10 PhMe 55 50 (0)  
 4 1 3 5 None 25 48 0  
 5
b
 2.8 1 28 PhMe 70 18 0  
 6
b
 1 3 10 DCM 45 20 (0)  
 a
Isolated yield unless otherwise stated; 
b
Yields determined by 
1
H NMR of the crude 
material are indicated in parentheses; 
b
Grubbs’ II 213 as opposed to the modified Grubbs’ 
catalyst 214 was used in these reactions. 
 
 
product (±)-215 as indicated by 
1
H NMR of the crude material (Scheme 3.10a). CM 
was then attempted using the TBS-protected homoallylic alcohol (±)-216, which was 
synthesised by reaction of the alcohol (±)-199 with TBSOTf in the presence of               
2,6-lutidine in DCM at 0 °C (Scheme 3.10b). Unfortunately, this olefin (±)-216 also 
failed to react with the enyne 200 under our CM conditions. On the basis of these 
results, it was concluded that the synthesis of the key intermediate (±)-194 would not 
be possible using a CM approach. This is because both the homoallylic alcohol             
(±)-199, and its TBS-protected derivative (±)-216, failed to react with either the 
enyne 200 or a standard, unfunctionalised olefin; and therefore these substrates were 
deemed incompatible in the reaction.  
The failure of the CM reaction between the enyne 200 and either the homoallylic 
























Reagents and conditions: (a) 1-Hexene (3.0 eq), 214 (5 mol%), DCM, 45 °C, 24 h, 0%; (b) TBSOTf (1.5 eq),              
2,6-lutidine (2.0 eq), DCM, 0 °C, 2 h, 97%; (c) Enyne 200 (3.0 eq), 214 (5 mol%), DCM, rt, 24 h, 0%. 
Scheme 3.10 Attempted cross-metathesis of (a) the homoallylic alcohol (±)-199 with                      
1-hexene; (b) the TBS-protected homoallylic alcohol (±)-216 with the enyne 200. 
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perhaps unsurprising. Grubbs previously outlined an empirical model for 
selectivity
107
 in olefin CM on the basis of rate of homodimerisation, which aids in 
predicting the probability of any two substrates to undergo CM and whether or not 
the CM reaction is likely to be efficient. Olefins were either classified as Type 1 (fast 
homodimerisation), Type 2 (slow homodimerisation), Type 3 (no homodimerisation) 
or Type 4 (no reaction under CM). Type 1 olefins are the most reactive and selective 
in CM with other classes of olefins because they are the least sterically hindered, are 
the most electron rich, and their homodimers are readily consumed. By contrast, 
Type 2 to Type 4 olefins are more sterically hindered, less electron rich, and their 
homodimers are not as readily consumed and are thus (progressively) poorer CM 





 would go some way to explaining the difficulty in achieving CM 
with enyne 200 and homoallylic alcohol (±)-199. In previous enyne–olefin CM, the 
enynes (unclassified by Grubbs, but likely to be Type 2) were most often reacted 
with a Type 1 olefin (such as allyl silane 211) and therefore the success of the 
reaction is greatly increased. By contrast, both enyne 200 and olefins [(±)-] 199/216 
would be predicted to be Type 2 olefins, and therefore do not readily undergo CM. 
It is also plausible that the failure of the reaction may have been caused by catalyst 
deactivation. Although both the homoallylic alcohol and Weinreb amide moieties 
have been shown to be compatible functionalities in CM,
108
 it has been shown that, if 
chelation is particularly stable, for example through formation of a 5- to 7-membered 
ring chelate Int-218 or Int-219 [which is plausible with our substrate (±)-199; 
Scheme 3.11], successful metathesis may be inhibited.
109
 Such a process may be 




 which compete with the 
metathesis catalyst for heteroatom binding;
109
 but unfortunately this was not 
investigated, and instead the CM approach was abandoned in favour of Approach B: 
epoxide ring-opening. 
 
Scheme 3.11 Formation of 5- and 7-membered-ring O→Ru chelates Int-218/Int-219 on 
attempted olefin CM using the Weinreb amide-containing homoallylic alcohol (±)-199. 
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3.3 Approach B: Epoxide Ring-Opening 
 
Scheme 3.12 Epoxide ring-opening approach towards the synthesis of the C(10)–C(19) 
fragment  86. 
 
The failure of the cross-metathesis approach necessitated the investigation of an 
alternative method (Scheme 3.12) for generating the key Weinreb amide 194. 
Inspired by the work of Kishi,
110
 who generated a TBS-protected homo-1,3-enynyl 
alcohol 222 from (S)-propylene oxide 220 (Scheme 3.13a), we decided to explore an 
epoxide ring-opening approach towards our more elaborate fragment 194 (Scheme 
3.13b). However, instead of the stepwise approach adopted by Kishi,
110
 we embarked 
upon a direct route towards the generation of the enyne 194. 
Our approach would require the synthesis of the C(13)–C(16) epoxide 201 and the 
C(10)–C(12) vinyl bromide 202 (Scheme 3.12). It was anticipated that epoxide 201 
could be synthesised from the alkene 223, which in turn could be prepared from the 
urea 224, or the previously synthesised aldehyde 195 (Scheme 3.14a). Vinyl 
bromide 202 was to be synthesised using a variant of the Wittig olefination from the 
aldehyde 225, which would be generated from the commercially available alcohol             
2-butyn-1-ol 124 (Scheme 3.14b). Epoxide ring-opening using a metallated 
derivative 226 of bromide 202,
111
 it was predicted, would give the C(10)–C(16)  
 
Reagents and conditions: (a) (i) TMS-ethyne, 
n
BuLi, Et2O, –78 to 0 °C, 40 min; (ii) 220, 10 min; (iii) BF3•OEt2,              
–78 °C, 1 h; (b) TBSCl, Im, DMF, rt, 48 h; (c) (i) NIS, AgNO3, DMF, rt, 5 h; (ii) Cy2BH, THF, 0 °C, 3 h; (iii) AcOH,           
5 °C, 12 h, 95% (4 steps); (d) Propyne, PdCl2(PPh3)2, CuI, Et2NH, rt, 3 h, 96%. 
Scheme 3.13 (a) Synthesis of an enantiopure homo-1,3-enynyl alcohol from an epoxide;
110
 
and (b) application of this approach towards the synthesis of C(10)–C(16) fragment 194. 




Scheme 3.14 Retrosynthesis of (a) epoxide 201; and (b) vinyl bromide 202. 
Weinreb amide 194, which should give access to the desired C(10)–C(19) fragment 
86 after Grignard addition. Stereoselective generation of the epoxide 201 would be 
achieved through the use of either an asymmetric epoxidation
112
 or through 




3.3.1 Synthesis of the C(13)–C(16) Epoxide [(±)-201] 
Our preferred route to the alkene 223 relied upon a single-step synthesis via reaction 
of a Grignard reagent with a Weinreb amide 224. The synthetic importance of 
Weinreb amides in carbon–carbon bond formation is well documented
114
 and indeed 
our overall synthetic plan relies upon the use of the functionality for the preparation 
of the C(10)–C(19) fragment 86. The Weinreb ketone synthesis has also been 
performed using amide substrates bearing more than one hydroxamic acid moiety
115
 
to give substituted, mono-Weinreb amides as the products; or indeed to give              
hetero-disubstituted ketones by sequential, two-step alkyl- and/or arylation. For 
example, the diamide 227
115a
 and the urea 224
115b,c
 may be transformed to alkyl- or 
arylated carbonyl compounds 228/230 through (sequential) addition of 
organomagnesium or -lithium reagents (Scheme 3.15a and b). Accordingly, we 
aimed to generate the required Weinreb amide 223 by reaction of urea 224 with an 
appropriate Grignard reagent 231 (Scheme 3.15c). 
Urea 224 was synthesised according to literature procedure
116
 by condensation of 
CDI and N,O-dimethylhydroxylamine hydrochloride in the presence of pyridine in 
DCM at reflux (Table 3.3). In the absence of the required Grignard  reagent 231 (the 
bromide precursor of which is not commercially available and would require 
preparation), to establish plausible addition conditions, we initially investigated the 




Reagents and conditions: (a) PhMgBr (1.5 eq), THF, 0 °C, 1 h, 95%; (b) CyMgCl (1.0 eq), THF, –78 to 0 °C, 3 h; 
(c) PhLi (1.1 eq), 0 °C to rt, 1.5 h, 41% (2 steps, one-pot). 
Scheme 3.15 (a) and (b) use of bis-Weinreb amides as carbonyl synthons;
115a,c
 (c) proposed 
route to the alkenyl Weinreb amide 223 from urea 224.
 
 
use of prenylmagnesium bromide 232 as a model substrate owing to its isomerism 
with Grignard reagent 231. Furthermore, this reagent often reacts in Grignard 
reactions to give the γ-addition product (cf. 223),
117
 as opposed to the α-adduct (cf. 
233), and so we were also conscious of a potentially desirable serendipitous 
discovery.  
Unfortunately, reaction of the urea 224 with freshly prepared prenylmagnesium 
Table 3.3 Attempted preparation of alkene 223 via a Grignard reaction with urea 224 
 
Reagents and conditions: (a) HNMe(OMe)•HCl (2.5 eq), Py (3.0 eq), DCM, 45 °C, 18 h, 91%; (b) 224, 
232, Et2O/THF (1:1); see Table for additional conditions. 












1 1.5 0 2 0 0 
2 2.0 0 2 0 Trace 
3 3.0 0 2 0 Trace 
4 1.5 0 to 25 2 0 Trace 
5 1.5 35 2 0 0 
6 4.0 –78 3 0 Trace 
7 2.0 –78 to 25 5 0 Trace 
a
As determined by 
1
H NMR of crude material. 
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bromide 232 across a number of conditions of temperature and Grignard reagent 
stoichiometry (Table 3.3) was unsuccessful, and resulted in only trace quantities of 
an alkenyl product (assumed to be α-adduct 233) or unreacted starting material in all 
cases. Given that the bromide required to react with the urea 224 is more sterically 
hindered and therefore likely to be further inert, no further work was done towards 
this approach. Instead, an overall three-step route to the alkene 223 from the 
previously synthesised aldehyde 195 was investigated. 
A Wittig olefination to generate the alkene 223 followed by an epoxidation to 
generate the racemic epoxide (±)-201 was the first route to be examined that 
commenced from aldehyde 195 (Scheme 3.16a). Although Weinreb amides are 
known to react with Wittig reagents,
118
 reaction times for the transformations 
according to the described protocol are long (overnight, e.g. Scheme 3.16b) and 
pivaloyl Weinreb amide 236 – which bears trisubstitution at the α-carbon and 
therefore has obvious structural similarities to our Weinreb amide 195 – failed to 
react
118
 (Scheme 3.16c). Therefore it was thought that the comparably shorter 
reaction times for rudimentary aldehyde-to-alkene Wittig reactions (~1 h) would 
allow the reaction to take place selectively at the aldehyde, and indeed such reactions 
are precedented in the literature (e.g. Scheme 3.16d).
119
  
To synthesise alkene 223, aldehyde 195 was added to a stirred solution of the  
 












, KHMDS,  
–78 °C, 1 h, 86%. 
Scheme 3.16 (a) Proposed synthesis of epoxide (±)-201 from Weinreb amide aldehyde 195; 
Wittig reactions to generate (b) and (c) ketones 235/237 from Weinreb amides 234/236;
118
 
and (d) an olefin 239 from an aldehyde 238 in a compound containing a Weinreb amide.
119 
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methyltriphenylphosphonium ylide – prepared by the addition of 
n
BuLi to 
methyltriphenylphosphonium iodide and heating to reflux in THF for 15 minutes
120
 – 
and reactions were monitored by TLC (Scheme 3.17a). Stirring for 30 min (3 eq of 
the phosphonium ylide) or 3 h (1.1 eq) at 0 °C indicated completion, but gave the 
desired product 223 in only 19 and 37% yields respectively. In an attempt to improve 
the yield, NaHMDS was used as the base, with ylide preparation and reaction at                 
0 °C, but unfortunately, after 2 h of reaction, these conditions also gave a low yield 
(37%) of alkene 223. Further efforts to optimise the yield were at this stage not 
performed, and synthesis of the epoxide (±)-201 from olefin 223 was investigated. 
In contrast to olefination, epoxidation was achieved straightforwardly using a 
standard oxone-mediated protocol,
121
 which gave a 61% yield of the product and 
concluded the synthesis of the C(13)–C(16) epoxide (±)-201 (Scheme 3.17a). It is 
worth noting that a direct approach to the epoxide from aldehyde 195 via the               
Corey–Chaykovski epoxidation
122
 was also investigated. Although the reaction of 
aldehyde with the trimethylsulfonium ylide seemed promising because a quantitative 
conversion to the epoxide (±)-201 was observed (
1
H NMR) under our initial 
screening conditions (Scheme 3.17b), attempts to obtain the product (±)-201 on a 
preparative scale (~1 g) led to its decomposition on chromatographic purification. It 
was initially thought that this could be attributed to the lower quality of silica gel
123
 
used in purification when compared to that used in the oxone-mediated epoxidation 
described above. However, attempts to repeat the procedure using higher-quality 
silica gel at the purification stage were unsuccessful, and it was later found that the 
problem overall was probably an issue of reproducibility, because attempts to obtain 
 




 (1.1 eq), 
n
BuLi (1.1 eq), THF, 0 °C to reflux, 15 min; (ii) 195, 0 °C,             




 (3.1 eq), NaHMDS (3.0 eq), THF, 0 °C, 30 min; (ii) 195, 2 h, 37%; (c) Oxone (6.0 eq), 




 (1.5 eq), 
n
BuLi (1.4 eq), 
THF, 0 °C, 15 min; (ii) 195, 0 °C to rt, 2 h, quant conv. 
Scheme 3.17 Synthesis of the C(13)–C(16) epoxide (±)-201 from aldehyde 195 via (a) a 
two-stage Wittig olefination/oxidation sequence; and (b) a Corey–Chaykovski epoxidation. 
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even a crude product in high yield were unsuccessful and typically gave 
epoxide/aldehyde mixtures. 
The route to the racemic epoxide (±)-201 via the alkene 223 therefore remains the 
most promising, and although this would require later optimisation at the key 
olefination step, we were satisfied that this could be returned to later once a reliable 
route to the vinyl bromide 202 had been established. In terms of an asymmetric 
synthesis, this would be achieved via a Jacobsen hydrolytic kinetic resolution
113
 of 
racemic (±)-201, which would afford the epoxide (R)-201 and a diol (S)-240 in the 
opposite sense; the latter of which could be later transformed to the desired 
enantiomer by conversion of the secondary (stereogenic) hydroxyl functionality to a 
leaving group (Scheme 3.18a).
121
 Alternatively, a Shi epoxidation
124
 – which uses a 
sugar-derived chiral ketone (e.g. 241) in conjunction with oxone to convert olefins to 
epoxides – may permit generation of the epoxide (R)-201 from alkene 223 
enantioselectively and thus without the requirement for hydrolytic kinetic resolution 
(Scheme 3.18b). 
 
Scheme 3.18 Proposed generation of the enantiopure epoxide (S)-201 from (a) the 
racemate (±)-201 using hydrolytic kinetic resolution; and (b) a Shi epoxidation of alkene 223. 
 
3.3.2 Synthesis of the C(10)–C(12) Vinyl Bromide (202) 
Towards the synthesis of the C(10)–C(12) vinyl bromide 202, we hoped to take 
advantage of Uenishi’s protocol
125a
 for the synthesis of (Z)-1,3-haloenynes, which 
involves Ramirez–Corey–Fuchs olefination
126
 to form the vicinal dihalide from an 
aldehyde, followed by regioselective palladium-catalysed reductive dehalogenation. 
This protocol was successfully exploited by Buchwald
125b
 in the synthesis of  




Reagents and conditions: (a) MnO2 (10 eq), Et2O, 0 °C to rt, 18 h, 65%; (b) (i) CBr4 (2.0 eq), PPh3 (2.0 eq), Zn 
(2.0 eq), DCM, 0 °C to rt, 30 min; (ii) 225, 0 °C to rt, 18 h, 85%; (c) 
n
Bu3SnH (1.05 eq), Pd(PPh3)4 (5 mol%), DCM, rt, 
2 h, quant conv. 
Scheme 3.19 Synthesis of the (Z)-vinyl bromide 202. 
analogous haloenynes and so we were hopeful that these conditions could be applied 
in our own efforts towards the (Z)-1,3-bromoenyne structural motif. Thus, in our 
attempts to access enyne 202 (Scheme 3.19), 2-but-yn-1-ol 124 was oxidised (MnO2) 
to the corresponding aldehyde 225 in 65% yield,
127
 and converted to the vicinal             
1,1-dibromo-1,3-enyne 242 in 85% yield according to the Ramirez–Corey–Fuchs 
protocol.
125b,126
 The final reductive dehalogenation step was then attempted through 
reaction of 242 with 
n
Bu3SnH (1.05 to 1.1 eq) catalysed by Pd(PPh3)4 (5 mol%) in 
DCM. Over a number of runs, consumption of starting material was complete after 1 
to 2 h at room temperature, and 
1
H NMR of the crude material showed only the 
presence of the (Z)-isomer of bromoalkene 202, as indicated by the olefinic coupling 
constant (J = 7.4 Hz) present between the alkene protons in the 
1
H NMR spectrum.  
Unfortunately, bromide 202 was too volatile to isolate in useful quantities by 
chromatography and was accompanied by residual stannane-byproduct contaminants. 
Attempts to eliminate the contaminants by stirring the crude product mixture in 
aqueous KF,
128
 resulted in product decomposition; while multiple chromatographic 
separations did facilitate byproduct removal, but removal of the solvent after each 
purification resulted in concomitant loss of the product through evaporation. Due to a 
lack of remaining precursor material 242, distillation, or alternative routes towards 
the synthesis of the C(10)–C(12) bromoenyne 202 were not investigated, and this 
approach was abandoned to focus on Approach C: the Mukaiyama aldol reaction. 
 
3.4 Approach C: Mukaiyama Aldol Reaction 
The Mukaiyama aldol reaction
129
 is the Lewis acid-catalysed synthesis of                         
β-hydroxyesters through reaction of a silyl enol ether with an aldehyde. Various 
asymmetric variations of this reaction exist which offer excellent yields and  









 and it has been used extensively in natural product 
synthesis,
127d
 including most synthetic efforts towards the disorazoles.
14,17,19,23–25,29,33 
Perhaps most notable in the context of the current study is the reaction performed by 
Hoffmann
14
 to generate the β-hydroxyester 245 (Scheme 3.21a) according to the 
Kiyooka protocol,
130
 which involved reaction of the silyl ketene acetal 203 with the 
aldehyde 244 in the presence of an enantiopure, amino acid-derived organoborane 
promoter; and gave the product 245 in excellent yield and enantioselectivity. On the 
basis of Hoffmann’s success on using 203 to access the required β-hydroxyketone 
scaffold directly, and because the use of the Mukaiyama reaction has proven a highly 
effective means of selectively imparting asymmetry in intermediates during other 
syntheses of the disorazoles, we felt it would be prudent to investigate this 
methodology in our own efforts. However, we preferred, in the first instance, to 
explore a more direct synthesis towards the C(10)–C(16) scaffold, as shown in 
Scheme 3.20.
 
Synthesis of the C(10)–C(16) β-hydroxyester 243 via the Mukaiyama protocol 
requires the synthesis of the C(10)–C(14) aldehyde 193, which can be prepared from 
3-butyn-1-ol 247
90
 via the vinyl iodide 246 (Scheme 3.21b). Conscious of the 
knowledge that aldehyde 193 is highly volatile,
90
 the aldehyde derivative of vinyl 
iodide 246 was also considered for investigation, as it was predicted to be easier to  
 
Reagents and conditions: (a) (i) BH3•THF, N-Ts-D-Valine, DCM, –78 °C; (ii) K2CO3, MeOH, 96% yield, 88 %ee. 
Scheme 3.21 (a) Hoffmann’s use of the Mukaiyama aldol reaction to generate the         
C(12)–C(16) β-hydroxyester 245;
14
 (b) retrosynthesis of the C(10)–C(14) aldehyde 193. 
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handle than the enyne 193 owing to its higher molecular weight. In addition to the 
aldehyde 193, the silyl ketene acetal 203 and a source of asymmetry were also 
required, and the synthesis of these components is discussed in the following section. 
 
3.4.1 Synthesis of the Silyl Ketene Acetal (203) and N-Ts-D-Valine (250) 
Silyl ketene acetal 203 was prepared in 72% yield on a 4 gram scale from methyl 
isobutyrate 248 by reaction of the (enolisable) ester with LDA and subsequent 
trapping of the in situ generated lithium enolate with freshly distilled TMSCl
131
 
(Scheme 3.22a). It is worth noting that filtration and distillation was not always 
completely effective in removing residual solids, and distilled samples occasionally 
appeared cloudy owing to the presence of the byproduct LiCl. However, an 
additional distillation step, or – more straightforwardly – filtration of the product 
through cotton wool or an HPLC filter immediately prior to use, was sufficient to 
fully remove the solid and give clear samples. 
The organoborane Lewis acidic source of asymmetry in Mukaiyama aldol reaction 
(according to the Kiyooka protocol) is derived by reaction of an N-protected amino 
acid with BH3•THF;
130
 with the N-tosyl derivative of D-valine perhaps being the 
most common ligand for this purpose, and certainly is so amongst the synthetic 
efforts towards the disorazoles.
14,17,19,23–25,29,33
 The most effective means of 
generating N-Ts-D-valine 250 involved the reaction of equimolar quantities of              
D-valine 249 and TsCl at 70 °C in aqueous K2CO3,
132
 followed by slow cooling        
(~1 h) to 0 °C. Acidification of the mixture with concentrated (37%) HCl and 
filtration of precipitate gave N-Ts-D-valine 250 in good yield (75%) on a 30 gram 
scale, and concluded the synthesis of the reagents for the Mukaiyama aldol reaction.
 
 
Reagents and conditions: (a) (i) 
n
BuLi (1.2 eq), 
i
Pr2NH (1.3 eq), THF, 0 °C, 30 min; (ii) 248 (1.0 eq), 0 °C, 1 h; (iii) 
TMSCl (2.0 eq), 0 °C, 1 h, 72%; (b) (i) TsCl (1.0 eq), K2CO3 (1.5 eq), H2O, rt to 70 °C, 30 min; (ii) 70 °C, 1 h; (iii) 70 
to 0 °C, 1 h, 75%. 
Scheme 3.22 Synthesis of (a) the silyl ketene acetal 203; and (b) N-Ts-D-valine 250. 
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3.4.2 Synthesis of the C(10)–C(14) Alcohol (197) 
 
Reagents and conditions: (a) I2 (1.3 eq), KOH (2.0 eq), H2O, 0 °C to rt, 3 h, 52%; (b) PADA (6.0 eq), AcOH (6.0 
eq), Py (6.0 eq), MeOH, rt, 16 h; (ii) 
n
BuNH2 (1.0 eq), rt, 6 h, 83%; (c) (i) ZnCl2 (5.0 eq), 1-propynylmagnesium 
bromide (5.0 eq), THF, 0 °C, 30 min; (ii) 246, PdCl2(PPh3)2 (10 mol%), 0 °C to rt, 16 h, 81%; (d) (i) I2 (1.0 eq), 
morpholine (3.0 eq), PhMe, 45 °C, 30 min; (ii) 247, 45 °C, 24 h, 97%; (e) PADA (3.0 eq), AcOH (6.3 eq), Py (6.0 
eq), MeOH, rt, 24 h; (ii) 
n
BuNH2 (10 eq), rt, 7 h, 69%. 
Scheme 3.23 (a) Dorgan’s synthesis of enyne 197;
90
 and (b) synthesis of vinyl iodide 246. 
The synthesis of both vinyl iodide 246 and enyne 197 have been achieved previously 
within the Hulme group
90
 in moderate overall yield (43 and 35% respectively) using 
initial KOH-mediated iodination of 3-butyn-1-ol 247 and subsequent (Z)-selective 
reduction of the iodide 251 thus obtained with dipotassium azodicarboxylate 
(PADA);
133
 with a Negishi coupling used to introduce the propyne moiety in the case 
of the enyne 197 (Scheme 3.23a). As such, this approach was used in the current 
study; however, in order to improve the overall yield, an alternative synthesis of 




 reported a quantitative yield of the iodoacetylene 251 through reaction of             
3-but-yn-1-ol 247 with the morpholine–iodine complex, and so 247 was added to a 
toluene solution of the pre-formed complex and the reaction was stirred overnight at 
45 °C. As reported, this method led to the successful synthesis of iodoacetylene 251 
in near-quantitative yield (97%; Scheme 3.23b). Subsequent reduction of the alkyne 
251 with a threefold excess of the diazene progenitor PADA gave a 69% yield of the 
vinyl iodide 246 exclusively as its (Z)-stereoisomer (Scheme 3.23b)
134
 and 
concluded the synthesis of one alcohol required for oxidation and aldolisation. 
The mechanism of the reaction
133
 (Scheme 3.24) involves a group transfer reaction 
during formal addition of H2 by diazene 253 (generated in situ from PADA 252) and 
accounts for the observed (Z)-selectivity in the product vinyl iodide 246 while 
stirring of the crude product mixture in an excess (10 eq) of 
n
BuNH2 removes any                    
over-reduction species 254 (formed via a second reduction step, Path B) through salt 
256 formation. Disproportionation of diazene 253 to form hydrazine 255
133
 (Path C; 




Scheme 3.24 Mechanism of the diazene reduction of alkyne 251.
133 
Scheme 3.24) necessitates an excess of PADA (and therefore this over-reduction 
pathway cannot be easily avoided), but the complete consumption of the starting 
material and high yield confirmed that close to an optimal quantity was used.  
Enyne 197 was prepared in 77% yield by PdCl2(PPh3)2-catalysed (10 mol%) Negishi 
coupling of the vinyl iodide 246 with 1-propynylzinc chloride, generated in situ by 
transmetallation of the corresponding organomagnesium reagent with ZnCl2 
(Scheme 3.25), according to the procedure reported by Dorgan.
90
 It is worth noting 
that, despite the high yield, two chromatographic separations (or distillation) were 
required to satisfactorily remove residual palladium-black from the product oil for 
use in the next step. Nevertheless, the reaction provided sufficient material (ca. 4 g) 
for the aldol reaction and an encouraging overall yield (52%) for the first three steps. 
 
Reagents and conditions: (i) ZnCl2 (3.5 eq), 1-propynylmagnesium bromide (3.0 eq), THF, 0 °C, 30 min; (ii) 246, 
PdCl2(PPh3)2 (10 mol%), 0 °C to rt, 24 h, 77%. 
Scheme 3.25 Negishi coupling of vinyl iodide 246 to generate enyne 195. 
 
3.4.3 The Mukaiyama Aldol Reaction: C(11)–C(14) Vinyl iodide (257) 
The remaining step required to perform the aldol reactions involved oxidation of the 
alcohol 197 and 246 to their corresponding aldehydes. As the homoenynyl aldehyde 
193 was previously found to be too volatile and prone to decomposition for 
straightforward isolation, a two-step reaction which required minimal purification 
and solvent removal was foreseen. On the other hand, in the case of iodide 257, 
which had not been synthesised previously, we believed that isolation would be 
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simplified owing to the likelihood of a reduced volatility because of the presence of 
the (high molecular weight) iodine atom in the structure. Although using this route 
would result in a loss of convergence in the synthetic pathway, it was believed that it 
would provide suitable contingency should difficulties in substrate handling arise 
upon oxidation of alcohol 197. Since Dess–Martin periodinane had been applied 
successfully in the synthesis of both homoenynyl aldehyde 193
90
 and an analogous 
(Z)-vinyl silane
135
 in the literature, this was used as a starting point for oxidation of 
both substrates. 
Dess–Martin periodinane and NaHCO3 were added to a solution of alcohol 246 in 
DCM and stirred at ambient temperature. After aqueous work-up, an orange-yellow 
oil was obtained (Scheme 3.26). Unfortunately, as indicated by gradual violet 
colouration, this oil began decomposing both during workup and in air almost 
immediately (<30 min) which precluded a full spectroscopic analysis of the resulting 
compound. However, the crude 
1
H NMR spectrum of 257 – although containing 
residual Dess–Martin periodinane and other minor peaks probably associated with 
decomposition – showed the presence of a major peak in the aldehyde region                
(δ = 9.77 ppm) with accompanying olefinic (δ = 6.62 and 6.55 ppm) and methylene 
(δ = 3.38 ppm) peaks and therefore we were satisfied that oxidation was successful. 
Furthermore, significant peaks indicative of olefin migration were not apparent, and 
therefore we were convinced that this compound could be of use in the Mukaiyama 
reaction. However, given that rapid decomposition could be problematic, it was 
obvious that this compound would have to be used immediately. 
The standard Mukaiyama aldol reaction under Kiyooka’s conditions
130
 involves the 
initial generation of an oxazaborolidine 258 from a N-Ts-D-valine 250, followed by 
either cooling of the resulting solution and addition of the aldehyde and silyl ketene 
acetal, or by addition of the oxazaborolidine solution to a cooled solution of the 
aldehyde (Scheme 3.27). Fortunately, DCM is often the solvent of choice in such 
 
Reagents and conditions: (a) Dess–Martin periodinane (1.2 eq), NaHCO3 (2.0 eq), DCM, rt, 75 min, quant conv. 
Scheme 3.26 Oxidation of alcohol 246 to aldehyde 257. 




Scheme 3.27 General organoborane-mediated Kiyooka aldol reaction using N-Ts-D-valine 
250 derived oxazaborolidine 258. 
 
reactions, and therefore addition of a DCM solution of the aldehyde 257 – which 
would simply be concentrated and used immediately after workup to minimise the 
timeframe for decomposition – would not affect the resulting reaction. 
Thus, the oxidation procedure as above was repeated and the aqueous workup was 
performed. Concurrently, oxazaborolidine 258 was prepared by dropwise addition of 
a 1.0 M solution of BH3•THF to N-Ts-D-valine 250 at room temperature and stirred 
for 30 min before cooling to –78 °C. After addition of the crude aldehyde 257 and 
the silyl ketene acetal 203 and reaction for 4 h in the presence of the organoborane 
promoter, we were pleased to discover that this procedure gave a 37% yield of the 
desired product 260 (%ee not determined; Scheme 3.28). Although low yielding, the 
knowledge that the desired β-hydroxyester motif could be generated using this 
method was encouraging, and we were convinced that the relatively low yield could 
be ascribed to the instability of the aldehyde 257. As such, and in the interests of 
convergency, we decided to abandon this approach in favour of using the enyne 193 
as our aldehyde substrate. 
 
Reagents and conditions: (a) Conditions as Scheme 3.26; (b) (i) N-Ts-D-valine 250 (1.0 eq), BH3•THF (1.0 eq), 
DCM, rt, 30 min; (ii) 257 (crude), 203 (1.5 eq) –78 °C, 4 h, 37% (2 steps), %ee not determined. 
Scheme 3.28 Mukaiyama aldol reaction with the aldehyde derived from vinyl iodide 246. 
 
3.4.4 The Mukaiyama Aldol Reaction: C(10)–C(14) Enyne (193) 
In a survey of a number of oxidation protocols, Dorgan
90
 found that the Dess–Martin 
oxidation provided the best results for the oxidation of alcohol 197 to the 
corresponding aldehyde 193. However, the product was found to be difficult to 




Reagents and conditions: (a) Dess–Martin periodinane (1.2 eq), NaHCO3 (2.0 eq), DCM, rt, 1.5 h; (b)                         
(i) N-Ts-D-valine 250 (1.2 eq), BH3•THF (1.2 eq), DCM, rt, 30 min; (ii) 4 Å MS, 193 (crude), 203 (1.5 eq), –78 °C,              
6 h, 48% (2 steps), %ee not determined. 
Scheme 3.29 Synthesis of aldol product 243 from alcohol 197. 
handle as a consequence of its volatility, and so, in a similar protocol to that carried 
out with vinyl iodide 257, use of the crude aldehyde 193 in the Mukaiyama aldol 
reaction was anticipated. Oxidation of the alcohol 197 was carried out using                  
Dess–Martin periodinane in the presence of NaHCO3 in DCM, followed by aqueous 
workup and careful concentration under reduced pressure to give a solution of the 
aldehyde 193 (Scheme 3.29). Addition of the crude product to the pre-prepared 
oxazaborolidinone in DCM, followed by the silyl ketene acetal 203 at –78 °C gave 
the β-hydroxyester 243 in moderate yield (48% over 2 steps; Scheme 3.29).  
Mechanistically,
129g,130a,b
 the Mukaiyama reaction according to the Kiyooka protocol 
involves association of the aldehyde with the organoborane catalyst via both an 
oxygen–boron bond, and a formyl hydrogen bond
136
 between the formyl CH and the 
oxygen atom of the oxazaborolidine ring (Scheme 3.30a).
130a,b
 Nucleophilic attack of 
the silyl ketene acetal 203 on the carbonyl group leads to generation of the 
intermediates Int-261, intramolecular O→O′ silyl migration forms the TMS 
derivative 262 and regenerates the catalyst; and silyl ether hydrolysis gives the 
product 259 (Scheme 3.30b). The stereochemical outcome of the reaction is 
controlled by the isopropyl and tosyl substituents. The rigid isopropyl group shields 
the upper face of the oxazaborolidinone ring, and therefore the steric bulk of the 
incoming aldehyde is orientated towards the opposite (lower) face, where the 
comparably flexible tosyl group is able to accommodate the aldehyde and its 
substitutents.
129g
 The aryl group obstructs the si face of the aldehyde, thus directing 
the incoming nucleophile to the re face and the product is generated 
enantioselectively (Scheme 3.30a).  
Unfortunately efforts to replicate the results of the Mukaiyama protocol led to poor 









product 243 yields, which were typically less than 20%; and this precluded further 
optimisation and measurement of the level of enantioselectivity of the reaction. The 
reasons for the poor, capricious product yields were unclear, but were initially 
suspected to be due to varying levels of water
137
 within the reaction mixture from the 
aqueous workup performed after Dess–Martin oxidation of the alcohol 197. Efforts 
to counteract this through purification of the aldehyde (by chromatography or 
distillation) were ultimately unsuccessful, because the aldehyde was highly volatile, 
unstable, and prone to olefin migration.  
Aside from water-induced deactivation, it is possible that the borane did not fully 
react with the ligand 250, or that reduction of the aldehyde by the borane–amino acid 
complex took place in competition with the desired aldol addition.
138
 The basis for 
this conjecture centres around the discovery that, on some runs, varying quantities 
(up to 32%) of alcohol starting material 197 were recovered following 
chromatography. Although this could have been a consequence of incomplete 
oxidation, TLC monitoring of the oxidation typically indicated only trace levels of 
unreacted starting material after the 1.5 h timeframe, which would predict only trace 
recovery of the alcohol following the aldol reaction. 
As a result of these difficulties, efforts towards the synthesis of the β-hydroxyketone 
243 via the Mukaiyama aldol approach – or indeed by any convergent means – were 
abandoned in favour of investigating a linear approach. However, sufficient material 
was obtained from the Mukaiyama protocol for investigation into the final steps of 
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the fragment synthesis, which would at least confirm that a linear approach that 
targets the Weinreb amide 194 would be worthwhile. 
 
3.5 Fragment Completion from the C(10)–C(16) β-Hydroxyester (243) 
The final steps required to access fragment 86 completion involved conversion of the 
C(10)–C(19) ester 243 to its Weinreb amide 194 derivative and subsequent Grignard 
addition with 1-propenylmagnesium bromide. Investigations into the synthesis of the 
Weinreb amide 194 commenced with the use of N,O-dimethylhydroxylamine 
hydrochloride in conjunction with AlMe3 as the coupling reagent for introducing the 
amide moiety,
139
 but this reagent system gave no conversion (
1
H NMR) to the 
desired product after 2 h at 0 °C. Fortunately, improved results were achieved 
through the use of 
n
BuLi: although reaction of the ester 243 with a modest excess (3 
eq) of the lithium amide of Weinreb’s amine gave a poor isolated yield (23%) on 
reaction at –78 °C, use of a large excess (9 eq) at the same temperature gave the 
product Weinreb amide 194 in excellent yield (88%, Scheme 3.31).  
Reaction of the Weinreb amide 194 with 20 equivalents of the Grignard reagent               
1-propenylmagnesium bromide for 4.5 h at 0 °C led to only a 34% yield of the enone 
86, albeit cleanly and with recovery of unreacted starting material. Reducing the 
temperature to –10 or –78 °C was ineffectual, and led to negligible conversion (TLC) 
and isolation. However, treatment of the Weinreb amide 194 with 10 equivalents of 
the Grignard reagent under ultrasonic vibration
140
 for 1.5 h led to a respectable 66% 
yield of the product, and concluded our first generation, convergent synthesis of the 
C(10)–C(19) fragment of disorazole C1 86 (Scheme 3.31). 
 
Reagents and conditions: (a) (i) HNMe(OMe)•HCl (9.0 eq), 
n
BuLi (18 eq), THF, –78 °C to rt, 30 min; (ii) 243,          
–78 °C, 2.5 h, 88%; (b) 1-propenylmagnesium bromide (10 eq), THF, ultrasound, 1.5 h, 66%. 
Scheme 3.31 Completion of the C(10)–C(19) β-hydroxyketone fragment 86 of disorazole C1 
from β-hydroxyester 243. 
 




Three convergent approaches were investigated towards the synthesis of the                
C(10)–C(19) fragment of disorazole C1, which relied on the synthesis of a key 
Weinreb amide. Routes towards the Weinreb amide included a cross-metathesis 
approach between an enyne and a homoallylic alcohol [C(11)–C(12) disconnection, 
Approach A]; an epoxide ring-opening approach between an epoxide and a 
(metallated) vinyl bromide [C(12)–C(13) disconnection, Approach B]; and a 
Mukaiyama aldol approach between a silyl ketene acetal and an aldehyde                  
[C(14)–C(15) disconnection, Approach C]. Approach A was unsuccessful owing to 
incompatibility of the substrates in the cross-metathesis reaction. Despite an 
unoptimised but nonetheless successful synthesis of the racemic epoxide, Approach 
B suffered from difficulties in substrate purification and handling with respect to the 
vinyl bromide, and therefore was discontinued as a route towards the required 
fragment. The most successful of the approaches was Approach C, and this allowed 
the generation of a derivative of our key Weinreb amide, from which the fragment 
could be derived. The Mukaiyama aldol route gave the desired fragment in 14% 
yield (7 steps), albeit without determination of %ee; but unfortunately the capricious 
nature of the key aldol step prevented an optimisation of the reaction in terms of its 
yield and enantioselectivity, and therefore the use of this route was ultimately 
deemed non-viable. Despite this, we were able to validate the use of the Weinreb 
amide as a means of installing the C(19)–C(17) propene group, and therefore the 
route provided a synthetic target for a linear synthesis of the C(10)–C(19) fragment.  
In general all three approaches suffered somewhat from inherent difficulties in the 
handling of small, volatile and/or unstable intermediates. This is understandable: the 
C(10)–C(19) fragment is only a twelve-carbon chain containing a large degree of 
unsaturation and conjugation, and therefore the various retrosynthetic disconnections 
will yield small and potentially volatile and reactive fragments. On this basis, it was 
believed that future work towards the synthesis of the C(10)–C(19) fragment may be 
more successful with – or indeed necessitate – a linear synthesis. This alternative 




Chapter 4      Results and Discussion 3 
    Linear Approaches towards the Synthesis of the                        
   C(10)–C(19) Fragment of Disorazole C1 
4.1 Overview, Previous Work and Retrosynthesis 
 
Scheme 4.1 Retrosynthesis of the C(10)–C(19) fragment 86 using a linear approach. 
As outlined in Chapter 3, convergent approaches towards the C(10)–C(19) fragment 
were unsuccessful; thus, a linear approach was explored (Scheme 4.1). It can be 
considered that there are three major challenges associated with the synthesis of the 
desired fragment 86: (1) induction of (S)-stereochemistry at C(14) whereby a              
gem-dimethyl β-hydroxyketone (or derivative) is formed simultaneously; (2) 
introduction of the (E)-propene group at C(16)–C(19); and (3) generation of a               
(Z)-1,3-enyne at C(10)–C(12). 
In their work towards the synthesis of the C(1)–C(19) disorazole C1 monomer, 
Hoffmann
14,25
 successfully overcame these challenges and used a Mukaiyama aldol 
reaction with aldehyde 244 to introduce the required (S)-stereochemistry at C(14), 
generating the key β-hydroxyester 245
14
 (Scheme 4.2a). This intermediate was later 
elaborated to the C(9)-protected C(9)–C(19) alkyne 269 and later to the C(1)–C(19) 
disorazole C1 monomer 28
25
 (for structure, see: Chapter 1, Section 1.2.3, Scheme 
1.5). Although a high overall yield (42%, 6 steps), was obtained for the steps of their 
fragment synthesis relevant to our own, we believed that there were a number of 
modifications to the route that could be applied in our synthesis that may improve 
yields, and reduce the number of steps required for completion of the fragment. 
The excellent 88 %ee that was achieved in the aldol step of Hoffmann’s synthesis 
(Scheme 4.2a) was suitable for the current study because we were confident that if 
the β-hydroxyketone 86 was synthesised, the step could be revisited later, if required, 
to obtain the fragment in enhanced optical purity while otherwise using the same  




Reagents and conditions: (a) See Chapter 3, Section 3.4, Scheme 3.21a; (b) DIBAL, PhMe, –78 °C, 1.5 h, 94%; 
(c) Dess–Martin periodinane, DCM, 0 °C to rt, 3 h, 83%; (d) (i) (E)-1-bromopropene, 
t
BuLi, Et2O/THF, 3 h, –95 °C; 




, NaHMDS, THF, rt, 30 min; (ii) 267, 
HMPA, –78 °C, 45 min, 82%; (f) TMS-acetylene, PdCl2(PPh3)2, CuI, Et3N, MeCN, 5 h, rt, 81%. 
Scheme 4.2 Relevant steps in Hoffmann’s fragment synthesis.
14,25
 
forward synthesis. This approach would allow us to focus on the important problem 
of finding conditions that would lead us to the skeletal framework of fragment 86. 
The introduction of the C(17)–C(19) propene group was a particular sequence for 
which it was believed improvements could be made over Hoffmann’s previous 
efforts (Scheme 4.2b). Aside from the desire to avoid the use of the particularly 
hazardous reagent 
t
BuLi, if Hoffmann’s sequence was used, a three-step route to 
install the C(17)–C(19) propene group and a final alcohol oxidation to generate the 
ketone at C(16) would be required to complete the C(16)–C(19) portion of the 
molecule. This four-step sequence was deemed unnecessary in light of the success 
obtained using the Weinreb amide functionality as a means of introducing the olefin 
to our target fragment (see: Chapter 3, Section 3.5). As such, we chose to retain the 
use of the Weinreb amide in the current study, which would make the synthesis more 
convergent 
The Hoffmann group was successful in carrying out a two-step synthesis of the         
(Z)-enyne functionality from an aldehyde 267 using a stereoselective Stork–Zhao 
modified Wittig reaction followed by palladium-mediated cross-coupling onto the 
resultant vinyl iodide 268 (Scheme 4.2c). Since high stereoselectivity was obtained 
(>99:1 Z:E) in the Wittig reaction, we felt it would be prudent and straightforward to 
transfer this two-step methodology to our studies. However, we were interested in 
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discovering whether or not a Wittig reaction by itself could potentially generate the 
C(10)–C(12) enyne group through use of a propargylic Wittig reagent.  
Scheme 4.3 shows our proposed forward synthesis of the C(10)–C(19) fragment of 
disorazole C1 86 based on the above discussions. The sequence would commence 
with an enantioselective aldol reaction to introduce (S)-stereochemistry at C(14) and 
provide the β-hydroxyester scaffold 245. Following protection of the free alcohol, the 
enyne and propene groups would then be installed in what could be considered 
separate key stages of the fragment synthesis. Construction of the C(10)–C(12) 
enyne would commence with cleavage of the PMB-ether followed by oxidation of 
the alcohol to give the aldehyde 263. A Wittig reaction followed by – if required – 
palladium-mediated cross-coupling would introduce the C(10)–C(12) (Z)-enyne and 
give the protected β-hydroxyester 270. To introduce the C(16) (E)-propene group, a 
Weinreb amide would be generated from the C(16) methyl ester 270 and 
subsequently treated with an appropriate Grignard reagent as carried out in Chapter 
3, Section 3.5. Deprotection of the protected C(10)–C(19) fragment 271 would 
complete the fragment 86 in 7 or 8 steps from the aldol product 245.  
 
Scheme 4.3 Simplified forward synthesis of the C(10)–C(19) fragment 86 using linear 
approaches. 
 
4.2 Synthesis of the C(12)–C(16) β-Hydroxyester Scaffold 
4.2.1 Synthesis of the C(12)–C(14) Aldehyde (244) 
The first step in the proposed synthesis of fragment 86 requires generation of the  
2,2-dimethyl-β-hydroxyester 245 from aldehyde 244 (Scheme 4.2a). Aldehyde 244 
was synthesised on a multi-gram scale (~30 g; Scheme 4.4) in two steps from freshly 
prepared PMBCl 273, which was synthesised by treatment of molten PMBOH 272 
with ultrasonic vibration in concentrated HCl.
141
 Base-mediated (KOH) reaction of 
the crude (>90% purity) PMBCl with an excess of 1,3-propanediol in DMSO 




Reagents and conditions: (a) HCl (12 eq), H2O, ultrasound, 1 to 2 h, quant; (b) 1,3-propanediol (4.0 eq), KOH (4.0 
eq), DMSO, 0 °C to rt, 3 h, 78%; (c) (i) (COCl)2 (1.5 eq), DMSO (4.5 eq), DCM, –78 °C, 10 min; (ii) 272, 1 h; (iii) 
Et3N (6.0 eq), –78 °C to rt, 1 h, 85%; or NaOCl (1.2 eq), TEMPO (5 mol%), KBr (10 mol%), NaHCO3 (2.1 eq), 
DCM/H2O (1:2), 0°C, 45 min, quant. 
Scheme 4.4 Synthesis of aldehyde 244. 
generated the mono-protected diol 274 in good yield (78%), while subsequent Swern 
oxidation gave the aldehyde 244 in 85% yield (66% over 3 steps) reproducibly, and 
on a large scale (>30 g).
142
 It is worth noting that the Swern oxidation can be 
replaced with a TEMPO-mediated protocol,
143
 which gave a quantitative yield of the 
aldehyde 244 (2 g scale); and avoids the requirement for anhydrous conditions, 
distillation of reagents and reduction of temperature below that of an ice-bath (0 °C). 
Importantly, it also simplifies the workup procedure because special precautions 
need not be taken to cope with the presence of the malodorous byproduct Me2S.  
 
4.2.2 The Mukaiyama Aldol Reaction 
The aldol reaction required for generation of the β-hydroxyester 245 was performed 
according to Hoffmann’s procedure.
14
 An in situ generated organoborane Lewis acid 
catalyst was prepared by addition of BH3•THF to N-Ts-D-Valine in DCM with 
stirring for 1.5 h, followed by cooling to –78 °C. Aldehyde 244 and silyl ketene 
acetal 203 were then added and allowed to react for 5 h at –78 °C. Following 
aqueous workup, the product β-hydroxyester 245 and its TMS-protected derivative 
275 were obtained in an approximate 1:1 ratio (Scheme 4.5). However, treatment of 
the crude material with aqueous HCl in THF gave the product 245 in 85% yield and 
89 %ee. This result was consistent on scales up to 100 mmol (~20 g 244) both with 
 
Reagents and conditions: (a) (i) BH3•THF (1.1 eq), N-Ts-D-valine 250 (1.1 eq), DCM, rt, 1.5 h; (ii) 244, 203 (1.8 
eq), DCM, –78 °C, 5 h; (b) HCl (5.0 eq), THF/H2O (1:1), 3 h, 85%, 89 %ee; 60% recovered N-Ts-D-valine. 
Scheme 4.5 Synthesis of the C(12)–C(16) β-hydroxyester 245 (100 mmol scale). 
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respect to the yield (>80%), and enantioselectivity (typically 88 to 89 %ee; measured 
by HPLC on comparison with the trace obtained for the same reaction performed 
with racemic N-Ts-valine), and therefore represented a highly reproducible and 
efficient means of generating our desired C(12)–C(16) β-hydroxyester scaffold. 
It should be noted that although large-scale preparation required multigram quantities 
of the stoichiometric ligand 250, it is easily synthesised (see: Chapter 3, Section 
3.4.1) and may be recovered (typically 60 to 80%) on each run through acidification 
of the aqueous extracts obtained during each workup and subsequent recrystallisation 
of the solid thus obtained. However, by contrast, it was found that for large-scale 
preparations of β-hydroxyketone 245, commercial acquisition of the silyl ketene 
acetal 203 was a preferred option owing to the difficulties of reproducibility 
encountered during its large-scale (~30 g) synthesis. The source of the solvent is also 
worthy of note: one should ensure that amylene-free DCM (obtained from a 
purification system or by distillation over CaH2) is used, because the use of 
commercially obtained, stabilised DCM led to diminished enantioselection. 
 
4.2.3 Synthesis of the C(12)–C(16) Aldehyde (263) 
 
Reagents and conditions: (a) TBSOTf (1.5 eq), 2,6-lutidine (2.0 eq), DCM, –78 °C, 2.5 h, 94%; (b) DDQ (1.5 eq), 
DCM/H2O (18:1), 1.5 h, quant; (c) (i) (COCl)2 (2.0 eq), DMSO (6.0 eq), DCM, –78 °C, 15 min; (ii) 276, 1.5 h; (iii) Et3N 
(8.0 eq), –78 °C to rt, 1.25 h, 95%.  
Scheme 4.6 Preparation of the key C(12)–C(16) aldehyde 263. 
Having successfully synthesised the β-hydroxyketone scaffold, synthesis of the key 
aldehyde 263 could be commenced (Scheme 4.6). A TBS group was chosen as the 
protecting group for our reaction sequence owing to its stability to organometallic 
reagents and most standard oxidation and reduction conditions; and its anticipated 
ease of removal,
144
 which would not compromise other functionalities in the 
protected C(10)–C(19) fragment. Thus, alcohol 245 was treated with TBSOTf in 
DCM in the presence of 2,6-lutidine at –78 °C to give the silyl ether 264 in 94% 
yield. DDQ-mediated cleavage of the PMB group from PMB-ether 264 (which may 
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be telescoped directly from the previous step) followed by Swern oxidation of the 
free alcohol 276 thus obtained afforded the key aldehyde 263 in 95% yield over 2 
steps (Scheme 4.6).  
This sequence of reactions presented few problems, although it should be noted that 
the workup used to obtain crude alcohol 276 can be problematic – particularly on a 
large scale – because the reaction mixture obtained after quenching has a tendency to 
emulsify. This was overcome by high dilution of the mixture with H2O and 
exhaustive aqueous extraction, and indeed this is a requirement to obtain the product 
in high yield because yields may diminish if dilution is not sufficient to allow a clean 
phase separation. It is also advisable that aldehyde 263 be used promptly, because 
decomposition was thought to occur (TLC) after 1 to 2 weeks at –18 °C. 
 
4.3 Installation of the C(10)–C(12) (Z)-Enyne 
 
Scheme 4.7 (a) Direct Wittig; and (b) iodo-olefination/Negishi coupling approaches towards 
the synthesis of the enyne 270. 
 
The next stage of our proposed fragment synthesis involved introduction of the             
(Z)-enyne moiety to our C(12)–C(16) β-hydroxyester scaffold, and two routes were 
considered, both of which centred around the use of a Wittig reaction: either (1) a 
direct Wittig reaction using propargylic phosphonium salt 113 (Approach A, 
Scheme 4.7); or (2) generation of vinyl iodide 278 followed by Negishi coupling 
would be used to generate the C(10)–C(12) enyne group (Approach B, Scheme 4.7).  
Clearly, both routes in our proposed synthesis require a highly (Z)-selective 
olefination, and such a transformation may be achieved through use of the           
Stork–Zhao reaction.
145
 The Stork–Zhao reaction (Scheme 4.8) involves generation 
of a methylene iodide ylide Int-279 by treatment of phosphonium salt 277 with 




Scheme 4.8 General Stork–Zhao olefination reaction. 
NaHMDS, followed by addition of HMPA and the aldehyde to give the (Z)-vinyl 
iodide 280. The role of HMPA in the reactions is unclear, but it has been suggested 
that it is involved in increasing phosphorane solubility
146a
 and preventing unwanted 
side reactions;
146
 and it may have a role in chelation of the sodium ion, thus 
destabilising the phosphonium ylide and promoting (Z)-selectivity.
147
 According to 
the Stork–Zhao procedure, we were confident that we could generate a vinyl iodide 
from our C(12)–C(16) aldehyde 263, but we were also curious to discover whether or 
not the addition of HMPA would lead aid in promoting a (Z)-selective Wittig 
olefination using a propargylic phosphonium salt. 
 
4.3.1 Approach A: Direct Synthesis Using a Wittig Olefination 
Our initial screening conditions for the Wittig olefination using the propargylic 
phosphonium salt 113 involved treatment of a THF suspension of phosphonium salt 
with NaHMDS at room temperature, followed by cooling, subsequent addition of 
HMPA and finally the aldehyde (±)-263 at –78 °C. Reaction for 2 h under these 
conditions led to completion of the reaction, but unfortunately an approximate 3:2 to 
1:1 ratio of E:Z stereoisomers [(±)-] 281:270 was observed on analysis of the crude 
1
H NMR spectrum (Table 4.1, Entry 1). The formation of the two products was 
immediately recognised by the presence of two resonances of approximately equal 
integral intensity at δ = 5.98 [1H, dt, J = 15.3, 7.5 Hz; (E)-isomer] and δ = 5.88 [1H, 
dt, J = 10.6, 7.4 Hz; (Z)-isomer] which correspond to the C(12) olefinic protons of 
each stereoisomer. The expected coupling constants for coupling to C(11) in an          
(E)- and (Z)-geometry were observed, while the doublet-of-triplet pattern occurred as 
a consequence of coupling to the neighbouring C(13) CH2 protons [which, 
importantly, indicated the formation of the C(12)–C(13) bond]. The formation of two 
enyne products was confirmed by the presence of two (CH3) resonances at δ = 2.01 
[3H, d, J = 2.2 Hz; (Z)-isomer] and δ = 1.98 [3H, d, J = 2.1 Hz; (E)-isomer]; and  
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1 THF NaHMDS HMPA –78 2 42:58 100 




3 THF NaHMDS HMPA 25 2 nd nd [99] 
4 Pentane NaHMDS HMPA –78 2 nd nd [99] 
5 THF/DMF
g 
NaHMDS HMPA –78 2 45:55 94 
6 THF NaHMDS HMPA
h
 –78 2 44:56 63 
7 THF NaHMDS None –78 2 42:58 99 
8 THF 
t
BuOK 18-crown-6 –78 2 47:53 62 
a
Screening was performed using the racemic form of aldehyde 263 on the basis of substrate availability; 
b
1.25 
eq of base and phosphonium salt 113 was used in all cases; 
c





H NMR of the crude material; 
e
Combined NMR yield of both stereoisomers; 
f
Where relevant, 
values in brackets refer to the extent of consumption of the aldehyde starting material; 
g
Ratio THF:DMF = 10:1; 
h
21.5 eq of HMPA was used on this run. 
 
the C(11) proton resonances for each stereoisomer at δ = 5.47 [1H, dqt, J = 10.6, 2.4, 
1.4 Hz, (Z)-isomer] and δ = 5.44 [1H, dqt, J = 15.4, 2.1, 1.7 Hz, (E)-isomer]. As a 
result of these observations, a range of alternative conditions were screened. 
Although Stork and Zhao found that increased temperature was shown to decrease 
selectivity,
145
 increased temperatures (0 and 25 °C, Table 4.1, Entries 2 and 3) under 
the same conditions of phosphonium salt and HMPA quantity were nonetheless 
screened. Perhaps unsurprisingly, both conditions led to a decrease in conversion to 
the desired product and generation of a number of byproducts which were not 
identified – an observation that was tentatively ascribed to instability of the resulting 
phosphorane or reactive intermediates at higher temperatures. As such, subsequent 
reactions were conducted at –78 °C. 
Reducing the solvent polarity (Table 4.1, Entry 4) by conducting the reaction in 
pentane led to reduced conversion and byproduct formation (cf. high temperature 
conditions), presumably as a consequence of decreased stabilisation of the 
intermediate phosphorane or betaine in the absence of a chelating solvent. Increasing 
the solvent polarity through addition of DMF
148
 (Table 4.1, Entry 5) was also  




Reagents and conditions: (i) 283 (1.5 eq), 
t
BuOK (1.5 eq), 18-crown-6 (1.8 eq), THF, rt, 1 h; (ii) 282, –78 °C to rt, 
70%, >99:1 Z:E. 





ineffectual in improving selectivity, and had no influence over the results relative to 
our initial conditions, giving quantitative conversion with an approximately equal 
Z:E ratio. The quantity of the HMPA co-solvent was also investigated; unfortunately, 
a tenfold increase (Table 4.1, Entry 6) did not improve Z:E selectivity and in fact 
hindered the extent of conversion. Interestingly, the absence of HMPA (Table 4.1, 
Entry 7) proved to have no influence on the reaction, indicating that the Stork–Zhao 
modification was not effective in reactions involving alkynylphosphoranes. 
In a final effort to find (Z)-selective conditions, an alternative procedure was chosen 
to establish whether or not the reaction of our aldehyde (±)-263 with the 
phosphonium salt 113 was worthy of further investigation. Kogen
147
 reported 
excellent (Z)-selectivity (83:17 to >99:1 Z:E) in low temperature (–78 °C) Wittig 
reactions reactions of α-acetal ketone substrates (e.g. 282) mediated by 
t
BuOK and 
18-crown-6 (Scheme 4.9), whereby the crown ether was thought to influence 
selectivity by chelating and sequestering the potassium ion, thus destabilising the 
phosphonium ylide. These conditions of base and additive were applied to our 
reaction, but unfortunately, this method also proved futile and led to a decrease in 
yield with no improvement in stereoselectivity (Table 4.1, Entry 8), and therefore 
direct efforts towards the synthesis of the (Z)-enyne were discontinued. 
The reaction conditions screened consistently led to an approximate 1:1 mixture of 
E:Z isomers, the reasons for which are not entirely clear and are difficult to speculate 
upon given the debate that surrounds the mechanism of the Wittig reaction;
30a,c
 and 
since the selectivity with alkynylphosphoranes in particular is poorly understood. 
However, it is plausible that the observed results may be attributed to one or more of 
the following factors (represented in Scheme 4.10):
149
 (i) the difference in steric 
demands between anti- and syn-addition (TS-285a and TS-285b, respectively) at the 






































Scheme 4.10 Proposed mechanism for the Wittig reaction with aldehyde (±)-263.149 Note 
that syn/anti- and (E/Z)-descriptors in 286/287 refer to the relationship between the R-group 
and the alkynyl group. 
 
carbonyl group were negligible and thus the Ph3PO elimination step could occur via 
both the (Z)- or (E)-oxaphosphetanes [(Z)-Int-287 and (E)-Int-287, respectively]; (ii) 
the phosphonium ylide is highly stabilised and the carbon–carbon bond forming step 
is slow and reversible, resulting in scrambling of the stereochemistry via                        
Int-286→TS-285 reversion followed by addition at the alternative face of the 
aldehyde; or (iii) the resulting eclipsed-betaine intermediate syn-Int-286 resulting 
from anti-addition (via TS-285a) is very sterically hindered as a result of a steric 
clash between the enyne group and the (large) ‘R’-group, which promotes reversion 
to the starting materials. Of these three options, (i) seems unlikely, because the large            
R-group – which contains a TBS-ether and gem-dimethyl substituents – would place 
strain on the syn-addition transition state TS-285b which perhaps explains why             
(Z)-selectivity was actually relatively high compared to many other Wittig reactions 
involving propargyl halide derived phosphoranes.
150
 However, (ii) and (iii) are 
plausible, and provide a means of improving the reaction conditions.  
It is likely that the use of a different Wittig reagent will be required to increase               
(Z)-selectivity, such that anti-addition is fast and irreversible. Potential options, 
without deviating from the use of a propargylic salt, include alteration of the 
phosphonium counterion (e.g. tetrafluoroborate);
151a
 or use of alternative phosphine 
ligands (e.g. pyridyl
151b
 or substituted phenyl).
151c
 Yamaguchi et al.
149
 demonstrated 
moderate (Z)-selectivity (~7:1 Z:E) on using trimethylgallium as the base in the 
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Wittig reaction with propargylphosphonium salts. Although this would involve the 
use of a highly expensive and reactive reagent, instead, addition of a cationic ligand 
or Lewis acid to chelate the aldehyde/betaine oxygen [as was speculated as the 
reason for high (Z)-selectivity]
149
 could increase the proportion of the desired 
product. Should these methods fail, a Julia olefination
152a
 with a propargylic 
sulfone
152b
 could be used instead of relying on organophosphorus chemistry. 
Nonetheless, these modifications are a matter for future investigation, and instead the 
single-step method of generating the (Z)-enyne was abandoned in favour of a             
two-step route via the vinyl iodide. 
 
4.3.2 Approach B: Synthesis via Iodo-olefination/Negishi Coupling 
The lack of success in the direct Wittig reaction (Approach A) was disappointing, 
but nonetheless we were confident that the Stork–Zhao reaction would lead to a            
(Z)-vinyl iodide which could be transformed using palladium-mediated                       
cross-coupling to generate the enyne. Towards this end, Wittig reagent 277 was 
synthesised by reaction of PPh3 with CH2I2 at 70 °C in the absence of light (Scheme 
4.11a) according to literature procedure.
153
 It should be noted that use of the correct 
concentration and temperature in this protocol is very important: high concentration 
(4 M) was required to achieve high product yields (~80 to 90%), while overheating 
(>100 °C) led to partial decomposition as indicated by a yellowing of the solid. 
Addition of the aldehyde 263 at –78 °C to a twofold excess of the phosphorane 
generated by the addition of NaHMDS to the freshly prepared phosphonium salt 277  
 





(2.0 eq), NaHMDS (2.0 eq), THF, rt, 5 min; (ii) HMPA (4.0 eq), –78 °C, 5 min; (iii) 263, 2 h, –78 °C, 75% yield, >99:1 
Z:E; (c) (i) 1-propynylmagnesium bromide (3.0 eq), ZnCl2 (3.6 eq), THF, 0 °C, 30 min; (ii) 278, PdCl2(PPh3)2                     
(5 mol%), 0 °C to rt, 16 h, 92%. 
Scheme 4.11 (a) Preparation of the iodomethyl Wittig reagent 277;
153
 and (b) installation of 
the C(10)–C(12) (Z)-enyne moiety using a Wittig olefination/Negishi coupling approach. 
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at room temperature in THF/HMPA led to complete conversion of the starting 
material to the vinyl iodide product 278 (Scheme 4.11b). Gratifyingly, a single 
stereoisomer was obtained after chromatography in good yield (75%); although 
owing to the overlapping multiplet for the olefinic protons in the 
1
H NMR spectrum, 
(Z)-stereochemistry could only be tentatively assigned for the double bond (Figure 
4.1a). Fortunately, having previously synthesised the TBS-deprotected form of the 
target enyne 270 (see: Chapter 3, Section 3.4.4), we were confident that the double 
bond geometry could be confirmed if a successful Negishi coupling could be carried 
out with the vinyl iodide product 278.  
Pleasingly, addition of vinyl iodide 278 and PdCl2(PPh3)2 (5 mol%) to freshly 
prepared 1-propynylzinc bromide and stirring of the reaction mixture overnight at 
room temperature gave the product 270 in 92% yield (Scheme 4.11b) and concluded 
the synthesis of the C(10)–C(16) enyne. Furthermore, the (Z)-geometry of the double 
bond was confirmed (Figure 4.1b), because two distinct proton resonances were now 
observed in the 
1
H NMR spectrum of the product with coupling constants consistent 
with (Z)-geometry: C(11) δ = 5.47 ppm; C(12) δ = 5.88 ppm; J11,12 = 10.7 Hz. The 
spectroscopic data that pertains to the double bond geometry also closely matched  
 
 
Figure 4.1 Comparison between the olefinic regions of the 500 MHz 
1
H NMR spectra for (a) 
vinyl iodide 278; and (b) enyne 270. In Figure (b), proton assignments are as follows:               
right-most peaks: C(11); left-most peaks: C(12).  
(a) 
(b) 
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that obtained for the previously synthesised TBS-free β-hydroxyketone 243, and 
indeed deprotection of silyl ether 270 would later confirm that the correct geometry 
had been obtained (see: Section 4.4.3). Confirmation of the successful synthesis of 
the C(10)–C(12) (Z)-enyne allowed the latter stages of the fragment synthesis to be 
investigated. 
 
4.4 Fragment Completion 
4.4.1 Weinreb Amide Synthesis 
 
Scheme 4.12 Proposed synthesis of the enone 271 from ester 270. 
The remaining steps of the fragment synthesis involved the introduction of the 
C(17)–C(19) (E)-propene group to generate the enone 271 – the TBS-protected form 
of our target fragment 86. This would involve conversion of the C(16) methyl ester 
to its corresponding Weinreb amide 217, and subsequent reaction of this key 
intermediate with an appropriate Grignard reagent (Scheme 4.12). As a starting point 
in the synthesis of the Weinreb amide 217, ester 270 was added to a THF/hexane 
solution of 6 equivalents of in situ generated lithium N,O-dimethylhydroxylamide 
(prepared by treatment of N,O-dimethylhydroxylamine hydrochloride with a               
two-fold excess of 
n
BuLi) at –78 °C followed by warming of the reaction to room 
temperature. Application of these conditions (Table 4.2, Entry 1) to two runs led to 
incomplete conversion as judged by TLC, and only a 58 and 55% isolated yield was 
obtained, albeit with some recovery (26%) of the reactant ester 270 on the second 
run. Purification was also complicated by column streaking, possibly due to residual 
lithium salts in the crude mixture, unidentified side reactions of the reactant ester 
270, or decomposition or further reaction of the product Weinreb amide 217. 
Although column streaking was inconvenient, results were promising at this stage 
and it was thought that insufficient reagent quantities were used in the reaction and 
therefore the quantities of 
n
BuLi and N,O-dimethylhydroxylamine hydrochloride  
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BuLi 10 THF –78 to 25 1 54 
9 3 
i
PrMgBr 6 THF 0 to 25 2 0 
10 3 
i
PrMgBr 6 THF 72 4 0 
11 3.3 
i
PrMgCl 6 THF –78 4 0 
12 3.3 
i
PrMgCl 6 THF 0 to 25 24 0 
13 3 
i





6 THF 72 20 0 
15 3 AlMe3 3 THF 25 to 72 24 0 
16 3 AlMe3 6 THF 72 18 0 
17 3 AlMe3 3 PhMe 110 18 0 







 25 6.5 0 
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Organometallic reagent carrier solvents  were 
also present and typically accounted for 10 to 33% of the solvent mixture. The carrier solvents for each 




PrMgBr (2-MeTHF), AlMe3 (Entry 16: 
Hexane, Entry 18: Heptane); 
d
As determined by 
1
H NMR of the crude material unless otherwise stated;
 
e
Isolated yields over six runs; 
f
Two runs under these conditions of reagent loading and temperature were 
attempted; 
g
Reaction was performed with the free amine as opposed to the hydrochloride salt; 
h
Performed 
under an air atmosphere; 
i
Ratio THF:H2O = 5000:1. 
 
were increased (Table 4.2, Entries 2 and 3). In accordance with these predictions, the 
use of a large excess of the Weinreb lithium amide (9 eq) gave quantitiative 
conversion to the desired product when performed on a small scale (0.1 mmol 270; 
Table 4.2, Entry 3). Unfortunately, attempts to scale up this reaction (~20 mmol) led 
to a very poor isolated yield (13%) of the desired product; distinctly worse than our 
initial conditions. Furthermore, on chromatographic purification, the recovered ester 
270 co-eluted with a side product (Figure 4.2), which was identified by NMR 
spectroscopy as enone 288. This indicates that either the starting material 270 or 




Figure 4.2 Enone side product 288 obtained from attempted amidation. 
(more likely) the product 217 cyclises under the harshly basic conditions.  
This cyclisation can be explained by both the Thorpe–Indold effect
154
 – which 
describes kinetically favoured cyclisation of a sterically hindered molecule 
containing gem-dimethyl substituents – and the thermodynamic stability associated 
with the highly conjugated π-system which would be formed on elimination of the 
leaving group. It is possible that the formation of enone 288 occurs as a result of the 
amide base acting as a nucleophile and a leaving group, by analogy with amines used 
to mediate the Baylis–Hillman reaction.
155
 Nucleophilic attack on the C(11) position 
of 217 leads to attack by the olefin on the carbonyl group and formation of the ring            
Int-289a in a 5-exo-trig fashion (Scheme 4.13a). Deprotonation of the ketone to 
generate the lithium enolate Int-289b followed by expulsion of the amino group as its 
lithium amide gives the product enone 288. Alternatively, the reaction may proceed 
by deprotonation of the propargylic methyl group under the harshly basic reaction 
conditions to generate the intermediate allene Int-290a. Deprotonation of the ketone 
α-proton to afford the lithium enolate Int-290b, followed by regeneration of the 
ketone and enyne moieties via proton transfer gives the product enone 288. 
The scale would be of importance due to the increased time required for the reaction 





















































Scheme 4.13 Possible mechanisms for the formation of enone 288. 
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process of raising the temperature would, with a larger volume, have a longer                 
time-frame to undergo cyclisation or an alternative pathway of decomposition. 
Unfortunately, use of a higher temperature was a necessity, because the substrate 270 
failed to react when the temperature was maintained at –78 °C (Table 4.2, Entries 4 
and 5) and appeared incomplete by TLC below room temperature. This implied that 
procedures involving the use of 
n
BuLi were perhaps not suitable for large-scale 
preparation because the harsh conditions required for complete conversion were 
counteracted by the increased time required to warm the mixture to temperatures 
suitable for formation of the Weinreb amide, and this led to product decomposition  
It was speculated that LiCl formed in the reaction of 
n
BuLi with the hydrochloride 
salt may promote side reactions;
156
 and as described above, the procedure suffered 
from difficulties during purification, possibly related to the large stoichiometry of the 
lithium amide. In an attempt to remedy these problems simultaneously, the reaction 
was performed using freebase N,O-dimethylhydroxylamine, which would require 
only 1 equivalent of 
n
BuLi to form the lithium amide and would not liberate LiCl as 
a byproduct (Table 4.2, Entries 6 to 8). Unfortunately, a large excess of the lithium 
amide (12 eq) was required for only 54% formation product 217, and therefore this 
means of amidation was not further investigated. Interestingly, the diminished 
reactivity in the absence of the byproduct LiCl indicates that the efficiency of the 
ester-to-amide transformation must be increased by the salt’s presence. This could be 
a consequence of the ability of LiCl to separate organometallic aggregates,
157
 thereby 
liberating monomeric lithium amide to react with the substrate. 
Given the disappointing results obtained on using 
n
BuLi, alternative organometallic 
coupling reagents were briefly investigated. Isopropylmagnesium bromide and 
chloride are often used for ester-to-amide transformations
158
 and therefore 
represented obvious alternatives. Disappointingly however, use of these 
organometallic coupling reagents led to no reaction with our methyl ester 270 over a 
range of temperatures (Table 4.2, Entries 9 to 14). Lewis acidic AlMe3 was also 
ineffective (Table 4.2, Entries 15 to 17), even under harsh conditions (110 °C). 







(Table 4.2, Entries 18 and 19) were also investigated, but both showed the presence  
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of only unreacted starting material on examination of the crude 
1
H NMR spectrum. 
Since a successful optimisation of the reaction conditions did not seem to be 
forthcoming, the initial conditions – which involved 6 equivalents of 
n
BuLi and 3 
equivalents of the Weinreb amine hydrochloride salt – were deemed the best for 
completion of the fragment. Unfortunately, this set of conditions also proved to be 
problematic on repetition, because capricious yields of Weinreb amide 217 – which 
ranged between a very poor 34% and a more respectable 67% – were obtained over a 
number of runs on a range of reaction scales.  
Given that quantitative conversion was achieved on reaction of the ester 270 with 9 
equivalents of the lithium amide on a small scale, it is possible that high yields may 
be achieved on conducting the reaction using a flow reactor.
161
 Under flow 
conditions, the inherently small scale of the reaction would allow the continuous 
generation of small quantities of the product, as opposed preparing the product in a 
large-scale (batch) process, the latter of which was found in the current study to be 
problematic. However, a microreactor for conducting a flow reaction was not 
available, and so an alternative route to the Weinreb amide 217 was required to be 
investigated. Fortunately, sufficient quantities of 217 were isolated from the 
reactions described to allow an investigation into the Grignard reaction, which was 
required for completion of the C(10)–C(19) fragment. 
 
4.4.2 Installation of the C(16)–C(19) Propene Group 
 
Scheme 4.14 Proposed routes towards the installation of the C(16)–C(19) propene group in 
the synthesis of the C(10)–C(19) fragment. 
 
The penultimate step of the fragment synthesis involved Grignard addition with the 
Weinreb amide 217 to generate the corresponding enone 271, either through direct 
formation of the enone with 1-propenylmagnesium bromide, or by use of 
allylmagnesium bromide followed by double bond isomerisation of allyl derivative  




Reagents and conditions: (a) TBSOTf (1.3 eq), 2,6-lutidine (2.0 eq), DCM, –78 °C, 1.5 h, 99%; (b) (i) 
HNMe(OMe)•HCl (1.5 eq), 
n
BuLi (3.0 eq), –78 °C to rt, 20 min; (ii) 292, THF/hexane (1:1), –78 °C to rt, 1.5 h, 73%. 
Scheme 4.15 Synthesis of the model Weinreb amide 293 for Grignard addition screening. 
 
291 with a non-nucleophilic base (e.g. Et3N, Scheme 4.14). However, due to the 
difficulties encountered on attempted synthesis of Weinreb amide 217, and the large 
degree of steric crowding in the molecule, this addition was not considered to be a 
formality. 
A model system 293 was therefore synthesised by TBS protection of alcohol 206 and 
subsequent conversion of the ester 292 to the Weinreb amide;
162
 a two-step sequence 
which proceeded in 72% yield overall (Scheme 4.15). Interestingly, the amidation 
step proceeded cleanly, with only a slight excess (1.5 eq) of the lithium amide 
required to provide product 293 in good yield. Although cyclisation is unlikely to be 
an issue with 293, this result highlights the influence of the enyne group on the rate 
and success of the amidation reaction, because harsh conditions were required with 
our substrate 217 to achieve quantitative conversion. Regardless, this model system 
used in conjunction with our fragment Weinreb amide 217, would allow the correct 
Grignard reagent for introduction of the propene group to be identified. 
 
4.4.2.1 Reaction with 1-Propenylmagnesium Bromide 
The most direct route towards the introduction of the propene group to our fragment 
would involve the use of 1-propenylmagnesium bromide, because a successful 
reaction with this reagent with high (E)-selectivity would negate the need for a 
subsequent isomerisation step. Our initial screening studies (Table 4.3, Entries 1 to 
3) involved treatment of Weinreb amide 293 with an excess of this reagent in THF at 
0 °C and quenching with an aqueous solution of NH4Cl. After a reaction time of            
2.5 h, treatment with two-, three- and fivefold excesses under these conditions led to 
only moderate conversion (30 to 58% by 
1
H NMR) of the starting material to enone 
products 294; these results easily determined by 
1
H NMR through the comparison in  
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1 2 0 0 2.5 71:29 30 
2 3 0 0 2.5 77:23 55 
3 5 0 0 2.5 83:17 58 
4
d
 3 25 25 2.5 nd Trace 
5 3 25
 
0 2.5 — 0 
6 3 25 0 24 — 0 
7 3 –10 –10 2.5 70:30 10 
8 3 –78 –78 2.5 — 0 
9 3 0 –78 5 83:17 17 
10 3 0 0 5 85:15 32 
11 3 0 0 0.25 88:12 17 
a
RMgBr = 1-propenylmagnesium bromide; 
b
As determined by 
1
H NMR of the crude material; 
c
Combined yield of both stereoisomers; 
d
Reaction mixture was treated with ultrasonic vibration. 
 
magnitude of the integrals of the Weinreb amide 293 NCH3 peak (δ = 3.20 ppm), 
with the sum of the product 294 C=CCH3 peaks (δtrans = 1.91 ppm, δcis = 2.07 ppm). 
It also became apparent that the crude material contained a marked proportion (up to 
19%) of the undesired (Z)-isomer 294b in all cases; the stereochemistry and product 
ratio identified through comparison of the olefinic coupling constants (Jcis = 11.7 Hz, 
Jtrans = 15.1 Hz) in the product alkenes and their relative integral intensities, 
respectively. Because a mixture was obtained, this indicated immediately that an 
additional isomerisation step to obtain the (E)-isomer 294a exclusively would be a 
likely requirement following Grignard addition, but this was predicted to be easily 
effected through treatment of the isomeric mixture 294 with a non-nucleophilic base 
and consequently conversion to both isomers was deemed acceptable – even if 
inconvenient – in this reaction sequence. 
At this stage it was unclear whether the unsatisfactory conversion was due to a 
straightforward lack of reactivity at the hindered carbonyl centre; or poor quenching, 
resulting in disruption of the reagent complexation to the Weinreb amide
163
 on 
addition of the aqueous solution.
164
 To investigate this supposition, the reaction was 
performed using ultrasonic vibration; and at both increased and decreased 
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temperature relative to our initial conditions (Table 4.3, Entries 4 to 6). Since the 
difference in the extent of conversion observed in Entries 2 and 3 was only marginal, 
3 equivalents of the Grignard reagent were used in each reaction. 
Use of ultrasound, as performed somewhat successfully with Weinreb amide 194 in 
our convergent route to the C(10)–C(19) fragment (see: Chapter 3, Section 3.5), 
was attempted; but this was ineffectual, leading to only trace conversion (Table 4.3, 
Entry 4). On conducting the reaction over a range of temperatures (25, –10 or               
–78 °C; Table 4.3, Entries 5 to 8), only reaction at –10 °C gave any conversion to the 
desired enones 294, and in poor yield, implying that 0 °C was the optimum 
temperature for the reaction from the conditions screened. Using this temperature              
(0 °C) but reducing the quench temperature to –78 °C (Table 4.3, Entry 9) did not 
improve the yield, nor did shortening or lengthening the reaction time (Table 4.3, 
Entries 10 and 11); it was therefore concluded that the modifications made to the 
conditions offered no advantages over our initial protocol (Table 4.3, Entry 2).  
Because these results were disappointing and indicated that reaction with                           
1-propenylmagnesium bromide was particularly disfavoured, the use of this Grignard 
reagent – which was expensive, and in any case was supplied as a mixture of isomers 
– was abandoned in favour of using an allylation/isomerisation approach. 
 
4.4.2.2 Reaction with Allylmagnesium Bromide 
 
Reagents and conditions: (a) AllylMgBr (6.0 eq), Et2O, –20 to –78 °C, 1.5 h; (b) Et3N, 60 h, rt, 91%, 96:4 E:Z. 
Scheme 4.16 Model Grignard addition with allylmagnesium bromide. 
Attention was focussed on a two-step procedure involving initial Grignard addition 
of allylmagnesium bromide to the Weinreb amide followed by isomerisation with a 
non-nucleophilic base.  Use of such a protocol would carry cost advantages, and the 
additional step was deemed inconsequential owing to the likely requirement for an 
additional (isomerisation) step in the direct route with 1-propenylmagnesium 
bromide. Thus, freshly prepared allylmagnesium bromide (6 eq) was added to the 
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model Weinreb amide 293 at –20 °C. After 1.5 h followed by quenching at                   
–78 °C,
165
 excellent conversion (91%) to the ketone product 295 was observed by 
1
H 
NMR, while stirring of the crude product for 60 h at room temperature in Et3N led to 
almost exclusive (96:4 E:Z) formation of the (E)-enone product 294a (Scheme 4.16). 
The success in obtaining useful conditions for Grignard addition with the model 
system 293 would go on to provide an excellent basis for the reaction of 
allylmagnesium bromide with our fragment Weinreb amide 217 (Scheme 4.17), 
although a slight increase in reagent quantity was used to ensure quantitative 
conversion and to account for additional steric hindrance present in the fragment 
Weinreb amide 217. Thus, treatment of 217 with 8 equivalents of freshly prepared 
allylmagnesium bromide at –20 °C followed by quenching at –78 °C with saturated 
aqueous NH4Cl gave, gratifyingly, quantitative conversion to the ketone product 296 
after 2 h. Unfortunately, isomerisation with Et3N according to the conditions used for 
the model system did not lead to satisfactory stereoselectivity in the resulting enone 
(~1:1 E:Z). However, this proved to be a minor problem and was easily remedied 
through the addition of DBU
24
 and heating (50 °C) of the Et3N solution of 296; and 
these conditions, upon repetition of the experiment, gave the product TBS-protected                                  
β-hydroxyenone 271 in 81% yield with excellent stereoselectivity (98:2 E:Z). 
The final step of the reaction sequence involved removal of the silyl protecting 
group, and it was envisaged that acidic conditions or a fluoride source would lead to 
successful silyl cleavage and generation of the free alcohol 86. Reaction of                 
TBS-ether 271 with TFA in THF led only to moderate yield (48%) of the deprotected 
product 86, and rather discouragingly required a large reagent excess (60 eq) and 
stirring overnight of the reaction mixture. Similarly, attempted fluoride-mediated 
deprotection with TBAF at reflux in THF was unsatisfactory and led to a complex 
mixture of products, with β-hydroxyketone 86 not detected by 
1
H NMR of the crude 
 
Reagents and conditions: (a) AllylMgBr (8.0 eq), Et2O, –20 to –78 °C, 2 h; (b) DBU (4.0 eq), Et3N (20 eq), 50 °C, 
18 h, 81% (2 steps), 98:2 E:Z. 
Scheme 4.17 Grignard addition to synthesise protected C(10)–C(19) fragment 271. 




Reagents and conditions: HF (30 eq), MeCN/H2O (~5:1), 0 °C to rt, 45 min, 85%. 
Scheme 4.18 Silyl deprotection to complete the synthesis of the C(10)–C(19) fragment 86. 
material; although this could possibly be ascribed to the use of poor quality reagent 
or reagent decomposition owing to the use of elevated temperature. Pleasingly 
however, use of 48% aqueous HF led to clean, quantitative deprotection of the silyl 
ether 271 and required a reaction time of only 1 h at room temperature; and, on  
scale-up (~6 g), an excellent yield (85%) of the alcohol product 86 was obtained after 
cautious aqueous workup and flash chromatography Scheme 4.18). It is worth noting 
that the addition–isomerisation–deprotection sequence may be telescoped to give the 
β-hydroxyketone in up to 68% yield, which is almost identical to the yield obtained 
with purification at each step (69%). These steps concluded the synthesis of the               
C(10)–C(19) fragment 86 of disorazole C1, but given the capricious yield obtained 
for the Weinreb amide 217 synthesis from ester 270, work still remained to be done 
to establish whether or not the route could be made more reliable.  
The alternative options (Scheme 4.19) without deviating from the use of the Weinreb 
amide as a means of introducing the propene group can be reduced to either: (i) base 
hydrolysis and conversion of the resulting acid 297 to Weinreb amide 217 using one 
of the multitude of acid or peptide coupling reagents available
166
 (Approach A, 
Scheme 4.19); or (ii) carrying out an early-stage silyl deprotection and completing 
 
Scheme 4.19 Alternative routes towards the fragment 86. 
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the fragment by Grignard addition with the Weinreb amide 194 (Approach B, 
Scheme 4.19) which we already knew from previous work (see: Chapter 3, Section 
3.5) would be successful, at least when it came to conversion of the ester 243 to the 
amide 194. The resulting Weinreb amide 194 could either be reacted directly with a 
Grignard reagent to complete the fragment in an identical number of steps, or if 
unsuccessful, reprotected and reacted with the Grignard reagent with a second, final 
deprotection completing the target C(10)–C(19) fragment.  
 
4.4.3 Early-Stage Deprotection and Grignard Reaction 
 
Reagents and conditions: (a) NaOH (10 eq), H2O, reflux, 18 h; (b) KOH (50 eq), H2O, reflux, 18 h. 
Scheme 4.20 Attempted base hydrolysis of ester 270. 
On investigating Approach A, alkaline hydrolysis of the methyl ester (which it was 
thought may also deprotect the TBS-ether concomitantly given the high temperature, 
Scheme 4.20) was found, surprisingly, to be unsuccessful even under forcing 
conditions (heating, large base excesses) and gave only unreacted starting material. 
This route was therefore ruled out immediately; and hence, without using the 
unreliable set of conditions described above, the only remaining option proceeding 
from ester 270 involved using an early stage deprotection approach (Approach B, 
Scheme 4.19) as the method of obtaining a useful Weinreb amide.  
To perform the silyl deprotection, TBS-ether 270 was treated with 48% aqueous HF 
in MeCN to give the product alcohol 243 in quantitative yield (99%; Scheme 4.21). 
Reaction of 243 with 4 equivalents of the Weinreb lithium amide at –78 °C and 
warming of the reaction to room temperature gave the product amide 194 in 82% 
yield on a large scale (~7 g; Scheme 4.21); which was comparable to the excellent 
yield (88%) obtained when performed on a smaller scale (~0.5 g) during our earlier 
convergent efforts towards the generation of Weinreb amide 194 (see: Chapter 3, 
Section 3.5). The final question that remained to be answered in our fragment 
synthesis was whether this Weinreb amide 194 could be converted directly to the           




Reagents and conditions: (a) HF (30 eq), MeCN/H2O (~5:1), 0 °C to rt, 1 h, 99%; (b) (i) HNMe(OMe)•HCl (4.0 eq), 
n
BuLi (8.0 eq), –78 °C to rt, 30 min; (ii) 243, THF/hexane (1:1), –78 °C to rt, 1.5 h, 82%. 
Scheme 4.21 Silyl deprotection and Weinreb amide 194 synthesis. 
β-hydroxyketone 86 using allylmagnesium bromide and isomerisation to the                 
(E)-enone, or whether a reprotection of the alcohol 194 and subjection of the product 
217 to the conditions outlined in the previous section was required. 
In order to gain clarity into which of these was the preferred option, Weinreb amide 
194 was subjected to the Grignard addition conditions which were found to be 
successful for its TBS-protected derivative 217, but this still left some 35% of the 
starting material unreacted (
1
H NMR). Doubling the quantity of Grignard reagent 
(from 8 to 16 eq) led to >90% consumption of the starting material, assumed to be 
complete conversion to the desired ketone product 86. Unfortunately, the product              
β-hydroxyketone 86 was accompanied by the di-addition product 299, with these 
compounds obtained in 22 and 34% isolated yields, respectively (Scheme 4.22). On 
closer inspection of the crude 
1
H NMR spectrum, this undesired di-addition at the 
carbonyl group should have been identified during screening due to the presence of 
the allylic CH (2H, δ = 6.04–5.93 ppm) and CH2 (4H, δ = 5.18–5.11 ppm) 
resonances, but was missed because of the complex overlapping peaks in this region. 
The remainder of the mass balance in this reaction was unaccounted for, but was 
presumably lost owing to the multiple chromatographic purifications that were used 
to separate the two products which had very similar polarity in a number of solvent 
systems and appeared as a homogenous, single product by TLC under the 
hexane/EtOAc conditions normally used in purification. Fortunately, the valuable  
 
Reagents and conditions: (i) AllylMgBr (16 eq), Et2O, –20 to –78 °C, 1 h; (ii) DBU (5.0 eq), Et3N (20 eq), 50 °C, 18 
h, 86 22%, >99:1 E:Z, 299 34%. 
Scheme 4.22 Reaction between allylmagnesium bromide with Weinreb amide 194. 




Reagents and conditions: (a) TBSOTf (1.3 eq), 2,6-lutidine (2.0 eq), –78 °C to rt, 2 h, 96%; (b) See: Scheme 4.17, 
and Scheme 4.18. 
Scheme 4.23 TBS protection of β-hydroxy-Weinreb amide 194 and fragment 86 completion. 
β-hydroxyketone 86 was recovered after careful separation using a DCM/Et2O 
eluent, but time constraints prevented a more complete optimisation of the reaction to 
limit the formation this unwanted side product; so in light of these results, the best 
route from TBS-protected β-hydroxyester 270 (from Scheme 4.19) would involve 
silyl deprotection, conversion of the ester 243 to the Weinreb amide 194, and 
reprotection of the alcohol 194 as its TBS ether. Thankfully, TBS protection of the  
β-hydroxy-Weinreb amide 194 under standard conditions gave the product                
TBS-ether 217 in 96% yield; submission of 217 to the conditions detailed above 
gives the C(10)–C(19) fragment of disorazole C1 86 (Scheme 4.23). 
 
4.5 Conclusions and Future Work 
The synthesis of the C(10)–C(19) fragment 86 of disorazole C1 was achieved in 13 
steps, 28% yield and 88 to 89 %ee from aldehyde 244 (Scheme 4.24), or 16 steps 
and 19% yield from commercially available PMBOH; and the preparation of this 
fragment represented a key triumph in our goal of successfully completing the total 
synthesis of disorazole C1 and its analogues according to our ET–AM methodology. 
Despite this success, carrying out the route highlighted inherent problems associated 
with reproducibility at key steps and the apparently unavoidable requirement for the 
use of extra protecting groups. 
The purpose of this section is to highlight one further study towards the synthesis of 
fragment 86 (which for reasons of relevance was not outlined above); and to offer 
alternative, improved syntheses of the required fragment for future investigation. 




Scheme 4.24 Overall synthesis of the C(10)–C(19) fragment 86 of disorazole C1. 
 
4.5.1 Early Installation of the Weinreb Amide 
The main problem encountered in carrying out the synthesis of the C(10)–C(19) 
fragment 86 was the difficulty in installing the C(16) Weinreb amide. It was 
suggested in Section 4.4.2.2 that either a base hydrolysis or a silyl deprotection, 
followed by amidation of the ester moiety, could give a reliable route to the Weinreb 
amide 217. The deprotection route was the one that was ultimately successful, albeit 
requiring an additional two steps relative to the planned route to successfully 
complete the fragment; but it is worth noting that a third option was briefly explored.  
This alternative route required early-stage conversion of the ester moiety in the aldol 
product 245 to its corresponding Weinreb amide 300 followed by installation of the 
(Z)-enyne; with a Grignard addition and silyl deprotection used to complete the 
C(10)–C(19) fragment 86 (Scheme 4.25). To investigate this route (Scheme 4.26), 
aldol product 245 was subjected to amidation conditions, which involved treatment 
of ester 245 with 3 equivalents of Weinreb’s lithium amide to give the product 300 in  
 
Scheme 4.25 Proposed forward synthesis with early Weinreb amide installation. 




Reagents and conditions: (a) (i) HNMe(OMe)•HCl (3.0 eq), 
n
BuLi (6.0 eq), –78 °C to rt, 35 min; (ii) 245, 
THF/Hexane (2:1), –78 to 0 °C, 1.5 h, 78%; (b) TBSOTf (1.3 eq), 2,6-lutidine (2.0 eq), DCM, –78 °C, 2.5 h, 94%. 
Scheme 4.26 Successful steps in the early-stage installation of the Weinreb amide. 
78% yield. TBS protection of 300 under standard conditions provided a precursor 
301 for generation of the (Z)-enyne. 
Unfortunately, attempted oxidative cleavage of the PMB-ether 301 with DDQ to 
reveal the primary alcohol 302 did not lead to the expected product, and instead 301 
was converted to a 6-membered-ring lactone 303 in excellent yield (86%; Table 4.4, 
Entry 1). A change of reagent to CAN also led to quantitative conversion to this 
product 303, as determined by 
1
H NMR of the crude material (Table 4.4, Entry 2). 
As such, one final standard deprotection protocol was attempted, and this involved 
catalytic hydrogenation of the PMB-ether 301 in the presence of 10% Pd/C. 
Although this procedure seemed promising because the desired alcohol 302 was the 
major product observed by 
1
H NMR (Table 4.4, Entry 3), the highly unstable 
synthetic intermediate decomposed on attempted flash chromatography to give the 
lactone 303 in quantitative yield (99%).  
Attempts to counteract this instability by immediate conversion of the crude product 
302 to the aldehyde 304 using a Swern oxidation failed, and gave only unreacted 
starting material (Scheme 4.27). Consequently, as a result of the instability of the 
intermediate alcohol 302, which we believed could prove problematic in large-scale 
preparation, this approach to the fragment’s synthesis was discontinued.  








Yield 302 Yield 303 
1 DDQ DCM/H2O (18:1) 1 0 86 
2 CAN MeCN/H2O (9:1) 1 0 ~100
a
 










As determined by 
1
H NMR of the crude material; 
b
Isolated yield after flash chromatography. 
 




Reagents and conditions: (a) H2, Pd/C (25 mol%), MeOH, 24 h, assumed quant; (b) (i) (COCl)2 (2.0 eq), DMSO 
(6.0 eq), DCM, –78 °C, 20 min; (ii) Crude 302, 1 h; (iii) Et3N (8.0 eq), –78 °C to rt, 0%. 
Scheme 4.27 Attempted synthesis of aldehyde 304 by Swern oxidation of crude 302. 
In hindsight it is perhaps unsurprising that the cyclisation was observed. On 
revealing the alcohol after deprotection, the ring-formation – likely to occur via a           
6-exo-trig cyclisation (Scheme 4.28a) – becomes highly favourable owing to the 
presence of a tethered nucleophile (hydroxyl group), the sterically hindered           
TBS-ether, the gem-dimethyl substituents and the formation of a 6-membered ring; 
all of which make the structure a prime candidate for cyclisation as a result of the 
Thorpe–Ingold effect.  
Previous studies have observed the same phenomenon with structurally similar 
substrates, for example, Weinreb amide 305
167a
 (Scheme 4.28b) and oxazolidinone 
308
167b
 (Scheme 4.28c) were both prone to a similar cyclisation, even in the absence 
of the gem-dimethyl substitutents, which implies that formation of a lactone is 
particularly favourable in the open chain δ-hydroxyamide structural motif. In the 
case of Weinreb amide 305, problems of cyclisation were overcome by recycling of 
any recovered lactone 307, through use of an alternative PMB-deprotection protocol 
(catalytic hydrogenation), and by the immediate use of the (crude) unstable alcohol  
 
Scheme 4.28 (a) Mechanism of the cyclisation observed on deprotection of PMB-ether 301. 
Cyclisation of structurally similar (b) Weinreb amide;
167a
 and (c) oxazolidinone substrates.
167b
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306. In the case of oxazolidinone 308, neutralisation of the commercially obtained 
silica gel used in purification allowed isolation of the alcohol product 309. 
 
4.5.2 Improvements to the Synthetic Route 
It became clear from our results that the size of the protecting group was a particular 
issue associated with our lack of success in obtaining a Weinreb amide from             
β-hydroxyester 270. Large steric bulk made the substrate vulnerable to cyclisation; 
and given that large excesses of the lithium amide were required for quantitative 
conversions (cf. free alcohol 243), the TBS group also acted to hamper the extent of 
the reaction, probably as a result of shielding the reaction site from the incoming 
nucleophile. One obvious way to remedy this problem would be to alter the identity 
of the protecting group from the start of the synthesis because a change to a smaller 
group may yield improved results at the problematic Weinreb amide synthesis stage 
of the reaction. On the basis of size, the conditions that must be withstood throughout 
our synthetic route, and the conditions allowable for deprotection of the final 
protected C(10)–C(19) fragment (which cannot be reductive), potential options 
include the TES, SEM, MOM, MEM and MTM groups.
144 
Of course, the ideal scenario would involve the generation of key fragments with 
minimal reliance on protecting groups, and this remains a possibility in the synthesis 
of the fragment 86. Hydrogenation of the PMB-ether 245 gives the diol 310, from 
which the aldehyde 311 could be obtained via a selective TEMPO oxidation;
168
 
giving a product that may be suitable for conversion to an enyne should a Wittig 
reaction in the presence of the free alcohol be successful
169
 (Scheme 4.29). This 
would give access to the Weinreb amide 194 (Scheme 4.29) from which the 
fragment can be synthesised, but would negate the requirement for the first 
protection/deprotection cycle. Instead of protection at the Weinreb amide 194 stage, 
 
Reagents and conditions: (a) H2, Pd/C (25 mol%), MeOH, rt, 18 h, 80%. 
Scheme 4.29 Potential protecting group free route to the Weinreb amide 194. 




Scheme 4.30 Enantioselective allylation/ozonoylsis route to key Weinreb amide 194. 
optimisation of the reaction conditions from Chapter 3, Section 3.5 – which used                                 
1-propenylmagnesium bromide to introduce the propene moiety and was, regrettably, 
not considered in our large-scale, linear approach – could give the product in a single 
step and as few as 8 steps overall from aldehyde 244, which would represent a 
sizable improvement to our synthetic route. 
One further route, which would not rely on an initial aldol reaction, involves the use 
of asymmetric allylation. Successful asymmetric allylation of aldehyde 195 (easily 
synthesised in two steps; see: Chapter 3, Section 3.2.2) would give homoallylic 
alcohol 199, which could be converted in a single step to a useful aldehyde 312 using 
ozonolysis (Scheme 4.30). This could then be transformed stepwise to the enyne 194 
from which the required fragment can be derived (Scheme 4.30).  
 
4.6 Summary 
The synthesis of the C(10)–C(19) fragment of disorazole C1 86 was successfully 
achieved in 16 steps, 19% overall yield and 88 to 89 %ee from commercially 
available starting materials. Key steps in the sequence included: an enantioselective 
Mukaiyama aldol reaction to generate the required (S)-stereochemistry at C(14) 
inspired by the work of Hoffmann et al.; and a (Z)-selective Stork–Zhao                      
iodo-olefination reaction followed by a palladium-catalysed Negishi coupling to 
generate the C(10)–C(12) (Z)-enyne. Problems were encountered during the 
installation of the C(17)–C(19) (E)-propene group owing to the difficulty in 
synthesising the Weinreb amide required to introduce the olefin. The best route was 
found to involve a deprotection, amidation and reprotection strategy, followed by 
Grignard addition and a final silyl deprotection. Although this is laborious, the 
approach reliably gave high yields at each reaction step and avoided the need to cope 
with capricious yields and the formation of side products at advanced stages of the 
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fragment synthesis. The main improvements required to be addressed in the future 
have also been highlighted, which would involve reduction in the number of steps 
and use of alternative protecting groups to prevent side reactions; alternative 
fragment preparations have also been proposed. With gram quantities of the key 
fragment now able to be synthesised in high enantiopurity, attention could now be 
focussed on the Evans–Tishchenko reaction which we hoped would lead to the 





Chapter 5              Results and Discussion 4 
 Evans–Tishchenko Coupling of Model Heterocycles 
5.1 Introduction 
The synthesis of the C(10)–C(19) β-hydroxyketone fragment 86 of disorazole C1 
proved to be a turning point in our approach towards the synthesis of the natural 
product since, with this fragment now in hand, attention could be focussed on the key 
Evans–Tishchenko (ET) coupling step of our proposed ET–AM strategy. ET 
coupling
36
 is the Lewis acid catalysed reaction between a β-hydroxyketone and an 
aldehyde to generate a 1,3-anti diol monoester (Scheme 5.1a), and was first 
demonstrated by Evans and Hoveyda. For example, in their studies, β-hydroxyketone 
313 was found to react with MeCHO in the presence of SmI2 to give 1,3-anti diol 
monoester 314 in excellent yield and diastereoselectivity (Scheme 5.1b).
36a
 The 
mechanism of the reaction (Scheme 5.1c) is believed to involve a Lewis acid 
catalysed hemiacetal formation, followed by intramolecular hydride transfer from the 
aldehyde to the newly formed carbinol centre via a 6,6-chair type transition state                
(TS-315), and it is the intramolecular delivery of the hydride in the aforementioned 
conformation that accounts for the observed anti-diastereoselectivity in the product.
36
  
The most common reagent used as the Lewis acid in the ET reaction is SmI2,
36b,170
 
although active species in the reaction is not the Sm(II) species. Instead, reaction of  
 
Scheme 5.1 (a) General Lewis acid catalysed ET reaction; (b) example ET reaction from 
Evans and Hoveyda’s initial publication; (c) mechanism of the SmI2-mediated ET reaction.
36a 




Scheme 5.2 (a) Formation of the active samarium pinacol adduct catalytic species;
36b,170a
 (b) 
use of a sacrificial aldehyde in ET coupling.
36b 
 
SmI2 with an aldehyde generates a pinacol intermediate Int-316, (Scheme 5.2a) and 
it is this species that is the active catalyst in ET coupling.
36b,170a
 Since an equivalent 
of an aldehyde is required to generate the active samarium pinacolate catalyst, it 
would be wasteful to use an aldehyde which was a valuable synthetic intermediate 
for this purpose. Fortunately, an inexpensive sacrificial aldehyde (e.g. PhCHO) can 
be used to generate the active catalyst before addition of the reactant aldehyde for 
reaction with a β-hydroxyketone (Scheme 5.2b).
36b 
 
5.1.1 Applications of Evans–Tishchenko Coupling 
The ET reaction has found extensive use in natural product synthesis, and its various 
applications can be broadly categorised to include protection/asymmetric induction, 
and fragment coupling. Because these applications have been recently reviewed,
36b
 a 
thorough background that deals with the use of the ET reaction in natural product 
synthesis is not presented herein. However, a brief description of these processes is 
worthy of note in the context of the current study.  
In the protection/asymmetric induction strategy (Scheme 5.3a), an ET reaction is 
used to set, from a β-hydroxyketone, 1,3-anti stereochemistry in a diol unit in the 
target molecule. In the process this generates what is effectively a mono-protected 
1,3-anti diol 317; the free hydroxyl group may then be protected as, for example, a 
silyl or PMB-ether, giving a differentially protected 1,3-anti diol 318. This                  
bis-protected diol 318 may be carried forward through other steps in the synthesis of 
the target natural product, or the ester may be hydrolysed and an alternative 
protecting group installed before pursuing further steps; in either case, the diol may 




Scheme 5.3 Simplified schematic diagram showing two key applications of ET coupling:            
(a) protection/asymmetric induction; and (b) fragment coupling. 
 
be differentially functionalised at a later stage of the synthesis by selective cleavage 
of the protecting groups.
36b
 An alternative strategy involves immediate ester 
hydrolysis following ET coupling, and subsequent installation of a diol protecting 
group (e.g. an acetonide), with the diol revealed at a later stage of the synthesis.
171
 
ET fragment coupling, as the term suggests, involves the combination of two 
advanced synthetic intermediates which are to be incorporated into the framework of 
the target molecule (Scheme 5.3b). The use of ET coupling for this purpose is 
comparably rare (cf. protection/asymmetric induction),
36b
 owing to the (typical) 
requirement for the use of an excess of the aldehyde component for successful ET 
coupling,
172
 although a small number of examples do exist of such a process being 
performed with only a modest excess (up to ~2 eq) of the aldehyde substrate.
172,173
  
One particularly noteworthy example, which was not previously reviewed, was 
reported by Fürstner in his synthesis of (–)-polycavernoside A.
172
 The                               
β-hydroxyketone 320 (synthesised in 13 steps) was coupled to the aldehyde 321 
(synthesised in 12 steps) to give the 1,3-anti diol monoester 322, impressively, in 
68% yield with only a 30% excess of the aldehyde 321 (Scheme 5.4a). A high 
catalyst loading and a reduced temperature (50 mol% SmI2, –50 °C) was required to 
achieve the transformation, because under more typical, higher-temperature 
conditions (35 mol% SmI2, –10 °C) the reaction led to formation of the                 
retro-aldol aldol–Tishchenko
36b,90,172,174
 product 324 (via reaction of enolate Int-323 
with aldehyde 321) in approximately equal quantity to the desired product 322  




Scheme 5.4 (a) Successful low-stoichiometry fragment coupling in Fürstner’s formal total 
synthesis of (–)-polycavernoside A; (b) formation of the RAAT product 324 observed at an 




(Scheme 5.4b; combined yield not reported). Nevertheless, the success obtained in 
this reaction represents a large advancement in the use of the ET methodology; and 
the results were particularly promising in light of the fragment coupling we intended 
to carry out in the current study, especially given the structural similarity of the 
reactant β-hydroxyketone to our own substrate. 
 
5.1.2 The Heteroaryl Evans–Tishchenko Reaction 
Critical to our efforts towards the synthesis of disorazole C1, ET coupling was 
recently shown to be successful with heteroaryl aldehydes.
90,174
 When                              
β-hydroxyketone 325 was allowed to react with a range of heteroaryl aldehydes in 
the presence of Sm(III), the product 1,3-anti diol monoesters Het-326 were obtained 
in excellent yields and dr (Scheme 5.5). A feature of this reaction was the difference 
in reactivity between electron-rich and electron-deficient heteroaryl aldehydes.
*
 The 
electron-deficient 3- and 4-formylpyridines 327/328, were found to react in the 
presence of only a catalytic quantity (10 mol%) of SmI2; but, by contrast,                 
electron-rich heteroaryl aldehydes [such as furans, (benzo)thiophenes, and the               
Boc-protected indole 333] required a stoichiometric loading of the Sm(III) pinacolate 
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catalyst (2 eq SmI2) for quantitative levels of conversion (Scheme 5.5).
90,174
 In both 
cases, the required Sm(III) pre-catalyst could (generally)
90
 be prepared by reaction of 
SmI2 with an equimolar quantity of the heterocyclic aldehyde, or by reaction with 
sacrificial PhCHO. 
Despite the successful coupling of a range of heteroaryl aldehydes, a number of 
substrates failed to undergo ET coupling. These included: aldehydes containing a 
nitrogen atom (e.g. oxazole 329), an amino group or a halogen (e.g. pyridine 330) at 
the 2-position relative to the formyl group; very electron-rich and N-unsubstituted               
1H-heterocycles (e.g. indole 331); and sterically hindered aldehyde substrates (e.g. 
N-Boc-pyrrole 332). Nevertheless, the heteroaryl ET reaction was highly successful 
with a number of substrates, and the results provide an excellent basis for 
investigation of our ET approach towards the C(1)–C(19) fragment of disorazole C1. 
 
Reagents and conditions: ET coupling with electron-deficient heteroaryl aldehydes: (a) (i) SmI2 (10 mol%), 
HetCHO (4.0 eq), THF, rt, 30 min; (ii) 325, 1 h; (b) (i) SmI2 (10 mol%), PhCHO (10 mol%), THF, rt, 30 min; (ii) 325, 
HetCHO (4.0 eq), 1 h; ET coupling with electron-rich heteroaryl aldehydes: (c) (i) SmI2 (2.0 eq), HetCHO (4.0 eq), 
THF, rt, 30 min; (ii) 325, –15 °C, 1 h; (d) (i) SmI2 (2.0 eq), PhCHO (2.0 eq), THF, rt, 30 min; (ii) 325, HetCHO (4.0 
eq), –15 °C, 1 h. 
Scheme 5.5 The heteroaryl Evans–Tishchenko reaction.
90,174
 
*For the purpose of both the present discussion and the work described throughout the remainder of 
this thesis, electron-rich heterocycles are defined as those whereby the number of π-electrons in the 
ring exceeds the number of atoms, and therefore includes most 5-membered-ring heterocycles and 
their benzo-fused derivatives. By contrast, electron-deficient heterocycles are 6-membered rings that 
contain an electron-withdrawing atom within the aryl framework (e.g. pyridine). The relative level of 
electron deficiency on comparing any two heterocycles (and indeed, in some cases, the appropriate 
definition for any one heterocycle) is dependent upon the identity of the substituents attached to the 
ring, in addition to the number of electron-withdrawing heteroatoms within the aryl framework, and 
their identities. 
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5.1.3 Retrosynthesis: C(1)–C(9)/C(10′)–C(19′) Fragment Analogues 
The heteroaryl ET study highlights heterocycles which would be promising 
candidates for development as C(1)–C(9) analogues, and identifies potential pitfalls 
in the ET approach towards the synthesis of the C(1)–C(9)/C(10′)–C(19′) 1,3-anti 
diol monoester bis-alkynes required for subsequent AM. The C(5)–C(9) alkyl 
substitution on the C(1)–C(9) heterocyclic aldehydes Het-85 provides negligible                      
electron-withdrawing capacity, which would not increase the likelihood of smooth 
coupling with the C(10)–C(19) β-hydroxyketone 86. Furthermore, unprotected                            
1H-N-heterocycles; and those containing a nitrogen atom, amino group or halogen at 
the α-position relative to the carbon atom bearing the formyl group are likely to fail. 
With these considerations in mind, three approaches towards the synthesis of             
C(1)–C(9)/C(10′)–C(19′) analogue fragments can be envisaged (Scheme 5.6). 
Approach A is the preferred route towards the synthesis of the required 1,3-anti diol 
monoesters Het-85/Het-336. In this route, the C(1)–C(9) heterocyclic aldehyde               
Het-85 couples directly with the C(10)–C(19) β-hydroxyketone 86 to give Het-84 in 
a single step; although depending on the functional group tolerance of the chosen 
AM catalyst, the free alcohol may be required to be protected (to give Het-336) prior 
to attempted ACM–RCAM dimerisation. Approach B represents a contingency 
strategy for use with N-heterocycles that only display reactivity in the ET reaction 
with β-hydroxyketone 86 when functionalised with an electron-withdrawing group. 
Following ET coupling of Het-334 with β-hydroxyketone 86, the alcohol is 
protected, the electron-withdrawing group is cleaved, and the heterocycle is               
N-alkylated by reaction with the C(5)–C(9) tosylate 95 to generate the desired 
product Het-336 (Scheme 5.6) 
Approach C follows the ET protection/asymmetric induction strategy and is a last 
resort for use only with heterocycles which fail to couple with either alkyl or 
electron-withdrawing N-substitution. β-Hydroxyketone 86 would be reacted with a 
sacrificial aldehyde (e.g. PhCHO) to give 1,3-anti diol monoester 337. The free 
alcohol would then be protected and the ester hydrolysed to give mono-protected diol 
338. Esterification of 338 with C(1)–C(9) heterocyclic carboxylic acids Het-111 
completes the synthesis of the protected bis-alkynes Het-336 (Scheme 5.6). 




Scheme 5.6 The ET approach towards the synthesis of C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol 
monoester bis-alkyne fragments and analogues Het-84/Het-336. 
 
5.2 Synthesis of Model N-Heterocycles 
5.2.1 Introduction 
It is necessary that a range of model heterocycles are reacted with β-hydroxyketone 
86 under ET coupling conditions with in order to determine the likely reactivity of 
their corresponding C(1)–C(9) fragment analogues Het-85. This also means that 
useful conditions for ET coupling can be found and the required route (Approach A 
to C) towards the synthesis of the bis-alkynes Het-84/Het-336 can be determined. 
Alkylation of N-heterocycles offers the most straightforward route towards the 
synthesis of heterocyclic analogues of disorazole C1.
16
 The C(1)–C(4) oxazole of 
disorazole C1 is a 1,3-disubstituted (or more specifically, based on the heteroatoms 
present, a 2,4-disubstituted) heterocycle, and therefore any N-heterocycles Het-339 
that bear the aldehyde (or a derivative) functionality at the 3-position relative to the 
nitrogen atom and can be readily N-alkylated (using tosylate 95) are suitable 
candidates for development as C(1)–C(9) analogues Het-85 (Scheme 5.7a).  




Scheme 5.7 Retrosynthesis of (a) N-heterocyclic C(1)–C(9) analogues Het-85; (b) model               
N-heterocyclic analogues Het-340. (c) Potential O→Sm chelation Int-342; and (d) the Boc 
group as a suitable electron-withdrawing group for N-heterocycles. 
 
Although a methyl group would perhaps be the most straightforward model                      
N-substitution, the 2-methoxyethanol derived tosylate 341 represents a superior 
model for the C(5)–C(9) N-alkyl substitution (Scheme 5.7b). Firstly, the presence of 
the methoxy group better replicates the subtle differences in electronics that may be 
present and would identify potential deleterious O→Sm chelation during the ET 
reaction (Int-342, Scheme 5.7c). Furthermore, use of this model would allow 
conditions for N-alkylation to be identified with a tosylate as opposed to, for 
example, an iodide or bromide, which potentially could offer different reactivity.  
To circumvent problems associated with poor reactivity of electron-rich 
heterocycles, protection of the nitrogen atom with an electron-withdrawing group 
was also necessary. For this purpose, the Boc group was chosen on the basis of both 
ease of synthesis, and its precedent in the heteroaryl ET reaction
90,174
 (Scheme 5.7d). 
A range of N-heterocyclic aldehydes were chosen for the ET model study, some of 
which were not studied previously. These included pyrrole, pyrazole, indole and 
triazole substrates, which could all be developed as analogues of the C(1)–C(9) 
fragment by either N-alkylation or (in the case of triazole) through use of the CuAAC 
reaction. A brief discussion of the syntheses of the relevant heterocycles along with 
N-Boc protection and N-alkylation will be presented in the following section. 
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5.2.2 Pyrrole and Indole Heterocycles 
 
Reagents and conditions: (a) (i) 
n
BuLi (1.1 eq), THF/hexane (~1:1), –78 °C, 30 min; (ii) TIPSCl (1.0 eq), 
THF/hexane (~1:1), –78 °C to rt, 30 min, absence of light, 98%; (b) (i) (COCl)2 (1.3 eq), DMF (1.3 eq), 0 °C, DCM, 
40 min; (ii) 345, DCM, reflux, 30 min, absence of light; (iii) NaOH (8.3 eq), H2O, rt, 18 h, 58%; (c) (i) (COCl)2 (1.2 
eq), DMF (10 eq), 1.25 h; (ii) 347, DMF, 0 to 40 °C, 2 h; (iii) NaOH (10 eq), DMF/H2O (~4:1), 100 °C, 20 min then 
DMF/H2O (~6:1), 4 °C, 18 h, 63%; (d) Boc2O (1.2 eq), DIPEA (2.2 eq), DMAP (5 mol%), DCM, 3 h, 73%; (e) Boc2O 
(1.2 eq), Et3N (2.2 eq), DMAP (5 mol%), THF, 24 h, 71%. 
Scheme 5.8 Synthesis of 3-formyl (a) -pyrrole 346; and (b) -indole 331 and their respective 
N-Boc derivatives (c) 348; and (d) 333. 
s 
The required 3-formylpyrrole and -indole substrates were synthesised using variants 
of the Vilsmeier protocol
175
 according to literature procedures. Gram-scale (~1.5 g) 
synthesis of 3-formylpyrrole 346 (Scheme 5.8a) was achieved by initial protection of 
freshly distilled pyrrole 344 as its N-TIPS-derivative 345 and subsequent Vilsmeier 
formylation with the iminium salt generated by reaction of (COCl)2 and DMF; basic 
workup (NaOH) gave the product aldehyde 346 in 58% yield.
176
 Preparation of                
3-formylindole 331 was accomplished in 63% yield directly from indole 347 using 
the Vilsmeier reaction followed by purification by recrystallisation
177
 (Scheme 5.8b). 
It is worth noting that Vilsmeier formylation of pyrroles normally occurs at the                
2-position.
176a
 Regioselectivity was controlled by the steric hindrance provided by 
the bulky TIPS group, which forces reaction at the 3-position and gives the 3-formyl 
derivative 346 selectively.
176a
 By contrast, indole preferentially reacts with 
electrophiles at the 3-position, and therefore N-protection was unnecessary.
178
 
Boc derivatisation was achieved in both cases using standard Boc coupling 
conditions. N-Boc-pyrrole 348 was synthesised in 73% yield by reaction of pyrrole 
346 with Boc2O in the presence of DIPEA and catalytic DMAP (5 mol%) in DCM
179
 
(Scheme 5.8c). N-Boc-indole 333 was synthesised analogously in 71% yield using 
Et3N as the auxiliary base and THF as the solvent (Scheme 5.8d). 
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5.2.3 Pyrazole Heterocycles 
 
Reagents and conditions: (a) (i) NaH (2.0 eq), ethyl formate (10 eq), Et2O, 0 °C to rt, 24 h; (b) Crude 350, 
H2NNH2•2HCl (1.2 eq), EtOH, 0 °C to rt, 50 h, 87% (2 steps); (c) NBS (1.0 eq), H2O, rt, 18 h, 90%; (d) Boc2O               
(1.2 eq), Et3N (2.2 eq), DMAP (5 mol%), THF, rt, 4 h, 354 91%, 355 91%; (e) Boc2O (1.0 eq), Et3N (2.2 eq), DMAP 
(5 mol%), THF, rt, 18 h, 92%. 
Scheme 5.9 Synthesis of (a) pyrazole ester 162; (b) pyrazole bromide 352; and (c) the             
Boc-protected derivatives 354, 355
184
 and 356 of 4-substituted pyrazoles 162, 352 and 353. 
 
Gram-scale (~6 g) preparation of pyrazole-4-ethyl ester 162 was achieved by 
condensation of ethyl formate and ethyl 3,3-diethoxypropionate 349 with NaH 
followed by acidic workup to give the crude bis-aldehyde 350. Reaction of 350 with 
hydrazine dihydrochloride gave the pyrazole 162 in 87% yield (2 steps; Scheme 
5.9a).
180
 Because the reduction of N-alkyl-pyrazole-4-esters to aldehydes is poorly 
precedented,
181
 and two-stage semi-reduction of N-Boc-pyrazole-4-ethyl ester 354 
was expected to be poor yielding,
182
 the synthesis of 4-halogenated pyrazoles was 
also performed to provide an alternate means of generating the aldehyde (after 
alkylation/Boc protection) should standard one- or two-step reduction protocols fail. 
Synthesis of 4-bromopyrazole 352 was accomplished by bromination of pyrazole 
351 with NBS (Scheme 5.9b).
183
 Boc protection of the pyrazole ester 162, bromide 
352,
184
 and commercially available iodide 353 was achieved in excellent yield 
(>91%) under standard Boc-protection conditions (Scheme 5.9c). 
The synthesis of N-Boc-4-formylpyrazole 357 proved to be particularly problematic 
and ultimately unsuccessful. Attempted semi-reduction of the ester 354 to the 
aldehyde 357 with lithium diisobutyl-tert-butoxyaluminium hydride (LDBBA)
185
 
(Scheme 5.10a) led only to quantitative Boc deprotection, although this was 
probably inadvertently effected during (acidic; HCl) quenching and aqueous workup. 
















































Reagents and conditions: (a) LDBBA (1.5 eq), THF, 0 °C, 3.5 h, 357 0%, 162 quant; (b) DIBAL (10 eq), THF,       
0 °C, 4 h, 6%; (c) (i) 
i
PrMgBr (1.3 eq), THF, 0 °C, 1 h; (ii) DMF (5.0 eq), rt, 1 h, 357 trace, 359 17% conv.; (d) (i) 
i
PrMgBr (1.3 eq), THF, 0 °C, 30 min; (ii) DMF (5.0 eq), rt, 1 h, 357 0%, 359 quant conv.; (e) (i) 
i
PrMgCl•LiCl (1.3 eq), 
THF, –15 °C, 30 min; (ii) DMF (5.0 eq), –15 to 0 °C, 2 h, 357 0%, 359 quant conv.; (f) (i) 
n
BuLi (1.3 eq), –78 °C, 
THF, 30 min; (ii) DMF (5.0 eq), –78 °C, 3 h, complex mixture. 
Scheme 5.10 Attempted synthesis of N-Boc-4-formylpyrazole 357. 
Two-stage reduction of the ester 354 via the intermediate alcohol 358 using DIBAL 
was also attempted with the intention of later MnO2 oxidation to the aldehyde 357.
182
 
However, reaction of the ester 354 with 3 equivalents of DIBAL led to no reaction 
(as determined by 
1
H NMR of the crude material), while an increase in the DIBAL 
stoichiometry to 10 equivalents gave quantitative conversion but a very poor isolated 
yield (6%) of the crude product and therefore oxidation was never attempted 
(Scheme 3.10b). The reasons for this poor result are unknown, but it is likely that the 
product 358 was either water soluble or remained chelated to residual aluminium 
salts during aqueous workup and was unknowingly discarded. 
Finally, generation of the aldehyde 357 was also attempted by in situ metallation and 
formylation of N-Boc-4-halopyrazoles 355/356 (Scheme 5.10c and d) but this too 






 of the substrates 
355/356 and reaction with DMF led only to hydrodehalogenation: the peaks at 8.11 
(1H, dd, J = 2.8, 0.6 Hz), 7.72 (1H, dd, J = 1.6, 0.6 Hz), 6.39 (1H, dd, J = 2.8, 1.6 
Hz) and 1.66 (9H, s) apparent in the crude 
1
H NMR spectra are consistent with the 
literature data
187
 for N-Boc-pyrazole 359, which would have formed by acidic 
quenching of the metallated pyrazole intermediate, which had apparently failed to 
undergo reaction with DMF under our conditions. Metallation/formylation (of 356) 
with 
n
BuLi gave only a complex mixture of products implying that this method, too, 
would be unsatisfactory. In light of these disappointing results, efforts were then 
focussed on generating 4-formylpyrazole 362 from which the N-Boc (and N-alkyl) 




Reagents and conditions: (a) (i) POCl3 (3.0 eq), DMF (10 eq), 0 °C to rt, 1.5 h; (ii) 360, 70 °C, 24 h, 0%; (b) (i) 
(COCl2), (1.2 eq), DMF (10 eq), 0 °C, 30 min; (ii) 351, 40 C, 1 h; (iii) NaOH (10 eq), DMF/H2O, 105 °C, 20 min, then 
4 °C, 18 h, 0% conv.; (c) LDBBA (1.3 eq), THF, 0 °C to rt, 18 h, trace conv.; (d) (i) 
n
BuLi (3.0 eq), THF, –78 °C to rt, 
2.5 h; (ii) DMF (1.5 eq), –78 °C to rt, 18 h, 0%. 
Scheme 5.11 Attempted synthesis of 4-formylpyrazole 362. 
derivatives could be accessed directly. 
Surprisingly, synthesis of the aldehyde 362 according to literature procedure was 
also unsuccessful, and these efforts are summarised in Scheme 5.11. Synthesis of 
362 via the reported preparation from hydrazine and trisformylmethane
188a
 was made 
impossible because the reaction used to generate the key tris-aldehyde precursor 
361
188b
 from bromoacetic acid 360 was unsuccessful, showing none of the desired 
product in the crude 
1
H NMR spectrum after aqueous workup (Scheme 5.11a). 
Vilsmeier formylation of 1H-pyrazole 351 using (COCl)2/DMF as the active reagent 
precursor (cf. preparation of indole 331; Scheme 5.11b) also proved futile, giving 
only unreacted starting material. Reduction of the ester 162 with LDBBA
189
 
(Scheme 5.11c), and a lithiation/formylation reaction
188a
 with 4-bromopyrazole 
(Scheme 5.11d) were also ineffective means of synthesising 362, although these 
cases of failure are perhaps less surprising: the reported protocol for the reduction of 
162
189
 was conducted in a flow reactor, meaning that the conditions are not 
necessarily transferable to a batch reaction such as that described herein. Similarly, 
the lithiation/formylation (of 352) failure is probably as easily explained by deviation 
from the reported protocol
188a
 by substitution (on the basis of in-house availability) 
of the more hazardous 
t





In a final effort to generate 4-formylpyrazole, it was thought that N-protection of               
4-iodopyrazole 353 followed by metallation/formylation and subsequent deprotection 
would yield the desired product in a straightforward albeit convoluted manner. 
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Table 5.1 Attempted deprotection of N-benzylated pyrazole 364. 
 
Reagents and conditions: (a) BnBr (1.2 eq), K2CO3 (2.0 eq), acetone, reflux, 3 h, 94%; (b) (i) 
i
PrMgBr (1.3 
eq), THF, 0 °C, 1 h; (ii) DMF (5.0 eq), 0 °C to rt, 1.75 h, 85%; (c) See table entries. 
Entry Reagents and conditions for (c) Conv. (%)
a
 Ref. 
1 HCO2H (175 eq), 10% Pd/C (65 mol%), EtOH, rt, 5 h. 0 191 
2 HCO2H (175 eq), 5% Pd/C (100 mol%), EtOH, reflux, 5 h. 0 191 
3 
t
BuOK (7.0 eq), DMSO (10 eq), THF, 0 °C to rt, 18 h. Decomp. 192 
4 
t
BuOK (10 eq), DMSO (10 eq), THF, rt, 72 h. Decomp. 192 
5 H2, 5% Pd/C (25 mol%), MeOH, rt, 18 h. 0 193 
 aAs determined by 1H NMR of the crude material.  
 
Towards this end (see scheme from Table 5.1), iodopyrazole 353 was N-benzylated 
by reaction with BnBr in acetone in the presence of K2CO3.
194
 Subsequent 




 gave the product 364 in 80% 
yield (over 2 steps). Unfortunately, a range of debenzylation conditions (Table 5.1) 
which included transfer hydrogenation protocols (Table 5.1, Entry 1 and 2), basic 
cleavage (Table 5.1, Entry 3 and 4) and standard catalytic hydrogenation (Table 5.1, 
Entry 5) were unsuccessful in generating the pyrazole 362 and efforts towards its 
synthesis were therefore drawn to a close.
195 
 
5.2.4 Triazole Heterocycles 
For reasons of convenience, the synthesis of the N-benzylated triazole 368 was 
carried out, as opposed to the preparation of a methoxyethanol derivative. Benzyl 
azide 365 was reacted with methyl propiolate 366 in the presence of Cu(I) (formed 
by the reduction of CuSO4•5H2O with sodium ascorbate) and TBTA
196
 to give the 
triazole ester 367 in 93% yield
197
 (Scheme 5.12a). Exclusion of atmospheric O2 and 
the use of the stabilising ligand TBTA was found to be essential for this 
transformation, because isolated yields for the CuAAC reaction greatly decreased (to 
~30%) without implementation of these measures, probably as a result of undesired 
oxidation of the active Cu(I) species to the inactive Cu(II) by atmospheric O2. 
DIBAL-mediated reduction of ester 367 gave the aldehyde 368 in 73% yield
198
 (68%  




Reagents and conditions: (a) (i) Sodium ascorbate (20 mol%), CuSO4•5H2O (10 mol%), 
t
BuOH/H2O (3:1), 5 min; 
(ii) TBTA (13 mol%), 15 min; (iii) 365, 366 (1.2 eq), 18 h, 93%; (b) DIBAL (3.3 eq), hexane/DCM (~2:1), –78 °C,            
2.5 h, 73%; (c) H2, Pd/C (5 mol%), 1,1,2-TCE (1.1 eq), MeOH, 24 h, 370 0%. 
Scheme 5.12 (a) Synthesis of 4-formyl-N-benzyl triazole 368; (b) attempted reductive 
cleavage of the N-benzyl triazoles 367 and 368 to give their corresponding 1H-triazoles 369. 
 
yield over 2 steps; Scheme 5.12a). Although we were satisfied that the benzylated 
derivative 368 was an adequate N-alkylated triazole model for ET coupling it is 
worth noting that with a view to synthesising a Boc derivative (and in the process 
provide a triazole substrate for potential N-alkylation), synthesis of the free                    
1H-triazoles 369 was attempted by benzyl cleavage using catalytic hydrogenation of 
both ester and formyl triazoles 367/368 in the presence of 1,1,2-TCE (Scheme 
5.12b).
199
 However, neither substrate was debenzylated under these conditions, and 
as a consequence, the Boc derivatives 370 were not synthesised, and we were 
restricted to the use of the benzyl derivative 368 as a model triazole for ET coupling. 
 
5.2.5 N-Alkylation of 1H-N-Heterocycles 
Niblock
16
 showed that the C(1)–C(9) pyrazole analogue 102 could be synthesised by 
the reaction of pyrazole 162 with the C(5)–C(9) fragment tosylate 95 in the presence 
of K2CO3 (Scheme 5.13a). Although these conditions gave a moderate yield of the 
product 102 (58%), an extended reaction time was required (48 h) and the conditions 
were not transferable for use with other heterocycles; for example, no reaction was 
observed with pyrrole 371 under the same conditions (Scheme 5.13b).
16
 Pyrrole 371 
also failed to react usefully with tosylate 95 using stronger, alternative bases (KOH 
or NaH), while indole 373 gave only trace conversion to the product 374 on reaction 
with 95 upon heating to 80 °C following reaction with NaH (Scheme 5.13c). 




Reagents and conditions: (a) 95, K2CO3, DMF, rt, 48 h, 58%; (b) 95, K2CO3, DMF, rt, 72 h, 0%; (c) 95, NaH, DMF, 
rt, 48 h, 0%; (d) 95, KOH, DMSO, rt, 18 h, trace; (e) 95, NaH, DMF, 80 °C, 72 h, trace; (f) MeI, NaH, THF, 0 °C to rt, 
18 h, 375a 90%; (g) MeI, NaH, DMF, 0 °C to rt, 18 h, 375b quant. 
Scheme 5.13 Early studies on N-alkylation of (a) pyrazole 162; (b) pyrrole 371; (c) indole 
373 with tosylate 95.
16
 (d) N-Methylation of pyrazole 162 and indole 373 with MeI.
200 
 
Aside from the substrate dependence of the bases used in promoting N-alkylation of            
1H-N-heterocycles, a brief examination of the literature highlights the importance of 
using the correct electrophile. Only trace conversion was observed upon attempted               
NaH-mediated N-alkylation of indole 373 with the C(5)–C(9) tosylate 95, even at 
elevated temperature (80 °C; Scheme 5.13c);
16
 but the NaH-mediated reaction of 
indole 373 (and indeed pyrazole 162) with MeI has been shown
200
 to give high yields 
of the corresponding N-methylated products 375 at only room temperature (Scheme 
5.13d), thus supporting the notion that a tosylate model system would be a likely 
requirement for reliable transfer of model conditions to the synthesis of C(1)–C(9) 
fragment analogues. With these points in mind, a straightforward and high-yielding 
N-alkylation protocol was required which would have a wide (N-heterocycle) 
substrate scope and be permissive of the use of an alkyl tosylate electrophile. 
Given that the use of K2CO3 at room temperature gave promising results for the 
reaction of pyrazole 162 with the C(5)–C(9) tosylate 95,
16
 the use of a carbonate base 
represented the best starting point for exploring the required conditions for                      
N-alkylation of heterocycles in the current study. However, it was reasoned that 
changing to the stronger base Cs2CO3 and heating the reaction mixture would 
perhaps push the moderate yield obtained previously towards quantitative levels. To 
investigate these modifications to Niblock’s conditions,
16
 N-alkylation of a range of 
3- (or 4- in the case of pyrazole) substituted heterocycles with 1 equivalent of the 
(easily synthesised)
201
 model tosylate 341 was attempted (Table 5.2). 
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Table 5.2 Synthesis of model N-alkylated heterocycles 
 













1 A 346 CHO 2 THF 72 18 376 (50) 
2
c
 A 346 CHO 2 THF 72 48 376 95
d 
3 A 346 CHO 2 DMF 120 18 376 25 (100) 
4 B 162 CO2Et 2 THF 72 18 377a 94 
5 B 351 H 2 THF 72 18 377b (Trace) 
6 B 351 H 2 DMF 158 18 377b (79) 
7 B 351 H 5 DMF 158 18 377b 27 (100) 
8 B 352 Br 2 THF 72 18 377c 68 
9 B 353 I 2 DMF 120 18 377d 80 
10 C 331 CHO 2 THF 72 18 378a 63 (100) 
11 C 373 CO2Me 5 THF 72 18 378b 97 
 aIsolated yield; bValues in parentheses refer to the extent of the conversion to the product as determined by 1H 
NMR of the crude material; 
c
10 mol% TBAI was also added to the reaction; 
d
Based on isolated yield of the 




Gratifyingly, high conversion was generally observed in all cases, with any poor or 
moderate yields obtained by heating in the relatively low-boiling-point solvent THF 
easily increased by addition of 10 mol% TBAI (Table 5.2, Entry 2), by reaction at 
higher temperatures in DMF (Table 5.2, Entries 3, 6, and 7) or by use of increased 
base stoichiometry (Table 5.2, Entry 7). As a side note, use of a larger quantity of 
base with indole-3-methyl ester 373 (Table 5.2, Entry 11) was not a consequence of 
poor yield during early screening, but rather was performed strategically to ensure 
maximum conversion to N-alkylated product 378b owing to the identical TLC Rf 
values of the starting material and product. 
The only poor to moderate isolated yields of the alkylated pyrrole 376 (Table 5.2, 
Entry 3) and indole 378a (Table 5.2, Entry 10) are somewhat surprising when 
compared to the extent of (NMR) conversion, but this anomaly stems from the 
apparent instability of these products to silica gel chromatography
202
 and therefore 
these compounds should be used without further purification (cf. Table 5.2, Entry 2). 
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Although inconsequential for a model study, this potential for diminished yield 
should be taken into consideration during synthesis of the C(1)–C(9) fragment 
analogues that incorporate these heterocycles. A similar anomaly with respect to 
NMR conversion and isolated yield was observed for the N-alkylation of                    
1H-pyrazole 351 (Table 5.2, Entry 7), but in this case the product 377b was found to 
be volatile, and thus a poor isolated yield owing to issues of handling is less likely to 
be a problem on alkylation with the higher molecular weight C(5)–C(9) fragment.  
It is worthwhile to comment on the differences in reactivity observed in the                     
N-alkylation of the series of heterocycles. Variations in reactivity stem from the 
influence that each group has over the basicity of the nitrogen atom and thus the 
lability of the proton attached to the reactive nitrogen atom. As a consequence of 
resonance and inductive effects, an electron-withdrawing substituent (at the                      
3-position; or in the case of pyrazole, the 4-position), an additional ring heteroatom 
or an additional resonance contribution by a fused aromatic group would be expected 
to simultaneously increase the acidity of the NH proton and stabilise the conjugate 
amide base leading to more facile reaction. The substituent effect was observed 
directly in the N-alkylation of pyrazoles, whereby the pyrazole ester 162 (Table 5.2, 
Entry 4) reacted more efficiently than the bromopyrazole 352 (Table 5.2, Entry 8) or 
iodopyrazole 353 (Table 5.2, Entry 9), which in turn reacted more efficiently than            
4-unsubstituted 1H-pyrazole 351 (Table 5.2, Entries 5 to 7). On comparing the 
systems of heterocycles, the benzofused heteroaromatic indoles (Table 5.2, Entries 
10 and 11) reacted equally efficiently to the most reactive pyrazole 162, while                 
3-formylpyrrole 346 (Table 5.2, Entries 1 to 3) was the least reactive of the 
(substituted) heterocycles because it lacks both an additional ring heteroatom (cf. 
pyrazole) or fusion with an aromatic ring system (cf. indole). 
To confirm the applicability of these conditions to potential C(1)–C(9) fragment 
syntheses, alkylation of pyrazole 162 with the C(5)–C(9) tosylate 95,
203a
 was 
attempted using the optimised conditions (Table 5.2, Entry 4). A 67% yield of the 
product 102 was obtained, which although represented a small improvement over the 
yield obtained in previous study, still fell short of the almost quantitative yield 
obtained in the model study. It is therefore likely that a harsher set of conditions from 




Reagents and conditions: Cs2CO3 (2.0 eq), THF, reflux, 18 h, 67%. 
Scheme 5.14 Alkylation of pyrazole 162 with the C(5)–C(9) fragment alkyl tosylate 95. 
Table 5.2 would need to be applied when using the more sterically demanding             
C(5)–C(9) fragment alkyl tosylate 95. Fortunately, the N-alkylation study indicates 
that a multitude of options are available including increased base stoichiometry, 
addition of catalytic TBAI, or heating in DMF at higher temperatures. 
 
5.2.6 Completion of the Series of Model Heterocycles 
Having established effective alkylation conditions, attempts could be made 
synthesise the remaining N-alkylated pyrazolyl aldehyde for ET coupling (Approach 
A, Scheme 5.6); and in case a contingency strategy was required (Approach C, 
Scheme 5.6), convert the N-alkylated heterocycles to their carboxylic acids.  
N-Alkylated 4-formylpyrazole 379 was synthesised according to the conditions used 
for N-benzylated 4-formylpyrazole 364 (see: Table 5.1). Thus, metallation of 
iodopyrazole 377d with 
i
PrMgBr followed by reaction with DMF gave the product 
aldehyde 379 in 71% yield (Scheme 5.15). Unfortunately, 379 is unstable, and 
rapidly decomposed under standard storage conditions and therefore was not 
practical for use in ET coupling. Fortunately, the prior synthesis of the stable            
N-benzylated analogue 364 meant that a suitable substitute was readily available. 
 
Reagents and conditions: (i) 
i
PrMgBr (1.3 eq), THF, 0 °C, 1 h; (ii) DMF (5.0 eq), 0 °C to rt, 2 h, 71%.  
Scheme 5.15 Synthesis of the N-alkylated pyrazole aldehyde 379. 





















377a Het = Pyrazole, R = Et
378b Het = Indole, R = Me
381 Het = Pyrazole
382 Het = Indole
 
Reagents and conditions: (a) AgNO3 (2.0 eq), NaOH (6.5 eq), MeOH/H2O (5:4), 70 °C, 18 h, 30%; (b) KOH (5.0 
eq), EtOH/H2O (9:1), reflux, 18 h, 381 97%, 382 quant.  
Scheme 5.16 Synthesis of model heterocyclic carboxylic acids: (a) pyrrole 380; and (b) 
pyrazole 381 and indole 382. 
 
Synthesis of the pyrrole-3-carboxylic acid 380 was carried out by reaction of 
aldehyde 376 with AgNO3 and NaOH
204
 in MeOH to give the product 380 (Scheme 
5.16a) in poor yield (30%), and contaminated with what is believed to be polymeric 
or decomposition material. Unfortunately, no attempts were made to purify the 
product (~86% purity by 
1
H NMR) beyond aqueous workup; and owing to lack of 
starting material 376 at the time of reaction, no optimisation or use of other 
conditions was investigated. Fortunately, the syntheses of the pyrazole 381 and 
indole 382 carboxylic acid derivatives
205
 were achieved more cleanly by hydrolysis 
of the corresponding esters 377a/378b with KOH in aqueous EtOH (Scheme 5.16b). 
It is worth noting that the workup procedure for obtaining pyrazole 381 was 
problematic owing to its low solubility in DCM, whereby a very poor isolated yield 
(27%) was initially obtained. Fortunately, this was easily overcome by the                          
re-extraction of the aqueous layers with EtOAc (to give a further 70% isolated yield), 
but because this problem occurred in the model studies, care should be taken to select 
a sufficiently polar solvent for workup when synthesising C(1)–C(9) heterocyclic 
fragment carboxylic acids from valuable C(1)–C(9) ester precursors. 
Further model systems for ET coupling or esterification could be derived from 
commercially available substrates, for example the key 2-methyl-substituted 
oxazoles 329/383. The substrate library thus developed (summarised in Figure 5.1) 
allowed ET coupling of model heterocyclic aldehydes with the C(10)–C(19)                                 
β-hydroxyketone fragment 86 to commence, and thus the approach required 
(Approach A, B or C, Scheme 5.6) for the synthesis of the C(1)–C(9)/C(10′)–C(19′) 
bis-alkynes to be determined. 




Figure 5.1 Model (a) N-alkylated and (b) N-Boc heterocyclic aldehydes for ET coupling; (c) 
N-alkylated heterocyclic carboxylic acids for esterification. 
 
5.3 Evans–Tischenko Coupling: the C(10)–C(19) β-Hydroxyketone (86) 
Initially it was deemed necessary to investigate ET coupling with a commercially 
available aldehyde for which precedent exists for successful reaction. Benzaldehyde 
was chosen because its use is frequently described,
36b,90,174
 the formyl group contains 
aryl substitution (and so the electronics are similar to heteroaryl systems), and it is 
cheap and easily purified by reduced-pressure distillation over K2CO3. Furthermore, 
it was used as a sacrificial aldehyde for the generation of the active pre-catalyst in the 
heteroaryl ET reaction
90,174
 and for the purposes of coupling valuable aldehydes, it 
would be necessary to use a similar methodology in the current study.  
Before a discussion of ET reaction screening, it is important to comment on the 
synthesis of SmI2. SmI2 (0.1 M in THF) was initially prepared by the               
ultrasound-promoted reaction between I2 (1 eq) and powdered metallic samarium           





 Although this led to the desired deep-blue 
solution, addition of the reagent when prepared in this fashion to PhCHO did not lead 
to the desired yellow reaction mixture [indicative of oxidation of Sm(II) to 
Sm(III)]
170a,c
 and instead led to the formation of a green solution (Scheme 5.17a).
207
 




Reagents and conditions: (a) THF (0.1 M wrt I2), ultrasonic vibration, absence of light, Ar atmosphere, 1 h. 
Scheme 5.17 Generation of the (a) Sm(III) pinacol adduct from SmI2 prepared with 2 
equivalents of samarium; (b) Sm(III) pinacol adduct upon minimisation of the quantity of 
residual metallic samarium. 
 
Speculating that this was due to residual metallic samarium causing reduction of the 
newly formed Sm(III) pinacol species back to Sm(II),
208
 the samarium stoichiometry 
was reduced (to 1.3 eq), and this proved successful in generating the required yellow 
solution upon addition of SmI2 to PhCHO (Scheme 5.17b).  
With a reliable procedure for the generation of SmI2 accomplished, ET coupling 
between β-hydroxyketone 86 and PhCHO was attempted towards the synthesis of 
1,3-anti diol monoester 337 (Table 5.3). Unfortunately, results were generally poor 
across the range of conditions screened, which included four different orders of 
reagent addition (Methods A to D); use of catalytic (Table 5.3, Entries 1, 2, 5 and 
10) and stoichiometric (Table 5.3, remaining entries) loadings of the SmI2                   
pre-catalyst; and different temperatures (–20, –10 and 25 °C). On runs where product 
was isolated by column chromatography (Table 5.3, Entries 7 to 10), yields were 
typically poor and the product was contaminated with the starting material and/or 
unidentified side products. It was therefore immediately apparent that: (i)                          
β-hydroxyketone 86 was likely to be poorly reactive under ET coupling conditions; 
and (ii) PhCHO was not a suitable substrate, and that a more electron-deficient aryl 
system would require to be investigated to establish suitable reaction conditions. 
Attention was therefore focussed on an alternative aryl system for ET coupling. 
Given that 3- and 4-formylpyridines showed the most facile reactivity in the 
heteroaryl ET study with what is effectively a model system, the use of 
formylpyridines was investigated. To our delight, following addition of 100 mol%  
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1 A 5.0 — 15 –10 1 (0) 
2 A 5.0 — 50 –10 6 (0) 
3 A 6.0 — 100 –10 1.5 (0) 
4 A 6.0 — 200 –10 1 (nd)
f 
5 B — 4.0 40 25 4 0 
6 B — 8.0 300 –10 1 0 
7 C 4.0 2.0 200 –20 3 ~41
g 
8 C 4.0 2.0 200 25 5 5 
9 C 4.0 4.0 300 –10 1 14 
10 D 2.0 1.0 50 25 18 (20) 
a
Method A (one-pot protocol): 86, PhCHO, SmI2, THF, absence of light; Method B (pre-catalyst protocol with 
early addition of the reactant aldehyde): (i) PhCHO, SmI2, rt, 30 min, absence of light; (ii) 86; Method C                      
(pre-catalyst protocol with addition of reactant aldehyde with the β-hydroxyketone): (i) PhCHO, SmI2, THF, 30 
min, absence of light; (ii) 86, PhCHO; Method D (pre-catalyst method with delayed addition of the                             
β-hydroxyketone): (i) PhCHO, SmI2, THF, 0 °C, absence of light; (ii) PhCHO, 30 min; (iii) 86; 
b
Number of 
equivalents of PhCHO for reaction with substrate 86; 
c
Number of equivalents of PhCHO used during the Sm(III) 




Values in parentheses refer to the extent of 
conversion to the product as determined by 
1
H NMR of the crude material. 
f
The crude NMR spectrum was 
unclear but appeared to lack any characteristic signals and purification was not attempted; 
g
The isolated 
product contained a marked proportion of impurities. 
 
SmI2 to THF solutions of the β-hydroxyketone 86 and 3- or 4-formylpyridine at              
–10 °C (cf. Method A, Table 5.4), good yields of the desired products were obtained 
as single diastereomers (Table 5.4, Entries 1 and 2). In each case, successful reaction 
was clear owing to additional peaks corresponding to aryl and allylic CHOH protons, 
and a pronounced (≥1 ppm) upfield shift in the resonances of the C(17) (δ = 6.56 → 
5.58 ppm) and C(18) (δ = 7.01 → 5.70 ppm) protons and the large downfield shift of 
the C(14) proton (δ = 3.84 → 5.39 ppm; exemplified for the 3-formylpyridine 
derivative 384a, Figure 5.2). In the case of the C(17) and C(18) protons, the 
reduction of the ketone to the allylic alcohol results in a loss of conjugation and 
therefore shielding on these protons is increased, while in the case of C(14), 
shielding is decreased as a consequence of being in the vicinity of an ester as 
opposed to the hydroxyl group. It is also worth noting that the C(11) and C(12)  
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 1 then 5 2 53 >95:5 
4 
 
6 4 384c 99 >95:5 
5 
 






As determined by 
1
H NMR spectroscopy; 
c
Sm(III) pre-catalyst was prepared by 
addition of SmI2 to 1 eq of the aldehyde in THF at the stated temperature followed, after 30 
mins, by addition of further aldehyde and β-hydroxyketone 86 cf. Method C, Table 5.3; 
d
Ketone 
byproduct 387 was also isolated in 12% yield. 
 
olefinic protons were slightly shielded (0.1–0.2 ppm) relative to the same protons in 
the β-hydroxyketone 86 precursor, probably as a result of π–π interactions with the 
newly introduced aryl system leading to subtle electronic changes as a result of the 
induced magnetic field created by the aromatic ring-current.
209
 
Because studies using valuable aldehydes would require the generation of the active 
Sm(III) catalyst from a sacrificial aldehyde, the protocol for 4-formylpyridine was 
repeated; but in this instance, with pre-stirring of 1 equivalent of the aldehyde with 
the SmI2 followed by addition of the remaining reactant aldehyde and finally, after 
10 minutes, the β-hydroxyketone (Table 5.4, Entry 3). This led to a slightly 
diminished but nonetheless acceptable 53% yield of the product, and indicated that 
the pre-catalyst method of Sm(III) generation would be a viable alternative to using 
the one-pot procedure employed in the first two reactions. 
Because PhCHO was found not to react usefully in ET coupling, we were interested 
in discovering whether or not a derivative would give a successful reaction. Obvious 
substitutes were the (more electron-deficient) nitrobenzaldehydes and so the use of 





Figure 5.2 Change in chemical shift of the C(14) (magenta), C(17) (blue), and C(18) (red) 
protons on conversion of the (a) β-hydroxyketone starting material 86 to the (b)                              
3-formylpyridine derived 1,3-anti diol monoester 384a [for clarity, only the left- and right-most 
peak values have been shown for the olefinic proton resonances in Figure (b)]. 
 
these substrates was investigated. Perhaps unsurprisingly, reaction of 3- and                     
4-nitrobenzaldehydes (Table 5.4, Entries 4 and 5 respectively) gave the desired 
products 384 in good to excellent yield. Somewhat curiously (on the basis of close 
intramolecular hydroxyl group proximity in 384d), some 12% of the β-ketoester 387 
was also isolated on reaction of 4-nitrobenzaldehyde with the β-hydroxyketone 86. 
The most likely explanation for its formation would involve an intermolecular 
transesterification
210
 whereby the nitrobenzoate ester moiety of the ET product 384d 
is transferred to the unreacted starting material 86 following Lewis acid activation of 
the ester by Sm(III) (Scheme 5.18). This would give rise to the β-ketoester 387 and 


















Scheme 5.18 Mechanism of transesterification in the reaction of 4-nitrobenzaldehyde with                                 
β-hydroxyketone 86 under Sm(III) catalysis. 
 
probably as a simple consequence of high polarity and thus a reduced propensity for 
elution on silica gel. 
Despite the isolation of this minor side product 387 from the reaction of                                 
β-hydroxyketone 86 with 4-nitrobenzaldehyde, the quantitative isolation of the                  
3-nitrobenzoate-derived 1,3-anti diol monoester 384c (Table 5.4, Entry 4) was 
particularly reassuring. This is because the high yield obtained for the reaction lends 
itself to the use of 3-nitrobenzaldehyde as a sacrificial aldehyde in the event that any 
model N-alkylated or N-Boc-protected N-heterocycles failed to react in the ET 
reaction, which in this instance would necessitate an esterification route towards the 
preparation of the heteroaryl 1,3-anti diol monoester derivative of 86. Unfortunately, 
the use of this esterification contingency strategy was to become a requirement, 
because all of the model heteroaryl aldehydes, in addition to a small sample of other 
aldehyde substrates, failed to react usefully under our previously established ET 
coupling conditions (Table 5.5). 
Reaction of the N-Boc-indole 333 (Table 5.5, Entries 1 to 3) and N-Ts-indole 390 
[which was synthesised under standard tosylation conditions (TsCl/Et3N in DCM)
211
 
and screened owing to the larger electron-withdrawing capacity of the tosyl group 
when compared to the Boc group; Table 5.5, Entry 4] did not lead to the formation 
or isolation of the desired products 389 in so much as trace quantities after 
chromatography, even with large loadings of SmI2 and extended reaction times.                  
N-Boc-pyrrole 348 also failed to react, either under the conditions established herein 
(Table 5.5, Entry 5), or Hulme’s heteroaryl coupling conditions (Table 5.5, Entry 6). 
Reaction of 3-furancarboxaldehyde 391 under ET coupling conditions provided some  




promise, giving (tentatively) an ~65% conversion to the 1,3-anti diol monoester 
389d by 
1
H NMR (Table 5.5, Entry 7). Unfortunately, the product 389d could not be 
separated from residual (unidentified) contaminants; and attempts to repeat the 
reaction under the same conditions were unsuccessful. As a result, an accurate yield 
could not be determined, and the product could not be isolated in sufficient purity for 
full characterisation. N-Benzyl-pyrazole 364 (Table 5.5, Entry 8) also coupled 
successfully under ET conditions, albeit giving only a meagre 7% isolated yield 
following purification. Given the difficulties in performing an esterification with        
N-alkylated pyrazole-4-carboxylic acid 382 (reported vide infra), ET coupling under 



















3.0 3-PyCHO 100 –10 3 
389a 
0 
2 4.0 None 10 25 18 0 
3 4.0 4-NO2ArCHO 800 25 18 0 
4 
 
6.0 None 100 –20 3 389b 0 
5 
 
3.0 4-PyCHO 100 –10 to 25 21 
389c 
0 
6 4.0 None 200 –10 3 0 
7 
 
6.0 None 100 –20 4 389d ~65 
8 
 





6.0 None 100 –20 4 389f 0 
10 
 
6.0 None 100 –10 4 389g 0 
11 iPrCHO 392 6.0 None 100 –10 3 389h 0 
12 
 
6.0 None 100 –20 4 389i 0 
a
Yields as determined by 
1
H NMR of the crude material unless otherwise stated; 
b
Isolated yield; 
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alternative conditions, which could lead to useful yields of the desired product 389e; 
and/or coupling of its N-Boc analogue, which is predicted to react more smoothly, 
would certainly be worthy of future investigation. 
Further heterocycles investigated in our ET studies include the N-benzyltriazole 368 
(Table 5.5, Entry 9) and the 2-methyloxazole 329 (Table 5.5, Entry 10). Reaction of 
these substrates under Sm(III) catalysis gave only unreacted starting material, which 
is perhaps unsurprising given that both heterocyclic aldehydes contain a nitrogen 
atom in the α-position relative to the reactant formyl group, and such substrates have 
been shown to be inert to ET coupling.
90,174
 Finally, alkyl aldehydes 392/393 (Table 
5.5, Entries 11 and 12) failed to react to give the desired 1,3-anti diol monoesters 389 
under the conditions screened. In particular, the outcome of these final two reactions 
perhaps serve to highlight the comparably inert nature of the C(10)–C(19) fragment 
under ET redox esterification conditions versus the model system 325 (see: Scheme 
5.5) as used by Hulme,
174




In the context of the synthesis of C(1)–C(9)/C(10′)–C(19′) fragments of disorazole 
C1 these results were very disappointing, because none of the heterocycles (even in 
their more electron-deficient, N-Boc form) which had been targeted as good       
C(1)–C(9) analogues, or other aldehydes with desirable cyclic structural motifs led to 
reactivity under SmI2 ET coupling conditions, implying that fully functionalised 
C(1)–C(9) analogues of these (hetero)cyclic systems would also be unsuccessful. The 
reasons for such poor reactivity are difficult to speculate upon considering the 
comparative success in the published heteroaryl ET study
174
 of at least two of the 
substrates investigated (N-Boc-indole 333 and 3-formylfuran 391). However, it is 
likely that the steric demands imparted by the enyne and gem-dimethyl groups in the 
β-hydroxyketone 86 probably had a role in the observed lack of reactivity, and the 
electronic stability provided by the enone over a standard ketone may also have made 
the reaction less energetically favourable. To confirm which of these groups had the 
largest detrimental influence, reactions with analogous substrates that do not contain 
one of the enyne, gem-dimethyl or enone groups would require to be studied.  
Also worthy of note is that the conditions found to be successful for the pyridyl and   
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nitrophenyl series of heterocyclic aldehydes were also slightly different (reduced 
SmI2 loading) from those found to be successful in the publication; although even 
those conditions were found not to give the desired product in the case of                   
N-Boc-pyrrole or benzaldehyde, further implicating the β-hydroxyketone 86 as the 
cause of poor ET reactivity. Fortunately, a number of substrates were successful, and 
this meant that our contingency approach could be examined as a potential means of 
generating C(1)–C(9)/C(10′)–C(19′) fragments. 
 
5.4 Esterification Approach 
Having established that a strategy involving direct ET coupling of C(1)–C(9) 
heterocyclic aldehyde fragments or Boc-protected heterocycles (with subsequent 
deprotection and N-alkylation) would most likely prove to be unsuccessful, attention 
was directed towards a stepwise approach. This would involve the use of a sacrificial 
aldehyde to introduce the 1,3-anti stereochemistry at C(14)–C(16), subsequent 
hydroxyl protection, ester hydrolysis and esterification of C(1)–C(9) carboxylic acids 
Het-111 to generate the required (O-protected) C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol 
monoester bis alkynes Het-336 (Approach C, Scheme 5.6, Section 5.1.4).  
Substrate screening results from the ET model study with β-hydroxyketone 86 
indicated that 3-nitrobenzaldehyde would be the best choice as a sacrificial aldehyde 
for the ET reaction owing to the superior yield obtained when compared to other 
counterparts; Wipf’s total synthesis of disorazole C1
26
 indicates that PMB protection 
would provide the safest means of maintaining the somewhat sensitive diene-yne 
moiety for the subsequent deprotection step (cf. silyl protection; see Chapter 1, 
Section 1.2) and thus, a PMB group was chosen as the alcohol protecting group. 
Subsequent ester hydrolysis following protection would generate the requisite                 
mono-O-protected 1,3-anti diol 338 for esterification (Scheme 5.19). 
 
Scheme 5.19 Proposed forward synthesis of mono-protected diol 338. 
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5.4.1 Synthesis of the C(10)–C(19) Mono-Protected Diol (338) 
Before a discussion of PMB protection, it is important to comment on the synthesis 
of the ET product 384c, because this would be required on a large scale. No 
problems of scalability were encountered, and large-scale (~350 mg) coupling of the 
β-hydroxyketone 86 was achieved using the same conditions as those in screening 
(Scheme 5.20), with yields typically between 60 and 94% and no apparent reduction 
in diastereoselectivity as determined by 
1
H NMR spectroscopy (>95:5 dr). On larger 
scales, stirring of the crude mixture with NaHSO3 (in aqueous EtOH) is advised for 
removal of excess 3-nitrobenzaldehyde (as its bisulfite adduct), as failure to do so 
tended to lead to co-elution of the aldehyde on silica with the desired product 384c. 
PMB protection of the alcohol 384c was then to be carried out, and it was required 
that this be performed under acidic conditions to minimise the potential for problems 
associated with concomitant cleavage of the base-labile C(14) ester. The reagent 
typically used for this process is PMB-TCA 394, and this was synthesised 
quantitatively by the reaction of PMBOH with trichloroacetonitrile under base 
catalysis (10 mol% NaH) according to literature procedure.
213
 The product 
trichloroacetimidate was unstable to flash chromatography, but was obtained in high 
purity (>95% by 
1
H NMR) and was therefore deemed suitable for PMB protection of 
the required substrate. 
PMB protection was not as straightforward as anticipated because a number of 
organic acid catalysts such as CSA (Table 5.6, Entry 1), TfOH (Table 5.6, Entry 2) 
and TFA (Table 5.6, Entry 3) failed to give satisfactory results and resulted in poor 
conversion to the desired product 395 and required long reaction times; thus, 
attention was focussed on the use of Lewis acid catalysis.  
 
Reagents and conditions: (i) 3-Nitrobenzaldehyde (5.6 eq), SmI2 (94 mol%), THF, –20°C, 4 h; (ii) NaHSO3 (11.3 
eq), EtOH/H2O (5:1), 3 h, 94%, >95:5 dr. 
Scheme 5.20 Large-scale preparation of 1,3-anti diol monoester 384c. 
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1 1.5 CSA 20 + 130
c
 DCM 25 144 (~50) — 
2 1.5 TfOH 20 DCM 25 1 0 — 
3 1.5 TFA 20 DCM 0 to 25 18 43 3.8:1 
4 2.0 Sc(OTf)3 5 PhMe 25 1 65 (88) 3.6:1 
5 3.0 Sc(OTf)3 10 PhMe 0 to 25 1 79 (100) 1.8:1 
6 1.2 Sc(OTf)3 10 PhMe 25 18 (60) — 






Values in parentheses refer to the extent of conversion to the product as determined by 
1
H NMR 
of the crude material.
c
The reaction commenced with 20 mol% CSA but after 24 h, an additional 130 mol% was 
added due to lack of apparent reactivity as determined by TLC; 
c
Isolated yield, calculated on the basis of purified 
product mass and subsequent comparison of the 395:396 ratio as determined by 
1
H NMR spectroscopy; 
d





 found that excellent yields were obtained when PMB-TCA was used 
to protect alcohols in the presence of lanthanide-based Lewis acids, in particular 
Sc(OTf)3. Thus, our initial Sc(OTf)3-mediated conditions (Table 5.6, Entry 4) 
involved the use of 2 equivalents of PMB-TCA and 5 mol% of the catalyst in toluene 
according to the reported conditions. After 1 h, excellent conversion (88%) was 
observed, and this was increased to quantitative conversion on doubling the catalyst 
loading and increasing the PMB-TCA stoichiometry, with good isolated yields 
obtained in each case. Unfortunately, it was found that in both cases the product 395 
was contaminated with significant quantities of PMB2O 396 after purification by 
silica-gel chromatography, as measured by comparison of the integrals of the CH2Ar 
protons for the product 395 [δ = 4.38 and 4.07 (2 × 1H, d)] and side product 396 [δ = 
4.49 (4H, s)].
215
 The formation of the dimer was thought to be a consequence of both 
the large excess of the PMB-TCA, and the use of an aqueous quench during workup.  
Attempts were then made to minimise the formation of the dimer by reducing the 
loading of PMB-TCA and by quenching with an alcohol substrate to consume 
residual PMB-TCA. Unfortunately, both measures proved ineffective: a reduction in 
the quantity of PMB-TCA used for reaction with the substrate lead to incomplete 
Results and Discussion 4 
154 
 
reaction (Table 5.6, Entry 6), while quenching of the reaction with a large excess of 
1,3-propanediol [which in a test reaction was found to react quantitatively with 
PMB-TCA in only 10 minutes under 10 mol% Sc(OTf)3 catalysis] also did not lead 
to a diminished quantity of PMB2O 396 in the purified product (Table 5.6, Entry 7).  
It is worth noting that product 395:PMB2O ratios varied following purification on 
repeated runs using conditions as in Table 5.6, Entry 5, typically between 2 to 7:1. 
This may have been a consequence of solubility (in DCM, used in column loading), 
and it is possible that crystallisation and filtration of the side product could be 
performed on larger scales. It is also plausible that direct chromatography without 
aqueous workup could reduce the quantity of PMB2O, although this was never 
attempted because attempted chromatography of PMB-TCA led to marked column 
streaking and it was believed that this may also lead to contamination of the product. 
Despite the problems of purity, the use of Sc(OTf)3 consistently gave high levels of 
conversion and good isolated yields (~80%) on moderate reaction scales (up to ~1 g) 
using conditions from Table 5.6 Entry 5, and so the product/PMB2O mixture was 
taken forward to the hydrolysis step required for the generation of the key                 
mono-protected diol 338. It was expected that ester 395 would still react smoothly 
given the likely inertness of PMB2O, and it was hoped that the hydrolysis product 
338 would be separable on revealing the polar hydroxyl group. Ester hydrolysis was 
achieved by treatment of the protected 1,3-anti diol monoester 395 with LiOH in 
aqueous MeOH, which gave the product in excellent yield (91% by 
1
H NMR), 
Scheme 5.21).  
Unfortunately, separation of PMB2O 396 at this stage was not possible, because the 
starting material 395, side product 396 and product 338 have identical Rf values on  
 
Reagents and conditions: LiOH (12 eq), MeOH/H2O (10:1), reflux, 18 h, 91%. 
Scheme 5.21 Completion of the C(10)–C(19) mono-protected diol 338 by hydrolysis of 
protected 1,3-anti diol monoester 395. 
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TLC. Although likely to be inert to most reaction conditions, the presence of the side 
product complicates the operation of experiments, and it is therefore clear that the 
PMB protection step will require a more rigorous optimisation in future studies to 
eliminate this contaminant. Other than changing existing conditions, other potential 
options would involve use of an alternative ET product (for example, the more polar 
pyridines 384a/b), or an acylation–purification–hydrolysis sequence; but since the 
latter option would add further steps it must be considered a last resort in the event 
that the esterification product was inseperable from the PMB2O side product. 
 
5.4.2 Esterification Reactions 
5.4.2.1 Pyrazole Esterification 
With the key C(10)–C(19) mono-protected diol 338 successfully synthesised, model 
esterification reactions were carried out in order to establish suitable conditions for 
coupling with the C(1)–C(9) heterocyclic carboxylic acid fragments Het-111. The 
pyrazole heterocycle was initially selected because a reliable route to the synthesis of 
its C(1)–C(9) analogue had already been devised within the group,
16,44,216
 and 
because the 2-heteroatom system closely mirrors that of the oxazole (which at the 
time was not readily available). Critically, we were also hopeful that the discovery of 
appropriate conditions would allow the successful generation of at least one 
heterocyclic 1,3-anti diol monoester bis-alkyne C(1)–C(9)/C(10′)–C(19′) analogue 
for future alkyne metathesis. 
In their total synthesis of disorazole C1, Wipf and Graham
26
 reported the successful 
esterification of an oxazole carboxylic acid to an alcohol fragment, which was not 
dissimilar to the one used in the current study (See: Chapter 1, Section 1.2.4). It was 
therefore thought that use of their conditions – which involved use of a standard 
Steglich esterification
27
 – would allow the coupling of heterocyclic carboxylic acids 
with our alcohol substrate 338 and therefore their conditions were used as a starting 
point for the esterification reaction with pyrazole 382, albeit with a slight reduction 
in the stoichiometry of the carboxylic acid (1.5 as opposed to 1.9 eq). 
Wipf’s conditions
26
 (Table 5.7, Entry 1) proved, surprisingly, to be unsuccessful;  
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1 1.5 DCC 5.0 DMAP 1.0 DCM 25 0 
2 1.0 DCC 1.3 DMAP 1.3 PhMe 25 11 
3
d
 1.0 DCC 10 DMAP 3.0 PhMe 0 to 25 12 
4 1.0 DCC 10 DMAP
d
 3.0 PhMe 0 to 25 12 
5 1.0 Boc2O 1.3 DMAP 0.05 MeNO2 50 0 
6 1.0 (COCl)2/DMF
e






In all cases, alcohol 338 was used as a solution in DCM and this typically accounted for 
20% of the solvent mixture in non-DCM systems; 
c
As determined by 
1
H NMR of the crude material unless 
otherwise stated; 
d
Reaction was conducted for 72 h; 
d
20 mol% 4-PPy was also added to the reaction; 
e
Carboxylic acid 382 was reacted for  3 h with (COCl2)/DMF to generate the corresponding acid chloride, 




and in any case required the use of an excess of the carboxylic acid component, 
which was undesirable given the synthetic value of the highly functionalised 
heterocyclic C(1)–C(9) fragments, and therefore the remaining the runs were 
conducted using an equimolar alcohol-to-carboxylic acid ratio. Unfortunately, the 
lack of success using the precedented conditions was mirrored in other attempted 
preparations of the ester 397 using DCC. Reaction using an approximately 
stoichiometric quantity of DCC and DMAP led to only 11% conversion as 
determined by 
1
H NMR (Table 5.7, Entry 2), while a larger excess of the reagents 
(Table 5.7, Entry 3) and use of a more efficient DMAP analogue
217
 in catalytic 
quantity (20 mol% 4-PPy; Table 5.7, Entry 4) gave similarly disappointing results  
As an alternative to the Steglich protocol, use of Gooβen’s Boc2O-mediated 
esterification
218
 was also investigated but this too proved unsuccessful, giving only 
unreacted starting material (Table 5.7, Entry 5). Finally, attempts were made to 
synthesise the ester 397 by acylation of the alcohol using the acid chloride derivative 
of pyrazole 382, which was prepared under standard chlorination conditions with 
(COCl)2/catalytic DMF in DCM.
219
 Unfortunately, this approach also proved futile, 
because immediate reaction of the crude acid chloride with alcohol 338 in the 
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presence of Et3N led only to the recovery of alcohol 338 after aqueous workup and 
flash chromatography (Table 5.7, Entry 6). 
The results with pyrazole 382 were disappointing, but perhaps unsurprising because 
few examples exist of either direct esterification of secondary alcohols with                      
N-alkylated pyrazole-4-carboxylic acids, or acylation of alcohols with pyrazoloyl 
chlorides.
220
 Those which do exist tend to be low yielding
215a
 or involve reactions 




 which can be used in vast excess 
and for the purposes of an advanced fragment coupling this is not a viable means of 
esterification. The reasons for such poor reactivity are probably related to a 
combination of slow formation and/or instability of the pyrazole activated ester
166
 
and the large steric hindrance imparted by the PMB-ether in the alcohol 338. 
Although there clearly remains scope for optimisation of the pyrazole esterification 
reaction – for example through use of alternative coupling reagents – attention was 
instead focussed on coupling C(10)–C(19) mono-protected diol 338 with oxazoles. 
 
5.4.2.2 Oxazole Esterification 
Successful esterification of an oxazole carboxylic acid was particularly important 
because – assuming successful AM dimerisation – it would allow access to natural 
disorazole C1. A number of esterification conditions were screened using both the 
(model) 2-methyloxazole 383 (Table 5.8) and the C(1)–C(9) oxazole fragment 
111
203b
 (Table 5.9). Again, screening commenced with use of the Steglich protocol; 
and conditions invoked the use of a number of different of DCC stoichiometries, or 
different loadings of DMAP or the (theoretically) more active analogue 4-PPy. In 
addition, given that the esterification products were found to be readily seperable 
from both of the starting materials on silica gel, an excess of the alcohol 338 [as 
opposed to the C(1)–C(9) oxazole 111 on the basis of availability and ease of 
recovery] was also used on some runs in an attempt to force the reaction. 
In general, the Steglich esterification conditions were low yielding, albeit improved 
over those obtained upon attempted esterification of the pyrazole 382. Runs included 
the use of stoichiometric DCC and catalytic DMAP (Table 5.8, Entry 1), or a large  
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1 1.3 DCC 1.1 DMAP 0.2 0 to 25 18 0 
2 2.0 DCC 5.0 DMAP 10 0 to 25 18 0 
3 2.0 DCC 10 DMAP 5.0 0 to 25 18 34 
4 1.0 DCC 20 DMAP 10 0 to 25 18 29 
5 2.0 DCC 5.0 4-PPy 0.5 0 to 25 86 23 
6 2.0 DCC 5.0 4-PPy 1.0 0 to 25 18 43 
7 2.0 DCC 5.0 4-PPy 1.0 0 to 25 86 15 
8 2.0 DCC 10 4-PPy 1.0 0 to 25 86 14 




 0 5 0 
10 1.0 YR/Et3N
d
 4.0/5.7 DMAP 3.0 40 4 93
e 
a
All reactions were conducted in PhMe with the alcohol 338 added as a solution in DCM to make up 
approximately 30 to 50% of the solvent mixture with the following exceptions (solvent in brackets): Entry 1 
(DCM reaction solvent), Entry 10 (PhMe alcohol carrier solvent); 
b
As determined by 
1
H NMR of the crude 
material; 
c
These reagents were added in 5 equal portions at hourly intervals (from t = 0) up to the values 
stated; 
d
YR = Yamaguchi reagent. This reagent was combined with Et3N and made up as in a stock solution in 
PhMe and reacted portionwise (5 portions) with the acid 383 at room temperature for 15 min. The mixture was 
then added (5 additions in total) to a heated solution of the alcohol and base in PhMe at 15 min intervals over 
1 h, and heating was continued until the time specified was reached; 
e
Isolated yield.  
 
excess of DMAP and moderate excess of DCC (Table 5.8, Entry 2); but both 
conditions gave rise to only unreacted starting material. Swapping the relative 
stoichiometry of the DMAP and DCC (Table 5.8, Entry 3) gave more promising 
results, but doubling these stoichiometries in the hope that this would allow a 
reduction in the loading of the alcohol 338 did not improve the conversion to the 
desired product 398 (Table 5.8, Entry 4).  
A change of base to 4-PPy gave a poor yield with 50 mol% of the base (Table 5.8, 
Entry 5), which was improved to a more workable 43% on addition of stoichiometric 
base (Table 5.8, Entry 6). Increased reaction times (Table 5.8, Entries 7 and 8) 
(surprisingly) reduced conversion below useful levels, perhaps indicative of a 
capricious reaction efficiency or large degree of reversibility. Finally, use of a more 
forcing reagent stoichiometry with a reduced reaction time and staggered reagent 
addition was found to be completely ineffectual, indicating the presence of only 
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unreacted starting material on examination of the crude 
1
H NMR spectrum (Table 
5.8, Entry 9). 
On the basis of these results – which did not appear to show any clear correlation 
between yield and reagent loading, and where the reaction could not be forced to 
completion by use of large reagent excesses or long reaction times – it was clear that 
the use of the Steglich protocol would not be the most useful method for 
esterification of the alcohol 338 with oxazolyl carboxylic acids. Hoffmann et al.
25
 
reported the use of the Yamaguchi reagent
22
 in their efforts to synthesise disorazole 
C1, and the method was particularly attractive owing to the equivalent                      
acid-to-alcohol stoichiometric ratio used in conducting the transformation. 
Furthermore, the slow nature of their reagent addition implies that activated oxazole 
ester intermediates exist only transiently. This would support the need to deviate 
from DCC-mediated conditions because an instability of the in situ generated 
activated ester would explain why the DCC-mediated reactions – which in general 
are often performed in a one-pot operation with bulk addition of reagents – were 
largely unsuccessful.  
The Yamaguchi protocol was therefore attempted using alcohol 338 and oxazole 
383. For simplicity, the procedure was modified from that reported,
25
 which required 
the use of a syringe pump in order to add the activated ester in a very slow and 
controlled manner. The protocol investigated in the current study involved 
portionwise generation and addition of an activated ester to a heated solution of the 
alcohol. This was achieved by addition of a portion of a pre-prepared stock solution 
containing the Yamaguchi reagent 399 and Et3N to a portion of the carboxylic acid 
383, followed by transfer of the activated ester Int-400 solution thus obtained to a 
heated (40 °C) mixture of the alcohol and DMAP (Scheme 5.22). To our delight, the 
application of these conditions (Table 5.8, Entry 10) gave a 93% isolated yield of the 
desired ester 398 after 5 activated ester additions over a period of 1 h, and a further            
3 h of reaction. Furthermore, this was achieved using an equal alcohol-to-carboxylic 
acid stoichiometry, making the process highly efficient. 
Having achieved successful esterification with a model oxazolyl carboxylic acid, 
conditions were investigated using the C(1)–C(9) carboxylic acid fragment 111. A  





































Scheme 5.22 Mechanism and implementation of the Yamaguchi protocol in the synthesis of 




small number of conditions were investigated in early stage screening using DCC 
and are worthy of note, including the use of Wipf and Graham’s esterification 
conditions
26
 between the carboxylic acid 111 and an equimolar ratio (Table 5.9, 
Entry 1) and twofold excess (Table 5.9, Entry 2) of the alcohol 338; and these 
conditions led to moderate yields of the desired 1,3-anti diol monoester bis-alkyne 
336. Conditions were also investigated using 4-PPy either as a direct DMAP 
substitute (Table 5.9, Entry 3 with respect to conditions described in Entry 2) or as 
part of an attempt to achieve forcing conditions (Table 5.9, Entry 4), but these 
offered no improvement over the initial DMAP-mediated conditions, and indeed in 
the latter case led to no reaction. It is interesting to note however, that in general, 
yields were higher with the more sterically demanding C(5)–C(9)-fragment                       
2-substituted oxazole, when compared to those obtained with the 2-methyl 
substituted oxazole.  
Finally the Yamaguchi protocol – as elucidated for the model system – was applied 
to the reaction between alcohol 338 and carboxylic acid 111 (Table 5.9, Entries 6 
and 7). As expected, this led to the highest yield of the desired product, albeit 
requiring a slight increase in reagent stoichiometry, and an increased activated ester 
generation reaction time (Table 5.9, Entry 7) because use of identical conditions 
gave only a moderate yield of the desired product (Table 5.9, Entry 6).   
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1 1.0 DCC 5.0 DMAP 1.0 0 to 25 18 57 
2 2.0 DCC 5.0 DMAP 1.0 0 to 25 18 39 
3 2.0 DCC 5.0 4-PPy 1.0 0 to 25 18 56 
4 1.0 DCC 10 4-PPy 10 50 18 0 
5 1.0 YR/Et3N
c
 3.6/4.8 DMAP 3.0 40 4 56 
6 1.0 YR/Et3N
c
 4.0/5.7 DMAP 3.1 40 20 71 
a
All reactions were conducted in PhMe with the alcohol 338 added as a solution in DCM to make up 
approximately 30 to 50% of the solvent mixture with the following exception (solvent in brackets): Entry 6 (PhMe 




YR = Yamaguchi reagent. This reagent was combined with Et3N and 
made up as in a stock solution in PhMe and reacted portionwise (5 portions) with the acid 111 at room 
temperature for 15 min. The mixture was then added (5 additions in total) to a heated solution of the alcohol and 
base in PhMe at 15 min (Entry 5) or 30 min (Entry 6) intervals over 1 (Entry 5) or 2 (Entry 6) h, and heating was 
continued until the time specified was reached.  
 
The optimal set of conditions translated reasonably well to a larger-scale preparation 
of the ester 336 (~150 mg), giving the product in a respectable albeit slightly 
diminished 63% yield. It is worth noting that, unlike with the alcohol precursor 338, 
the fragment material was now fully separable from the PMB2O byproduct (carried 
over from the PMB protection step) by silica-gel chromatography. The product also 
appeared as a single diastereomer, and no apparent racemisation had occurred during 
any of the transformations as judged by 
1
H NMR spectroscopy; although these 
potential problems will perhaps require further confirmation using analytical 
techniques such as HPLC. The successful implementation of the Yamaguchi 
esterification between the C(1)–C(9) oxazole carboxylic acid 111 and the                      
C(10)–C(19) alcohol 338 concluded the synthesis of the C(1)–C(9)/C(10′)–C(19′)                 
1,3-anti diol monoester bis-alkyne, and therefore efforts can now be focussed on 
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5.5 Conclusions and Future Work 
The reaction of the C(10)–C(19) β-hydroxyketone 86 with a number of model 
heteroaryl aldehydes under ET coupling was investigated. Unfortunately, 86 was 
found to react poorly with the majority of the substrates screened, although the 
electron-deficient formylpyridines and nitrobenzaldehydes were successful, giving 
the products in good to excellent yield (~60 to 99%). A contingency strategy was 
then explored whereby the ET reaction was used to introduce the 1,3-anti 
stereochemistry in the product, and subsequent protection, hydrolysis and 
esterification steps allowed the synthesis of the C(16)-O-PMB-protected                      
C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol monoester bis-alkyne 336 in 43% yield (4 
steps from β-hydroxyketone 86; Scheme 5.23). However, the synthesis of a pyrazole 
derivative was unsuccessful, and so the conditions required for the preparation of this 
C(1)–C(9)/C(10′)–C(19′) analogue will require further investigation. 
Future work with respect to ET coupling requires that conditions be found for which: 
(i) electron-rich heteroaryl aldehydes react to give 1,3-anti diol monoesters; and (ii) 
the reaction proceeds smoothly with sterically crowded or electronically modified              
β-hydroxyketones. However, formylpyridines and nitrobenzaldehydes reacted 
successfully and so little further work is required with these systems; thus synthesis 
of their C(1)–C(9) derivatives would be worthy of investigation in view of a direct 
ET approach to their corresponding 1,3-anti diol monoester bis-alkynes. With these 
two points in mind, modifications to the ET reaction which may improve substrate 
scope, and the synthesis of further C(1)–C(9) analogues will be briefly discussed. 
 
Reagents and conditions: (a) (i) 3-Nitrobenzaldehyde (5.6 eq), SmI2 (94 mol%), THF, –20°C, 4 h; (ii) NaHSO3 
(11.3 eq), EtOH/H2O (5:1), 3 h, 94%, >95:5 dr; (b) PMB-TCA (3.0 eq), Sc(OTf)3 (10 mol%), PhMe, 0°C to rt, 1 h, 
79%; (c) LiOH (12 eq), MeOH/H2O (10:1), reflux, 18 h, 91%.(d) (i) C(1)–C(9) oxazole 111 (0.2 eq) 2,4,6-TCBC (0.8 
eq), Et3N (1.1 eq), PhMe, rt, 30 min; (ii) Addition of mixture from (i) to 338, DMAP (3.0 eq), PhMe, 40 °C, 30 min; (iii) 
4 further iterations of steps (i) and (ii); (iv) 40 °C, 18 h, 63%. 
Scheme 5.23 Preparation of the C(1)–C(9)/C(10′)–C(19′)1,3-anti diol monoester bis-alkyne 
336 from β-hydroxyketone 86. 
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5.5.1 The Evans–Tishchenko Reaction 
The ET reaction with the β-hydroxyketone 86 was found to have a limited substrate 
scope, with only the most electron-deficient systems reacting successfully to give 
useful product yields. Because some substrates investigated were found to react 
successfully with a simpler β-hydroxyketone (see: Section 5.1.3), this poor reactivity 
can probably be ascribed to the structure of the β-hydroxyketone 86; which is not 
only very sterically hindered, but contains an enone, which would modify the 
energetics of the reaction in terms of the reduction potential at the site of hydride 
transfer. In addition, some heterocycles (such as pyrrole) may have been too 
electron-rich to undergo successful reaction. In such situations, it would be highly 
desirable to have a contingency set of reaction conditions – applicable to demanding 
substrates – for performing the ET reaction.  
Fürstner
172
 found that reduced temperature (–50 °C) was successful in promoting an 
ET fragment coupling, and therefore a straightforward modification such as this may 
prove to be successful using the C(10)–C(19) β-hydroxyketone 86 (and indeed 
provides an excellent starting point for further optimisation). If such measures were 
unsuccessful however, modifications to the reagent would be a requirement. The 
addition of (coordinating) additives was briefly investigated by Dorgan
90
 in the 
context of forcing α-formyl N-heterocycles to react under ET coupling conditions. 
However, in the context of forcing heterocycles that were found to be ‘too                 
electron-rich’ to react under standard conditions applicable to other heterocycles, the 
use of additives was never investigated.  
The ET reaction with heterocycles may fail if an enolate intermediate Int-402 forms 
in preference to the cationic species Int-401,
16,90
 which is required for formation of 
the hemiacetal Int-403 (which reacts to give the ET product). In electron-rich 
systems, it is likely that the positive charge is stabilised by delocalisation within the 
ring-system (Scheme 5.24a), whereas in electron-deficient systems, an excess of 
positive charge in the ring would be comparably disfavoured and the cationic form 
Int-401 would predominate (Scheme 5.24b); any conditions which favour Int-401 
should lead to successful ET coupling. The use of the Boc group (and tosyl group) to 
reduce electron density in the heterocycle proved unsuccessful on reaction of those  




Scheme 5.24 Selectivity between the cationic and enolate forms of the Sm(III) species. 
Preference in (a) electron-rich; and (b) electron-deficient heterocyclic systems. The favoured 
species are shown in boxes. 
 
substrates with the C(10)–C(19) fragment, although it is possible that more powerful 
electron-withdrawing groups such as the nosyl group could lead to positive results. 
Any additives that would increase the stability of the cationic intermediate Int-401 
may also aid in promoting the ET pathway. Such an additive could be a polar aprotic 
solvent compatible with SmI2 such as HMPA,
221
 which has been shown to promote 
reductive processes with SmI2,
170,221
 and increases solvent conductivity,
221
 and 
therefore may shift the course of the reaction in favour the desired, more ionic 
intermediate Int-401. The nature of the active Sm(III) catalyst is also worthy of 
investigation because the effects of the substitution on the aldehyde used for forming 
the active pinacol intermediate could have a minor influence over the Int-401/Int-402 
selectivity, in the sense that electron-withdrawing substituents on the aryl ring could 
have an effect on the electrophilicity of the cationic intermediate Int-401. Finally, the 
use of an alternative catalyst could be investigated. The ET reaction and the related 
aldol–Tishchenko reaction
222







 and so catalyst screening may unearth a 
superior system to the samarium pincolate for ET coupling of (hetero)aryl aldehydes. 
 
5.5.2 Synthesis of Further C(1)–C(9) Analogues 
Given that pyridine- and nitrobenzene-derived aldehydes reacted successfully in ET 
coupling, the synthesis of C(1)–C(9) analogues that incorporate these frameworks 
would be worthy of investigation. Not only would they provide additional analogues 
for further SAR studies, but given that they are 6-membered-ring heterocycles  




Figure 5.3 Pyridine and nitrobenzene analogues of the C(1)–C(9) fragment of disorazole C1. 
pyridine and nitrobenzaldehyde analogues would provide a slight structural change 
relative to the 5-membered-ring oxazole. On considering the reactivity of the 
pyridines (whereby 2-formylpyridine is known to react poorly)
90,174
 and the angle 
required for similarity to the 5-membered-ring heterocycles (a 1,3-substitution) the 
formyl group would be required to be at the 3- or 4-position, with the C(5)–C(9) 
(‘R’) group in a 1,3-relationship to this functionality (405a and b, Figure 5.3). 
Similarly, 1-formyl-3-nitro-5-R 405c and 1-formyl-4-nitro-5-R 405d derivatives are 
viable analogues in terms of complementarity to the 5-membered-ring heterocycles 
for the nitrobenzaldehyde series of analogues (Figure 5.3).  
Cross-coupling of an organoboronate derivative of the C(5)–C(9) fragment would 
represent a highly convergent means of generating the required pyridyl or 
nitrophenyl C(1)–C(9) analogues. The known C(5)–C(9) tosylate 95 or iodide 96
16
 
would be converted to its boronate ester derivative 407 according to, for example, 
Liu’s copper-catalysed borylation protocol
224
 (Scheme 5.25a). Suzuki–Miyaura 
coupling
225





(Figure 5.3) would then provide access to the desired C(1)–C(9) fragment analogues 
405 (Scheme 5.25b). 
 
Scheme 5.25 (a) Synthesis of a C(5)–C(9) boronic ester 407 from tosylate 95 or iodide 96; 
(b) Potential Suzuki–Miyaura coupling route towards the syntheses of 405 and further             
C(1)–C(9) fragment analogues. 
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Extension of this methodology towards the synthesis of other (hetero)aryl systems
228
 
would permit the preparation of further C(1)–C(9) analogues (Scheme 5.25b). The 
approach, importantly, may also provide a direct route towards the C2 alkylation of 
the oxazole,
228c
 which has proven problematic in previous efforts to synthesise the 
natural C(1)–C(9) fragment.
16
 For novel (hetero)aryl analogues, model ET and 
esterification reactions would be required to identify the appropriate route for the 
synthesis of the corresponding C(1)–C(9)/C(10′)–C(19′) bis-alkynes. However, the 
successful synthesis of novel bis-alkynes will allow investigation into the generation 
of their tetrahydro-disorazole C1 analogue derivatives, and thus their disorazole C1 
(hetero)aryl analogues, according to our proposed alkyne metathesis strategy. 
 
5.6 Summary 
The Evans–Tishchenko coupling between the C(10)–C(19) β-hydroxyketone 86 and 
range of aryl and heteroaryl aldehydes was investigated. Highly electron-deficient 
aryl aldehydes reacted successfully to give good yields of their corresponding              
1,3-anti diol monoester products. However, moderately electron-deficient aldehydes 
failed to react usefully under our conditions, and these included a range of potential 
N-heterocycles which would be synthesised by straightforward N-alkylation with the 
C(5)–C(9) tosylate 95; potential conditions for which were developed in the herein. 
To circumvent the problems associated with ET coupling, a contingency strategy for 
the introduction of heterocycles to a C(10)–C(19) mono-protected diol 338 via 
esterification was investigated and although unsuccessful for a model pyrazole, it 
was successful in generating the ester derivatives of both a model and C(1)–C(9) 
fragment oxazole. The latter step of the reaction sequence concluded the synthesis of 
a C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol monoester bis-alkyne 336 and thus further 
progress can be made towards the construction of the disorazole C1 macrocyclic 
framework using an alkyne metathesis strategy. Future work should aim to develop 
the ET reaction methodology in order to allow the synthesis of 1,3-anti diol 
monoesters from sterically hindered β-hydroxyketones and electron-rich (hetero)aryl 
aldehydes; and to investigate the synthesis of further heterocyclic C(1)–C(9) 




Chapter 6         Future Work 
6.1 Overview: Alkyne Metathesis Dimerisation 
Having successfully achieved the synthesis of the requisite C(16)-O-PMB-protected                
C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol monoester bis-alkyne 336, the next step 
involves subjecting the substrate to alkyne metathesis dimerisation conditions in 
order to examine the viability of this approach as a means of constructing the                  
30-membered-ring, protected tetradehydro-disorazole C1 41. Of course, 41 was an 
advanced synthetic intermediate in Wipf’s disorazole C1 total synthesis,
26
 and so 
successful dimerisation will represent a formal total synthesis, therefore providing 
access to the natural product 1 for use in biological testing after elaboration 
according to literature procedure. 
In order to achieve the synthesis of 41 using AM, two processes are required to take 
place during the course of the reaction: (1) an alkyne cross-metathesis (ACM) 
reaction must occur between one alkyne moiety (each) of two reactant molecules of 
the bis-alkyne 336; and (2) after the ACM event, an intramolecular ring-closing 
alkyne metathesis (RCAM) reaction must take place within the newly-formed linear 
dimer 408 between the two remaining methyl-capped alkynes (Scheme 6.1). 


















































Scheme 6.1 Dimerisation of the C(1)–C(9)/C(10′)–C(19′) bis-alkyne fragment 336 to give the 
tetradehydro-disorazole C1 (‘head-to-tail) scaffold 41 using an ACM–RCAM approach. 
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Firstly, formation of the desired C2-symmetric scaffold 41 requires that the 
molecules approach in the correct ‘head-to-tail’ [C(9)→C(10)] orientation (cf. 
Scheme 6.1). However, it is possible that ACM could occur in an undesired              
‘head-to-head’ fashion (to form either or both of the dimers 409 and thus cyclic 
dimer 410; Scheme 6.2) or undergo intramolecular RCAM to form a cyclic monomer 
(not shown). Although computational studies performed within the Hulme group
229
 
indicate a thermodynamic preference for head-to-tail dimerisation, these results will 
require experimental verification. Secondly, following ACM, the intramolecular 
RCAM event must take place, as opposed to oligomerisation via further ACM. This 
problem is perhaps easier to overcome, because such a process would be disfavoured 
(over intramolecular RCAM), especially at moderate-to-high dilution.
38a,c
 
Alkyne metathesis has been widely applied as a means of ring-closing and is growing 
in stature as an alternative to olefin metathesis or metal-mediated cross-coupling for 
carbon–carbon bond formation.
37
 However, perhaps unsurprisingly given the 
inherent difficulties present, use of alkyne metathesis for cross-metathesis 
dimerisation has rarely been reported.
38
 Indeed, the reaction presents a challenging 
proposition, but is one that must be overcome in our quest to synthesise the 
disorazoles and their analogues according to our retrosynthesis. Pleasingly, early 
work has been promising, and this is detailed in the following section.  
 
Scheme 6.2 ‘Head-to-head’ ACM of the C(1)–C(9)/C(10′)–C(19′) bis-alkyne and subsequent 
RCAM of the linear dimers 409 thus formed to give the cyclic dimer 410. 
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6.2 Preliminary Alkyne Metathesis Dimerisation Results* 
Time constraints applicable to the current project prevented investigation into AM 
dimerisation using the C(1)–C(9)/C(10′)–C(19′) bis-alkyne 336, but it has been 
investigated by co-workers within the Hulme group and some promising preliminary 
results have been obtained that are certainly worthy of discussion in the context of 
future research. In terms of a catalyst system, model studies indicated that Fürstner’s
 
molybdenum alkylidyne catalyst 411 was the most active in promoting alkyne 
metathesis and so this was selected for reaction with the bis-alkyne 336.
224–226 
In a glovebox, a solution/suspension of the C(1)–C(9)/C(10′)–C(19′) bis-alkyne 336 
(36 mM) and 5 Å MS in toluene was treated with the catalyst 411 (10 mol%) in a 
sealed tube (Scheme 6.3). After reaction overnight (~18 h), the crude product was 
submitted to RP-HPLC, and each fraction was then isolated (preparative HPLC, 
shown in Figure 6.1)
†
 and analysed by mass spectrometry. Mass-spectral analysis of 
the isolates indicated that the crude mixture contained the bis-alkyne starting material 
336 (Rt = 15 min), two ring-closed dimers (46 and 51 min), and three linear dimers 
(~68, 71 and 78 min). 
Following mass-spectral analysis, NMR analysis has allowed identification of the 
unknown products of the reaction. The two large linear-dimer peaks (Rt = 71 and 78 
min) were identified as the two head-to-head dimers 409, while the remaining       
linear-dimer peak (~68 min) was confirmed as the head-to-tail dimer 408. Of 
particular note is that the peak intensity for the desired, intermediate, head-to-tail 
linear dimer is greatly diminished compared to the head-to-head dimers, implying 
that either its initial formation is unfavourable; or – and far more likely on the basis 
of relative cyclised dimer peak intensity – ring-closure of this dimer via RCAM is 
rapid and more energetically favourable than with the head-to-head dimers. This is 
important, not only with respect to the success of our synthesis, but also in terms of 
optimisation of the reaction, because the knowledge that formation of the head-to-tail  
*All experimental work described in this section was carried out by Richard Brewster, Hulme group, 
The University of Edinburgh. The description of the experimental protocol and the figures presented 
herein have been reproduced with his kind permission, and the permission of Dr. Alison Hulme. 
†
Unfortunately integration data for each peak was unavailable.
 






Scheme 6.3 ACM–RCAM reaction; and Figure 6.1 (a) Preparative HPLC output from the 
ACM–RCAM reaction; and (b) the 
1
H NMR spectrum (800 MHz, CDCl3) of the desired          
head-to-tail cyclic dimer 41. 
(a) 
(b) 








linear dimer 408 
 
C(10)–C(10′)  
linear dimer 409b 
 
C(9)–C(9′)  
linear dimer 409a 




cyclic dimer 41 
 
head-to-head 
cyclic dimer 410 
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dimer is more favourable energetically means that is tuning of the reaction conditions 
towards formation of this product may be more straightforward.  
Finally, formation and successful isolation of the desired cyclic head-to-tail dimer 
was confirmed. The 
1
H NMR spectrum for the product obtained at Rt = 51 min did 
not visually match that for known disorazole intermediate 41, and was therefore 
tentatively ascribed to being the head-to-head cyclic dimer 410; although the small 
quantity of material prevented a full characterisation. However, the 
1
H NMR 
spectrum (Figure 6.1b) of the material isolated at Rt = 46 min was in good 
agreement with that reported by Wipf and Graham,
26
 which confirmed the successful 
application of AM dimerisation to the construction of the protected                 
tetradehydro-disorazole C1 41 scaffold, and completed the formal total synthesis of 
disorazole C1.  
 
6.3 Implications for Future Work 
As evidenced by the successful synthesis of protected tetradehydro-disorazole C1 41, 
early results validate the use of an AM dimerisation strategy as a means of 
constructing the large-ring macrocyclic core of disorazole C1. Future work should 
seek to discover conditions that both maximise the yield of the reaction (which 
currently leads to large proportions of starting material and intermediate ACM 
products) and to control reaction selectivity such that the cyclic C(9)–C(10) dimer is 
formed preferentially. Potential methods include concentration studies; and metal 
templating strategies,
233
 which could aid the desired ACM process by co-ordination 
to oxygen and nitrogen moieties and orientating the monomers for the desired              
head-to-tail reaction. Additionally, our initial retrosynthesis envisaged the use of an 
AM dimerisation of a bis-alkyne 84 bearing a free alcohol at C(16) (which was 
hoped would be obtained immediately after ET coupling; Scheme 6.4), and work 
with this substrate is currently under investigation.
234
 If results prove to be more 
successful with this substrate 84, a PMB deprotection prior to ACM–RCAM may 
streamline the optimisation process. 
Once an optimised procedure with the C(1)–C(9)/C(10′)–C(19′) oxazole is fully  




Scheme 6.4 ACM–RCAM using the C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol bis-alkyne 84. 
 
developed, work can commence towards the use of AM dimerisation for the 
synthesis of disorazole C1 analogues. Potential analogues include those derived from 
dimerisation of C(6)-methoxy C(1)–C(9)/C(10′)–C(19′) heterocyclic fragment 
analogues and from C(6)-amino analogues of the C(1)–C(9)/C(10′)–C(19′) fragment. 
Mixed heterocyclic and/or C(6)-amino analogues would also provide interesting 
entries in the library of disorazole analogues; and the likelihood of obtaining a 
mixture of alkyne metathesis products in the reaction between two (or more) distinct 
bis-alkynes may allow the tetradehydro-disorazole C1 scaffold of several different 
disorazoles to be assembled in a small-scale combinatorial
235
 fashion (Scheme 6.5), 
rapidly providing analogues for biological testing. The head-to-head disorazole C1 
alkyne metathesis products are also natural-product–like structures, and therefore the 
biological testing of these products (and that of their tetrahydro-disorazole-C1–like 
derivatives) would also be worthy of investigation. Biological testing of disorazole 
analogues and related compounds on the basis of their cytotoxicity and anti-tubulin 













175 A = B = oxazole, X = Y = NHMe
413 A = B = triazole, X = Y = OMe






disorazole C1 analogues + natural-product–like molecules
 
Scheme 6.5 Synthesis of mixed disorazole C1 analogues using an ACM–RCAM 
methodology in a combinatorial fashion. 
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6.4 Concluding Remarks 
A number of studies towards the total synthesis of disorazole C1 and its analogues, 
centred around a novel Evans–Tishchenko/alkyne metathesis methodology, have 
been investigated and were detailed herein.  
The synthesis of a novel C(6)-amino C(5)–C(9) fragment analogue was achieved, 
and further route optimisation and elaboration of the molecule to C(1)–C(9) fragment 
analogues according to established procedures will allow the development of novel 
C(6)-amino analogues of disorazole C1. 
Convergent and linear strategies towards the synthesis of the key C(10)–C(19)                 
β-hydroxyketone were investigated. This synthesis was eventually achieved using a 
linear strategy, and large-scale preparation of the fragment has allowed investigation 
into the scope of the Evans–Tishchenko reaction with model heteroaryl aldehydes.  
Although it was deemed unsatisfactory as a potential fragment coupling strategy, the 
Evans–Tishchenko reaction has allowed esterification to be investigated as a means 
of synthesising the C(1)–C(9)/C(10′)–C(19′) oxazole fragment of disorazole C1. 
Optimisation of the esterification route to the C(1)–C(9)/C(10′)–C(19′) oxazole 
fragment, and application of the methodology to the synthesis of heterocyclic 
analogues will maximise the potential of our synthetic strategy toward the synthesis 
of the disorazole core. Further Evans–Tishchenko investigations may yet allow the 
pursuit of this route as a means of fragment coupling. 
Synthesis of the C(1)–C(9)/C(10′)–C(19′) fragment has allowed investigation into its 
dimerisation using AM. This allowed others within the research group to complete 
the formal total synthesis of disorazole C1, and efforts towards its total synthesis and 
the synthesis of analogues are ongoing. 
Research into the construction of the tetradehydro-disorazole C1 macrocycle via an 
AM methodology is still very much in its infancy, and so future work in this area 
should focus on the optimisation of the ACM–RCAM procedure. Early results have 
been promising, and the development of a general procedure for the critical           
ACM–RCAM step will allow the synthesis of a library of disorazole analogues for 




Chapter 7       Experimental 
7.1 General Experimental 
Nuclear magnetic resonance (NMR) spectra were recorded at ambient temperature 
(298 K) on a Bruker AV400, AV500 or AV600 spectrometer running at 400, 500 or 
600 MHz  (
1
H spectra) or 100, 125 or 150 MHz (
13
C spectra), respectively; 
31
P NMR 
spectra were recorded on a Bruker AV400 spectrometer running at 162 MHz. 





C spectra; δTMS = 0) or 85% aqueous phosphoric acid 
(
31
P spectra; δH3PO4 = 0) and are calibrated to the residual solvent peak. 
1
H NMR data 
are reported as chemical shift, relative intensity, peak multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, qn = quintet, sept = septet, m = multiplet; br = broad), 
coupling constant (J value, Hz), and interpretation. 
13
C spectra are reported as 
chemical shift, coupling constant (where relevant), relative intensity, and assignment 
(CH3 = methyl, CH2 = methylene, CH = methine, C = quaternary); 
31
P spectra are 
reported analogously. All 
13
C assignments were confirmed by DEPT90 and/or 
DEPT135 (distortionless enhancement by polarisation transfer) spectra 
Infra red (IR) spectra were recorded using a Shimadzu IRAffinity-1 solid state IR 
instrument. Values of peaks corresponding to absorbance maxima (νmax) are 
expressed in wavenumbers (cm
-1
). 
Electron ionisation (EI) and chemical ionisation (CI) mass spectra were obtained 
using a MAT 900 XP mass spectrometer. Electrospray ionisation (ESI) was 
performed using a Bruker micrOTOF II or a Finnigan LCQ mass spectrometer.             
Fast-atom bombardment (FAB) mass spectra were obtained using a Finnigan LCQ 
mass spectrometer. All mass-spectral analyses were performed at The University of 
Edinburgh. Mass-to-charge ratios (m/z) of all parent (molecular) ions ([M]
+
) and 
their intensities are reported, followed by (major) fragment ions and their intensities.  
HPLC was carried out using an Agilent Systems T100 Series HPLC instrument. 
Retention times (Rt, minutes) are reported according to the elution parameters as 
specified in Table 7.1 (Method A or B). Samples were dissolved in propan-2-ol and 




Table 7.1 HPLC methods used for determining enantiomeric excess. 
 Method A Method B 
Stationary Phase AS-H (ChiralPAK) IC (ChiralCEL) 
Column Particle Size (µm) 5 20 
Column Length (mm) 250 250 
Column Internal Diameter (mm) 4.6 4.6 





Runtime (min) 45 60 
 
Optical rotations were obtained at ambient temperature with a cell of 1 dm length 
using an AA Series PolAAr 20 polarimeter running at a wavelength of 589 nm 
(sodium D-line). Concentrations (c) for the derived specific rotations ([α]D values) 




 Melting points (mp) were measured using a 
Gallenkamp melting point apparatus; the temperature range and whether the 
substance undergoes decomposition (dec.) over this range is reported. 
Flash chromatography was carried out on powdered silica (Kieselgel 60,                  
Sigma–Aldich, procedures pertaining to Chapter 3; or Geduran 60, Merck, all other 
procedures) of pore size 60 Å and particle size 40 to 63 µm. Thin-layer 
chromatography (TLC) was performed using aluminium/silica plates (0.25 mm, F254 
silica gel 60, Merck) and visualised by ultraviolet irradiation or KMnO4 stain.
†
 
All non-aqueous reactions were performed using oven-dried glassware (140 °C) with 
magnetic stirring under a positive pressure of argon gas using anhydrous solvents 
[obtained from a Grubbs solvent purification system (GlassContour)] unless 
otherwise stated. Reactions at reflux were carried out at a bath temperature 5 °C 
above accepted literature solvent boiling points. Reactions involving ultrasonic 
vibration were carried out using a Grant XB2 ultrasonic bath. 
*For compounds 338 and 395, where an achiral contaminant was present in the sample, the calculated 
concentration was corrected-for according to the analyte:contaminant ratio (as determined by 1H NMR 
spectroscopy) to account for the mass discrepancy that the contaminant presented. For example, 30.0 
mg of optically active and achiral material of equal molecular mass dissolved in 2 cm3 of solvent in a 
2:1 molar ratio would have a concentration, c, equal to 1.00 g/100 cm3. 
†Prepared by stirring KMnO4 (1.00 % 
w/v), K2CO3 (0.40 % 
w/v) and NaOH (4 pellets/dm
3) in H2O in 




Aqueous (aq) solutions of acids, bases or inorganic salts are reported as: solution 
(volume; molarity or level of saturation). Concentrated aqueous (conc aq) HCl refers 
to the commercially obtained (Fisher) ~37% 
w
/v solution. Solutions described as 
“25% sat aq“ or “50% sat aq” refer, respectively, to the saturated aqueous (sat aq) 
solution diluted 1:3 or 1:1 with H2O. Reduced pressure removal of solvents was 
carried out at a bath temperature of 40 °C unless otherwise stated. All distillations, 
unless otherwise stated, were carried out under an atmosphere of nitrogen.  
The following solvents and reagents were purified and dried by distillation over the 
drying agent (in its powdered, anhydrous form) that is indicated in parentheses: 
acetone (K2CO3); DIPEA, Et3N, morpholine, 
i
Pr2NH, TMSCl (CaH2); glacial acetic 
acid (CuSO4); oxalyl chloride (CaCl2). Pyrrole was purified by short-path distillation 
in the absence of light. BnBr was purified by washing its Et2O solution (0.3 M) with 
20 % 
v
/v of H2SO4 (1.0 M aq), NaHCO3 (sat aq), Na2S2O3 (0.1 M aq), H2O and brine; 
before drying (MgSO4), removing the solvent under reduced pressure and subjecting 
the liquid thus obtained to short-path distillation. Benzaldehyde was purified by 
washing its Et2O solution (0.1 M) with 20% 
v
/v of NaOH (1.0 M aq), Na2SO3 (sat 
aq), H2O and brine; before drying (MgSO4), removing the solvent under reduced 
pressure and subjecting the liquid thus obtained to reduced-pressure distillation over 
anhydrous K2CO3. Unless otherwise stated, distilled reagents were stored under 
nitrogen gas over their respective drying agents (where relevant) and used within 2 d. 
Anhydrous DMF was obtained commercially (VWR BakerDRY) and used as 
purchased. Solvents and glassware used in CuAAC reactions and Pd/C mediated 
catalytic hydrogenations were purged with a stream of nitrogen gas for ~15 min prior 
to experiment. Magnesium turnings used in Grignard reagent preparations were 
activated by washing with HCl (0.1 M aq), H2O, acetone, Et2O and anhydrous Et2O 
immediately prior to experiment. HNMe(OMe)•HCl was recrystallised from EtOH. 
TsOH•H2O was recrystallised from its concentrated aqueous solution, washing with 
toluene following filtration. ZnCl2 and anhydrous CrCl2 were dried by heating with a 
hot-air blower (200–300 °C) under vacuum for 10 to 15 min prior to use. The 




determined by iodometric titration with KI, HCl and Na2S2O3.
236
 Molecular sieves  
(4 Å) were pulverised and activated by oven-heating for at least 24 h before use.  
The following metal catalysts and metals were obtained from the supplier that is 
indicated in brackets and used as purchased unless otherwise stated: CrCl2 [Alfa 
Aesar]; Grubbs’ II, 10% Pd/C, Pd(PPh3)4, PdCl2(PPh3)2, indium (100 mesh), 
magnesium (turnings), tin (325 mesh), zinc (170 mesh) [Sigma–Aldrich]; samarium 
(40 mesh) [Strem]. The following reagents were obtained in the purity or formulation 
that is indicated in parentheses from the supplier that is indicated brackets and used 
as purchased unless otherwise stated: BnN3 (94%) [Alfa Aesar]; 
n
BuLi (2.4 M, 
hexanes), LiAlH4 (2.4 M, hexanes), NaHMDS (2.4 M, THF), 
i
PrMgBr (3.0 M,                 
2-MeTHF) [Fisher]; 
n
BuLi (1.6 M, hexanes), DIBAL (1.0 M, hexanes), ethyl                 
3,3-diethoxypropionate (90%), NaH (60%, dispersion in mineral oil), 1-propenyl- 
and 1-propynylmagnesium bromide (both 0.5 M, THF) [Sigma-Aldrich]. All other 
reagents (specified >98% purity) were obtained from one of the aforementioned 
suppliers and were used as purchased unless otherwise stated. 
 
7.1.1 Index for General Procedures 
General Procedures for the preparation of compounds according to standard 
protocols can be found on the following pages: 
General Procedure A: Weinreb Amide Synthesis with 
n
BuLi  196 
General Procedure B: Swern Oxidation     196  
General Procedure C: TBS Protection of Alcohols with TBSOTf 196  
General Procedure D: N-Boc Protection of N-Heterocycles  232 
General Procedure E: N-Alkylation of N-Heterocycles   232 
General Procedure F: The Evans–Tishchenko Reaction   250 
Noteworthy protocol deviations are underlined in the experimental description. 
In addition to General Procedures, it should be noted that three syntheses of 
compounds from Chapter 3 are presented alongside those from Chapter 4 in order 
to keep the relevant spectroscopic data collated. The index for these reactions can be 




7.2 Experimental from Chapter 2 
(R)-2-Amino-3-hydroxy-propionic acid methyl ester hydrochloride (65) 
D-serine methyl ester hydrochloride 65 was prepared according to a 





, 260 mmol) was added dropwise (~15 min) to a suspension 
of D-serine (21.0 g, 200 mmol) in MeOH (200 cm
3
) at 0 °C and the solution was 
stirred for 1 h, warmed to rt, and stirred overnight (~18 h). The solvent was removed 
under reduced pressure and the beige solid thus obtained was recrystallised 
(MeOH/Et2O) to give D-serine methyl ester hydrochloride 65 as a colourless solid 
(29.3 g, 94%). Rf (DCM:MeOH:Et3N, 200:20:1) = 0.27; mp 162–163 °C, lit
237
             
163–164 °C; [α]D = –5.00 (c 1.00, MeOH), lit
237
 [α]D = –4.30 (c 1.80, EtOH); IR 
(neat, cm
-1
) 3345 (OH), 3070 (NH), 3028 (NH), 2990 (NH), 2922 (NH), 1745 
(C=O); 
1
H NMR δ (500 MHz, D2O) 4.23 (1H, dd, J = 4.4, 3.5 Hz, NCH), 4.05 (1H, 
dd, J = 12.6, 4.4 Hz, NCHCHAHBOH), 3.95 (1H, dd, J = 12.6, 3.5 Hz, 
NCHCHAHBOH), 3.80 (3H, s, OCH3); 
13
C NMR δ (125 MHz, D2O) 168.9 (C), 59.2 
(CH2), 54.7 (CH), 53.7 (CH3); m/z (ESI+, MeOH) 142 ([M+Na]
+










(R)-2-tert-Butoxycarbonylamino-3-hydroxy-propionic acid methyl ester (122) 
N-Boc-D-serine methyl ester 122 was prepared according to a 
modification of the procedure described by Chang et al.
50a
 Freshly 
distilled Et3N (65.6 cm
3
, 471 mmol) was added to a suspension of             
D-serine methyl ester hydrochloride 65 (29.3 g, 188 mmol) in DCM 
(300 cm
3
) at 0 °C and the mixture was stirred for 15 min before slow addition (~20 
min) of Boc2O (49.3 g, 226 mmol) in DCM (100 cm
3
). The reaction mixture was 
warmed to rt, stirred overnight (~16 h) and diluted with DCM (600 cm
3
). The 
organic layer was washed with HCl (3 × 400 cm
3
; 0.5 M aq), NaHCO3 (400 cm
3
; sat 
aq), H2O (400 cm
3
), brine (400 cm
3
) and dried (MgSO4). Removal of the solvent 
under reduced pressure gave N-Boc-D-serine methyl ester 122 as a yellow syrup 
(35.3 g, ~76% by 
1
H NMR; ~8–9% Boc2O present), which was used without further 







= –9.37 (c 3.18, CHCl3); IR (neat, cm
-1
) 3397 (OH), 1748 (C=O), 1715 (C=O), 1697 
(C=O); 
1
H NMR δ (500 MHz, CDCl3) 5.49 (1H, br s, NH), 4.42 (1H, br s, NCH), 
3.99 (1H, dd, J = 11.2, 3.8 Hz, NCHCHAHBOH), 3.93 (1H, dd, J = 11.2, 3.5 Hz, 
NCHCHAHBOH), 3.81 (3H, s, OCH3), 1.48 (9H, s, 3C(CH3)3); 
13
C NMR δ (125 
MHz, CDCl3) 171.3 (C), 155.8 (C), 80.4 (C), 63.6 (CH2), 55.7 (CH), 52.7 (CH3), 
28.3 (3CH3); m/z (EI) 219 ([M]
+
, 15%), 191 (15), 60 (21), 59 (21), 57 (100). The 




(R)-2,2-Dimethyl-oxazolidine-3,4-dicarboxylic acid 3-tert-butyl ester 4-methyl 
ester (123) 
Garner’s ester 123 was prepared according to a modification of the 
procedure described by Chang et al.
50a
 To a cooled (0 °C) solution of 
N-Boc-D-serine methyl ester 122 (35.1 g, 160 mmol) and                        
2,2-dimethoxypropane (294 cm
3
, 2.40 mol) in DCM (300 cm
3
) was 
added TsOH•H2O (3.04 g, 16.0 mmol, 10 mol%) and the solution was stirred for 30 
min, warmed to rt and stirred overnight (~16 h). NaHCO3 (500 cm
3
; sat aq) was 
added to quench the reaction, and the aqueous layer was extracted with DCM              
(3 × 100 cm
3
). The combined organic layers were washed with NaHCO3 (3 × 200 
cm
3
; sat aq), H2O (200 cm
3
), brine (400 cm
3
) and dried (MgSO4). Removal of the 
solvent under reduced pressure gave Garner’s ester 123 as a light-yellow syrup (39.3 
g, 95%), which was used without further purification. Rf (Hexane:EtOAc, 6:1) = 
0.35; [α]D = +53.3 (c 1.05, CHCl3), lit
50b 
[α]D = +49.8 (c 1.04, CHCl3); IR (neat,              
cm
-1
) 1757 (C=O), 1705 (C=O); 
1
H NMR δ (400 MHz, DMSO-d6, 353 K) 4.42 (1H, 
dd, J = 7.2, 3.0 Hz, NCH), 4.18 (1H, dd, J = 9.2, 7.2 Hz, NCHCHAHBO), 3.95 (1H, 
dd, J = 9.2, 3.0 Hz, NCHCHAHBO), 3.71 (3H, s, OCH3), 1.58 (3H, s, NCCH3), 1.48 
(3H, s, NCCH3), 1.42 (9H, br s, 3C(CH3)3); 
13
C NMR δ (100 MHz, DMSO-d6, 353 
K) 171.6 (C), 151.3 (C), 94.5 (C), 80.1 (C), 66.1 (CH2), 59.3 (CH), 52.3 (CH3), 28.4 
(3CH3), 25.5–24.9 (2CH3); m/z (ESI+, MeOH) 541 ([2M+Na]
+
, 29), 342 
([M+2MeCN+H]
+
, 100), 282 ([M+Na]
+
, 84). The spectroscopic data are in good 








(R)-4-Formyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester (116) 
Garner’s aldehyde 116 was prepared according to the procedure 
described by Chang et al.
50a
 A cooled (–78 °C) solution of DIBAL 
(17.0 cm
3
, 8.50 mmol; 0.50 M in Hexane/PhMe, 1:1) was added via 
cannula to a solution of Garner’s ester 123 (1.30 g, 5.00 mmol) in 
PhMe (10 cm
3
) at –78 °C at a rate such that the internal temperature of the solution 
did not exceed –70 °C (~45 min). The mixture was stirred for 3 h before cold               
(–78 °C) MeOH (2.27 cm
3
, 89.4 mmol) was added via cannula, keeping the 
temperature below –70 °C [CAUTION: H2 gas evolution]. Stirring was continued at 
–78 °C until a constant internal temperature (below –70 °C) was maintained (~10 
min); and the emulsion was then poured into a slurry of ice (~20 g) and HCl (15 cm
3
; 
1.0 M aq) and warmed to rt. Sodium potassium tartrate (20 cm
3
; sat aq) was added, 
and the mixture was stirred for a further 30 min and subsequently poured into sodium 
potassium tartrate (20 cm
3
; sat aq) and DCM (50 cm
3
). The aqueous layer was 
extracted with DCM (5 × 20 cm
3
), and the combined organic layers were washed 
with brine (50 cm
3
) and dried (MgSO4). Removal of the solvent under reduced 
pressure gave Garner’s aldehyde 116 as a colourless oil (1.09 g, 94%), which was 
used without further purification. Rf (Hexane:EtOAc, 6:1) = 0.19; [α]D = +67.5 (c 
1.20, CHCl3), lit
50b 
[α]D = +83.8 (c 1.00, CHCl3); IR (neat, cm
-1
) 1738 (C=O), 1693 
(C=O); 
1
H NMR δ (400 MHz, DMSO-d6, 353 K) 9.55 (1H, d, J = 1.9 Hz, CHO), 
4.37 (1H, ddd, J = 7.1, 3.5, 1.9 Hz, NCH), 4.10 (1H, dd, J = 9.5, 7.1 Hz, 
NCHCHAHBO), 4.05 (1H, dd, J = 9.5, 3.5 Hz, NCHCHAHBO), 1.56 (3H, s, NCCH3), 
1.50 (3H, s, NCCH3), 1.44 (9H, m, 3C(CH3)3); 
13
C NMR δ (100 MHz, DMSO-d6, 
353 K) 199.6 (CH), 151.6 (C), 94.4 and 94.0 (C), 80.0 and 79.7 (C), 65.0 (CH), 63.5 
(CH2), 28.4 (3CH3), 26.2 (CH3), 24.6 (CH3); m/z (EI) 229 ([M]
+
, 3%), 200 (23), 144 












(R)-4-Ethynyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester (129) 
Method A (from Garner’s aldehyde 116): According a modification 
of the procedure described by Meffre et al.,
55
 K2CO3 (7.09 g, 51.3 
mmol) was added to a solution of Garner’s aldehyde (1.16 g, 5.13 
mmol) and dimethyl-1-diazo-2-oxopropylphosphonate
63
 (5.98 g, 21.1 
mmol; 67% purity) in MeOH (40 cm
3
) at 0 °C, and the reaction mixture was left to 
warm to rt overnight (~18 h). The solvent was removed under reduced pressure, and 
H2O (50 cm
3
) was added to the residue, followed by extraction of the aqueous layer 
with DCM (4 × 20 cm
3
). The combined organic layers were washed with brine (20 
cm
3
), dried (MgSO4), and the solvent was removed under reduced pressure. Flash 
chromatography (Hexane:EtOAc, 6:1) of the resulting yellow residue gave alkyne 
129 as a colourless oil (575 mg, 50%).  
Method B (from Garner’s ester 123): According to a modification of the procedure 
described by Hinkle et al.,
56
 a cooled (–78 °C) solution of DIBAL (3.40 cm
3
, 1.70 
mmol; 0.50 M in hexane/PhMe, 1:1) was added via cannula to a solution of Garner’s 
ester 123 (259 mg, 1.00 mmol) in PhMe (3 cm
3
) at a rate such that the internal 
temperature of the solution did not exceed –65 °C (~20 min). The mixture was stirred 
for 3 h at –78 °C and cold (–78 °C) MeOH (5 cm
3
, 124 mmol) was added via cannula 
at a rate such that the internal temperature of the solution did not exceed –70 °C [~20 
min; CAUTION: H2 gas evolution]. The reaction mixture was warmed to 0 °C, then 
MeOH (5 cm
3
), K2CO3 (829 mg, 6.00 mmol) and a solution of dimethyl-1-diazo-2-
oxopropylphosphonate
63
 (773 mg, 2.73 mmol; 67% purity) in MeOH (5 cm
3
) were 
added and stirring was continued overnight (~18 h) at rt. Sodium potassium tartrate 
(20 cm
3
; sat aq) was added, and the mixture was stirred for 1 h and poured into H2O 
(20 cm
3
). The aqueous layer was extracted with Et2O (5 × 10 cm
3
), and the combined 
organic layers were washed with brine (20 cm
3
) and dried (MgSO4). The solvent was 
removed under reduced pressure and the crude yellow oil thus obtained was purified 
by flash chromatography (Hexane:EtOAc, 6:1) to give alkyne 129 as a colourless oil 
(71.7 mg, 32% over 2 steps). Rf (Hexane:EtOAc, 6:1) = 0.47; [α]D = +125 (c 1.30, 
CHCl3), lit
238
 [α]D = +96.6 (c 1.00, CHCl3); IR (neat, cm
-1
) 3294 (CC–H), 3257 
(CC–H), 2116 (C≡C), 1697 (C=O); 
1
H NMR δ (500 MHz, DMSO-d6, 323 K)              





J = 8.7, 2.0 Hz, CHAHBO), 3.15 (1H, br s, C≡CH), 1.53 (3H, s, NCCH3), 1.45 (9H, s, 
3C(CH3)3), 1.43 (3H, s, NCCH3); 
13
C NMR δ (125 MHz, DMSO-d6, 323 K) 151.3 
(C), 93.9 (C), 83.8 (C), 80.1 (C), 72.9 (CH), 68.8 (CH2), 48.4 (CH), 28.5 (3CH3), 
27.3–26.0 (CH3), 25.6–24.3 (CH3); m/z (EI) 228 ([M+3H]
+





, 14), 225 ([M]
+
, 2), 224 ([M–H]
+
, 8), 223 ([M–2H]
+
, 17), 210 (100), 




(1′E,4S)-4-(2′-Iodoethenyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl 
ester (127) 
Method A (Takai olefination using anhydrous CrCl2 as the chromium 
source): According to a modification of the conditions described by 
Marquez
60
 for the Takai olefination
40
 of an (alternative) aldehyde, a 
solution containing Garner’s aldehyde 116 (1.63 g, 7.20 mmol) and CHI3 (17.0 g, 
43.2 mmol) in THF (50 cm
3
) was added to a suspension of anhydrous CrCl2 (16.0 g, 
130 mmol) in THF (150 cm
3
), and the mixture was stirred for 1 d in the absence of 
light. H2O (100 cm
3
) was added to quench the reaction, the slurry was stirred for 30 
min, and the reaction mixture was diluted with Et2O (100 cm
3
). The aqueous layer 
was extracted with Et2O (4 × 50 cm
3
), and the combined organic layers were washed 
with Na2S2O3 (2 × 50 cm
3
; sat aq), H2O (2 × 50 cm
3
), brine (50 cm
3
) and dried 
(MgSO4). The solvent was removed under reduced pressure and the brown residual 
oil thus obtained was purified twice by flash chromatography (Hexane:EtOAc, 6:1) 
to give vinyl iodide 127 as a yellow solid (1.14 g, 45%, >99:1 E:Z).  
Method B (Takai olefination using CrCl3•6H2O as the chromium source): In this 
protocol, CrCl3•6H2O was dehydrated according to the protocol described by Augé et 
al,
53a
 and the anhydrous CrCl3 thus obtained was reduced with LiAlH4 according to 
Hiyama’s conditions
61
 to give the active Cr(II) reagent that was then used for the 
iodo-olefination of Garner’s aldehyde 116. A 1 dm
3
 round-bottomed flask fitted with 
a cold-trap (–10 °C) was charged with CrCl3•6H2O (124 g, 465 mmol), and the 
system was placed under high-vacuum (~10 mmHg), heated to 120 °C, and stirred 
gently for 30 min. The pale-green solid thus obtained was heated to 250 °C, and 
maintained at this temperature until effervescence of the solid had ceased and a violet 




H2O apparent in the flask was removed through the use of a hot-air blower, the solid 
was cooled to rt, the vacuum was released and the system was placed under an 
atmosphere of argon. THF (300 cm
3
) was added, the purple suspension was cooled to 
0 °C and LiAlH4 (75.0 cm
3
, 180 mmol; 2.4 M in THF) was added dropwise (~1 h) 
[CAUTION: H2 gas evolved, exothermic]. The black slurry was warmed to rt, stirred 
for 1 h and re-cooled to 0 °C. In the absence of light, a solution containing Garner’s 
aldehyde 116 (5.26 g, 23.3 mmol) and CHI3 (54.9 g, 140 mmol) in THF (100 cm
3
) 
was then added, and the mixture was stirred for 1 h, warmed to rt and stirred 
overnight (~18 h). Pyridine (10.8 cm
3
, 151 mmol) was added, the slurry was stirred 
for 30 min, cooled to 0 °C and brine (500 cm
3
) was added to quench the reaction. 
The aqueous layer was extracted with EtOAc (5 × 300 cm
3
) and the combined 
organic layers were washed with Na2S2O3 (500 cm
3





) and dried (MgSO4). The solvent was removed under reduced pressure and 
the brown residue thus obtained was purified by flash chromatography 
(Hexane:EtOAc, 10:1; dry loaded) to give vinyl iodide 127 as a yellow oil that 
solidifies to a yellow solid on cooling (2.71 g, 33%, >99:1 E:Z).  
Method C (hydrostannylation/iododestannylation of alkyne 129): According to a 
modification of the procedure described by Ramstadius
44
 for the hydroiodination of 




, 0.40 mmol) was added to a solution of 
alkyne 129 (46.0 mg, 0.20 mmol) and PdCl2(PPh3)2 (1.60 mg, 2.00 µmol, 1 mol%) in 
THF (2 cm
3
) at –30 °C and the solution was stirred for 1 h. A solution of I2 (105 mg, 
0.25 mmol) in THF (2 cm
3
) was added dropwise (~10 min), and the violet solution 
was warmed to rt and stirred for 1 h. The reaction was quenched with a combined 
solution of KF (5 cm
3
; sat aq) and Na2S2O3 (5 cm
3
; sat aq) and after 20 min, the 
aqueous layer was extracted with Et2O (3 × 10 cm
3
). The combined organic layers 
were washed with Na2S2O3 (10 cm
3
; sat aq), KF (10 cm
3





) and dried (MgSO4). The solvent was removed under reduced pressure 
and the resulting brown oil was purified by flash chromatography (Hexane:EtOAc, 
10:1; SiO2 doped with 10% 
w
/w powdered KF) to give vinyl iodide 127 as a yellow 
oil (27.5 mg, 39%, >99:1 E:Z). Rf (Hexane:EtOAc, 10:1) = 0.28; mp 35–39 °C; [α]D 
= +101 (c 0.73, CHCl3); IR (neat, cm
-1
) 1694 (C=O); 
1
H NMR δ (500 MHz,   




Hz, CH=CHI), 4.32 (1H, m, NCH), 3.99 (1H, dd, J = Hz, 9.1, 6.1 Hz, 
NCHCHAHBO), 3.76 (1H, dd, J = 9.1, 2.5 Hz, NCHCHACHBO), 1.51 (3H, s, 
NCCH3), 1.44 (3H, s, NCCH3), 1.41 (9H, s, 3C(CH3)3); 
13
C NMR δ (125 MHz, 
DMSO-d6, 328 K) 151.6 (C), 145.0 (CH), 93.7 (C), 79.8 (C), 79.6 (CH), 67.1 (CH2), 
61.1 (CH), 28.5 (3CH3), 27.4–26.5 (CH3), 24.7–23.8 (CH3); m/z (EI) 353 ([M]
+
, 1%), 
297 (16), 282 (83), 238 (43), 170 (96), 84 (23), 57 (100). The spectroscopic data are 





Propargylic bromide 125 was prepared according to the procedure 
described by Lu et al.
51
 PBr3 (7.52 cm
3
, 80.0 mmol) was added to a 
solution of 2-butyn-1-ol (14.0 g, 200 mmol) and pyridine (1.61 cm
3
, 20.0 mmol) in 
Et2O (150 cm
3
) at –30 °C and the mixture, which immediately turned cloudy, was 
stirred for 10 min, warmed to rt, stirred for 1.5 h and subsequently heated to reflux 
for 1 h. The yellow mixture was cooled to rt, poured into a slurry of ice (200 g) and 
brine (200 cm
3
), and stirred until the biphasic mixture reached rt. The aqueous layer 
was extracted with Et2O (3 × 50 cm
3
) and the combined organic layers were washed 
with brine (200 cm
3
) and dried (MgSO4). The solvent was removed at atmospheric 
pressure (bath temperature = 60 °C) and the resulting orange oil was subjected to 
reduced-pressure distillation to afford propargylic bromide 125 as a volatile, 
colourless to pale-yellow liquid (19.4 g, 73%). Rf (Hexane) = 0.63; bp 60 °C (113 
mmHg), lit
51
 89–90 °C (150 mmHg); IR (neat, cm
-1
) 2239 (C≡C); 
1
H NMR δ (500 
MHz, CDCl3) 3.93 (2H, q, J = 2.5 Hz, CH2), 1.91 (3H, t, J = 2.5 Hz, CH3); 
13
C NMR 

















, 23), 53 




2-Butynyltriphenylphosphonium bromide (113) 
2-Butynyltriphenylphosphonium bromide 113 was prepared 
according to a modification of the procedure described by 
Niblock.
16
 A solution of propargylic bromide 125 (18.2 g, 137 






heated to 70 °C for 1 d (~24 h), after which time an orange-yellow suspension had 
formed. The precipitate was filtered, washed with hexane (5 × 100 cm
3
) and dried in 
vacuo to give 2-butynyltriphenylphosphonium bromide 113 as a beige solid (48.5 g, 
90%). Rf (DCM:MeOH, 10:1) = 0.50; mp 196–199 °C (dec.), lit
16
 195–197 °C; IR 
(neat, cm
-1
) 2236 (C≡C), 1684 (C=C), 1585 (C=C), 1568 (C=C), 1545 (C=C), 1485 
(C=C), 1435 (P–Ar); 
1
H NMR δ (500 MHz, CDCl3) 7.94–7.80 (6H, m, 6ArH),  
7.84–7.82 (3H, m, 3ArH), 7.74–7.70 (6H, m, 6ArH), 5.10 (2H, dq, J = 14.8, 2.3 Hz, 
CH2), 1.70 (3H, dt, J = 6.5, 2.3 Hz, CH3); 
13
C NMR δ (125 MHz, CDCl3) 135.2 (d,  
J = 3.0 Hz, 3CH), 134.0 (d, J = 10.0 Hz, 6CH), 130.3 (d, J = 12.7 Hz, 6CH), 117.9 
(d, J = 87.3 Hz, 3C), 84.8 (d, J = 9.5 Hz, C), 66.4 (d, J = 13.6 Hz, C), 18.3 (d,                      
J = 55.7 Hz, CH2), 3.72 (d, J = 3.3 Hz, CH3); 
31
P NMR δ (162 MHz, CDCl3) 21.9 








, 4), 347                    
([{M–Br}+MeOH+H]
+
, 50]), 315 ([M–Br]
+
, 100). The spectroscopic data are in 





butyl ester (126) 
Method A (from Garner’s aldehyde 116): According to a 
modification of the procedure described by Ersack and Krause
49
 for 
the preparation of analogous 1,3-enynyl Garner aldehyde 
derivatives, NaHMDS (16.3 cm
3
, 32.5 mmol; 2.0 M in THF) was 
added to a suspension of 2-butynyltriphenylphosphonium bromide 113 (12.9 g, 32.5 
mmol) in THF (110 cm
3
) at rt and the deep-red solution was stirred for 5 min before 
cooling to –78 °C. Aldehyde 116 (2.94 g, 13.0 mmol) in THF (20 cm
3
) was added, 
the solution was stirred for 6 h, and the reaction was quenched with H2O (50 cm
3
). 
The slurry was poured into H2O (100 cm
3
) and the aqueous layer was extracted with 
DCM (5 × 50 cm
3
). The combined organic layers were washed with Na2S2O3                 
(50 cm
3
; 50% sat aq), H2O (100 cm
3
), brine (100 cm
3
) and dried (MgSO4). The 
solvent was removed under reduced pressure to give a red residue that was 
suspended in cold (–20 °C) Et2O and filtered, rinsing with cold Et2O (3 × 100 cm
3
). 










chromatography (Hexane:EtOAc, 10:1; dry loaded) to give enyne 126 as a yellow oil 
that solidifies to a light-yellow solid on cooling (1.69 g, 49%, ~5:1 E:Z). 
Method B (from vinyl iodide 127): According to a modification of the standard 
Negishi coupling protocol,
44
 1-propynylmagnesium bromide (60.0 cm
3
, 30.0 mmol; 
0.5 M in THF) was added to a suspension of ZnCl2 (4.50 g, 33.0 mmol) in THF                
(5 cm
3
) and the slurry was stirred for 30 min at 0 °C. Vinyl iodide 127 (2.56 g, 7.22 
mmol) in THF (10 cm
3
) was added, followed by PdCl2(PPh3)2 (263 mg, 0.38 mmol, 
5 mol%) and the pale-yellow mixture was warmed to rt and stirred for 2 h. The 
reaction mixture was concentrated under reduced pressure and to the brown paste 
thus obtained was added NH4Cl (50 cm
3
; 50% sat aq). The reaction mixture was 
poured into H2O (50 cm
3
), the aqueous layer was extracted with DCM (3 × 50 cm
3
), 
and the combined organic layers were washed with brine (50 cm
3
), dried (MgSO4), 
and the solvent was removed under reduced pressure. Flash chromatography 
(Hexane:EtOAc, 10:1; dry loaded) of the black residue thus obtained gave enyne 126 
as an orange oil that solidifies to a yellow solid on cooling (1.70 g, 89%, >99:1 E:Z). 
N.B. All subsequent steps were carried out using material derived from enyne 126 
that was prepared in this fashion (i.e. >99:1 E:Z). Rf (Hexane:EtOAc, 10:1) = 0.34; 
mp 47–51 °C; [α]D = +70.0 (c 0.10, CHCl3); IR (neat, cm
-1
) 2220 (C≡C), 1694 
(C=O); 
1
H NMR δ (500 MHz, DMSO-d6, 328 K) 5.93 (1H, ddd, J = 15.8, 7.3, 0.6 
Hz, NCHCH=CH), 5.57 (1H, dqd, J = 15.8, 2.2, 1.1 Hz, NCHCH=CH), 4.33–4.31 
(1H, m, NCH), 4.02 (1H, dd, J = 9.0, 6.3 Hz, CHAHBO), 3.70 (1H, dd, J = 9.0, 2.5 
Hz, CHAHBO), 1.93 (3H, d, J = 2.2 Hz, C≡CCH3), 1.51 (3H, s, NCCH3), 1.44 (3H, s, 
NCCH3), 1.41 (9H, s, 3OC(CH3)3); 
13
C NMR δ (125 MHz, DMSO-d6, 328 K) 151.6 
(C), 141.2 (CH), 111.6 (CH), 93.6 (C), 87.6 (C), 79.6 (C), 78.1 (C), 67.8 (CH2), 58.7 
(CH), 28.5 (3CH3), 27.4–26.6 (CH3), 24.8–23.8 (CH3), 4.2 (CH3); m/z (EI) 265 
([M]
+
, 1%), 209 (21), 194 (60), 150 (27), 134 (18), 108 (48), 107 (100); HRMS (EI) 
[M]
+
 found 265.1670, C15H23NO3 requires 265.1673. 
(Z)-isomer: 
1
H NMR δ (500 MHz, DMSO-d6, 328 K) 5.82 (1H, dd, J = 10.6, 8.8 Hz, 
NCHCH=CH), 5.57 (1H, dq, J = 10.6, 2.2 Hz, NCHCH=CH), 4.75–4.71 (1H, m, 
NCH), 4.11 (1H, dd, J = 8.8, 6.5 Hz, NCHCHAHBO), 3.64 (1H, dd, J = 8.8, 3.0 Hz, 




s, NCCH3), 1.41 (9H, s, 3OC(CH3)3); 
13
C NMR δ (125 MHz, DMSO-d6, 325 K) 
151.7 (C), 141.2 (CH), 110.5 (CH), 93.7 (C), 87.6 (C), 79.6 (C), 76.3 (C), 68.2 
(CH2), 56.9 (CH), 28.6 (3CH3), 27.4–26.6 (CH3), 24.8–23.8 (CH3), 4.4 (CH3). 
 
(2S,3E)-2-(tert-Butoxycarbonyl)amino-hept-3-en-5-yn-1-ol (115) 
Amino alcohol 115 was prepared according to the acetonide 
deprotection protocol described by Iwata.
68
 CuCl2•2H2O (1.68 g, 
9.86 mmol) was added to a solution of oxazolidine 126 (1.70 g, 
6.40 mmol) in MeCN (70 cm
3
) and the orange-brown solution was 
stirred for 1 h. NH4Cl (150 cm
3
; sat aq) was added to quench the reaction, and the 
mixture was poured into DCM (100 cm
3
). The aqueous layer was extracted with 
DCM (4 × 50 cm
3
), and the combined organic layers were washed with NH4Cl (50 
cm
3
; sat aq), H2O (50 cm
3
), brine (50 cm
3
) and dried (MgSO4). Removal of the 
solvent under reduced pressure and flash chromatography (DCM:MeOH, 20:1) of the 
yellow-brown solid thus obtained gave amino alcohol 115 as a yellow solid (1.26 g, 
87%). Rf (DCM:MeOH, 20:1) = 0.39; mp 90–93 °C; [α]D = +50.0 (c 0.24, CHCl3); 
IR (neat, cm
-1
) 3348 (NH), 3307 (OH), 2220 (C≡C), 1678 (C=O), 1518 (C=C); 
1
H 
NMR δ (500 MHz, CDCl3) 6.00 (1H, dd, J = 15.9, 6.0 Hz, NCHCH=CH), 5.70 (1H, 
ddq, J = 15.9, 2.2, 2.0 Hz, NCHCH=CH), 4.85 (1H, br s, NH), 4.29 (1H, br s, NCH), 
3.72 (1H, dd, J = 11.2, 4.1 Hz, NCHCHAHBO), 3.66 (1H, dd, J = 11.2, 5.4 Hz, 
NCHCHAHBO), 1.96 (3H, d, J = 2.2 Hz, C≡CCH3), 1.47 (9H, s, 3OC(CH3)3); 
13
C 
NMR δ (125 MHz, CDCl3) 155.7 (C), 138.5 (CH), 112.7 (CH), 87.3 (C), 80.0 (C), 





, 100), 226 ([M+H]
+
, 2); HRMS (ESI+, MeOH) [M+H]
+
 found 




To a suspension of alcohol 115 (1.24 g, 5.50 mmol) and 
imidazole (1.12 g, 16.5 mmol) in DMF (55 cm
3
) was added 
TBSCl (1.24 g, 8.25 mmol) and the reaction mixture was 
stirred overnight (~18 h) at rt. NH4Cl (500 cm
3




added to quench the reaction, and the aqueous layer was extracted with Et2O (5 × 
100 cm
3
). The combined organic layers were washed with NH4Cl (100 cm
3
; sat aq), 
H2O (3 × 100 cm
3
), brine (100 cm
3
) and dried (MgSO4). Removal of the solvent 
under reduced pressure gave a yellow oil that was purified by flash chromatography 
(Hexane:EtOAc, 10:1) to give TBS-protected amino alcohol 135 as a light-yellow oil 
(1.79 g, 96%). Rf (Hexane:EtOAc, 10:1) = 0.39; [α]D = +71.4 (c 0.14, CHCl3); IR 
(neat, cm
-1
) 3451 (NH), 2224 (C≡C), 1705 (C=O); 
1
H NMR δ (500 MHz, CDCl3) 
6.02 (1H, dd, J = 15.9, 6.1 Hz, NCHCH=CH), 5.66 (1H, m, NCHCH=CH), 4.82 (1H, 
br s, NH), 4.21 (1H, br s, NCH), 3.69 (1H, dd, J = 10.1, 4.4 Hz, NCHCHAHBO), 3.62 
(1H, dd, J = 10.1, 3.9 Hz, NCHCHAHBO), 1.96 (3H, d, J = 2.2 Hz, C≡CCH3), 1.47 
(9H, s, 3OC(CH3)3), 0.92 (9H, s, 3SiC(CH3)3), 0.08 (6H, s, 2SiCH3); 
13
C NMR δ 
(125 MHz, CDCl3) 155.2 (C), 139.8 (CH), 111.6 (CH), 86.4 (C), 79.5 (C), 77.7 (C), 
65.1 (CH2), 53.6 (CH), 28.4 (3CH3), 25.9 (3CH3), 18.3 (C), 4.3 (CH3), –5.4 (CH3),   
–5.5 (CH3); m/z (ESI+, MeOH) 379 ([M+K]
+
, 16), 340 ([M+H]
+
, 39), 284            
[M–C(CH3)3+H]
+
, 100); HRMS (EI) [M+H]
+





N-Methylated carbamate 133 was prepared according to a 





 for the N-methylation of amino acids. To a 
suspension of NaH (1.25 g, 31.2 mmol; 60% dispersion in 
mineral oil) in THF (30 cm
3
) was added a solution of carbamate 135 (1.77 g, 5.20 
mmol) in THF (20 cm
3
) at 0 °C, and the solution was warmed to rt and stirred for             
1 h. MeI (6.47 cm
3
, 104 mmol) in DMF (5 cm
3
) was added, and the solution was 
heated to 35 °C and stirred overnight (~18 h) in the absence of light before cooling to 
rt. NH4Cl (100 cm
3
; sat aq) was added to quench the reaction and the aqueous layer 
was extracted with Et2O (5 × 50 cm
3
). The combined organic layers were washed 
with Na2S2O3 (50 cm
3
; sat aq), H2O (3 × 50 cm
3
), brine (50 cm
3
) and dried (MgSO4). 
The solvent was removed under reduced pressure and the residue was purified by 




a light-yellow oil (1.84 g, quant) Rf (Hexane:EtOAc, 12:1) = 0.35; [α]D = +32.4                
(c 0.74, CHCl3); IR (neat, cm
-1
) 2224 (C≡C), 1694 (C=O); 
1
H NMR δ (500 MHz, 
DMSO-d6, 323 K) 5.96 (1H, ddd, J = 16.1, 6.1, 0.5 Hz, NCHCH=CH), 5.59 (1H, 
ddq, J = 16.1, 2.2, 1.8 Hz, NCHCH=CH), 4.53 (1H, br s, NCH), 3.68 (1H, d, J = 2.2 
Hz, NCHCHAHBO), 3.67 (1H, d, J = 0.9 Hz, NCHCHAHBO), 2.69 (3H, s, NCH3), 
1.93 (3H, d, J = 2.2 Hz, C≡CCH3), 1.40 (9H, s, 3OC(CH3)3), 0.87 (9H, s, 
3SiC(CH3)3), 0.05 (6H, s, 2SiCH3); 
13
C NMR δ (125 MHz, DMSO-d6, 323 K) 155.4 
(C), 138.1 (CH), 112.8 (CH), 87.6 (C), 79.2 (C), 78.3 (C), 62.6 (CH2), 59.9–58.4 
(CH), 30.3 (CH3), 28.6 (3CH3), 26.1 (3CH3), 18.2 (C), 4.2 (CH3), –5.0 (CH3), –5.1 
(CH3); m/z (ESI+, MeOH) 729 ([2M+Na]
+
, 15%), 376 ([M+Na]
+
, 100), 354 
([M+H]
+
, 31), 353 ([M]
+
, 2); HRMS (EI) [M]
+






, 2.08 mmol, 1.0 M in THF) was added to a 
solution of TBS-ether 133 (491 mg, 1.39 mmol) in THF (14 cm
3
) 
and the yellow solution was stirred for 30 min. The solvent was 
removed under reduced pressure and the brown oil thus obtained 
was purified by flash chromatography (Hexane:EtOAc, 1:1) to give alcohol 136 as a 
light-yellow oil (253 mg, 93%). Rf (Hexane:EtOAc, 1:1) = 0.47; [α]D = +68.1                    
(c 1.10, CHCl3); IR (neat, cm
-1
) 3435 (OH), 2224 (C≡C), 1690 (C=C), 1667 (C=O); 
1
H NMR δ (500 MHz, DMSO-d6, 323 K) 5.96 (1H, ddd, J = 16.1, 6.0, 0.6 Hz, 
NCHCH=CH), 5.53 (1H, ddq, J = 16.1, 2.3, 1.9 Hz, NCHCH=CH), 4.72 (1H, t,              
J = 5.9 Hz, OH), 4.48 (1H, br s, NCH), 3.50 (2H, dd, J = 6.9, 5.9 Hz, CH2OH), 2.68 
(3H, s, NCH3), 1.92 (3H, d, J = 2.3 Hz, C≡CCH3), 1.41 (9H, s, 3OC(CH3)3); 
13
C 
NMR δ (125 MHz, DMSO-d6, 323 K) 155.6 (C), 138.8 (CH), 112.2 (CH), 87.3 (C), 
79.1 (C), 78.4 (C), 61.3 (CH2), 59.1 (CH), 30.0 (CH3), 28.6 (3CH3), 4.2 (CH3); m/z 
(ESI+, MeOH/DCM) 501 ([2M+Na]
+
, 44%), 262 ([M+Na]
+













Attempted synthesis of 139: I2 (1.53 g, 6.01 mmol) was added to a 
solution of PPh3 (1.70 g, 6.00 mmol), imidazole (817 mg, 12.0 
mmol) and alcohol 136 (239 mg, 1.00 mmol) in MeCN (10 cm
3
) at 
0 °C and the solution was warmed to rt, stirred for 30 min and 
subsequently heated to reflux overnight (~18 h) in the absence of light. The red 
solution thus obtained was cooled to rt, quenched with NaHCO3 (20 cm
3
; sat aq) and 
diluted with Et2O (50 cm
3
). The biphasic mixture was filtered, and the aqueous layer 
was extracted with Et2O (3 × 10 cm
3
). The combined organic layers were washed 
with Na2S2O3 (20 cm
3
; sat aq), H2O (20 cm
3
), brine (20 cm
3
) and dried (MgSO4). 
The solvent was removed under reduced pressure and the residue was purified by 
flash chromatography (Hexane:EtOAc, 1:1) to give oxazolidinone 137 as a yellow 
liquid (116 mg, 70%); iodide 139 was not observed. 
 
(1E′,4S)-3-Methyl-4-(pent-1′-en-3′-ynyl)-oxazolidin-2-one (137) 
Rf (Hexane:EtOAc, 1:1) = 0.37; [α]D = +3.60 (c 1.10, CHCl3); IR 
(neat, cm
-1
) 2222 (C≡C), 1746 (C=O); 
1
H NMR δ (500 MHz, 
CDCl3) 5.86 (1H, dd, J = 15.7, 8.7 Hz, NCHCH=CH), 5.76 (1H, dq, 
J = 15.7, 2.2 Hz, NCHCH=CH), 4.44 (1H, t, J = 8.7 Hz, CHAHBO), 4.14 (1H, dt,      
J = 8.7, 7.3 Hz, NCH), 3.95 (1H, dd, J = 8.7, 7.3 Hz, CHAHBO), 2.80 (3H, s, NCH3), 
1.99 (3H, d, J = 2.2 Hz, C≡CCH3); 
13
C NMR δ (125 MHz, CDCl3) 158.1 (C), 136.8 
(CH), 116.5 (CH), 89.1 (C), 76.5 (C), 66.6 (CH2), 60.2 (CH), 29.2 (CH3), 4.1 (CH3); 
m/z (ESI+, MeOH) 353 ([2M+Na]
+
, 17%), 188 ([M+Na]
+
, 100), 166 ([M+H]
+
, 13); 
HRMS (ESI+, MeOH) [M+Na]
+
 found 188.0680, C9H11NO2Na requires 188.0682. 
 
(2S,3E)-1-(tert-Butyldimethylsilanyloxy)-2-methylamino-hept-3-en-5-yne (142) 
Amine 142 was prepared according to a modification of the               





, 19.8 mmol) was added dropwise to a solution of 
carbamate 133 (2.34 g, 6.60 mmol) and 2,6-lutidine (2.68 cm
3
, 23.1 mmol) in DCM 
(20 cm
3
) at 0 °C and the solution was stirred for 45 min before quenching of the 
reaction with NaHCO3 (25 cm
3





layer was extracted with DCM (3 × 20 cm
3
), and the combined organic layers were 
washed with NaHCO3 (20 cm
3
; sat aq), H2O (20 cm
3
), brine (20 cm
3
) and dried 
(MgSO4). Removal of the solvent and residual 2,6-lutidine under reduced pressure 
(70 °C) and flash chromatography (DCM:MeOH, 20:1) gave amine 142 as a brown 
oil (1.54 g, 92%). Rf (DCM:MeOH, 20:1) = 0.17; [α]D = +52.3 (c 0.65, CHCl3); IR 
(neat, cm
-1
) 2224 (C≡C); 
1
H NMR δ (500 MHz, CDCl3) 5.84 (1H, ddd, J = 15.9, 8.0, 
0.4 Hz, NCHCH=CH), 5.68 (1H, dqd, J = 15.9, 2.2, 0.8 Hz, NCHCH=CH), 3.63 
(1H, dd, J = 9.9, 4.1 Hz, NCHCHAHBO), 3.50 (1H, dd, J = 9.9, 7.9 Hz, 
NCHCHAHBO), 3.10 (1H, tdd, J = 7.9, 4.1, 0.8 Hz, NCH), 2.39 (3H, s, NCH3), 1.97 
(3H, dd, J = 2.2, 0.4 Hz, C≡CCH3), 0.91 (9H, s, 3SiC(CH3)3), 0.08 (6H, s, 2SiCH3); 
13
C NMR δ (125 MHz, CDCl3) 140.9 (CH), 113.2 (CH), 86.2 (C), 77.7 (C), 65.8 
(CH2), 64.5 (CH), 34.1 (CH3), 25.9 (3CH3), 18.3 (C), 4.3 (CH3), –5.4 (2CH3); m/z 
(ESI+, MeOH) 254 ([M+H]
+
, 98%), 223 ([M–CH3NH]
+
, 100); HRMS (ESI+, 
MeOH) [M+H]
+




A suspension of amine 142 (50.6 mg, 0.20 mmol), freshly 
prepared PMBCl (47.6 mg, 0.28 mmol; for preparation, see 
Section 7.4), K2CO3 (68.0 mg, 0.49 mmol) and TBAI (17.0 
mg, 0.05 mmol, 23 mol%) in THF (2 cm
3
) was heated to reflux 
for 2 d. The orange solution thus obtained was cooled to rt, the 
reaction was quenched with NH4Cl (10 cm
3
; sat aq) and the aqueous layer was 
extracted with Et2O (3 × 10 cm
3
). The combined organic layers were washed with 
H2O (10 cm
3
), brine (10 cm
3
) and dried (MgSO4); and the solvent was removed 
under reduced pressure. The brown residual oil thus obtained was purified by flash 
chromatography (Hexane:EtOAc, 10:1) to give PMB-protected amine 144 as an 
orange-yellow syrup (68.2 mg, 91%). Rf (Hexane:EtOAc, 10:1) = 0.37; [α]D = +47.9 
(c 0.73, CHCl3); IR (neat, cm
-1
) 2210 (C≡C), 1610 (C=C), 1585 (C=C), 1510 (C=C); 
1
H NMR δ (500 MHz, DMSO-d6, 323 K) 7.22–7.19 (2H, m, 2ArH), 6.88–6.85              
(2H, m, 2ArH), 6.02 (1H, ddd, J = 16.0, 7.8, 0.6 Hz, NCHCH=CH), 5.64 (1H, dqd,            




3.75 (3H, s, OCH3), 3.68 (1H, dd, J = 10.3, 6.6 Hz, NCHCHAHBO), 3.57 (1H, d,        
J = 13.4 Hz, CHAHBAr), 3.45 (1H, d, J = 13.4 Hz, CHAHBAr), 3.16–3.12 (1H, m, 
NCH), 2.14 (3H, s, NCH3), 1.94 (3H, d, J = 2.2 Hz, C≡CCH3), 0.88 (9H, s, 
3SiC(CH3)3), 0.05 (3H, s, SiCH3), 0.04 (3H, s, SiCH3); 
13
C NMR δ (125 MHz, 
DMSO-d6, 323 K) 158.7 (C), 140.0 (CH), 132.0 (C), 129.9 (2CH), 114.1 (2CH), 
113.4 (CH), 86.5 (C), 78.8 (C), 65.9 (CH), 64.1 (CH2), 58.1 (CH2), 55.5 (CH3), 38.2 
(CH3), 26.2 (3CH3), 18.3 (C), 4.2 (CH3), –4.9 (CH3), –5.0 (CH3); m/z (ESI+, MeOH) 
396 ([M+Na]
+
, 5%), 374 ([M+H]
+
, 100); HRMS [M+H]
+
 found 374.2509, 





, 13.5 mmol; 1.0 M in THF) was added to a 
solution of silyl ether 144 (843 mg, 2.26 mmol) in THF (5 cm
3
) at 
0 °C and the solution was stirred for 30 min, warmed to rt and 
stirred for a further 30 min. NH4Cl (10 cm
3
; sat aq) was added, and 
the mixture was stirred for 1 h before dilution with H2O (20 cm
3
). 
The aqueous layer was extracted with DCM (5 × 10 cm
3
), and the combined organic 
layers were washed with brine (10 cm
3
) and dried (MgSO4); and the solvent was 
removed under reduced pressure. Flash chromatography (Hexane:EtOAc, 1:1) of the 
brown residual oil gave alcohol 146 as an orange-yellow oil (583 mg, quant). Rf 
(Hexane:EtOAc, 1:1) = 0.42; [α]D = +109 (c 0.33, CHCl3); IR (neat, cm
-1
) 3431 
(OH), 2220 (C≡C), 1610 (C=C), 1585 (C=C), 1510 (C=C); 
1
H NMR δ (500 MHz, 
DMSO-d6, 323 K) 7.23–7.20 (2H, m, 2ArH), 6.89–6.86 (2H, m, 2ArH), 6.04 (1H, 
ddd, J = 16.0, 7.9, 0.5 Hz, NCHCH=CH), 5.64 (1H, dqd, J = 16.0, 2.2, 1.1 Hz, 
NCHCH=CH), 4.30 (1H, br s, OH), 3.75 (3H, s, OCH3), 3.60 (1H, br dd, J = 10.8, 
6.2 Hz, NCHCHAHBO), 3.55 (1H, d, J = 13.3 Hz, CHXHYAr), 3.49–3.46 (1H, m, 
NCHCHAHBO), 3.41 (1H, d, J = 13.3 Hz, CHXHYAr), 3.13–3.09 (1H, m, NCH), 2.11 
(3H, s, NCH3), 1.94 (3H, d, J = 2.2 Hz, C≡CCH3); 
13
C NMR δ (125 MHz,          
DMSO-d6, 323 K) 158.7 (C), 140.3 (CH), 132.0 (C), 130.0 (2CH), 114.1 (2CH), 
113.4 (CH), 86.5 (C), 78.9 (C), 66.2 (CH), 62.2 (CH2), 57.9 (CH2), 55.5 (CH3), 37.9 
(CH3), 4.2 (CH3); m/z (EI) 259 ([M]
+
, 5%), 229 (74), 228 (100), 122 (59), 121 (96); 
HRMS (EI) [M]
+






To a solution of amine 142 (278 mg, 1.09 mmol), Et3N (0.46 
cm
3
, 3.28 mmol) and DMAP (15.0 mg, 0.11 mmol, 11 mol%) 
in DCM (10 cm
3
) was added TsCl (313 mg, 1.64 mmol), and 
the brown solution was stirred overnight (~18 h) at rt. The 
reaction mixture was poured into cold (~0 °C) HCl (30 cm
3
; 0.5 M aq) and the 
aqueous layer was extracted with DCM (3 × 10 cm
3
). The combined organic layers 
were washed with HCl (2 × 10 cm
3
; 0.5 M aq), NaHCO3 (2 × 10 cm
3
; sat aq), H2O 
(10 cm
3
), brine (10 cm
3
) and dried (MgSO4). The solvent was removed under 
reduced pressure to give sulfonamide 143 (378 mg, 85%) as a brown oil, which was 
used without further purification. Rf (Hexane:EtOAc, 10:1) = 0.39; [α]D = +45.4              
(c 0.22, CHCl3); IR (neat, cm
-1
) 2216 (C≡C), 1597 (C=C), 1341 (S=O); 
1
H NMR δ 
(500 MHz, DMSO-d6, 323 K) 7.68–7.66 (2H, m, 2ArH), 7.40 (2H, d, J = 8.0 Hz, 
2ArH), 5.80 (1H, dd, J = Hz, 16.0, 6.8 Hz, NCHCH=CH), 5.57 (1H, dqd, J = 16.0, 
2.2, 1.5 Hz, NCHCH=CH), 4.41 (1H, m, NCH), 3.63 (1H, dd, J = 10.6, 6.0 Hz, 
NCHCHAHBO), 3.60 (1H, dd, J = 10.6, 6.8 Hz, NCHCHAHBO), 2.69 (3H, s, NCH3), 
2.40 (3H, s, ArCH3), 1.90 (3H, d, J = 2.0 Hz, C≡CCH3), 0.84 (9H, s, 3SiC(CH3)3), 
0.01 (6H, s, 2SiCH3); 
13
C NMR δ (125 MHz, DMSO-d6, 323 K) 143.5 (C), 137.1 
(C), 136.5 (CH), 130.1 (2CH), 127.4 (2CH), 114.3 (CH), 88.2 (C), 78.0 (C), 63.4 
(CH2), 60.0 (CH), 30.3 (CH3), 26.1 (3CH3), 21.4 (CH3), 18.3 (C), 4.2 (CH3), –5.0 
(CH3), –5.1 (CH3); m/z (ESI+, MeOH) 1245 ([3M+Na]
+





, 26), 408 ([M+H]
+
, 1); HRMS (ESI+, MeOH) [M+Na]
+
 found 





, 4.80 mmol; 1.0 M in THF) was added to a 
solution of silyl ether 143 (326 mg, 0.80 mmol) in THF (2 cm
3
), 
and the solution was stirred for 1 h at 0 °C. NH4Cl (10 cm
3
; sat aq) 
was added, the mixture was stirred for 1 h, and the aqueous layer 
was extracted with Et2O (3 × 10 cm
3
). The combined organic layers were washed 
with brine (10 cm
3











pressure. Flash chromatography (Hexane:EtOAc, 2:1) of the residual brown oil gave 
alcohol 145 as an orange oil (221 mg, 94%). Rf (Hexane:EtOAc, 2:1) = 0.24; [α]D = 
+41.6 (c 0.24, CHCl3); IR (neat, cm
-1
) 3512 (OH), 2224 (C≡C), 1734 (C=C), 1630 
(C=C), 1597 (C=C), 1329 (S=O); 
1
H NMR δ (500 MHz, DMSO-d6, 323 K) 7.69 
(2H, m, 2ArH), 7.39 (2H, d, J = 8.0 Hz, 2ArH), 5.80 (1H, ddd, J = 16.1, 6.6, 0.6 Hz, 
NCHCH=CH), 5.53 (1H, dqd, J = 16.1, 2.2, 1.3 Hz, NCHCH=CH), 4.76 (1H, t,           
J = 5.7 Hz, OH), 4.41–4.37 (1H, m, NCH), 3.45–3.42 (2H, m, CH2O), 2.66 (3H, s, 
ArCH3), 2.40 (3H, s, NCH3), 1.90 (3H, d, J = 2.3 Hz, C≡CCH3);
 13
C NMR δ (125 
MHz, DMSO-d6, 323 K) 143.4 (C), 137.1 (C), 137.0 (2CH), 130.0 (2CH), 127.5 
(2CH), 113.8 (CH), 88.0 (C), 78.2 (C), 61.7 (CH2), 60.3 (CH), 30.0 (CH3), 21.4 
(CH3), 4.2 (CH3); m/z (ESI+, MeOH) 609 ([2M+Na]
+
, 42), 332 ([M+K]
+
, 5), 316 
([M+Na]
+
, 100), 294 ([M+H]
+
, 3); HRMS (ESI+, MeOH) [M+Na]
+
 found 316.0929, 






, 0.40 mmol; 1.0 M in DCM) was added 
dropwise to a solution of alcohol 145 (29.0 mg, 0.10 mmol), 
Et3N (0.50 cm
3
, 3.58 mmol), and DMAP (2.40 mg, 0.02 mmol, 
20 mol%) in DCM (0.5 cm
3
) at 0 °C and the cloudy suspension 
was stirred for 1 h, warmed to rt and stirred for 2.5 h. The reaction mixture was 
diluted with Et2O (30 cm
3
), and the organic layer was washed with HCl (2 × 10 cm
3
; 
1.0 M aq), NaHCO3 (2 × 10 cm
3
; sat aq), H2O (10 cm
3
), brine (10 cm
3
) and dried 
(MgSO4). The solvent was removed under reduced pressure to give mesylate 164 as 
an orange-yellow oil (35.0 mg, 95%), which was used without further purification. 
Rf (Hexane:EtOAc, 2:1) = 0.37; [α]D = +37.2 (c 0.51, CHCl3); IR (neat, cm
-1
) 2222 
(C≡C), 1736 (C=C), 1630 (C=C), 1597 (C=C), 1354 (S=O), 1335 (S=O); 
1
H NMR δ 
(500 MHz, DMSO-d6, 323 K) 7.71–7.68 (2H, m, 2ArH), 7.42–7.40 (2H, m, 2ArH), 
5.77 (1H, ddd, J = 16.0, 6.9, 0.6 Hz, NCHCH=CH), 5.65 (1H, dqd, J = 16.0, 2.3,            
1.2 Hz, NCHCH=CH), 4.79–4.74 (1H, m, NCH), 4.27 (1H, dd, J = 10.7, 8.0 Hz, 
NCHCHAHBO), 4.22 (1H, dd, J = 10.7, 5.7 Hz, NCHCHAHBO), 3.14 (3H, s, 






C NMR δ (125 MHz, DMSO-d6, 323 K) 143.8 (C), 136.5 (C), 134.0 
(CH), 130.2 (2CH), 127.6 (2CH), 115.9 (CH), 89.3 (C), 77.7 (C), 68.2 (CH2), 57.5 
(CH), 37.4 (CH3), 29.9 (CH3), 21.4 (CH3), 4.2 (CH3); m/z (ESI+, MeOH) 765 
([2M+Na]
+
, 9%), 394 ([M+Na]
+
, 15), 372 ([M+H]
+
, 3), 225 ([M+2K]
2+
, 100); 
HRMS (ESI+, MeOH) [M+H]
+






















7.3 Experimental from Chapter 3 
General Procedure A: Weinreb Amide Synthesis with 
n
BuLi 
To a suspension of HNMe(OMe)•HCl (1.5 to 9.0 eq) in THF was added 
n
BuLi (3.0 
to 18 eq) at –78 °C, and the mixture was stirred for 15 min, warmed to rt 
[CAUTION: butane gas evolution], stirred for 20 min and re-cooled to –78 °C to 
give a light-yellow solution of the lithium amide of Weinreb’s amine. A solution of 
the reactant ester (1.0 eq) in THF was added, and the reaction mixture was stirred at 
the temperature(s) and time(s) indicated before quenching of the reaction with NH4Cl 
(aq). The solution was stirred vigorously until a clean phase separation was visible 
(~30 min) and the biphasic mixture was separated. The aqueous layer was extracted 
with DCM or Et2O, and the combined organic layers were washed with brine, dried 
(MgSO4) and the solvent was removed under reduced pressure. Flash 
chromatography gave the product Weinreb amide. 
 
General Procedure B: Swern Oxidation
101
 
DMSO (3.0 to 6.0 eq) in DCM, was added dropwise over the stated time to a solution 
of (COCl)2 (1.3 to 2.0 eq) in DCM at –78 °C, and the solution was stirred for the 
stated time [CAUTION: gases evolved]. The reactant alcohol (1.0 eq), in DCM, was 
added dropwise [CAUTION: gases evolved] over the stated time, and the mixture 
was stirred for 1 h before cautious addition of freshly distilled Et3N (5.0 to 8.0 eq) 
over the stated time. The slurry thus obtained was warmed to rt (typically ~1 h) and 
the reaction was quenched with H2O. The aqueous layer was extracted with DCM, 
and the combined organic layers were washed with H2O and brine. Drying (MgSO4), 
removal of the solvent and Me2S byproduct under reduced pressure [CAUTION: 
toxic, malodorous] and purification of the crude material by flash chromatography 
gave the product aldehyde. 
 
General Procedure C: TBS Protection of Alcohols with TBSOTf 
Cautiously, TBSOTf (1.3 to 1.5 eq) was added to a solution of the reactant alcohol 
(1.0 eq) and 2,6-lutidine (2.0 eq) in DCM and the reaction mixture was stirred for the 
stated time and temperature, before quenching of the reaction with NaHCO3 (sat aq) 




combined organic layers were washed with the indicated aqueous solutions. Drying 
(MgSO4), removal of the solvent and residual 2,6-lutidine under reduced pressure 
(bath temperature = 70 °C), and purification of the crude material by flash 
chromatography gave the product TBS-ether. 
 
Toluene-4-sulfonic acid pent-3-ynyl ester (204) 
Tosylate ester 204 was prepared according to the procedure 
described by Niblock.
16
 TsCl (12.7 g, 66.4 mmol) was added 
to boiling pyridine (6.00 cm
3
, 75.9 mmol) and the yellow 
solution was cooled rapidly to 0 °C (immediate ice-bath immersion) to give a 
suspension of pale-yellow crystals to which 3-pentyn-1-ol (5.00 g, 59.4 mmol) was 
added dropwise (~30 min) [CAUTION: exothermic reaction]. The mixture was 
stirred vigorously for 30 min, warmed to rt, stirred overnight (~19 h) and the 
resulting colourless slurry was diluted with H2O (10 cm
3
) and Et2O (50 cm
3
). The 
aqueous layer was extracted with Et2O (3 × 20 cm
3
), and the combined organic layers 
were washed with HCl (3 × 20 cm
3
; 1.0 M aq), NaHCO3 (50 cm
3
; sat aq), brine (50 
cm
3
) and dried (MgSO4). The solvent was removed under reduced pressure to give 
tosylate ester 204 as a colourless syrup that solidifies to a colourless wax on standing 
(13.3 g, 94%), which was used without further purification. Rf (Hexane) = 0.17; mp                
35–40 °C, lit
97b
 39 °C; bp 170 °C (3.2 mmHg); IR (neat, cm
-1
) 2237 (C≡C), 1595 
(C=C), 1358 (S=O); 
1
H NMR δ (400 MHz, CDCl3) 7.85–7.82 (2H, m, 2ArH),          
7.39–7.36 (2H, m, 2ArH), 4.08 (2H, t, J = 7.2 Hz, OCH2), 2.51 (2H, tq, J = 7.2, 2.6 
Hz, C≡CCH2), 2.48 (3H, s, ArCH3), 1.74 (3H, t, J = 2.6 Hz, C≡CCH3); 
13
C NMR δ 
(100 MHz, CDCl3) 144.9 (C), 133.0 (C), 129.9 (2CH), 128.0 (2CH), 78.2 (C), 73.1 
(C), 68.3 (CH2), 21.7 (CH3), 19.7 (CH2), 3.4 (CH3); m/z (EI) 238 ([M]
+
, 1%), 155 
(100), 91 (93); HRMS (EI) [M]
+
 found 238.0656, C12H14O3S requires 238.0658. The 





Enyne 200 was prepared according to a modification of the procedure 
described by Niblock.
16
 KOH (19.7 g, 351 mmol) and tosylate ester 204 
(14.5 g, 50.8 mmol) were added to 1-octanol (100 cm
3







) at rt. A Liebig condenser was attached to the flask, and the 
reaction mixture was heated with stirring to 135 °C, keeping the still-head 
temperature below 70 °C and the collecting flask at 0 °C. Distillation for 4 h gave 
enyne 200 as a volatile colourless liquid (2.51 g, 65%). Rf (Hexane) = 0.21; bp 60 °C 
(760 mmHg), lit
16
 60 °C (760 mmHg); IR (neat, cm
-1
) 2236 (C≡C), 1714 (C=C); 
1
H 
NMR δ (400 MHz, CDCl3) 5.78 (1H, ddq, J = 17.5, 11.0, 2.3 Hz, H2C=CH),                 
5.41–5.59 (1H, ddq, J = 17.5, 2.3, 0.6 Hz, HC=CHtransHcis), 5.40 (1H, ddq, J = 11.0, 
2.3, 0.6 Hz, HC=CHtransHcis), 1.97 (3H, dt, J = 2.3, 0.6 Hz, CH3); 
13
C NMR δ (100 
MHz, CDCl3) 125.5 (CH2), 117.6 (CH), 86.6 (C), 78.5 (C), 4.2 (CH3). The 





General Procedure A was followed with HNMe(OMe)•HCl (11.7 g, 






, 240 mmol; 1.6 M in 
hexanes); and 3-hydroxy-2,2-dimethyl-propionic acid methyl ester 
(5.29 g, 40.0 mmol) in THF (20 cm
3
) with reaction at –78 °C (30 min), –78 °C to rt 
(~1 h) and rt (30 min). Quenching with NH4Cl (400 cm
3
; 50% sat aq); workup with                
DCM (1 × 300 cm
3
, 3 × 100 cm
3
) and brine (200 cm
3
); and flash chromatography 
(EtOAc:Hexane, 2:1) gave Weinreb amide 207 as a light-yellow oil (6.19 g, 95%). Rf 
(EtOAc:Hexane, 2:1) = 0.25; IR (neat, cm
-1
) 3456 (OH), 1620 (C=O); 
1
H NMR δ 
(400 MHz, CDCl3) 3.73 (3H, s, OCH3), 3.54 (2H, s, CH2), 3.25 (1H, br s, OH), 3.22 
(3H, s, NCH3), 1.28 (6H, s, 2CCH3); 
13
C NMR δ (100 MHz, CDCl3) 178.6 (C), 71.9 
(CH2), 60.8 (CH3), 44.3 (C), 33.3 (CH3), 21.1 (2CH3); m/z (CI) 162 ([M+H]
+
, 
100%); HRMS (ESI+, MeOH) [M+H]
+




General Procedure B was followed with DMSO (3.20 cm
3
, 45.0 
mmol) in DCM (10 cm
3
), added over 10 min; (COCl)2 (1.27 cm
3
, 
15.0 mmol) in DCM (10 cm
3
), with stirring for 15 min; alcohol 207 
(1.61 g, 10.0 mmol) in DCM (5 cm
3
), added over 5 min; and Et3N (8.34 cm
3
, 60.0 
mmol), added over 5 min. Quenching with H2O (20 cm
3












), H2O (3 × 20 cm
3
) and brine (30 cm
3
); and flash chromatography 
(Hexane:EtOAc, 1:1) of the yellow residue thus obtained gave the aldehyde 195 as a 
yellow oil (1.51 g, 95%). Rf (Hexane:EtOAc, 3:1) = 0.23; Rf (Hexane:EtOAc, 1:1)             
= 0.45; bp 136 °C (760 mmHg, slight dec.); IR (neat, cm
-1
) 2714 (CHO), 1721 
(C=O), 1657 (C=O); 
1
H NMR δ (400 MHz, CDCl3) 9.53 (1H, s, CHO), 3.58 (3H, s, 
OCH3), 3.22 (3H, s, NCH3), 1.34 (6H, s, 2CCH3); 
13
C NMR δ (100 MHz, CDCl3) 
197.7 (CH), 173.9 (C), 60.7 (CH3), 52.69 (C), 33.0 (CH3), 20.2 (2CH3); m/z (CI) 160 
([M+H]
+





(±)-3-Hydroxy-2,2-dimethyl-hex-5-enoic acid methoxy-methyl-amide [(±)-199] 
Method A (indium-mediated Barbier allylation): Allyl bromide 
(0.23 cm
3
, 2.66 mmol) was slowly added to a stirred solution of 
aldehyde 195 (70.4 mg, 0.44 mmol) and indium (101 mg, 0.88 
mmol) in THF (14 cm
3
) at rt. The reaction mixture was stirred vigorously for 24 h 
after which time a grey solution had developed. The reaction was quenched with 
NH4Cl (10 cm
3
; sat aq) and the mixture was poured into H2O (20 cm
3
) and Et2O (20 
cm
3
). The aqueous layer was extracted with Et2O (3 × 10 cm
3
) and the combined 
organic layers were washed with NH4Cl (10 cm
3
; sat aq), brine (10 cm
3
) and dried 
(MgSO4). The solvent was removed under reduced pressure and the resulting             
pale-yellow residue was purified by flash chromatography (Hexane:EtOAc, 2:1) to 
give homoallylic alcohol (±)-199 as a yellow oil (85.2 mg, 97%).  
Method B (tin-mediated Barbier allylation): According to a modification of the 
procedure decribed by Malvestiti et al.,
103
 HCl (100 cm
3
, 100 mmol; 1.0 M aq) was 
added to tin (1.87 g, 15.8 mmol) and the mixture was stirred vigorously until 
complete dissolution of the solid had occurred (~45 min). Allyl bromide (2.02 cm
3
, 
23.3 mmol) was added, followed by aldehyde 195 (1.00 g, 6.28 mmol) and the 
reaction mixture was stirred vigorously for a further 2.5 h. The aqueous layer was 
extracted with DCM (5 × 20 cm
3
), and the combined organic layers were washed 
with NaHCO3 (20 cm
3
; sat aq), brine (20 cm
3
) and dried (MgSO4). Removal of the 
solvent under reduced pressure gave a yellow residue that was purified by flash 









yellow oil (1.07 g, 85%). Rf (Hexane:EtOAc, 2:1) = 0.25; Rt (Method A) = 21.0, 
27.5; IR (neat, cm
-1
) 3451 (OH), 1639 (C=O), 1622 (C=C); 
1
H NMR δ (500 MHz, 
CDCl3) 5.98 (1H, ddt, J = 17.2, 10.1, 6.6 Hz, HC=CH2), 5.17–5.10 (2H, m, 
HC=CH2), 3.80 (1H, ddd, J = 10.1, 6.1, 2.5 Hz, CHOH), 3.73 (3H, s, OCH3), 3.21 
(3H, s, NCH3), 3.12 (1H, d, J = 6.1 Hz, OH), 2.33–2.28 (1H, m, CHAHB), 2.23–2.17 
(1H, m, CHAHB), 1.30 (3H, s, CCH3), 1.29 (3H, s, CCH3); 
13
C NMR δ (125 MHz, 
CDCl3) 178.4 (C), 136.6 (CH), 116.7 (CH2), 76.9 (CH), 60.7 (CH3), 47.2 (C), 36.3 
(CH2), 33.7 (CH3), 21.4 (CH3), 20.1 (CH3); m/z (EI) 202 ([M]
+
, 3%), 160 (30), 71 







Grubbs’ catalyst 214 was prepared according to the 
procedure described by Grubbs et al.
104
 Grubbs’ II (500 mg, 
0.59 mmol) was added to 3-bromopyridine (0.57 cm
3
, 5.92 
mmol) and the red mixture was stirred for 5 min, after which 
time a lime-green slurry had formed to which pentane (20 
cm
3
) was added. The mixture was then cooled and maintained at 4 °C (fridge) 
overnight (~18 h); and the precipitate was filtered, washed with pentane (5 × 10 cm
3
) 
and dried thoroughly in vacuo to give Grubbs’ catalyst 214 as a green solid (459 mg, 
88%). mp 142–146 °C (dec.), lit
239
 140 °C (dec.); IR (neat, cm
-1
) 2369, 2324, 1961, 




































, 2), 405 (19), 307 (97), 154 




















General Procedure C was followed with TBSOTf (0.43 cm
3
, 
1.86 mmol), alcohol (±)-199 (251 mg, 1.24 mmol) and 2,6-lutidine 
(0.29 cm
3
, 2.28 mmol) in DCM (10 cm
3
) with reaction for 2 h at             
0 °C. Quenching with NaHCO3 (10 cm
3
; sat aq); workup with 
DCM (3 × 10 cm
3
) and brine (10 cm
3
); and flash chromatography (Hexane:EtOAc, 
1:1) gave silyl ether (±)-216 as a yellow oil (380 mg, 97%). Rf (Hexane:EtOAc, 1:1) 
= 0.71; IR (neat, cm
-1
) 1651 (C=O); 
1
H NMR δ (400 MHz, CDCl3) 5.81 (1H, ddt,             
J = 17.0, 10.1, 7.2 Hz, H2C=CH), 5.04–5.00 (2H, m, HC=CH2), 4.31 (1H, t, J = 5.2 
Hz, SiOCH), 3.69 (3H, s, OCH3), 3.16 (3H, s, NCH3), 2.26–2.14 (2H, m, CH2), 1.26 
(3H, s, CCH3), 1.20 (3H, s, CCH3), 0.92 (9H, s, 3SiC(CH3)), 0.09 (3H, s, SiCH3), 
0.07 (3H, s, SiCH3); 
13
C NMR δ (100 MHz, CDCl3) 177.8 (C), 136.5 (CH), 116.4 
(CH2), 74.6 (CH), 60.5 (CH3), 49.1 (C), 39.4 (CH2), 33.9 (CH3), 26.1 (3CH3), 23.3 
(CH3), 19.1 (CH3), 18.3 (C), –3.3 (CH3), –4.1 (CH3); m/z (EI) 316 ([M+H]
+
, 12%), 
274 (31), 258 (100), 185 (20), 115 (30); HRMS (EI) [M+H]
+
 found 316.2299, 
C16H34NO3Si requires 316.2303. 
 
N,Nʹ-Dimethoxy-N,Nʹ-dimethylurea (224) 
Weinreb urea 224 was prepared according to a modification of the 
procedure described by Marshall and Yanik.
116
 To a suspension of 
HNMe(OMe)•HCl (2.50 g, 25.0 mmol) and pyridine (1.71 cm
3
, 30.0 
mmol) in DCM (120 cm
3
) was added CDI (1.68 g, 10.0 mmol), and the white 
suspension was heated to reflux overnight (~19 h). The resulting yellow solution was 
cooled to rt and quenched with HCl (40 cm
3
; 1.0 M aq). The aqueous layer was 
extracted with DCM (3 × 10 cm
3
), the combined organic layers were washed with 
HCl (5 × 10 cm
3
; 1.0 M aq), and the combined aqueous layers were backwashed with 
DCM (10 cm
3
). The combined organic layers were washed with brine (10 cm
3
), dried 
(MgSO4) and the solvent was removed under reduced pressure to give a yellow oil 
that was purified by flash chromatography (Hexane:EtOAc, 3:1) to afford Weinreb 
urea 224 as a pale-yellow oil (1.35 g, 91%). Rf (Hexane:EtOAc, 3:1) = 0.33; IR 
(neat, cm
-1
) 1661 (C=O); 
1





(6H, s, 2NCH3); 
13
C NMR δ (100 MHz, CDCl3) 163.4 (C), 60.6 (2CH3), 36.2 
(2CH3); m/z (EI) 148 ([M]
+
, 63%), 88 (100), 61 (38), 60 (100). The spectroscopic 




2,2-Dimethyl-but-3-enoic acid methoxymethyl-amide (223) 
NaHMDS (8.50 cm
3
, 8.50 mmol; 1.0 M in THF) was added dropwise 




 (3.54 g, 8.78 mmol) in THF 
(20 cm
3
) at 0 °C and the yellow solution was stirred for 30 min after 
which time a deepening of the colour had ensued. Aldehyde 195 (451 mg, 2.83 
mmol) in THF (5 cm
3
) was added, and the red solution was stirred for 140 min 
before quenching of the reaction with H2O (20 cm
3
). The mixture was warmed to rt, 
diluted with Et2O (50 cm
3
) and the aqueous layer was extracted with Et2O (3 × 20 
cm
3
). The combined organic layers were washed with brine (50 cm
3
) and dried 
(MgSO4); and the solvent was removed under reduced pressure. The yellow oil thus 
obtained was purified by flash chromatography (Hexane:EtOAc, 3:1) to give alkene 
223 as a light-yellow oil (165 mg, 37%). Rf (Hexane:EtOAc, 3:1) = 0.50; IR (neat, 
cm
-1
) 1654 (C=O), 1637 (C=C); 
1
H NMR δ (600 MHz, CDCl3) 6.06 (1H, dd,                
J = 17.8, 10.4 Hz, H2C=CH), 5.08 (1H, d, J = 10.4 Hz, HC=CHcisHtrans), 5.07 (1H, d, 
J = 17.8 Hz, HC=CHcisHtrans), 3.60 (3H, s, OCH3), 3.18 (3H, s, NCH3), 1.33 (6H, s, 
2CCH3); 
13
C NMR δ (100 MHz, CDCl3) 177.0 (C), 143.4 (CH), 111.9 (CH2), 60.5 
(CH3), 45.0 (C), 33.8 (CH3), 25.2 (2CH3); m/z (EI) 157 ([M]
+
, 8%), 69 (100); HRMS 
(EI) [M]
+
 found 157.1095, C8H15NO2 requires 157.1097. 
 
(±)-N-Methoxy-N-methyl-2-oxiranyl-isobutyramide [(±)-201] 
Method A (epoxidation of alkene 223): According to a modification 
of the procedure described by Liu et al.
121
 for the epoxidation of an 
analogous alkene, oxone (696 mg, 1.13 mmol) and NaHCO3 (218 mg, 
2.59 mmol) were added simultaneously to a solution of alkene 223 (58.8 mg, 0.37 
mmol) and EDTA (~1.00 mg, 0.34 µmol, 0.92 mol%; disodium salt) in acetone/H2O 
(10 cm
3
, 1:1) at 0 °C and the mixture warmed to rt and stirred vigorously for 3 h 
before a second addition of oxone (696 mg, 1.13 mmol) and NaHCO3 (218 mg, 2.59 







), and the combined organic layers were washed with brine (10 cm
3
) and dried 
(MgSO4). The solvent was removed under reduced pressure to give a yellow residue 
that was purified by flash chromatography (Hexane:EtOAc, 3:1) to give epoxide          
(±)-201 as a colourless oil (39.0 mg, 61%). 





mmol; 2.5 M in hexanes) was added to suspension of trimethylsulfonium iodide (306 
mg, 1.50 mmol) in THF (3 cm
3
) and the solution was stirred for 15 min at 0 °C. 
Aldehyde 195 (159 mg, 1.00 mmol) in THF (12 cm
3
) was then added, and the              
pale-yellow suspension was stirred for 1 h, warmed to rt and stirred for 2 h. H2O (10 
cm
3
) was added to quench the reaction, and the aqueous layer was extracted with 
Et2O (5 × 10 cm
3
). The combined organic layers were washed with Na2S2O3 (10 cm
3
; 
sat aq), H2O (10 cm
3
), brine (10 cm
3
) and dried (MgSO4). Removal of the solvent 
and Me2S byproduct under reduced pressure [CAUTION: toxic, malodorous] gave 
epoxide (±)-201 as a light-yellow residue (quantitative conversion by 
1
H NMR), 
which was used without further purification. N.B. This procedure was not 
reproducible. Rf (Hexane:EtOAc, 3:1) = 0.50; IR (neat, cm
-1
) 1643 (C=O), 1277 
(COC), 995 (COC); 
1
H NMR δ (400 MHz, CDCl3) 3.72 (3H, s, OCH3), 3.25 (1H, 
dd, J = 4.0, 2.8 Hz, CHCH2), 3.22 (3H, s, NCH3), 2.78 (1H, dd, J = 4.6, 4.0 Hz, 
CHAHB), 2.69 (1H, dd,  J = 4.6, 2.8 Hz, CHAHB); 
13
C NMR δ (125 MHz, CDCl3) 
196.7 (C), 60.9 (CH3), 56.3 (CH), 46.5 (C), 44.8 (CH2), 33.6 (CH3), 21.8 (CH3), 19.3 
(CH3); m/z (EI) 173 ([M]
+
, 44%), 113 (68), 85 (100); HRMS (EI) [M]
+
 found 
173.1043, C8H15NO3 requires 173.1046. 
 
But-2-yn-al (225) 
Aldehyde 225 was prepared according to a modification of the procedure 
described by Tietze et al.
127
 A suspension of MnO2 (86.9 g, 1.00 mol) in 
Et2O (120 cm
3
) was treated with ultrasonic vibration for 30 min and 
cooled to 0 °C before dropwise addition (~10 min) of 2-butyn-1-ol (7.01 g, 100 
mmol) in Et2O (10 cm
3
) [CAUTION: exothermic reaction]. The reaction mixture was 
stirred vigorously for 30 min at 0 °C, warmed to rt and stirred overnight (~18 h). The 
black slurry was filtered through a pad of celite, the filter cake was rinsed with Et2O 
(10 × 25 cm
3







crude orange oil thus obtained afforded aldehyde 225 as a pale-yellow liquid (4.14 g, 
61%). Rf (Pentane) = 0.33; bp 107 °C (760 mmHg), lit
127
 105–108 °C (760 mmHg); 
IR (neat, cm
-1
) 2860 (CHO), 2207 (C≡C), 1664 (C=O); 
1
H NMR δ (400 MHz, 
CDCl3) 9.18 (1H, q, J = 1.0 Hz, CHO), 2.11 (3H, d, J = 1.0 Hz, CH3); 
13
C NMR δ 
(100 MHz, CDCl3) 177.2 (CH), 95.0 (C), 81.0 (C), 4.30 (CH3); m/z (EI) 69 ([M+H]
+
, 






Dibromoenyne 242 was prepared according to the procedure described 
by Buchwald for the preparation of analogous vicinal 1,1-dibromo-
1,3-enynes.
125b
 A solution of PPh3 (15.4 g, 58.8 mmol) in DCM (35 
cm
3
) was added dropwise (30 min) to a suspension of zinc (3.85 g, 58.8 mmol) and 
CBr4 (19.5 g, 58.8 mmol) in DCM (20 cm
3
) at 0 °C [CAUTION: exothermic 
reaction]. The green-brown mixture was stirred for 5 min, warmed to rt, and stirred 
for 30 min before cooling of the reaction mixture back to 0 °C. Aldehyde 225 (2.00 
g, 29.3 mmol) in DCM (5 cm
3
) was then added slowly (~5 min) and the mixture was 
warmed to rt and stirred overnight (~24 h). The resulting dark-brown slurry was 
filtered through a plug of silica, eluting with DCM (50 cm
3
), and the solvent was 
removed under reduced pressure. Flash chromatography (PE 40–60) of the red 
residue thus obtained gave dibromoenyne 242 as a yellow liquid (5.56 g, 85%). Rf 
(PE 40–60) = 0.73; IR (neat) 2222 (C≡C) 1572 (C=C); 
1
H NMR δ (400 MHz, 
CDCl3) 6.54 (1H, q, J = 2.4 Hz, CH), 2.00 (3H, d, J = 2.4 Hz, CH3); 
13
C NMR δ 















, 46), 145 (71), 143 
(76); HRMS (EI) [M]
+
 found 221.8672, C5H4
79
Br2 requires 221.8674. 
 
(Z)-1-Bromo-pent-1-en-3-yne (202) 
The preparation of (Z)-bromoenyne 202 was attempted according to the 




 Pd(PPh3)4 (0.58 
g, 0.50 mmol, 5 mol%) was added to a solution of dibromoenyne 242 (2.23 g, 10.0 
mmol) in DCM (30 cm
3









, 10.5 mmol) in DCM (10 cm
3
) was then added, and the mixture was stirred for 2 
h after which time the reaction was quenched with H2O (10 cm
3
) and the organic 
layer was separated. The aqueous layer was extracted with DCM (5 × 5 cm
3
) and the 
combined organic layers were washed with brine (20 cm
3
) and dried (MgSO4). The 
solvent was removed carefully under reduced pressure at rt and purification of the 
resulting brown oily residue (ca. quantitative conversion by 
1
H NMR) by flash 
chromatography (PE 40–60) was attempted. Volatility and co-elution of byproducts 
prevented the isolation of (Z)-bromoenyne 202. Rf (PE 40–60) = 0.50; 
1
H NMR δ 
(400 MHz, CDCl3) 6.50 (1H, dq, J = 7.4, 0.6 Hz, HC=CHBr), 6.30 (1H, dq, J = 7.4, 
2.4 Hz, HC=CHBr), 2.05 (3H, dd, J = 2.4, 0.6 Hz, CH3); 
13
C NMR δ (100 MHz, 




Silyl ketene acetal 203 was prepared according to the procedure described 
by Paquette et al.
131





40.0 mmol) in THF (40 cm
3




, 36.6 mmol;              
1.6 M in hexanes) over 10 min and the reaction mixture was stirred for  
30 min at 0 °C. Methyl isobutyrate (3.07 g, 30.0 mmol) in THF (10 cm
3
) was then 
added and the mixture was stirred for 1 h before addition of freshly distilled TMSCl 
(7.61 cm
3
, 60.0 mmol) over 5 min and stirring for a further 1 h. The resulting cloudy 
mixture was twice filtered, each time washing the residue with Et2O (3 × 10 cm
3
) and 
the filtrate was concentrated under reduced pressure. The resulting yellow residue 
was purified by reduced-pressure distillation to afford silyl ketene acetal 203 as a 
colourless liquid (3.79 g, 72%), which was filtered through cotton wool or an                  
iso-disc HPLC filter prior to use. Rf (Hexane:EtOAc, 3:1) = 0.14; bp 89 °C (128 
mmHg), lit
131
 68–70 °C (30 mmHg); IR (neat, cm
-1
) 1705 (C=C); 
1
H NMR δ (400 
MHz, CDCl3) 3.53 (3H, s, OCH3), 1.60 (3H, s, CCH3), 1.54 (3H, s, CCH3), 0.23 (9H, 
s, 3SiCH3); 
13
C NMR δ (100 MHz, CDCl3) 149.3 (C), 90.9 (C), 56.5 (CH3), 16.9 
(CH3), 16.1 (CH3), 0.0 (3CH3); m/z (CI) 175 ([M+H]
+
, 21%), 159 (15), 143 (21), 89 








(R)-3-Methyl-2-(toluene-4-sulfonylamino)-butyric acid (250) 
N-Ts-D-Valine 250 was prepared according to a modification of the 
procedure described by Schröder et al. for the preparation of 
analogous N-sulfonylated amino acids.
132
 To a vigorously stirred 
solution of D-(–)-valine (17.6 g, 150 mmol) and K2CO3 (30.4 g, 221 
mmol) in H2O (300 cm
3
) was added TsCl (28.6 g, 150 mmol) and the suspension was 
heated to 70 °C until complete dissolution of the reactants had occurred (~30 min). 
The reaction mixture was maintained at 70 °C for a further 1 h and cooled slowly  
(~1 h) to 0 °C before acidification of the reaction mixture to pH 1 by dropwise 
addition of HCl (50 cm
3
; conc aq) [CAUTION: gases evolved]. The resulting 
precipitate was filtered, washed with cold (~0 °C) H2O (3 × 150 cm
3
) and dried 
thoroughly in vacuo to give N-Ts-D-valine 250 as a colourless solid (30.7 g, 75%). 
Rf (DCM:MeOH, 10:1) = 0.28; mp 144–147 °C, lit
240a
 150–151 °C; [α]D = –24.7           
(c 1.01, EtOH), lit
240a
 [α]D = –27.7 (c 1.00, EtOH); IR (neat, cm
-1
) 3291 (NH), 2967 
(OH), 1705 (C=O), 1331 (S=O), 1161 (S=O); 
1
H NMR δ (400 MHz, CDCl3)               
7.76–7.74 (2H, m, ArH), 7.32–7.30 (2H, m, ArH), 5.05 (1H, d, J = 9.8 Hz, NH), 3.84 
(1H, dd,  J = 9.8, 4.7 Hz, CHNH) 2.44 (3H, s, ArCH3), 2.18–2.09 (1H, m, NCHCH), 
1.00 (3H, d, J = 6.8 Hz, CH3), 0.90 (3H, d, J = 6.9 Hz, CH3); 
13
C NMR δ (100 MHz, 
CDCl3) 175.3 (C), 143.9 (C), 136.6 (C), 129.7 (2CH), 127.3 (2CH), 60.6 (CH), 31.4 
(CH), 21.6 (CH3), 19.0 (CH3), 17.2 (CH3); m/z (EI) 271 ([M]
+
, 1%), 226 (100), 155 
(50), 91 (30), 78 (26), 63 (18). The spectroscopic data are in good agreement with the 





Iodoacetylene 251 was prepared according to a modification of the 
procedure described by Yenjai and Isobe.
134
 Freshly distilled 
morpholine (18.5 cm
3
, 214 mmol) in PhMe (25 cm
3
) was added over 
10 min to a solution of I2 (18.3 g, 72.0 mmol) [CAUTION: gases evolved] in PhMe 
(250 cm
3
) at 45 °C and the mixture was stirred vigorously for 30 min, after which 
time a deep-red mixture had developed. A solution of 3-butyn-1-ol (5.00 g, 71.3 
mmol) in PhMe (10 cm
3
) was added, and the reaction mixture stirred at 45 °C for            





rinsed with Et2O (5 × 50 cm
3
). The solution was washed with Na2HPO4 (100 cm
3
; 
0.1 M aq), Na2S2O3 (100 cm
3
; 0.1 M aq) and NaHCO3 (100 cm
3
; sat aq); and the 
combined aqueous layers were backwashed with Et2O (2 × 50 cm
3
). The combined 
organic layers were washed with brine (100 cm
3
), dried (MgSO4) and the solvent was 
removed under reduced pressure to give iodoacetylene 251 as a red oil (13.5 g, 97%), 
which was used without further purification. Rf (Hexane:EtOAc, 3:1) = 0.22; IR 
(neat, cm
-1
) 3335 (OH), 2183 (C≡C); 
1
H NMR δ (400 MHz, CDCl3) 3.78–3.74 (2H, 
m, CH2OH), 2.67 (2H, t, J = 6.2 Hz, CH2CH2OH), 1.86 (1H, t, J = 5.5 Hz, OH); 
13
C 
NMR δ (100 MHz, CDCl3) 91.2 (C), 61.0 (CH2), 25.1 (CH2), –4.4 (C); m/z (EI) 196 
([M]
+





Dipotassium Azodicarboxylate (252) 
PADA 252 was prepared according to a modification of the 
procedure described by Dorgan.
90
 Azodicarbonamide (29.0 g, 250 
mmol) was added in 5 portions over 30 min to a solution of KOH 
(70.1 g, 1.25 mol) in H2O (175 cm
3
) at 0 °C. The orange solution was stirred for 5 h 
at rt before cooling of the yellow suspension overnight (~18 h) at –15 °C (freezer). 
The precipitate was filtered, washed with cold (~0 °C) MeOH (2 × 250 cm
3
) and 
dried thoroughly under reduced pressure at rt to afford PADA 252 as a bright-yellow 
solid (43.9 g, 90%). IR (neat, cm
-1
) 1682 (C=O); 
13
C NMR δ (100 MHz, D2O) 164.8 
(C); m/z (EI) 194 ([M]
+
, 1%), 91 (35), 83 (32), 78 (16), 63 (15), 44 (100). The 





Vinyl iodide 246 was prepared according to an amalgamation of the 





distilled glacial AcOH (24.0 cm
3
, 418 mmol) in MeOH (25 cm
3
) was added dropwise 
(~2 h) [CAUTION: gases evolved] to a suspension of PADA 252 (38.6 g, 199 mmol) 
and iodoacetylene 251 (13.0 g, 66.3 mmol) in MeOH (225 cm
3
) and pyridine (32.1 
cm
3
, 398 mmol) and the suspension was stirred vigorously overnight (~23 h), after 
which time a pale–orange-yellow mixture had developed. HCl (400 cm
3




was added to quench the reaction, and the reaction mixture was diluted with Et2O 
(500 cm
3
). The aqueous layer was extracted with Et2O (5 × 100 cm
3
), and the 
combined organic layers were washed with NaHCO3 (200 cm
3
; sat aq), brine (200 
cm
3
) and dried (MgSO4). The solvent was removed under reduced pressure and the 




, 668 mmol), and the 
solution was stirred for 7 h at rt before pouring of the mixture into Et2O (200 cm
3
) 
and HCl (100 cm
3
; 1.0 M aq). The aqueous layer was extracted with Et2O (3 × 100 
cm
3
), the combined organic layers were washed with HCl (3 × 100 cm
3
; 1.0 M aq) 
and the combined aqueous layers were backwashed with Et2O (100 cm
3
). The 
combined organic layers were washed with NaHCO3 (200 cm
3
; sat aq), Na2S2O3 (200 
cm
3
; 0.1 M aq), brine (200 cm
3
), and dried (MgSO4). The solvent and residual
 
n
BuNH2 were removed under reduced pressure and the crude brown oil thus obtained 
was subjected to flash chromatography (Hexane:EtOAc, 1:1) to give vinyl iodide 246 
as a light-sensitive orange-yellow oil (9.10 g, 69%). Rf (Hexane:EtOAc, 1:1) = 0.46; 
IR (neat, cm
-1




δ (400 MHz, CDCl3) 6.41–6.39 
(1H, m, CH2CH=CHI), 6.31 (1H, dt, J = 7.3, 6.8 Hz, CH2CH=CHI), 3.78 (2H, t,               
J = 6.4 Hz, CH2OH), 2.67 (1H, t, J = 6.2 Hz, OH), 2.47 (1H, q, J = 6.4 Hz, 
CH2CH=CHI); 
13
C NMR δ (100 MHz, CDCl3) 137.7 (CH), 84.8 (CH), 61.0 (CH2), 
38.1 (CH2); m/z (EI) 198 ([M]
+
, 75%), 196 (49), 168 (55), 167 (23), 166 (26), 127 






Enyne 197 was prepared according to the modification of the Negishi 
protocol
41
 described by Dorgan.
90
 To ZnCl2 (24.1 g, 177 mmol) was 
added, over a period of 30 min, 1-propynylmagnesium bromide (303 
cm
3
, 152 mmol; 0.5 M in THF) at 0 °C and the mixture was stirred vigorously for 45 
min. Vinyl iodide 246 (10.0 g, 50.5 mmol) in THF (50 cm
3
) was added to the slurry, 
followed by PdCl2(PPh3)2 (3.55 g, 5.05 mmol, 10 mol%) in THF (50 cm
3
) and the 
beige mixture was warmed to rt and stirred overnight (~18 h) before quenching of 
the dark-brown mixture thus obtained by addition of NH4Cl (100 cm
3
; sat aq). The 
aqueous layer was extracted with Et2O (5 × 200 cm
3






layers were washed with brine (100 cm
3
) and dried (MgSO4). The solvent was 
removed under reduced pressure and the residue was purified twice by flash 
chromatography (Hexane:EtOAc, 3:1) to give enyne 197 as a light-brown oil (4.23 g, 
77%). Rf (Hexane:EtOAc, 3:1) = 0.19; bp 132 °C (98 mmHg); IR (neat, cm
-1
) 3337 
(OH), 2222 (C≡C), 1618 (C=C); 
1
H NMR δ (400 MHz, CDCl3) 5.88 (1H, dt,                
J = 10.7, 7.4 Hz, CH2CH=CH), 5.60 (1H, dqt, J = 10.7, 2.3, 1.3 Hz, CH2CH=CH), 
3.74 (3H, t, J = 6.4 Hz, CH2OH), 2.60 (2H, dtd, J = 7.4, 6.4, 1.3 Hz, CH2CH=CH), 
2.01 (3H, d,  J = 2.3 Hz, CH3); 
13
C NMR δ (100 MHz, CDCl3) 137.8 (CH), 112.2 
(CH), 90.6 (C), 76.2 (C), 61.9 (CH2), 33.6 (CH2), 4.4 (CH3); m/z (EI) 110.1 ([M]
+
, 
61%), 95 (44), 91 (32), 80 (81), 79 (99), 77 (100). The spectroscopic data are in good 




(Z)-3-Hydroxy-6-iodo-2,2-dimethylhex-5-enoic acid methyl ester (260) 
β-Hydroxyester 260 was prepared by Dess–Martin oxidation
28
 of 
alcohol 246 (according to Hinkle’s conditions),
135
 followed by 





 Dess–Martin periodinane (509 mg, 1.20 
mmol) and NaHCO3 (336 mg, 2.00 mmol) were added in succession to a solution of 
alcohol 246 (198 mg, 1.00 mmol) in DCM (10 cm
3
), and the mixture was stirred for 
75 min at rt. The suspension was diluted with DCM (10 cm
3
) and poured into a 
mixture of NaHCO3 (10 cm
3
; sat aq), Na2S2O3 (10 cm
3
; sat aq), and H2O (20 cm
3
). 
The aqueous layer was extracted with DCM (3 × 10 cm
3
), and the combined organic 
layers were washed with brine (10 cm
3
), dried (MgSO4) and concentrated to a 
volume of ~15 cm
3
 under reduced pressure. The solution, which contained crude 
aldehyde 254, was added to a solution of (R)-4-isopropyl-3-(toluene-4-sulfonyl)-
[1,3,2]oxazaborolidin-5-one in DCM at –78 °C [which had been pre-prepared by 
dropwise addition of BH3•THF (1.00 cm
3
, 1.00 mmol; 1.0 M in THF) to                         
N-Ts-D-Valine 250 (272 mg, 1.00 mmol) in DCM (10 cm
3
) and stirring for 30 min at 
rt before cooling] and stirred for 5 min before addition of silyl ketene acetal 203 
(262.4 mg, 1.50 mmol) in DCM (2 cm
3
). The mixture was stirred for 4 h before 
quenching of the reaction with phosphate buffer solution (10 cm
3
; pH 7). The slurry 
was poured into DCM (30 cm
3
) and H2O (30 cm
3








extracted with DCM (3 × 10 cm
3
). The combined organic layers were washed with 
brine (50 cm
3
), dried (MgSO4), and the solvent was removed under reduced pressure 
to give a yellow oil that was subjected to flash chromatography (Hexane:EtOAc, 3:1) 
to afford β-hydroxyester 260 as an orange-yellow oil (110 mg, 37% over 2 steps, 
%ee not determined). Rf (Hexane:EtOAc, 3:1) = 0.34; IR (neat, cm
-1
) 3505 (OH), 
1721 (C=O), 1611 (C=C); 
1
H NMR δ (400 MHz, CDCl3) 6.45–6.35 (2H, m, 
HC=CH), 3.81–3.77 (1H, m, CHOH), 3.76 (3H, s, OCH3), 2.69 (1H, br d, J = 6.8 Hz, 
OH), 2.43–2.36 (1H, m, CHAHB), 2.27–2.19 (1H, m, CHAHB), 1.29 (3H, s, CCH3), 
1.27 (3H, s, CCH3); 
13
C NMR δ (100 MHz, CDCl3) 177.9 (C), 138.5 (CH), 84.3 
(CH), 75.7 (CH), 52.1 (CH3), 47.0 (C), 37.4 (CH2), 22.6 (CH3), 20.3 (CH3); m/z (EI) 
299 ([M+H]
+
, 1%), 221 (17), 153 (56), 131 (100), 102 (92), 99 (84); HRMS (EI) 
[M]
+
 found 298.0067, C9H15O3I requires 298.0071. 
 
N.B. The remaining syntheses from Chapter 3 are presented alongside procedures 
from Chapter 4. Procedures pertaining to Chapter 3 are clearly indicated, and can 
be found on the following pages: 
Mukaiyama aldol reaction to synthesise Ester 243 from Alcohol 197 221 
Conversion of Ester 243 to Weinreb Amide 194    223 












7.4 Experimental from Chapter 4 
4-Methoxybenzyl chloride (273) 
PMBCl 273 was prepared according to a modification of the 
procedure described by Luzzio and Chen.
141
 A molten suspension of 
PMBOH (34.5 g, 250 mmol) in HCl (250 cm
3
; conc aq) was treated 
with ultrasonic vibration. On completion of the reaction (TLC monitoring, typically 
1–2 h) the pale-yellow mixture thus obtained was poured into H2O (200 cm
3
) and the 
aqueous layer was extracted with DCM (3 × 100 cm
3
). The combined organic layers 
were washed with NaHCO3 (100 cm
3
; sat aq), H2O (100 cm
3
), brine (100 cm
3
) and 
dried (MgSO4). Removal of the solvent under reduced pressure gave PMBCl 273 as 
a malodorous yellow oil (39.1 g, quant), which was used immediately without further 
purification. Rf (Hexane:EtOAc, 12:1) = 0.50; IR (neat, cm
-1
) 1611 (C=C), 1585 
(C=C), 1514 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 7.37–7.34 (2H, m, 2ArH),             
6.94–6.91 (2H, m, 2ArH), 4.61 (2H, s, CH2), 3.85 (3H, s, CH3); 
13
C NMR δ (125 
MHz, CDCl3) 159.7 (C), 130.1 (2CH), 129.7 (C), 114.2 (2CH), 55.3 (CH3), 45.3 





Alcohol 274 was prepared according to a modification of the 
procedure described by Hatakeyama et al.
142
 To a suspension 
of powdered KOH (56.1 g, 1.00 mol) in DMSO (230 cm
3
) at             
0 °C was added 1,3-propanediol (72.3 cm
3
, 1.00 mol) and mixture was warmed to rt, 
stirred for 30 min and cooled back down to 0 °C. A solution of PMBCl 273 (39.2 g, 
250 mmol) in DMSO (20 cm
3
) was added dropwise, and the solution was warmed to 
rt and stirred for 3 h. After cooling of the reaction mixture to 0 °C, HCl (200 cm
3
; 5.0 
M aq) was slowly added (~30 min) to quench the reaction, and the yellow mixture 
was poured into H2O (500 cm
3
). The aqueous layer was extracted with DCM (5 × 
100 cm
3
) and the combined organic layers were washed with NaHCO3 (100 cm
3
; sat 
aq), H2O (3 × 100 cm
3
), brine (100 cm
3
) and dried (MgSO4). Removal of the solvent 
under reduced pressure gave an orange-yellow oil that was purified by flash 
chromatography (Hexane:EtOAc, 1:1) to give alcohol 274 as a yellow oil (38.5 g, 







3407 (OH), 1612 (C=C), 1587 (C=C), 1513 (C=C); 
1
H NMR δ (400 MHz, CDCl3) 
7.30–7.27 (2H, m, 2ArH), 6.93–6.89 (2H, m, 2ArH), 4.49 (2H, s, CH2Ar), 3.84 (3H, 
s, CH3), 3.81 (2H, t, J = 5.7 Hz, CH2OCH2CH2), 3.67 (2H, t, J = 5.7 Hz, CH2OH), 
2.28 (1H, br s, OH). 1.89 (2H, qn, J = 5.7 Hz, CH2CH2OH); 
13
C NMR δ (100 MHz, 
CDCl3) 159.3 (C), 130.2 (C), 129.3 (2CH), 113.9 (2CH), 73.0 (CH2), 69.3 (CH2), 
55.3 (CH3), 32.1 (CH2); m/z (ESI+, MeOH) 415 ([2M+Na]
+
, 24%), 219 ([M+Na]
+
, 





Method A (Swern oxidation of alcohol 274): General 
Procedure B was followed with DMSO (63.9 cm
3
, 900 
mmol), added over 20 min; (COCl)2 (25.8 cm
3
, 300 mmol) in 
DCM (500 cm
3
), with stirring for 10 min; alcohol 274 (39.3 g, 300 mmol) in DCM 
(100 cm
3
) added over 10 min; and Et3N (167 cm
3
, 1.20 mol), added over 10 min. 
Quenching with H2O (800 cm
3
); workup with DCM (3 × 100 cm
3
), H2O (3 × 200 
cm
3
) and brine (300 cm
3
); and flash chromatography (Hexane:EtOAc, 3:1) of the 
orange residual oil thus obtained gave aldehyde 244 as a yellow oil (33.1 g, 85%). 
Method B (TEMPO-mediated oxidation of alcohol 274): A cooled (0 °C) solution of 
bleach (6.85 cm
3
, 9.60 mmol; 1.40 M) buffered with NaHCO3 (6.85 cm
3
; sat aq) was 
added to alcohol 274 (1.96 g, 10.0 mmol), TEMPO (78.1 mg, 0.50 mmol, 5 mol%) 





; sat aq) at 0 °C over a period of ~10 min by which time the              
deep-red mixture had become pallid. Stirring was continued for 15 min, further 
cooled bleach (1.80 cm
3
, 2.52 mmol; 1.40 M) buffered with NaHCO3 (1.80 cm
3
; sat 
aq) was added and the mixture was stirred for 20 min before MeOH (2 cm
3
) was 
added to quench the reaction. After warming to rt, the reaction mixture was diluted 
with H2O (30 cm
3
) and the aqueous layer was extracted with DCM (3 × 20 cm
3
). The 
combined organic layers were washed with Na2S2O3 (10 cm
3
; 50% sat aq) 
[CAUTION: Cl2 gas evolution], H2O (20 cm
3
), brine (20 cm
3
) and dried (MgSO4). 
The solvent was removed under reduced pressure and the resulting orange oil was 
purified by flash chromatography (Hexane:EtOAc, 3:1) to give aldehyde 244 as a 







(CHO), 1722 (C=O), 1612 (C=C), 1585 (C=C), 1512 (C=C); 
1
H NMR δ (500 MHz, 
CDCl3) 9.81 (1H, t, J = 1.9 Hz, CH2CHO), 7.29–7.26 (2H, m, 2ArH), 6.92–6.89 (2H, 
m, 2ArH), 4.49 (2H, s, CH2Ar), 3.83 (3H, s, CH3), 3.81 (2H, t, J = 6.1 Hz, 
OCH2CH2), 2.71 (2H, td, J = 6.1, 1.9 Hz, CH2CHO); 
13
C NMR δ (126 MHz, CDCl3) 
201.3 (CH), 159.3 (C), 129.9 (C), 129.4 (2CH), 113.9 (2CH), 72.9 (CH2), 63.5 
(CH2), 55.3 (CH3), 43.9 (CH2); m/z (EI) 194 ([M]
+
, 87%), 137 (94), 122 (72), 121 




(S)-3-Hydroxy-5-(4-methoxybenzyloxy)-2,2-dimethylpentanoic acid methyl ester 
(245) 
Alcohol 245 was prepared according to a modification of 
the procedure described by Hartung.
14b
 BH3•THF (106 
cm
3
, 106 mmol; 1.0 M in THF) was added dropwise over 
15 min to a suspension of N-Ts-D-valine 250 (28.8 g, 106 mmol) [CAUTION: gases 
evolved] in DCM (500 cm
3
) at rt and the solution was stirred until gas evolution 
ceased (~1.5 h) before cooling of the reaction mixture to –78 °C. Aldehyde 244 (19.4 
g, 100 mmol) in DCM (300 cm
3
) was added at such a rate as to maintain the internal 
temperature below –70 °C (~15 min) before dropwise addition (30 min) of silyl 
ketene acetal 203 (30.5 g, 175 mmol) in DCM (100 cm
3
). The solution was stirred 
for 5.5 h, quenched by addition of phosphate buffer solution (500 cm
3
; pH 7) and the 
reaction mixture was warmed to rt. The aqueous layer was extracted with DCM (3 × 
100 cm
3
), and the combined organic layers were washed with brine (400 cm
3
), dried 
(MgSO4) and the solvent was removed under reduced pressure. The yellow oil thus 
obtained was dissolved in THF (100 cm
3
) and HCl (100 cm
3
; 5.0 M aq), the solution 
was stirred for 3 h at rt, and the aqueous layer was extracted with Et2O (4 × 100 
cm
3
). The combined organic layers were washed with NaOH (2 × 100 cm
3
; 1.0 M 
aq), NaHCO3 (100 cm
3
; sat aq), brine (100 cm
3
) and dried (MgSO4), and the solvent 
was removed under reduced pressure. The combined aqueous layers from both 
aqueous workups were acidified to pH 1 by addition of HCl (200 cm
3
; conc aq), 
extracted with EtOAc (3 × 400 cm
3
), washed with brine (400 cm
3
), dried (MgSO4) 
and the solvent was removed under reduced pressure. Two recrystallisations 




(17.2 g, 60% recovery). Purification of the resulting pale-yellow oil (obtained from 
the Et2O layers) by flash chromatography (Hexane:EtOAc, 3:1) gave β-hydroxyester 
245 as a light-yellow oil (24.0 g, 85%, 89 %ee). N.B. Repeated runs typically gave 
comparable yield (75–85%) and enantioselectivity (88–89 %ee). Rf (Hexane:EtOAc, 
3:1) = 0.36; Rt (Method B) = 30.5 [(S)-isomer], 33.5 [(R)-isomer]; [α]D = –1.50                
(c 2.52, CHCl3), lit
14
 [α]D = –1.04 (c 1.15, CHCl3); IR (neat, cm
-1
) 3516 (OH), 1726 
(C=O), 1612 (C=C), 1585 (C=C), 1512 (C=C); 
1
H NMR δ (500 MHz, CDCl3)              
7.28–7.27 (2H, m, 2ArH), 6.91–6.88 (2H, m, 2ArH), 4.49 (1H, d, J = 11.4 Hz, 
OCHAHBAr), 4.46 (1H, d, J = 11.4 Hz, OCHAHBAr), 3.93 (1H, dt, J = 8.7, 3.8 Hz, 
CHOH), 3.83 (3H, s, ArOCH3), 3.75–3.72 (1H, m, CHXHYOCH2Ar), 3.72 (3H, s, 
CO2CH3), 3.69–3.65 (1H, m, CHXHYOCH2Ar), 3.23 (1H, d, J = 3.8 Hz, OH),              
1.74–1.68 (2H, m, CH2CHOH), 1.21 (3H, s, CCH3), 1.20 (3H, s, CCH3); 
13
C NMR δ 
(125 MHz, CDCl3) 177.8 (C), 159.3 (C), 130.1 (C), 129.4 (2CH), 113.8 (2CH), 75.7 
(CH), 73.0 (CH2), 69.1 (CH2), 55.3 (CH3), 51.9 (CH3), 47.0 (C), 31.4 (CH2), 21.7 
(CH3), 20.4 (CH3); m/z (EI) 296 ([M]
+
, 1%), 142 (15), 137 (47), 135 (19), 121 (100). 





pentanoic acid methyl ester (264) 
General Procedure C was followed with TBSOTf (13.9 
cm
3
, 56.5 mmol), β-hydroxyester 245 (10.9 g, 38.3 
mmol) and 2,6-lutidine (8.92 cm
3
, 76.6 mmol) in DCM 
(120 cm
3
) with reaction for 2.5 h at –78 °C. Quenching 
with NaHCO3 (200 cm
3
; sat aq); workup with DCM (3 × 50 cm
3
), NaHCO3 (100 
cm
3
; sat aq), H2O (100 cm
3
) and brine (100 cm
3
); and flash chromatography 
(Hexane:EtOAc, 3:1) gave TBS-ether 264 as a colourless oil (14.8 g, 94%). N.B. 
Provided residual 2,6-lutidine is completely removed, the crude product may be 
taken forward to the subsequent PMB-deprotection step without chromatography. Rf 
(Hexane:EtOAc, 3:1) = 0.72; [α]D = –4.20 (c 1.17, CHCl3), lit
14
 [α]D = –4.20 (c 1.02, 
CHCl3); IR (neat, cm
-1
) 1732 (C=O), 1612 (C=C), 1585 (C=C), 1512 (C=C); 
1
H 
NMR δ (500 MHz, CDCl3) 7.30–7.27 (2H, m, 2ArH), 7.92–7.90 (2H, m, 2ArH), 





dd, J = 7.7, 3.1 Hz, CHOSi), 3.83 (3H, s, ArOCH3), 3.66 (3H, s, CO2CH3), 3.54–3.46 
(2H, m, CH2OCH2Ar), 1.84–1.78 (1H, m, CHXHYCHOSi), 1.70–1.63 (1H, m, 
CHXHYOSi), 1.18 (3H, s, CCH3), 1.11 (3H, s, CCH3), 0.88 (9H, s, 3SiC(CH3)3), 0.06 
(3H, s, SiCH3), 0.03 (3H, s, SiCH3); 
13
C NMR δ (125 MHz, CDCl3) 177.5 (C), 159.2 
(C), 130.6 (C), 129.2 (2CH), 113.8 (2CH), 73.9 (CH), 72.5 (CH2), 67.4 (CH2), 55.3 
(CH3), 51.7 (CH3), 48.4 (C), 33.9 (CH2), 26.0 (3CH3), 21.5 (CH3), 20.5 (CH3), 18.3 
(C), –4.0 (CH3), –4.3 (CH3); m/z (ESI+, MeOH) 433 ([M+Na]
+
, 100%). The 





methyl ester (276) 
DDQ (25.7 g, 113 mmol) was added in 5 portions (5 × 5.14 g) over 
10 min to a solution of PMB-ether 264 (31.0 g, 75.5 mmol; 
telescoped) in DCM (302 cm
3
) and H2O (17 cm
3
) at 0 °C and the 
red-brown mixture was stirred for 1.5 h. The reaction was 
quenched by cautious addition of NaHCO3 (400 cm
3
; sat aq) [CAUTION: potential 
for HCN gas evolution; careful, controlled extrusion is required] and stirred until gas 
evolution ceased (~1 h). The black emulsion was poured into H2O (3 dm
3
), and the 
aqueous layer was extracted with DCM (5 × 500 cm
3
). The combined organic layers 
were washed with NaHCO3 (1 dm
3
; sat aq), H2O (1 dm
3
), brine (1 dm
3
) and dried 
(MgSO4). The solvent was removed under reduced pressure and the brown oil thus 
obtained was purified by flash chromatography (DCM:MeOH, 50:1) to give alcohol 
276 as a brown oil (21.9 g, quant). Rf (DCM:MeOH, 50:1) = 0.32; [α]D = –1.80               
(c 1.10, CHCl3); IR (neat, cm
-1
) 3468 (OH), 1720 (C=O); 
1
H NMR δ (500 MHz, 
CDCl3) 4.11 (1H, dd, J = 6.9, 4.3 Hz, CHOSi), 3.75–3.66 (2H, m, CH2OH), 3.70 
(3H, s, OCH3), 1.75–1.66 (2H, m, CH2CHOSi), 1.52 (1H, br s, OH), 1.21 (3H, s, 
CCH3), 1.14 (3H, s, CCH3), 0.91 (9H, s, 3SiC(CH3)3), 0.13 (3H, s, SiCH3), 0.08 (3H, 
s, SiCH3); 
13
C NMR δ (125 MHz, CDCl3) 177.8 (C), 73.6 (CH), 60.1 (CH2), 51.8 
(CH3), 48.1 (C), 36.9 (CH2), 26.0 (3CH3), 22.4 (CH3), 19.8 (CH3), 18.3 (C), –4.0 
(CH3), –4.3 (CH3); m/z (ESI+, MeOH/DCM) 314 ([M+Na]
+
, 100%), 292 ([M+H]
+
, 
4%); HRMS (ESI+, MeOH/DCM) [M+H]
+





(S)-3-(tert-Butyldimethylsilanyloxy)-2,2-dimethyl-5-oxo-pentanoic acid methyl 
ester (263) 
General Procedure B was followed with DMSO (63.9 cm
3
, 900 
mmol) in DCM (50 cm
3
), added over 15 min; (COCl)2 (11.4 cm
3
, 
134 mmol) in DCM (100 cm
3
), with stirring for 15 min; alcohol 276 
(19.5 g, 67.1 mmol) in DCM (100 cm
3
), added over 25 min; and 
Et3N (74.8 cm
3
, 537 mmol), added over 15 min. Quenching with H2O (250 cm
3
); 
workup with DCM (3 × 50 cm
3
), H2O (3 × 250 cm
3
) and brine (250 cm
3
); and flash 
chromatography (Hexane:EtOAc, 6:1) of the orange residual oil thus obtained gave 
aldehyde 263 as a yellow oil (18.4 g, 95%). Rf (Hexane:EtOAc, 6:1) = 0.47; [α]D = 
+11.2 (c 0.80, CHCl3); IR (neat, cm
-1
) 2723 (CHO), 1725 (C=O); 
1
H NMR δ (500 
MHz, CDCl3) 9.83 (1H, dd, J = 2.4, 1.6 Hz, CHO), 4.57 (1H, dd, J = 5.8, 4.7 Hz, 
CHOSi), 3.69 (3H, s, OCH3), 2.62 (1H, ddd, J = 17.2, 4.7, 1.6 Hz, CHAHB), 2.57 
(1H, ddd, J = 17.2, 5.8, 2.4 Hz, CHAHB), 1.22 (3H, s, CCH3), 1.14 (3H, s, CCH3), 
0.88 (9H, s, 3SiC(CH3)3), 0.10 (3H, s, SiCH3), 0.05 (3H, s, SiCH3); 
13
C NMR δ (125 
MHz, CDCl3) 201.1 (CH), 176.8 (C), 71.5 (CH), 51.9 (CH3), 48.4 (CH2), 48.1 (C), 
25.8 (3CH3), 21.3 (CH3), 20.7 (CH3), 18.1 (C), –4.1 (CH3), –4.9 (CH3); m/z (ESI+, 
MeOH/DCM) 343 ([M+MeOH+Na]
+
, 100%), 311 ([M+Na]
+
, 62%); HRMS (ESI+, 
MeOH/DCM) [M+Na]
+
 found 311.1643, C14H28O4NaSi requires 311.1649. 
 
(Iodomethyl)triphenylphosphonium iodide (277) 
Wittig reagent 277 was prepared according to the procedure 
described by Quayle et al.
153
 In the absence of light, a suspension of 
PPh3 (26.2 g, 100 mmol) and CH2I2 (11.5 cm
3
, 142 mmol) in PhMe 
(25 cm
3
) was heated to 70 °C with vigorous stirring for 1 d (~24 h). 
The resulting suspension was cooled to rt, the precipitate was filtered, washed with 
hexane (5 × 100 cm
3




 277 as a colourless 
solid (48.5 g, 91%). Rf (DCM:MeOH, 10:1) = 0.46; mp 225–226 °C (dec.), lit
153
  
230 °C (dec.); IR (neat, cm
-1
) 1726 (C=C), 1660 (C=C), 1585 (C=C), 1533 (C=C), 
1483 (C=C), 1467 (C=C); 
1
H NMR δ (500 MHz, DMSO-d6) 7.95–7.91 (3H, m, 
3ArH), 7.88–7.84 (6H, m, 6ArH), 7.82–7.78 (6H, m, 6ArH), 5.09 (2H, d, J = 8.7 Hz, 
CH2); 
13









Hz, 6CH), 130.7 (d, J = 12.0 Hz, 6CH), 118.7 (d, J = 88.8 Hz, 3C), –16.1 (d, J = 52.4 
Hz, CH2); 
31
P NMR δ (162 MHz, DMSO-d6) 23.8 (P). The spectroscopic data are in 





methyl ester (278) 
Vinyl iodide 278 was prepared according to a modification of Stork 
and Zhao’s iodo-olefination procedure.
145
 NaHMDS (58.4 cm
3
, 126 





 (67.0 g, 126 mmol) in THF (365 cm
3
) and the red 
solution was stirred for 5 min before cooling to –78 °C. HMPA (43.9 cm
3
, 243 
mmol) was added, and the solution was stirred for a further 5 min before aldehyde 
263 (18.2 g, 63.2 mmol) in THF (60 cm
3
) was added dropwise (15 min). The reaction 
mixture was stirred for 2 h and quenched with H2O (200 cm
3
); and the suspension 
thus obtained was warmed to rt and filtered through celite, rinsing the filter cake with 
Et2O (5 × 100 cm
3
). The filtrate was further diluted with Et2O (500 cm
3
), and the 
combined organic layers were washed with Na2S2O3 (200 cm
3
; sat aq), H2O (3 × 200 
cm
3
), brine (3 × 200 cm
3
) and dried (MgSO4). The solvent was removed under 
reduced pressure and the residue was purified by flash chromatography 
(Hexane:EtOAc, 15:1) to give vinyl iodide 278 as an orange oil (19.5 g, 75%, >99:1 





H NMR δ (500 MHz, CDCl3) 6.33–6.27 (2H, m, HC=CH), 4.15 (1H, 
t, J = 5.7 Hz, SiOCH), 3.69 (3H, s, OCH3), 2.35–2.33 (2H, m, CH2), 1.22 (3H, s, 
CCH3), 1.17 (3H, s, CCH3), 0.91 (9H, s, 3SiC(CH3)3), 0.10 (3H, s, SiCH3), 0.07 (3H, 
s, SiCH3); 
13
C NMR δ (125 MHz, CDCl3) 177.3 (C), 138.7 (CH), 83.6 (CH), 75.3 
(CH), 51.8 (CH3), 48.4 (C), 39.4 (CH2), 25.9 (3CH3), 22.0 (CH3), 20.3 (CH3), 18.2 





, 49), 400 (34), 372 (29); HRMS (ESI+, MeOH/DCM) [M+H]
+
 found 








methyl ester (270) 
Enyne 270 was prepared according to a modification of the standard 
Negishi coupling protocol.
44
 To a suspension of ZnCl2 (23.3 g, 171 
mmol) in THF (180 cm
3
) was added 1-propynylmagnesium 
bromide (244 cm
3
, 142 mmol; 0.5 M in THF) over 15 min and the 
pale-yellow slurry was stirred for 15 min at 0 °C. Vinyl iodide 278 (19.5 g, 47.4 
mmol) in THF (30 cm
3
) and PdCl2(PPh3)2 (1.66 g, 2.37 mmol, 5 mol%) rinsed into 
the flask with THF (10 cm
3
) were added in quick succession, and the pale-yellow 
mixture was warmed to rt and stirred overnight (~16 h). The solvent was removed 
under reduced pressure and NH4Cl (300 cm
3
; sat aq) was added to the resulting 
brown paste to quench the reaction. The aqueous layer was extracted with DCM               
(4 × 100 cm
3
), and the combined organic layers were washed with brine (100 cm
3
) 
and dried (MgSO4). The solvent was removed under reduced pressure to give a 
brown residue that was purified by flash chromatography (Hexane:DCM, 3:1; dry 
loaded) to afford enyne 270 as an orange oil (14.2 g, 92%). Rf (Hexane:DCM, 3:1) = 
0.24; [α]D = +2.90 (c 1.01, CHCl3); IR (neat, cm
-1
) 2218 (C≡C), 1732 (C=O); 
1
H 
NMR δ (500 MHz, CDCl3) 5.88 (1H, dt, J = 10.7, 7.4 Hz, CH2CH=CH), 5.47 (1H, 
dqt, J = 10.7, 2.4, 1.4 Hz, CHC≡CCH3), 4.09 (1H, t, J = 5.7 Hz, CHOSi), 3.67 (3H, 
s, OCH3), 2.55–2.43 (2H, m, CH2), 2.01 (3H, d, J = 2.4 Hz, C≡CCH3), 1.21 (3H, s, 
CCH3), 1.16 (3H, s, CCH3), 0.90 (9H, s, 3SiC(CH3)), 0.10 (3H, s, SiCH3), 0.06 (3H, 
s, SiCH3); 
13
C NMR δ (125 MHz, CDCl3) 177.5 (C), 139.1 (CH), 110.7 (CH), 90.7 
(C), 76.5 (C), 76.2 (CH), 51.6 (CH3), 48.4 (C), 34.8 (CH2), 25.9 (3CH3), 21.9 (CH3), 
20.2 (CH3), 18.1 (C), 4.4 (CH3), –3.7 (CH3), –4.7 (CH3); m/z (ESI+, MeOH/DCM) 
347 ([M+Na]
+
, 70%), 325 ([M+H]
+
, 34), 165 ([M+2H]
2+
, 100); HRMS (ESI+, 
MeOH/DCM) [M+H]
+













Method A (amidation of ester 270): General Procedure A was 







, 21.6 mmol; 2.5 M in hexanes); and ester 
270 (1.17 g, 3.60 mmol) in THF (5 cm
3
); with reaction at –78 °C 
(30 min), –78 °C to rt (~30 min) and rt (1.5 h). Quenching with NH4Cl (10 cm
3
; sat 
aq); workup with Et2O (5 × 10 cm
3
) and brine (20 cm
3
); and flash chromatography 
(Hexane:EtOAc, 9:1) gave Weinreb amide 217 as a yellow oil (738 mg, 58%). N.B. 
Repeated runs under identical or very similar conditions did not give reproducible 
yields of product 217. On repetition of the experiment, the cyclised product 288 
occasionally co-eluted on silica with any recovered starting material 270. 
Method B (TBS protection of β-hydroxy-Weinreb amide 194, below): General 
Procedure C was followed with TBSOTf (8.50 cm
3
, 37.0 mmol), alcohol 194 (6.81 
g, 28.5 mmol) and 2,6-lutidine (6.62 cm
3
, 56.9 mmol) in DCM (30 cm
3
); with 
reaction for 1.5 h at –78 °C, then –78 to rt (~30 min). Quenching with NaHCO3 (100 
cm
3
; sat aq); workup with DCM (3 × 50 cm
3
) and brine (100 cm
3
); and flash 
chromatography (Hexane:EtOAc, 6:1) gave TBS-ether 217 as an orange oil (9.67 g, 
96%). Rf (Hexane:EtOAc, 9:1) = 0.15; [α]D = +3.30 (c 0.54, CHCl3); IR (neat, cm
-1
) 
2218 (C≡C), 1651 (C=O); 
1
H NMR δ (500 MHz, CDCl3) 5.88 (1H, dt, J = 10.6, 7.6 
Hz, CH2CH=CH), 5.46 (1H, br d, J = 10.6 Hz, CHC≡CCH3), 4.37 (1H, t, J = 5.8 Hz, 
CHOSi), 3.70 (3H, s, OCH3), 3.17 (3H, s, NCH3), 2.51–2.41 (2H, m, CH2), 1.99 (3H, 
br s, C≡CCH3), 1.27 (3H, s, CCH3), 1.23 (3H, s, CCH3), 0.93 (9H, s, 3SiC(CH3)3), 
0.11 (3H, s, SiCH3), 0.08 (3H, s, SiCH3); 
13
C NMR δ (125 MHz, CDCl3) 177.6 (C), 
139.7 (CH), 110.6 (CH), 90.3 (C), 76.7 (C), 74.3 (CH), 60.4 (CH3), 49.1 (C), 35.4 
(CH2), 33.9 (CH3), 26.0 (3CH3), 23.0 (CH3), 19.4 (CH3), 18.2 (C), 4.5 (CH3), –3.6 
(CH3), –4.3 (CH3); m/z (ESI+, MeOH/DCM) 729 ([2M+Na]
+





, 32); HRMS (ESI+, MeOH/DCM) [M+H]
+
 found 354.2459, 









Cyclisation product diagnostic peaks: 
1
H NMR δ (500 MHz, 
CDCl3) 6.49–6.46 (1H, m, H3CC≡CCH), 3.96 (1H, t, J = 6.5 
Hz, CHOSi), 2.97 (1H, dddq, J = 17.6, 6.5, 2.5, 0.6 Hz, 
CHAHB), 2.97 (1H, dddq, J = 17.6, 6.5, 3.2, 1.0 Hz, CHAHB), 
2.11 (3H, dt, J = 2.4, 0.8 Hz, H3CC≡CCH), 1.07 (3H, s, CCH3), 1.03 (3H, s, CCH3), 
0.92 (9H, s, 3SiC(CH3)), 0.12 (3H, s, SiCH3), 0.10 (3H, s, SiCH3); 
13
C NMR δ (125 
MHz, CDCl3) 207.6 (C), 144.0 (C), 115.0 (CH), 99.3 (C), 77.6 (C), 75.9 (CH), 51.0 
(C), 35.6 (CH2), 25.7 (3CH3), 21.9 (CH3), 18.1 (C), 17.7 (CH3), 5.1 (CH3), –4.5 
(CH3), –4.9 (CH3). 
 
3-(tert-Butyl-dimethyl-silanyloxy)-2,2-dimethyl-propionic acid methyl ester 
(292) 
General Procedure C was followed with TBSOTf (8.17 cm
3
, 40.0 
mmol), 3-hydroxy-2,2-dimethyl-propionic acid methyl ester (3.96 g, 
30.0 mmol) and 2,6-lutidine (6.95 cm
3
, 60.0 mmol) in DCM (30 
cm
3
); with reaction for 1.5 h at –78 °C, then –78 to rt (~30 min). 
Quenching with NaHCO3 (50 cm
3





; sat aq), H2O (3 × 20 cm
3
) and brine (20 cm
3
); and flash 
chromatography (Hexane:EtOAc, 10:1) gave TBS-ether 292 as a colourless liquid 
(7.31 g, 99%). Rf (Hexane:EtOAc, 10:1) = 0.54; IR (neat, cm
-1
) 1738 (C=O); 
1
H 
NMR δ (500 MHz, CDCl3) 3.68 (3H, s, OCH3), 3.59 (2H, s, CH2), 1.18 (6H, s, 
2CCH3), 0.89 (9H, s, 3SiC(CH3)3), 0.05 (6H, s, 2SiCH3); 
13
C NMR δ (125 MHz, 
CDCl3) 177.2 (C), 70.0 (CH2), 51.6 (CH3), 44.9 (C), 25.8 (3CH3), 21.9 (2CH3), 18.8 
(C), –5.6 (2CH3); m/z (ESI+, MeOH/DCM) 333 (100%), 269 ([M+Na]
+
, 93), 247 
([M+H]
+












General Procedure A was followed with HNMe(OMe)•HCl 







mmol; 2.5 M in hexanes); and ester 292 (6.16 g, 25.0 mmol) in 
THF (10 cm
3
); with reaction at –78 °C (30 min), –78 °C to rt (~30 
min) and rt (1 h). Quenching with NH4Cl (50 cm
3
; sat aq); workup with Et2O (5 × 25 
cm
3
) and brine (50 cm
3
); and flash chromatography (Hexane:EtOAc, 9:1) gave 
Weinreb amide 293 as a colourless oil (5.03 g, 73%). Rf (Hexane:EtOAc, 9:1) = 
0.20; IR (neat, cm
-1
) 1651 (C=O); 
1
H NMR δ (500 MHz, CDCl3) 3.71 (5H, s, OCH3 
and CH2), 3.20 (3H, s, NCH3), 1.24 (6H, s. 2CCH3), 0.91 (9H, s, 3SiC(CH3)3), 0.06 
(6H, s, 2SiCH3); 
13
C NMR δ (125 MHz, CDCl3) 177.2 (C), 69.2 (CH2), 60.6 (CH3), 
45.3 (C), 33.7 (CH3), 25.9 (3CH3), 22.2 (2CH3), 28.3 (C), –5.5 (2CH3); m/z (ESI+, 
MeOH/DCM) 276 ([M+H]
+
, 100), 298 ([M+Na]
+
, 65), 573 ([2M+Na]
+
, 24). The 




(3S,5Z)-3-Hydroxy-2,2-dimethyl-non-5-en-7-ynoic acid methyl ester (243) 
Method A [oxidation/Mukaiyama aldol approach from alcohol 197 
(from Chapter 3)]: β-Hydroxyester 243 was prepared by                   
Dess–Martin oxidation
28
 of alcohol 197 (according to Hinkle’s 
conditions),
135
 followed by reaction of the crude aldehyde 193
90
 with silyl ketene 




 Dess–Martin periodinane (2.55 
g, 6.00 mmol) and NaHCO3 (0.84 g, 10.0 mmol) were added in succession to a 
solution of alcohol 197 (0.54 g, 4.90 mmol) in DCM (10 cm
3
) and the mixture was 
stirred for 1.5 h at rt. The yellow suspension was poured into NaHCO3 (10 cm
3
; sat 
aq), Na2S2O3 (10 cm
3
; sat aq) and H2O (20 cm
3
). The aqueous layer was extracted 
with DCM (3 × 10 cm
3
), and the combined organic layers were washed with brine 
(20 cm
3
) and twice dried (MgSO4), with DCM (30 cm
3
) rinsing of the desiccant. The 
solvent was reduced to a volume of ~30 cm
3
 under reduced pressure and the yellow 
solution of the crude aldehyde 193 was immediately added to (R)-4-isopropyl-3-
(toluene-4-sulfonyl)-[1,3,2]oxazaborolidin-5-one in DCM at –78 °C [which had been 
pre-prepared by dropwise addition of BH3•THF (6.00 cm
3




THF) to N-Ts-D-Valine 250 (1.63 g, 6.00 mmol) [CAUTION: gases evolved] in 
DCM (70 cm
3
), and stirring for 30 min at rt before addition of 4 Å molecular sieves 
(2.00 g) and subsequent cooling] and stirred for 10 min before addition of silyl 
ketene acetal 203 (1.32 g, 7.50 mmol) in DCM (5 cm
3
). The mixture was stirred for  
6 h before quenching of the reaction with H2O (30 cm
3
). The slurry was warmed to 
rt, filtered through celite, and the filter cake was rinsed with DCM (3 × 20 cm
3
). The 
organic layer was washed with H2O (30 cm
3
), and the aqueous layer was backwashed 
with DCM (10 cm
3
). The combined organic layers were washed with brine (50 cm
3
), 
dried (MgSO4) and the solvent was removed under reduced pressure. Flash 
chromatography (Hexane:EtOAc, 3:1) of the orange-yellow residual oil thus 
obtained gave ester 243 as an orange-yellow oil (0.50 g, 49% over 2 steps, %ee not 
determined). N.B. This procedure was not reproducible. 
Method B (silyl deprotection of TBS-ether 270): HF (37.7 cm
3
, 1.05 mol; 48% aq) 
was added to a solution of TBS-ether 270 (11.3 g, 34.9 mmol) in MeCN (70 cm
3
) at 
0 °C and the solution was stirred for 15 min, warmed to rt, stirred for 1 h and cooled 
back down to 0 °C. A suspension of NaHCO3 (84.0 g, 1.00 mol) in NaHCO3 (600 
cm
3
; sat aq) was added in small portions over ~15 min [CAUTION: vigorous gas 
evolution] and the mixture was warmed to rt and stirred for 30 min. The aqueous 
layer was extracted with DCM (4 × 200 cm
3
) and the combined organic layers were 
washed with NaHCO3 (200 cm
3
; sat aq), brine (200 cm
3
) and dried (MgSO4). The 
solvent was removed under reduced pressure and the resulting oil was purified by 
flash chromatography (Hexane:EtOAc, 3:1) to give β-hydroxyester 243 as a yellow 
oil (7.28 g, 99%). Rf (Hexane:EtOAc, 3:1) = 0.44; [α]D = –29.7 (c 1.01, CHCl3); IR 
(neat, cm
-1
) 3503 (OH), 2220 (C≡C), 1726 (C=O); 
1
H NMR δ (400 MHz, CDCl3) 
6.00 (1H, dt, J = 10.6, 7.3 Hz, CH2CH=CH), 5.59 (1H, dqt, J = 10.6, 2.3, 1.0 Hz, 
CHC≡CH3), 3.80–3.76 (1H, m, CHOH), 3.74 (3H, s, OCH3), 2.56–2.50 (2H, m, OH 
and CHAHB), 2.40–2.31 (1H, m, CHAHB), 2.00 (3H, d, J = 2.3 Hz, C≡CCH3), 1.28 
(3H, s, CCH3), 1.27 (3H, s, CCH3); 
13
C NMR δ (100 MHz, CDCl3) 177.9, (C), 138.8 
(CH), 111.7 (CH), 90.7 (C), 76.4 (CH), 76.3 (C), 52.0 (CH3), 47.1 (C), 32.7 (CH2), 
22.3 (CH3), 20.3 (CH3), 4.4 (CH3); m/z (EI) 210 ([M]
+
, 1%), 192 (34), 177 (26), 131 
(95), 102 (100); HRMS (EI) [M]
+





(3S,5Z)-3-Hydroxy-2,2-dimethyl-non-5-en-7-ynoic acid methoxymethyl amide 
(194) 
Method A [low-temperature preparation (from Chapter 3)]: 
General Procedure A was followed with HNMe(OMe)•HCl 







mmol; 1.6 M in hexanes); and ester 243 (247 mg, 1.17 mmol) in THF (2 cm
3
); with 
reaction at –78 °C (2.5 h). Quenching with NH4Cl (20 cm
3
; sat aq); workup with 
EtOAc (3 × 20 cm
3
) and brine (20 cm
3
); and flash chromatography (Hexane:EtOAc, 
1:1) gave Weinreb amide 194 as a yellow oil (247 mg, 88%). 
Method B (large-scale preparation): General Procedure A was followed with 







mmol; 1.6 M in hexanes); and ester 243 (7.28 g, 34.6 mmol) in THF (50 cm
3
); with 
reaction at –78 °C (30 min), –78 °C to rt (~1 h) and rt (5 min). Quenching with 
NH4Cl (400 cm
3
; 50% sat aq); workup with Et2O (5 × 100 cm
3





); and flash chromatography (Hexane:EtOAc, 1:1) gave Weinreb 
amide 194 as an orange-red oil (6.81 g, 82%). Rf (Hexane:EtOAc, 1:1) = 0.33;        
[α]D = –45.2; IR (neat, cm
-1
) 3453 (OH), 2220 (C≡C), 1624 (C=O); 
1
H NMR δ (400 
MHz, CDCl3) 6.08 (1H, dt, J = 10.6, 7.2 Hz, CH2CH=CH), 5.56 (1H, dtq, J = 10.6, 
2.1, 1.0 Hz, CHC≡CH3), 3.79 (1H, ddd, J = 10.2, 6.7, 2.6 Hz, CHOH), 3.73 (3H, s, 
OCH3), 3.29 (1H, d, J = 6.7 Hz, OH), 3.22 (3H, s, NCH3), 2.61–2.55 (1H, m, 
CHAHB), 2.45–2.37 (1H, m, CHAHB), 2.00 (3H, d, J = 2.1 Hz, C≡CCH3), 1.33 (3H, s, 
CCH3), 1.32 (3H, s, CCH3); 
13
C NMR δ (100 MHz, CDCl3) 178.5 (C), 140.1 (CH), 
110.8 (CH), 90.3 (C), 77.6 (CH), 76.5 (C), 60.7 (CH3), 47.2 (C), 33.7 (CH3), 32.5 





, 100), 240 ([M+H]
+
, 34); HRMS (ESI+, MeOH/DCM) 
[M+Na]
+











TBS-protected β-hydroxyketone 271 was prepared according to a 
modification of the procedure described by Scheidt
165
 for the 
preparation of an analogous enone from a Weinreb amide. A 
solution of allyl bromide (6.30 cm
3
, 72.8 mmol) in Et2O (100 cm
3
) 
was added dropwise to a suspension of magnesium turnings (1.98 g, 81.3 mmol) in 
Et2O (46 cm
3
) and the solution was stirred until spontaneous boiling ceased (~30 
min), heated to reflux for a further 15 min, cooled to rt and stirred for 1 h to give 
allylmagnesium bromide (146 cm
3
, 73.0 mmol; 0.50 M in Et2O) as a grey solution. 
The Grignard reagent thus obtained was transferred via cannula over ~20 min to a 
solution of Weinreb amide 217 (3.22 g, 9.10 mmol) in Et2O (20 cm
3
) and the 
reaction mixture was stirred for 2 h, cooled to  –78 °C and quenched by cautious 
addition (~10 min) of NH4Cl (100 cm
3
; sat aq). After warming to rt, the aqueous 
layer was extracted with Et2O (3 × 100 cm
3
) and the combined organic layers were 
washed with brine (100 cm
3
) and dried (MgSO4). The solvent was removed under 
reduced pressure to give the crude allylic ketone 296 as an orange oil to which Et3N 
(25.4 cm
3
, 182 mmol) and DBU (5.44 cm
3
, 36.4 mmol) were added, and the solution 
was heated to 50 °C overnight (~18 h). The reaction mixture was cooled to rt, diluted 
with Et2O (100 cm
3
) and washed with HCl (3 × 50 cm
3
; 1.0 M aq) [CAUTION: 
exothermic], NaHCO3 (50 cm
3
; sat aq) and brine (50 cm
3
). Drying (MgSO4), removal 
of the solvent under reduced pressure and purification of the orange oil thus obtained 
by flash chromatography (Hexane:EtOAc, 10:1) gave the product TBS-protected         
β-hydroxyketone 271 as a yellow oil (2.45 g, 81%, 98:2 E:Z). N.B. Repeated runs 
typically gave comparable stereoselectivity in the product enone (greater than 96:4 
E:Z). Rf (Hexane:EtOAc, 10:1) = 0.53; [α]D = –5.90 (c 1.01, CHCl3); IR (neat, cm
-1
) 
2220 (C≡C), 1687 (C=O), 1626 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 6.91 (1H, dq, 
J = 15.1, 6.9 Hz, CH3CH=CH), 6.58 (1H, dq, J = 15.1, 2.2, 1.6 Hz, CH3CH=CH), 
5.88 (1H, dt, J = 10.7, 7.4 Hz, CH2CH=CH), 5.44 (1H, br d, J = 10.7 Hz, 
CHC≡CCH3), 4.05 (1H, dd, J = 5.8, 5.6 Hz, SiOCH), 2.52–2.41 (2H, m, CH2), 1.99 
(3H, d, J = 2.2 Hz, C≡CCH3), 1.90 (3H, dd, J = 6.9, 1.6 Hz, C=CHCH3), 1.16 (3H, s, 







C NMR δ (125 MHz, CDCl3) 203.1 (C), 142.2 (CH), 139.4 (CH), 127.4 
(CH), 110.9 (CH), 90.7 (C), 76.5 (CH), 76.4 (C), 52.1 (C), 35.0 (CH2), 26.0 (3CH3), 
21.6 (CH3), 20.3 (CH3), 18.2 (CH3), 18.1 (C), 4.4 (CH3), –3.7 (CH3), –4.5 (CH3); m/z 
(ESI+, MeOH/DCM) 357 ([M+Na]
+
, 100%); HRMS (ESI+, MeOH/DCM) [M+H]
+
 




Rf (Hexane:EtOAc, 10:1) = 0.50; 1H NMR δ (600 MHz, CDCl3) 
5.96 (1H, ddt, J = 17.1, 10.3, 6.7 Hz, CH2=CH), 5.84 (1H, dt,                
J = 10.6, 7.4 Hz, CH2CH=CH), 5.45 (1H, br d, J = 10.6 Hz, 
CHC≡CCH3), 5.17 (1H, br d, J = 10.3, 2.9 Hz, CHcisHtrans=CH), 
5.10 (1H, br d, J = 17.1, 2.9 Hz, CHcisHtrans=CH), 4.06 (1H, t, J = 5.7 Hz, CHOSi), 
3.40 (1H, br dd, J = 18.1, 6.8 Hz H2C=CHCHAHB), 3.29 (1H, br dd, J = 18.1, 6.8 Hz, 
H2C=CHCHAHB), 2.53–2.39 (2H, m, CH2CH=CH), 2.00 (3H, d, J = 2.3 Hz, 
C≡CCH3), 1.17 (3H, s, CCH3), 1.15 (3H, s, CCH3), 0.92 (9H, s, 3SiC(CH3)3), 0.11 
(3H, s, SiCH3), 0.07 (3H, s, SiCH3); 
13
C NMR δ (150 MHz, CDCl3) 213.0 (C), 139.0 
(CH), 131.7 (CH), 117.8 (CH2), 111.0 (CH), 91.0 (C), 76.5 (CH), 76.4 (C), 53.3 (C), 
43.5 (CH2), 35.1 (CH2), 26.0 (3CH3), 22.2 (CH3), 20.2 (C), 18.2 (CH3), 4.4 (CH3),          
–3.8 (CH3), –4.5 (CH3). 
 
 (2E,6S,8Z)-6-Hydroxy-5,5-dimethyl-dodeca-2,8-dien-10-yn-4-one (86) 
Method A [Grignard addition with Weinreb amide 194 using       
1-propenylmagnesium bromide (from Chapter 3)]: To a solution 
of Weinreb amide 194 (366 mg, 1.53 mmol) in THF (3 cm
3
) was 
added 1-propenylmagnesium bromide (15.3 cm
3
, 15.3 mmol; 0.5 M in THF) at 0 °C 
and the reaction mixture was warmed to rt and treated with ultrasonic vibration for 
1.5 h. Vibration was ceased, and the reaction mixture was cooled to 0 °C and 
quenched with cold (~0 °C) NH4Cl (20 cm
3
; sat aq). The aqueous layer was extracted 
with Et2O (5 × 10 cm
3
) and the combined organic layers were washed with brine (20 
cm
3






chromatography (Hexane:EtOAc, 3:1) of the residual brown oil thus obtained gave                           
β-hydroxyketone 86 as a light-brown oil (222 mg, 66%). 
Method B (Grignard addition with Weinreb amide 194 using allylmagnesium 
bromide): In duplicate, a solution of allyl bromide (19.4 cm
3
, 224 mmol) in Et2O 
(112 cm
3
) was added dropwise (~1 h) to a suspension of magnesium turnings (8.14 g, 
336 mmol) spiked with I2 (1 large crystal, ~15.0 mg, 0.06 mmol) in Et2O (112 cm
3
) 
and the suspension, which boiled spontaneously, was heated to reflux for 30 min, 
cooled to rt and stirred for 1 h to give a solution of allylmagnesium bromide (224 
cm
3
, 224 mmol; 1.0 M in Et2O). Stirring was discontinued for ~10 min to allow 
excess magnesium to settle, then both solutions of allylmagnesium bromide (448 
cm
3
, 448 mmol; 1.0 M in Et2O) were transferred via cannula (~20 min) to a solution 
of Weinreb amide 194 (6.70 g, 28.0 mmol) in Et2O (100 cm
3
) at –20 °C and the 
reaction mixture was stirred for 40 min, cooled to –78 °C and quenched by addition 
of NH4Cl (300 cm
3
; sat aq). The reaction mixture was warmed to rt, and the organic 
layer was separated and concentrated to a volume of ~100 cm
3
 by rotary evaporation. 
The aqueous layer was extracted with Et2O (3 × 100 cm
3
) and the combined organic 
layers were washed with Na2S2O3 (100 cm
3
; sat aq), H2O (100 cm
3
), brine (2 × 100 
cm
3
) and dried (MgSO4). The solvent was removed under reduced pressure to give 
an orange-yellow oil to which Et3N (78.1 cm
3
, 560 mmol) and DBU (21.8 cm
3
, 140 
mmol) were added. The mixture was heated to 50 °C overnight (~18 h), cooled to rt 
and diluted with Et2O (300 cm
3
). The organic layer was washed with cold (~0 °C) 
HCl (3 × 50 cm
3
; 5.0 M aq) [CAUTION: exothermic], NaHCO3 (50 cm
3
; sat aq), 
H2O (50 cm
3
), brine (50 cm
3
) and dried (MgSO4). The solvent was removed under 
reduced pressure and the brown residue was purified by flash chromatography 
(Hexane:EtOAc, 6:1) to give a mixture of β-hydroxyketone 86 and diol 299 as a 
brown oil. A further two chromatographic purifications (Hexane:EtOAc, 4:1; then 
DCM:Et2O, 25:1) of material containing β-hydroxyketone 86 gave β-hydroxyketone 
86 (1.34 g, 22%, >99:1 E:Z) and diol 299 (2.28 g, 31%) as yellow oils. 
Method C (silyl deprotection of TBS-ether 271): HF (18.3 cm
3
, 510 mmol; 48% aq) 
was added to a solution of TBS-ether 271 (5.71 g, 17.0 mmol) in MeCN (40 cm
3
) at 




cooled back down to 0 °C. A suspension of NaHCO3 (50.4 g, 600 mmol) in NaHCO3 
(300 cm
3
; sat aq) was added in small portions [CAUTION: vigorous gas evolution] 
and the mixture was warmed to rt and stirred for 30 min. The aqueous layer was 
extracted with DCM (4 × 100 cm
3
) and the combined organic layers were washed 
with NaHCO3 (100 cm
3
; sat aq), brine (100 cm
3
) and dried (MgSO4). The solvent 
was removed under reduced pressure and the resulting orange oil was purified by 
flash chromatography (Hexane:EtOAc, 6:1) to give β-hydroxyketone 86 as a             
light-yellow oil (3.18 g, 85%). Rf (Hexane:EtOAc, 3:1) = 0.44; Rf (Hexane:EtOAc, 
6:1) = 0.25; Rf (DCM:Et2O, 25:1) = 0.63; [α]D = –56.1 (c 1.05, CHCl3); IR (neat, 
cm
-1
) 3487 (OH), 2218 (C≡C), 1682 (C=O), 1620 (C=C); 
1
H NMR δ (500 MHz, 
CDCl3) 7.01 (1H, dq, J = 15.1, 6.9 Hz, CH3CH=CH), 6.56 (1H, dq, J = 15.1, 1.7 Hz, 
CH=CHCO), 6.01 (1H, dt, J = 10.6, 7.3 Hz, CH2CH=CH), 5.57 (1H, br dq, J = 10.6, 
2.2 Hz, CHC≡CCH3), 3.84 (1H, dd, J = 10.2, 2.5 Hz, CHOH), 2.68 (1H, br s, OH),          
2.53–2.48 (1H, m, CHAHB), 2.39–2.33 (1H, m, CHAHB), 1.99 (3H, d, J = 2.2 Hz, 
C≡CCH3), 1.93 (3H, dd, J = 6.9, 1.7 Hz, C=CHCH3), 1.23 (3H, s, CCH3), 1.20 (3H, 
s, CCH3); 
13
C NMR δ (125 MHz, CDCl3) 204.5 (C), 143.9 (CH), 139.3 (CH), 126.4 
(CH), 111.5 (CH), 90.6 (C), 76.3 (C), 76.1 (CH), 50.3 (C), 32.5 (CH2), 21.5 (CH3), 





, 100), 221 ([M+H]
+
, 7); HRMS (ESI+, MeOH/DCM) [M+Na]
+
 found 
243.1356, C14H20O2Na requires 243.1356. 
 
(6S,8Z)-4-Allyl-5,5-dimethyl-dodeca-1,8-dien-10-yne-4,6-diol (299) 
Rf (Hexane:EtOAc, 6:1) = 0.30; Rf (DCM:Et2O, 25:1) = 0.50; 
[α]D = –43.8 (c 1.05, CHCl3); IR (neat, cm
-1
) 3352 (OH), 3074 
(OH), 2222 (C≡C), 1638 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 
6.04–5.93 (3H, m, 2CH2=CH and CH2CH=CHC≡C), 5.61 (1H, br 
dq, J = 10.6, 2.3 Hz, CHC≡CCH3), 5.18–5.11 (4H, m, 2CH2=CH), 4.06 (1H, dd,         
J = 9.9, 2.8 Hz, CHOH), 3.04 (2H, br s, 2OH), 2.59–2.41 (6H, m, 3CH2CH=CHn), 
2.00 (3H, d, J = 2.3 Hz, C≡CCH3), 1.10 (3H, s, CCH3), 0.90 (3H, s, CCH3); 
13
C 
NMR δ (125 MHz, CDCl3) 139.6 (CH), 135.3 (CH), 135.0 (CH), 118.3 (CH2), 118.1 
(CH2), 111.9 (CH), 90.8 (C), 79.0 (C), 76.4 (C), 76.1 (CH), 44.2 (C), 40.7 (CH2), 






, 34%), 525 ([2M+H]
+
, 59), 285 ([M+Na]
+
, 17), 263 ([M+H]
+
, 100); 
HRMS (ESI+, MeOH) [M+H]
+




General Procedure A was followed with 







, 300 mmol; 1.6 M in hexanes); 
addition of THF (163 cm
3
) then ester 245 (7.11 g, 25.0 mmol) in THF (25 cm
3
); with 
reaction at –78 °C (1.5 h) then –78 °C to 0 °C (~1 h). Quenching with NH4Cl (500 
cm
3
; 50% sat aq); workup with Et2O (5 × 100 cm
3
), H2O (100 cm
3
) and brine (100 
cm
3
); and flash chromatography (EtOAc:Hexane, 3:2) gave Weinreb amide 300 as a 
light-yellow oil (6.11 g, 78%). Rf (EtOAc:Hexane, 3:2) = 0.41; [α]D = +36.3 (c 0.11, 
CHCl3); IR (neat, cm
-1
) 3472 (OH), 1612 (C=O), 1585 (C=O); 
1
H NMR δ (500 
MHz, CDCl3) 7.30–7.27 (2H, m, 2ArH), 6.91–6.88 (2H, m, 2ArH), 4.48 (2H, s, 
OCH2Ar), 3.97 (1H, dd, J = 8.8, 3.6 Hz, CHOH), 3.83 (3H, s, ArOCH3), 3.73–3.68 
(2H, m, CH2OCH2Ar), 3.71 (3H, s, NOCH3), 3.20 (3H, s, NCH3), 1.79–1.73 (2H, m, 
CH2CHOH), 1.29 (3H, s, CCH3), 1.27 (3H, s, CCH3); 
13
C NMR δ (125 MHz, 
CDCl3) 178.5 (C), 159.2 (C), 130.5 (C), 129.3 (2CH), 113.8 (2CH), 75.4 (CH), 72.9 
(CH2), 68.9 (CH2), 60.7 (CH3), 55.3 (CH3), 47.2 (C), 33.7 (CH3), 31.6 (CH2), 21.1 
(CH3), 20.2 (CH3); m/z (EI) 325 ([M]
+
, 1%), 171 (16), 122 (19), 121 (100); HRMS 
(EI) [M]
+
 found 325.1888, C17H27NO5 requires 325.1888. 
 
(S)-3-(tert-Butyl-dimethyl-silanyloxy)-5-(4-methoxy-benzyloxy)-2,2-dimethyl-
pentanoic acid methoxy-methyl-amide (301) 
General Procedure C was followed with TBSOTf 
(5.67 cm
3
, 24.7 mmol), β-hydroxy-Weinreb amide 300 
(5.95 g, 19.0 mmol) and 2,6-lutidine (4.41 cm
3
, 38.0 
mmol) in DCM (40 cm
3
); with reaction for 2.5 h at         
–78 °C. Quenching with NaHCO3 (100 cm
3
; sat aq); workup with DCM (3 × 50 
cm
3
), NaHCO3 (50 cm
3
; sat aq), H2O (50 cm
3
) and brine (50 cm
3
); and flash 
chromatography (Hexane:EtOAc, 2:1) gave TBS-ether 301 as a colourless oil that 





0.63; mp 44–47 °C; [α]D = +12.6 (c 0.63, CHCl3); IR (neat, cm
-1
) 1636 (C=O), 1612 
(C=C); 
1
H NMR δ (400 MHz, CDCl3) 7.28–7.25 (2H, m, 2ArH), 6.91–6.87 (2H, m, 
2ArH), 4.42 (2H, br d, J = 1.3 Hz, OCH2Ar), 4.37 (1H, dd, J = 7.9, 3.0 Hz, CHOSi), 
3.83 (3H, s, ArOCH3), 3.65 (3H, s, NOCH3), 3.54–3.50 (2H, m, CH2OCH2Ar), 3.15 
(3H, s, NCH3), 1.80–1.64 (2H, m, CH2CHOSi), 1.26 (3H, s, CHCCH3), 1.18 (3H, s, 
CHCCH3), 0.91 (9H, s, 3SiC(CH3)3), 0.09 (3H, s, SiCH3), 0.07 (3H, s, SiCH3); 
13
C 
NMR δ (125 MHz, CDCl3) 177.7 (C), 159.1 (C), 130.8 (C), 129.2 (2CH), 113.7 
(2CH), 72.4 (CH2), 71.7 (CH), 67.4 (CH2), 60.4 (CH3), 55.3 (CH3), 49.1 (C), 34.5 
(CH2), 33.8 (CH3), 26.1 (3CH3), 22.8 (CH3), 19.3 (CH3), 18.4 (C), –3.8 (CH3), –3.9 
(CH3); m/z (ESI+, MeOH) 901 ([2M+Na]
+
, 100%), 462 ([M+Na]
+
, 52), 440 
([M+H]
+
, 83); HRMS (ESI+, MeOH) [M+H]
+





Attempted Synthesis of 302  
Method A: DDQ (5.79 g, 25.5 mmol) was added to a solution of 
PMB-ether 301 (7.47 g, 17.0 mmol) in DCM (72 cm
3
) and H2O 
(4 cm
3
) and the mixture, which turned immediately green-black 
was stirred for 1 h, by which time an orange-brown mixture had developed. The 
reaction was quenched with NaHCO3 (200 cm
3
; sat aq) [CAUTION: potential for 
HCN gas evolution, careful, controlled extrusion is required]. The orange mixture 
was diluted with H2O (200 cm
3
) and the aqueous layer was extracted with DCM (5 × 
100 cm
3
). The combined organic layers were washed with NaHCO3 (100 cm
3
; sat 
aq), H2O (100 cm
3
), brine (100 cm
3
) and dried (MgSO4). The solvent was removed 





; 5.1 M aq) was added, and the mixture was stirred for 1 h, filtered, 
and the filtrate was concentrated under reduced pressure. The residue was dissolved 
in Et2O (100 cm
3
) and washed with Na2HSO3 (20 cm
3





) and dried (MgSO4). The solvent was removed under reduced pressure 





However, alcohol 302 was not observed; instead lactone 303 was obtained as a 
yellow crystalline solid (3.76 g, 86%). 
Method B: CAN (275 mg, 0.50 mmol) was added to a solution of PMB-ether 301 
(109 mg, 0.25 mmol) in MeCN (4.5 cm
3
) and H2O (0.5 cm
3
). The orange solution 
was stirred for 1 h, by which time the initially bright-orange colour had faded to 
pale-yellow. NaHCO3 (20 cm
3
; sat aq) was added to quench the reaction, and the 
aqueous layer was extracted with DCM (3 × 20 cm
3
). The combined organic layers 
were washed with brine (10 cm
3
), dried (MgSO4) and the solvent was removed under 
reduced pressure. The residue was dissolved in EtOH (10 cm
3
), NaHSO3 (1.00 cm
3
; 
0.4 M aq) was added and the solution was stirred overnight (~18 h) at rt and filtered, 
rinsing with EtOH (3 × 10 cm
3
). The solvent was removed under reduced pressure, 
the residue was dissolved in EtOAc (20 cm
3
) and the organic layer was washed with 
NaHSO3 (10 cm
3
; 0.4 M aq), H2O (10 cm
3
), brine (10 cm
3
) and dried (MgSO4). 
Removal of the solvent under reduced pressure gave a yellow oil. 
1
H NMR of the 
crude material indicated ca. quantitative conversion to lactone 303. 
Method C: H2 was bubbled through a suspension of PMB-ether 301 (87.9 mg, 0.20 
mmol) and 10% Pd/C (53.9 mg, 0.05 mmol, 25 mol% Pd) in MeOH (10 cm
3
) over a 
period of 30 min, and the reaction mixture was stirred for 24 h under an atmosphere 
of H2. The mixture was filtered through celite, the filter cake was rinsed with MeOH 
(5 × 10 cm
3
) and the solvent was removed under reduced pressure. 
1
H NMR of the 
crude material indicated ca. quantitative conversion to alcohol 302. 
1
H NMR δ (500 
MHz, CDCl3) 4.36 (1H, t, J = 5.4 Hz, CHOSi), 3.81–3.80 (1H, m, OH), 3.72 (3H, s, 
OCH3), 3.71–3.63 (2H, m, CH2OH), 3.19 (3H, s, NCH3), 1.70 (2H, dt, J = 6.1, 5.4 
Hz, CHCH2), 1.26 (3H, s, CCH3), 1.23 (3H, s, CCH3), 0.93 (9H, s, 3SiC(CH3)3), 0.14 
(3H, s, SiCH3), 0.10 (3H, s, SiCH3). However, purification by flash chromatography 











Rf (Hexane:Et2O, 3:2) = 0.30; Rf (DCM:MeOH, 50:1) = 0.19; mp 
59–61 °C; [α]D = +39.1 (c 1.20, CHCl3); IR (neat, cm
-1
) 1724 
(C=O), 1697 (C=O); 
1
H NMR δ (500 MHz, CDCl3) 4.59 (1H, ddd, 
J = 10.1, 9.9, 4.4 Hz, CHAHBO), 4.31 (1H, ddd, J = 10.4, 10.1, 5.5 Hz, CHAHBO), 
3.81 (1H, dd, J = 6.1, 2.5 Hz, CHOSi), 2.22 (1H, dddd, J = 14.2, 9.9, 5.5, 2.5 Hz, 
CHXHYCH2O), 1.84 (1H, ddt, J = 14.2, 6.1, 4.4 Hz, CHXHYCH2O), 1.31 (3H, s, 
CCH3), 1.29 (3H, s, CCH3), 0.93 (9H, s, 3SiC(CH3)3), 0.12 (3H, s, SiCH3), 0.10 (3H, 
s, SiCH3); 
13
C NMR δ (125 MHz, CDCl3) 176.9 (C), 73.0 (CH), 65.4 (CH2), 45.0 
(C), 28.0 (CH2), 25.8 (CH3), 25.7 (3CH3), 22.5 (CH3), 18.0 (C), –4.5 (CH3), –5.0 
(CH3); m/z (ESI+, MeOH) 517 ([2M+H]
+
, 9%), 347 ([4M+3H]
+
, 43), 315 
([6M+5H]
+
, 100), 259 ([M+H]+, 94); HRMS (CI) [M+H]
+
 found 259.1725, 
C13H27O3Si requires 259.1724. 
 
(S)-3,5-Dihydroxy-2,2-dimethyl-pentanoic acid methyl ester (310) 
H2 was bubbled through a suspension of PMB-ether 245 (812 mg, 
2.85 mmol) and 10% Pd/C (759 mg, 0.71 mmol, 25 mol% Pd) in 
MeOH (20 cm
3
) over a period of 30 min and the reaction mixture 
was subsequently stirred for 24 h under an atmosphere of H2. The mixture was 
filtered, the residue was rinsed with EtOAc (5 × 10 cm
3
), and the solvent was 
removed under reduced pressure to give a colourless oil. Flash chromatography 
(EtOAc:Hexane, 3:1) afforded diol 310 as a turbid oil that solidifies to a colourless 
wax on cooling (400 mg, 80%). Rf (EtOAc:Hexane, 3:1) = 0.19; mp 39–42 °C; [α]D 
= –1.30 (c 1.50, CHCl3); IR (neat, cm
-1
) 3428 (OH), 3300 (OH), 1728 (C=O), 1661 
(C=O); 
1
H NMR δ (500 MHz, CDCl3) 3.94 (1H, ddd, J = 9.8, 5.2, 3.3 Hz, CHOH), 
3.90–3.88 (2H, m, CH2OH), 3.74 (3H, s, OCH3), 3.27 (1H, br d, J = 5.2 Hz, CHOH), 
2.58 (1H, br s, CH2OH), 1.72–1.61 (2H, m, CHCH2), 1.23 (3H, s, CCH3), 1.22 (3H, 
s, CCH3); 
13
C NMR δ (125 MHz, CDCl3) 178.2 (C), 76.7 (CH), 62.1 (CH2), 52.1 
(CH3), 46.9 (C), 32.9 (CH2), 22.3 (CH3), 20.0 (CH3); m/z (EI) 177 ([M+H]
+
, 2%), 
131 (22), 102 (100); HRMS (EI) [M+H]
+






7.5 Experimental from Chapter 5 
General Procedure D: N-Boc Protection of N-Heterocycles 
To a solution of the N-heterocycle (1.0 eq), Et3N or DIPEA (2.2 eq) and DMAP (5 
mol%) in DCM or THF was added a solution of Boc2O (1.0 to 1.2 eq) in the 
appropriate solvent (DCM or THF) and the solution was stirred for the specified time 
at rt. The solvent was removed under reduced pressure, and the residue thus obtained 
was either (i) partitioned between an organic solvent and H2O (with extraction of the 
aqueous layer and combination of the organic layers); or (ii) dissolved in EtOAc. In 
both cases, the (combined) organic layers were washed with the stated aqueous 
solutions, dried (MgSO4) and the solvent was removed under reduced pressure. 
Purification of the crude material by flash chromatography or recrystallisation gave 
the product N-Boc-heterocycle. 
 
General Procedure E: N-Alkylation of N-Heterocycles 
The N-heterocycle (1.0 eq) and Cs2CO3 (2.0 to 5.0 eq) in THF were heated to reflux 
for 1 h before the addition of tosylate ester 341 (1.0 eq) in THF. Heating was 
continued overnight (~18 h), the resulting suspension was cooled to rt, and the 
reaction was quenched with excess HCl (aq) [CAUTION: gases evolved]. The 
mixture was stirred at rt until a clear solution was obtained (~10 min) and in some 
cases, further diluted with an aqueous solvent. The aqueous layer was extracted with 
DCM, Et2O or EtOAc (volumes/iterations as indicated), and the combined organic 
layers were washed with appropriate volumes (25 to 50% 
v
/v of the combined organic 
layers) of NaHCO3 (sat aq), H2O and brine. Drying (MgSO4), removal of the solvent 
under reduced pressure and purification of the crude material by flash 
chromatography gave the product N-alkylated heterocycle. 
 
7.5.1 Preparation of Model Heterocycles 
Toluene-4-sulfonic acid 2-methoxy-ethyl ester (341) 
Tosylate ester 341 was prepared according to the procedure 
described by Howell et al.
201
 To a solution of 2-methoxyethanol 
(7.61 g, 100 mmol) in pyridine (17.0 cm
3




TsCl (19.1 g, 100 mmol) at 0 °C in small portions over 10 min [CAUTION: 
exothermic reaction]. The suspension was stirred vigorously for 4 h, warmed to rt, 
diluted with DCM (100 cm
3
) and poured into HCl (100 cm
3
; 5.0 M aq). The aqueous 
layer was extracted with DCM (2 × 50 cm
3
) and the combined organic layers were 
washed with HCl (2 × 50 cm
3
; 5.0 M aq), NaHCO3 (2 × 100 cm
3
; sat aq), H2O (100 
cm
3
), brine (100 cm
3
) and dried (MgSO4). The solvent was removed under reduced 
pressure to give tosylate ester 341 as a colourless oil (21.8 g, 92%), which was used 
without further purification. Rf (Hexane:EtOAc, 3:1) = 0.27; IR (neat, cm
-1
) 1597 
(C=C), 1495 (C=C), 1450 (C=C), 1402 (C=C), 1354 (S=O); 
1
H NMR δ (400 MHz, 
CDCl3) 7.85–7.82 (2H, m, 2ArH), 7.38–7.36 (2H, m, 2ArH), 4.20–4.18 (2H, m, 
SOCH2), 3.62–3.60 (2H, m, COCH2), 3.34 (3H, s, OCH3), 2.48 (3H, s, ArCH3); 
13
C 
NMR δ (100 MHz, CDCl3) 144.8 (C), 133.0 (C), 129.8 (2CH), 128.0 (2CH), 69.9 












N-TIPS-pyrrole 345 was prepared according to the procedure described by 
Muchowski et al.
176b
 To a solution of freshly distilled 1H-pyrrole (10.1 g, 
150 mmol) in THF (100 cm
3





mmol; 1.6 M in hexanes) over 15 min and the pale-yellow mixture was 
stirred for 15 min in the absence of light. A solution of TIPSCl (28.9 g, 150 mmol) in 
THF (25 cm
3
) was then added and the mixture was stirred for 15 min, warmed to rt 
and stirred for a further 15 min before H2O (100 cm
3
) was added to quench the 
reaction. The mixture was poured into H2O (150 cm
3
) and Et2O (150 cm
3
), and the 
aqueous layer was extracted with Et2O (5 × 100 cm
3
). The combined organic layers 
were washed with H2O (250 cm
3
), brine (250 cm
3
) and dried (MgSO4). Removal of 
the solvent under reduced pressure gave N-TIPS-pyrrole 345 as a brown oil (32.9 g, 
98%), which was used without further purification. Rf (Hexane) = 0.34; IR (neat,   
cm
-1
) 1460 (C=C); 
1




6.35 (2H, t, J = 1.9 Hz, 2NCCH), 1.48 (3H, sept, J = 7.6 Hz, 3SiCH), 1.13 (18H, d,  
J = 7.6 Hz, 6CH3); 
13
C NMR δ (125 MHz, CDCl3) 124.1 (2CH), 110.0 (2CH), 17.9 
(6CH3), 11.7 (3CH); m/z (EI) 223 ([M]
+
, 63%), 181 (36), 180 (100), 152 (34), 124 




1H-Pyrrole-3-carboxylic acid ethyl ester (346) 
3-Formylpyrrole 346 was prepared according to the procedure described 
by Griengl et al.
176a
 DMF (2.97 cm
3
, 38.4 mmol) in DCM (10 cm
3
) was 
added in portions over 10 min to a solution of (COCl)2 (3.30 cm
3
, 39.0 
mmol) in DCM (200 cm
3
) and the white suspension was stirred for 30 min at 0 °C. A 
solution of N-TIPS-pyrrole 345 (7.42 cm
3
, 30.0 mmol) in DCM (10 cm
3
) was added, 
and the mixture was heated to reflux for 30 min in the absence of light. The             
pale-yellow suspension was cooled to rt, the solvent was removed under reduced 
pressure and the residue was treated with NaOH (200 cm
3
, 250 mmol; 1.25 M aq). 
The solution was stirred overnight (~18 h), and the aqueous layer was extracted with 
DCM (5 × 50 cm
3
). The combined organic layers were washed with brine (100 cm
3
), 
dried (MgSO4), and the solvent was removed under reduced pressure. Flash 
chromatography (Hexane:EtOAc, 1:1) of the resulting orange-brown oil gave           
3-formylpyrrole 346 as a brown solid (1.64 g, 58%). Rf (Hexane:EtOAc, 1:1) = 0.27; 
mp 60–62 °C, lit
176b
 68 °C; IR (neat, cm
-1
) 3252 (NH), 2853 (CHO), 1643 (C=O), 
1632 (C=N), 1504 (C=C), 1433 (C=C), 1413 (C=C); 
1
H NMR δ (400 MHz, CDCl3) 
9.87 (1H, s, CHO), 8.92–8.66 (1H, br m, NH), 7.49–7.47 (1H, m, NCHCCHO), 
6.88–6.87 (1H, m, NCHCH), 6.75–6.73 (1H, m, NCHCH); 
13
C NMR δ (100 MHz, 
CDCl3) 185.8 (CH), 127.0 (C), 126.8 (CH), 120.4 (CH), 107.8 (CH); m/z (EI) 95 
([M]
+
, 100%), 94 (79), 92 (18), 66 (68). The spectroscopic data are in good 




Pyrrole-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester (348) 
General Procedure D was employed with 3-formylpyrrole 346 
(406 mg, 5.00 mmol), DIPEA (1.88 cm
3
, 11.0 mmol) and DMAP 
(30.9 mg, 0.25 mmol, 5 mol%) in DCM (5 cm
3
); and Boc2O (10.5 g, 
40.1 mmol) in DCM (5 cm
3











) and H2O (20 cm
3
) with DCM (2 × 10 cm
3
) extraction; washing with 
HCl (3 × 10 cm
3
; 1.0 M aq), NaHCO3 (10 cm
3
; sat aq) and brine (10 cm
3
); and flash 
chromatography (Hexane:EtOAc, 6:1) gave N-Boc-3-formylpyrrole 348 as a           
light-yellow oil that solidifies to a pale-yellow solid on cooling (717 mg, 73%). Rf 
(Hexane:EtOAc, 6:1) = 0.34; mp 35–38 °C, lit
179
 35–36 °C; IR (neat, cm
-1
) 2980 
(CHO), 1748 (C=O), 1717 (C=N), 1678 (C=O), 1549 (C=C), 1497 (C=C), 1416 
(C=C); 
1
H NMR δ (500 MHz, CDCl3) 9.87 (1H, s, CHO), 7.87 (1H, t,  J = 1.7 Hz, 
NCHCCHO), 7.30–7.29 (1H, m, NCHCH), 6.68 (1H, dd, J = 3.3, 1.7 Hz, NCHCH), 
1.66 (9H, s, 3CH3); 
13
C NMR δ (125 MHz, CDCl3) 185.7 (CH), 147.9 (C), 128.9 
(C), 128.3 (CH), 122.1 (CH), 109.3 (CH), 85.6 (C), 27.9 (3CH3); m/z (EI) 195 ([M]
+
, 
34%), 140 (17), 136 (18), 122 (57), 95 (63), 94 (41), 66 (22), 57 (100). The 





In a modification of General Procedure E, 3-formylpyrrole 346 (190 
mg, 2.00 mmol), Cs2CO3 (1.30 g, 4.00 mmol), tosylate ester 341 (461 
mg, 2.00 mmol), and TBAI (73.9 mg, 0.20 mmol, 10 mol%) in THF (10 
cm
3
) were reacted for 2 d with no 1 h aging period prior to electrophile 
addition. HCl (10 cm
3
; 1.0 M aq) quenching and an Et2O (5 × 10 cm
3
) workup 
afforded N-alkylated 3-formylpyrrole 376 as a brown oil (290 mg, 95%), which was 
unstable to silica gel chromatography and was therefore used without further 
purification. Rf (Hexane:EtOAc, 1:1) = 0.20; IR (neat, cm
-1
) 2984 (CHO), 1661 
(C=O), 1531 (C=C), 1514 (C=C), 1440 (C=C), 1398 (C=C); 
1
H NMR δ (400 MHz, 
CDCl3) 9.77 (1H, s, CHO), 7.38 (1H, t, J = 1.9 Hz, NCHCCHO), 6.75–6.73 (1H, m, 
NCHCH), 6.65 (1H, dd, J = 2.9, 1.6 Hz, NCHCH), 4.10 (2H, t, J = 5.3 Hz, OCH2), 
3.69 (2H, t, J = 5.3 Hz, NCH2), 3.38 (3H, s, CH3); 
13
C NMR δ (100 MHz, CDCl3) 
185.4 (CH), 129.5 (CH), 126.7 (C), 123.7 (CH), 108.3 (CH), 71.9 (CH2), 59.1 (CH3), 
50.2 (CH2); m/z (EI) 153 ([M]
+
, 100%), 108 (33). HRMS (EI) [M]
+
 found 153.0783, 







1-(2-Methoxy-ethyl)-1H-pyrrole-3-carboxylic acid (380) 
N-Alkylated pyrrole-3-carboxylic acid 380 was prepared according to 
the procedure described by Mai et al.
204
 for the preparation of an 
analogous pyrrole-3-carboxylic acid. NaOH (4.13 cm
3
, 12.4 mmol; 3.0 
M aq) and AgNO3 (646 mg, 3.80 mmol) were added to a solution of           
N-alkylated 3-formylpyrrole 376 (290 mg, 1.90 mmol) in MeOH (5 cm
3
) and the 
black mixture was heated to reflux for 1 d. The reaction mixture was cooled to rt and 
filtered; and the residue was rinsed with MeOH (3 × 10 cm
3
) and H2O (3 × 10 cm
3
). 
The filtrate was concentrated under reduced pressure, washed with DCM (3 × 30 
cm
3
) and acidified to pH 1 by addition of HCl (15.0 cm
3
; conc aq). The aqueous 
layer was extracted with Et2O (5 × 20 cm
3
), and the combined organic layers were 
washed with brine (50 cm
3
), dried (MgSO4), and the solvent was removed under 
reduced pressure to give N-alkylated pyrrole-3-carboxylic acid 380 (97.8 mg, 30%) 
as a gummy brown solid, which was used without further purification (~86% purity 
by 
1
H NMR). Rf (Hexane:EtOAc, 1:1) = 0.20; mp 75–78 °C; IR (neat, cm
-1
) 2920 
(OH), 1759 (C=N), 1705 (C=N), 1651 (C=O), 1614 (C=C), 1593 (C=C); 
1
H NMR δ 
(500 MHz, CDCl3) 7.44 (1H, t, J = 1.9 Hz, NCHCCO2H), 6.69 (1H, dd, J = 2.9, 2.6 
Hz, NCHCH), 6.65 (1H, dd, J = 2.9, 1.7 Hz, NCHCH), 4.07 (2H, t, J = 5.3 Hz, 
OCH2), 3.68 (2H, t, J = 5.3 Hz, NCH2), 3.37 (3H, s, OCH3); 
13
C NMR δ (125 MHz, 
CDCl3) 169.4 (C), 127.8 (CH), 122.4 (CH), 115.2 (C), 110.6 (CH), 71.8 (CH2), 59.2 
(CH3), 49.9 (CH2); m/z (EI) 170 ([M+H]
+
, 10%), 169 ([M]
+
, 100), 139 (15), 124 
(37); HRMS (EI) [M]
+




3-Formylindole 331 was prepared according to a modification of the 
procedure described by James and Snyder.
177
 Freshly distilled (COCl)2 
(5.08 cm
3
, 60.0 mmol) was added dropwise over 1 h to DMF (40 cm
3
, 
515 mmol) [CAUTION: vigorous reaction, gases evolved] at 0 °C and the mixture 
was stirred for 15 min to form an orange-pink slurry. Indole (5.86 g, 50.0 mmol) in 
DMF (40 cm
3




stirred for 1 h at 0 °C, warmed to 40 °C and stirred for 1 h. The reaction mixture was 
removed from the heating source, and crushed ice (~100 g) was added, giving an 
opaque-yellow slurry. NaOH (200 cm
3
, 500 mmol; 2.5 M aq) was added cautiously, 
and the solution was heated to reflux for 20 min. The orange-red solution thus 
obtained was diluted with H2O (200 cm
3
) and cooled to 4 °C overnight (~18 h) after 
which time a suspension had formed. The precipitate was filtered, washed with H2O 
(5 × 50 cm
3
), and recrystallised (EtOH) to give 3-formylindole 331 as an orange 
solid (4.56 g, 63%). Rf (Hexane:EtOAc, 1:1) = 0.33; mp 199–203 °C, lit
177
           
196–197 °C; IR (neat, cm
-1
) 3144 (NH), 2818 (CHO), 1628 (C=O), 1612 (C=N), 
1574 (C=C), 1520 (C=C), 1497 (C=C), 1437 (C=C), 1393 (C=C); 
1
H NMR δ (500 
MHz, DMSO-d6) 12.13 (1H, br s, NH), 9.95 (1H, s, CHO), 8.29 (1H, s, NCH),  
8.11–8.10 (1H, m, ArH), 7.53–7.51 (1H, m, ArH), 7.29–7.21 (2H, m, 2ArH); 
13
C 
NMR δ (125 MHz, DMSO-d6) 185.4 (CH), 138.9 (CH), 137.5 (C), 124.6 (C), 123.9 










3-Formyl-indole-1-carboxylic acid tert-butyl ester (333) 
General Procedure D was employed with 3-formylindole 331 (2.90 
g, 20.0 mmol), Et3N (6.14 cm
3
, 44.0 mmol) and DMAP (122 mg, 
1.00 mmol, 5 mol%) in THF (20 cm
3
); and Boc2O (5.24 g, 24.0 
mmol) in THF (20 cm
3
). Reaction for 24 h; dissolution in EtOAc 
(200 cm
3
); washing with H2O (50 cm
3
), HCl (2 × 50 cm
3
; 0.5 M aq), NaHCO3              
(50 cm
3
; sat aq) and brine (50 cm
3
); and recrystallisation (EtOH) afforded                      
N-Boc-3-formylindole 333 in the form of colourless needles (3.50 g, 71%). Rf 
(Hexane:EtOAc, 5:1) = 0.47; mp 125–126 °C, lit
243
 124–126 °C; IR (neat, cm
-1
) 
2814 (CHO), 1740 (C=O), 1676 (C=O), 1557 (C=C), 1450 (C=C); 
1
H NMR δ (500 
MHz, CDCl3) 10.13 (1H, s, CHO), 8.33–8.31 (1H, m, ArH), 8.18 (1H, br d, J = 8.2 
Hz, ArH), 7.46–7.39 (2H, m, ArH), 1.74 (9H, s, 3CH3); 
13
C NMR δ (125 MHz, 
CDCl3) 185.8 (CH), 148.8 (C), 136.5 (CH), 136.0 (C), 126.2 (C), 126.1 (CH), 124.6 






40%), 189 (55), 145 (58), 144 (31), 116 (16), 57 (100). The spectroscopic data are in 





General Procedure E was employed using 3-formylindole 331 
(1.43 g, 9.86 mmol) and Cs2CO3 (6.52 g, 20.0 mmol) in THF (80 
cm
3





; 1.0 M aq) quenching; EtOAc (1 × 100 cm
3
, 3 × 50 
cm
3
) workup; and flash chromatography (Hexane:EtOAc, 1:1) gave N-alkylated                
3-formylindole 378a as a red oil (1.26 g, 63%). Rf (Hexane:EtOAc, 1:1) = 0.27; IR 
(neat, cm
-1
) 2826 (CHO), 1654 (C=O), 1612 (C=N), 1578 (C=C), 1531 (C=C), 1485 
(C=C), 1465 (C=C), 1447 (C=C), 1400 (C=C), 1386 (C=C); 
1
H NMR δ (500 MHz, 
CDCl3) 10.04 (1H, s, CHO), 8.37–8.33 (1H, m, ArH), 7.84 (1H, s, CH2NCH),             
7.42–7.33 (3H, m, 3ArH), 4.37 (2H, t, J = 5.2 Hz, OCH2), 3.78 (2H, t, J = 5.2 Hz, 
NCH2), 3.36 (3H, s, CH3); 
13
C NMR δ (125 MHz, CDCl3) 184.7 (CH), 139.4 (CH), 
137.2 (C), 125.3 (C), 123.9 (CH), 122.9 (CH), 122.3 (CH), 118.3 (C), 109.8 (CH), 
70.7 (CH2), 59.1 (CH3), 47.0 (CH2); m/z (EI) 204 ([M+H]
+
, 19%), 203 ([M]
+
, 100%), 
158 (99), 130 (16); HRMS (EI) [M]
+
 found 203.0941, C12H13NO2 requires 203.0941. 
 
1-(Toluene-4-sulfonyl)-1H-indole-3-carbaldehyde (390) 
N-Tosyl-3-formylindole 390 was prepared according to a 
modification of the procedure described by Plietker et al.
211
 To a 
solution of 3-formylindole 331 (1.45 g, 10.0 mmol) and Et3N (4.18 
cm
3
, 30.0 mmol) in DCM (40 cm
3
) was added TsCl (2.86 g, 15.0 
mmol), and the orange mixture was stirred overnight (~18 h) at rt. 
The reaction mixture was poured into HCl (50 cm
3
; 1.0 M aq), which resulted in 
violet colouration of the organic layer. The aqueous layer was extracted with DCM 
(3 × 20 cm
3
), and the combined organic layers were washed with HCl (30 cm
3
; 1.0 M 
aq), NaHCO3 (30 cm
3
; sat aq), H2O (30 cm
3
), brine (30 cm
3
) and dried (MgSO4). 
Removal of the solvent under reduced pressure and recrystallisation (EtOAc/Hexane) 
of the orange residue thus obtained afforded N-tosyl-3-formylindole 390 as a              






142 °C; IR (neat, cm
-1
) 1676 (C=O), 1593 (C=C), 1541 (C=C), 1479 (C=C), 1443 
(C=C), 1377 (S=O); 
1
H NMR δ (500 MHz, CDCl3) 10.12 (1H, s, CHO), 8.29–8.27 
(1H, m, ArH), 8.25 (1H, s, ArH), 7.98–7.97 (1H, m, ArH), 7.89–7.87 (2H, m, 2ArH), 
7.46–7.36 (2H, m, 2ArH), 7.33–7.32 (2H, m, 2ArH), 2.41 (3H, s, CH3); 
13
C NMR δ 
(125 MHz, CDCl3) 185.3 (CH), 146.2 (C), 136.2 (CH), 135.3 (C), 134.4 (C), 130.3 
(2CH), 127.3 (2CH), 126.3 (CH), 126.2 (C), 125.1 (CH), 122.6 (CH), 122.4 (C), 
113.3 (CH), 21.7 (CH3); m/z (EI) 299 ([M]
+
, 80%), 155 (75), 116 (16), 91 (100). The 




1-(2-Methoxy-ethyl)-1H-indole-3-carboxylic acid methyl ester (378b) 
General Procedure E was employed using indole-3-methyl ester 
(8.76 g, 50.0 mmol) and Cs2CO3 (81.5 g, 250 mmol) in THF (250 
cm
3





; 5.0 M aq) quenching; H2O (250 cm
3
) dilution; 
workup with Et2O (5 × 100 cm
3
); and flash chromatography (Hexane:EtOAc, 3:1) 
gave N-alkylated indole-3-methyl ester 378b as an orange-pink syrup that solidifies 
to a light-pink wax on cooling (11.3 g, 97%). Rf (Hexane:EtOAc, 3:1) = 0.20; mp 
38–40 °C; IR (neat, cm
-1
) 1684 (C=O), 1530 (C=N), 1487 (C=C), 1466 (C=C), 1437 
(C=C), 1404 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 8.24–8.19 (1H, m, ArH), 7.92 
(1H, s, CH2NCH), 7.42–7.38 (1H, m, ArH), 7.33–7.30 (2H, m, 2ArH), 4.34 (2H, t,          
J = 5.4 Hz, OCH2), 3.94 (3H, s, CO2CH3), 3.76 (2H, t, J = 5.4 Hz, NCH2), 3.34 (3H, 
s, CH2OCH3); 
13
C NMR δ (125 MHz, CDCl3) 165.5 (C), 136.6 (C), 135.0 (CH), 
126.7 (C), 122.7 (CH), 121.9 (CH), 121.8 (CH), 109.8 (CH), 107.2 (C), 70.9 (CH2), 
59.1 (CH3), 51.0 (CH3), 46.8 (CH2); m/z (EI) 233 ([M]
+
, 57%), 188 (100), 153 (21), 
126 (22), 107 (21); HRMS (EI) [M]
+
 found 233.1046, C13H15NO3 requires 233.1046. 




1-(2-Methoxy-ethyl)-1H-indole-3-carboxylic acid (382) 
A solution of N-alkylated indole-3-methyl ester 378b (4.67 g, 20.0 
mmol) and KOH (5.61 g, 100 mmol) in EtOH (90 cm
3
) and H2O 
(10 cm
3
) was heated to reflux overnight (~18 h). The light-yellow 




pressure and the residue was dissolved in H2O (100 cm
3
). The aqueous layer was 
washed with DCM (3 × 20 cm
3
) and acidified to pH 1 by addition of HCl (10 cm
3
; 
conc aq). The aqueous layer was extracted with DCM (5 × 50 cm
3
), and the 
combined organic layers were washed with H2O (50 cm
3
), brine (50 cm
3
) and dried 
(MgSO4). The solvent was removed under reduced pressure to give N-alkylated 
indole-3-carboxylic acid 382 as a beige solid (4.39 g, quant), which was used without 
further purification. Rf (Hexane:EtOAc, 1:1) = 0.27; mp 122–124 °C; IR (neat, cm
-1
) 
2879 (OH), 1658 (C=O), 1614 (C=N), 1576 (C=C), 1526 (C=C), 1491 (C=C), 1468 
(C=C), 1443 (C=C), 1402 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 8.28–8.25 (1H, m, 
ArH), 8.02 (1H, s, CH2NCH), 7.44–7.41 (1H, m, ArH), 7.35–7.32 (2H, m, 2ArH), 
4.37 (2H, t, J = 5.4 Hz, OCH2), 3.78 (2H, t, J = 5.4 Hz, NCH2), 3.36 (3H, s, OCH3); 
13
C NMR δ (125 MHz, CDCl3) 169.2 (C), 136.8 (C), 136.2 (CH), 126.9 (C), 122.9 
(CH), 122.2 (CH), 121.9 (CH), 109.9 (CH), 106.4 (C), 70.8 (CH2), 59.1 (CH3), 46.9 
(CH2); m/z (EI) 220 ([M+H]
+
, 6%), 219 ([M]
+
, 53), 174 (100). The spectroscopic 





1H-Pyrazole-4-carboxylic acid ethyl ester (162) 
Pyrazole-4-ethyl ester 162 was prepared according to a modification 
of the procedure described by Allin et al.
180
 To NaH (4.00 g, 100 
mmol; 60% dispersion in mineral oil) in Et2O (80 cm
3
) at 0 °C was 
added ethyl formate (40.4 cm
3
, 500 mmol), followed by a solution of ethyl                   
3,3-diethoxypropionate (10.6 g, 50.0 mmol) in Et2O (20 cm
3
). The suspension was 
stirred for 1.5 h at 0 °C, warmed to rt and stirred for 24 h [CAUTION: H2 gas 
evolved, safe gas extrusion required], after which time the reaction was quenched 
with H2O (200 cm
3
). The aqueous layer was washed with Et2O (3 × 50 cm
3
) and 
acidified to pH 1 by addition of HCl (10 cm
3
; conc aq). The aqueous layer was 
extracted with DCM (3 × 50 cm
3
), and the combined DCM layers were washed with 
brine (100 cm
3
) and dried (MgSO4). Removal of the solvent under reduced pressure 
gave crude bis-aldehyde 350 as an orange liquid (~7.20 g, assumed quant) which was 
dissolved in EtOH (20 cm
3




(6.30 g, 60.0 mmol) in EtOH (280 cm
3
) at 0 °C. The orange solution was stirred for  
2 h, warmed to rt, stirred for 48 h and the solvent was removed under reduced 





; sat aq), and the biphasic mixture was stirred vigorously for 5 min 
[CAUTION: gases evolved]. The aqueous layer was extracted with EtOAc (3 × 50 
cm
3
), and the combined organic layers were washed with NaHCO3 (50 cm
3
; sat aq), 
brine (100 cm
3
), dried (MgSO4) and the solvent was removed under reduced 
pressure. Purification of the red residue thus obtained by flash chromatography 
(Hexane:EtOAc, 3:1) gave pyrazole-4-ethyl ester 162 as a red oil that solidifies to an 
orange solid on cooling (6.09 g, 87% over 2 steps). Rf (Hexane:EtOAc, 3:1) = 0.10; 
mp 72–76 °C, lit
246
 69 °C; IR (neat, cm
-1
) 1721 (C=O), 1703 (C=N), 1525 (C=C), 
1402 (C=C); 
1
H NMR δ (400 MHz, CDCl3) 8.10 (2H, s, 2NCH), 4.34 (2H, q, J = 7.2 
Hz, CH2), 1.37 (3H, t, J = 7.2 Hz, CH3); 
13
C NMR δ (100 MHz, CDCl3) 163.4 (C), 
136.5 (2CH), 115.0 (C), 60.4 (CH2), 14.4 (CH3); m/z (EI) 140 ([M]
+
, 100%), 126 





Pyrazole-1,4-dicarboxylic acid 1-tert-butyl ester 4-ethyl ester (354) 
General Procedure D was employed with pyrazole-4-ethyl ester 
162 (1.40 g, 10.0 mmol), Et3N (3.07 cm
3
, 22.0 mmol) and 
DMAP (64.3 mg, 0.53 mmol, 5 mol%) in THF (10 cm
3
); and 
Boc2O (2.63 g, 12.0 mmol) in THF (10 cm
3
). Reaction for 4 h; 
partitioning between EtOAc (20 cm
3
) and H2O (20 cm
3
) with EtOAc (4 × 10 cm
3
) 
extraction; washing with HCl (3 × 10 cm
3
; 1.0 M aq), NaHCO3 (20 cm
3
; sat aq) and 
brine (20 cm
3
); and flash chromatography (Hexane:EtOAc, 3:1) afforded                             
N-Boc-pyrazole-4-ethyl ester 354 as a yellow oil (2.20 g, 91%). Rf (Hexane:EtOAc, 
3:1) = 0.47; IR (neat, cm
-1
) 1782 (C=O), 1757 (C=O), 1721 (C=O), 1568 (C=N), 
1396 (C=C); 
1
H NMR δ (400 MHz, CDCl3) 8.58 (1H, s, CONCH), 8.08 (1H, s, 
CONNCH), 4.36 (2H, q, J = 7.2 Hz, CH2), 1.69 (9H, s, C(CH3)3), 1.39 (3H, t, J = 7.2 
Hz, CH2CH3); 
13
C NMR δ (100 MHz, CDCl3) 162.1 (C), 146.8 (C), 143.9 (CH), 











1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylic acid ethyl ester (377a) 
General Procedure E was employed using pyrazole-4-ethyl ester 
162 (2.80 g, 20.0 mmol) and Cs2CO3 (13.0 g, 40.0 mmol) in THF (80 
cm
3





; 1.0 M aq) quenching; EtOAc (5 × 50 cm
3
) workup; 
and flash chromatography (Hexane:EtOAc, 1:1) gave N-alkylated pyrazole-4-ethyl 
ester 377a as a colourless oil (3.81 g, 96%). Rf (Hexane:EtOAc, 1:1) = 0.40; IR 
(neat, cm
-1
) 1710 (C=O), 1554 (C=N), 1449 (C=C), 1462 (C=C), 1408 (C=C); 
1
H 
NMR δ (400 MHz, CDCl3) 7.99 (1H, s, CH2NNCH), 7.94 (1H, s, CH2NCH), 4.32 
(2H, q, J = 7.2 Hz, CH2CH3), 4.32 (2H, dd, J = 5.2, 5.0 Hz, OCH2CH2), 3.77 (2H, 
dd, 5.2, 5.0 Hz, NCH2CH2), 3.36 (3H, s, OCH3), 1.37 (3H, t, J = 7.2 Hz, CH2CH3); 
13
C NMR δ (100 MHz, CDCl3) 163.1 (C), 141.1 (CH), 133.5 (CH), 115.2 (C), 70.7 
(CH2), 60.1 (CH3), 59.0 (CH2), 52.6 (CH2), 14.4 (CH3); m/z (EI) 198 ([M]
+
, 9%), 168 
(98), 153 (100), 140 (17), 125 (18), 112 (31); HRMS (EI) [M]
+
 found 198.0997, 
C9H14N2O3 requires 198.0999. 
 
1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylic acid (381) 
A solution of N-alkylated pyrazole-4-ethyl ester 377a (1.98 g, 10.0 
mmol) and KOH (2.81 g, 50.0 mmol) in EtOH (45 cm
3
) and H2O                   
(5 cm
3
) was heated to reflux overnight (~18 h). The reaction mixture 
was cooled to rt, concentrated under reduced pressure and the residue 
was dissolved in H2O (50 cm
3
). The aqueous layer was washed with DCM (3 × 10 
cm
3
) and acidified to pH 1 by the addition of HCl (6 cm
3
; conc aq). The aqueous 
layer was extracted with DCM (5 × 10 cm
3
), and the combined organic layers were 
washed with H2O (20 cm
3
), brine (20 cm
3
) and dried (MgSO4). Removal of the 
solvent under reduced pressure gave N-alkylated pyrazole-3-carboxylic acid 381 as a 
beige solid (457 mg, 27%). The combined aqueous layers were made basic (pH 14) 
by the addition of KOH (~7.5 g; pellets), washed with DCM (20 cm
3
), and acidified 
to pH 1 by the addition of HCl (10 cm
3







), washing of the combined organic layers with brine (50 cm
3
), drying (MgSO4) 
and removal of the solvent under reduced pressure gave further N-alkylated                        
pyrazole-4-carboxylic acid 381 as a beige solid (1.19 g, 70%; thus 1.65 g, 97% total 
yield). Rf (EtOAc:Hexane, 2:1) = 0.19; mp 82–85 °C; IR (neat, cm
-1
) 2737 (OH), 
1699 (C=O), 1557 (C=N); 
1
H NMR δ (500 MHz, CDCl3) 8.07 (1H, s, CH2NCH), 
8.01 (1H, s, CH2NNCH), 4.36 (2H, dd, J = 5.0, 4.9 Hz, OCH2), 3.78 (2H, dd, J = 5.0, 
4.9 Hz, NCH2), 3.36 (3H, s, OCH3); 
13
C NMR δ (125 MHz, CDCl3) 168.0 (C), 141.7 
(CH), 134.5 (CH), 114.2 (C), 70.5 (CH2), 59.0 (CH3), 52.7 (CH2); m/z (EI) 171 
([M+H]
+
, 3%), 170 ([M]
+
, 6), 140 (100), 125 (23), 112 (29). The spectroscopic data 
are in good agreement with the literature.
247 
 
(2S,3E)-1-(2-Methoxy-hept-3-en-5-ynyl)-1H-pyrazole-4-carboxylic acid ethyl 
ester (102) 
In a modification of General Procedure E which replaced 
tosylate ester 341 with C(5)–C(9) tosylate ester 95,
203a
 
pyrazole-4-ethyl ester 162 (46.4 mg, 0.33 mmol), tosylate 
ester 95, (97.4 mg, 0.33 mmol; 14:1 E:Z) and Cs2CO3 (216 mg, 0.66 mmol) in THF 
(5 cm
3
) were reacted with no 1 h aging period prior to electrophile addition. HCl (10 
cm
3
; 1.0 M aq) quenching; DCM (3 × 10 cm
3
) workup; and flash chromatography 
(Hexane:EtOAc, 3:1; dry loaded) gave the C(1)–C(9) fragment pyrazole-4-ethyl ester 
analogue 102 as a light-yellow syrup (58.3 mg, 67%, 14:1 E:Z). Rf (Hexane:EtOAc, 
3:1) = 0.34; [α]D = +26.0 (c 0.50, CHCl3), lit
16
 = +28.2 (c 0.43, CHCl3); IR (neat, 
cm
-1
) 2224 (C≡C), 1713 (C=O), 1633 (C=N), 1553 (C=C); 
1
H NMR δ (500 MHz, 
CDCl3) 7.93 (1H, s, ArCH), 7.90 (1H, s, ArCH), 5.82 (1H, dd, J = 15.9, 7.2 Hz, 
HC=CHC≡CCH3), 5.72 (1H, dqd, J = 15.9, 2.2, 0.8 Hz, HC=CHC≡CCH3), 4.29 (2H, 
q, J = 7.1 Hz, OCH2CH3), 4.19 (1H, dd, J = 13.9, 3.9 Hz, CHAHBCHOCH3), 4.09 
(1H, dd, J = 13.9, 8.0 Hz, CHAHBCHOCH3), 4.02 (1H, ddd, J = 8.0, 7.2, 3.8 Hz, 
CHOCH3), 3.22 (3H, s, OCH3), 1.95 (3H, d, J = 2.2 Hz, C≡CCH3), 1.34 (3H, t,               
J = 7.1 Hz, OCH2CH3); 
13
C NMR δ (125 MHz, CDCl3) 163.0 (C), 141.1 (CH), 137.2 
(CH), 133.9 (CH), 115.1 (C), 115.0 (CH), 88.1 (C), 80.1 (CH), 76.9 (C), 60.1 (CH2), 













, 100); HRMS (ESI+, MeOH) [M+Na]
+
 found 285.1211, 
C14H18N2O3Na requires 285.1210. 
(Z)-isomer diagnostic peaks: 
1
H NMR δ (500 MHz, CDCl3) 7.96 (1H, s, ArCH), 
3.27 (3H, s, OCH3), 1.98 (3H, d, J = 2.4 Hz, C≡CCH3); 
13
C NMR δ (125 MHz, 
CDCl3) 163.1 (C), 140.8 (CH), 137.3 (CH), 133.8 (CH), 115.3 (CH), 114.9 (C), 93.1 
(CH), 75.0 (C), 60.0 (CH2), 56.7 (CH3), 55.9 (CH2), 4.4 (CH3). The spectroscopic 






4-Bromopyrazole 352 was prepared according to the procedure described 
by Moslin et al.
183
 A suspension of 1H-pyrazole (6.81 g, 100 mmol) and 
NBS (17.9 g, 101 mmol) in H2O (125 cm
3
) was stirred overnight (~18 h) 
at rt. The reaction mixture was extracted with EtOAc (3 × 100 cm
3
), and the 
combined organic layers were washed Na2S2O3 (100 cm
3
; 50% sat aq), NaHCO3 (2 × 
100 cm
3
; sat aq), H2O (100 cm
3
), brine (100 cm
3
) and dried (MgSO4). The solvent 
was removed under reduced pressure to give 4-bromopyrazole 352 as a colourless 
solid (13.3 g, 90%), which was used without further purification. Rf (Hexane:EtOAc, 
1:1) = 0.40; mp 94–95 °C, lit
248
 89–91 °C; IR (neat, cm
-1
) 3136 (NH), 1714 (C=N), 
1557 (C=C), 1533 (C=C), 1516 (C=C), 1496 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 
7.63 (2H, s, 2CH); 
13









, 100), 121 (46), 119 (52). The spectroscopic 





General Procedure E was employed using 4-bromopyrazole 377c (266 
mg, 2.00 mmol) and Cs2CO3 (1.30 g, 4.00 mmol) in THF (8 cm
3
); and 
tosylate ester 341 (461 mg, 2.00 mmol) in THF (1 cm
3
). HCl (20 cm
3
; 1.0 
M aq) quenching; HCl (10 cm
3
; 1.0 M aq) dilution; Et2O (1 × 20 cm
3
, 5 × 
10 cm
3
) workup; and flash chromatography (DCM:MeOH, 100:1) gave N-alkylated      
4-bromopyrazole 377c as a light-yellow oil (261 mg, 68%). Rf (DCM:MeOH, 100:1) 
= 0.42; IR (neat, cm
-1
) 1670 (C=N), 1442 (C=C), 1381 (C=C); 
1





MHz, CDCl3) 7.53 (1H, s, CH2NNCH), 7.49 (1H, s, CH2NCH), 4.28 (2H, dd,                      
J = 5.2, 5.0 Hz, OCH2), 3.74 (2H, dd, J = 5.2, 5.0 Hz, NCH2), 3.36 (3H, s, CH3); 
13
C 
NMR δ (125 MHz, CDCl3) 139.9 (CH), 130.2 (CH), 92.9 (C), 71.0 (CH2), 59.0 








, 55%), 176 (88), 
174 (92), 161 (88), 159 (89), 148 (96), 146 (100); HRMS (EI) [M]
+
 found 203.9893, 
C6H9
79
BrN2O requires 203.9892. 
 
4-Iodo-pyrazole-1-carboxylic acid tert-butyl ester (356) 
General Procedure D was employed with 4-iodopyrazole (7.76 g, 
40.0 mmol), Et3N (12.3 cm
3
, 88.0 mmol) and DMAP (244 mg, 2.00 
mmol, 5 mol%) in THF (40 cm
3
); and Boc2O (10.5 g, 40.1 mmol) in 
THF (40 cm
3
). Reaction for 18 h; dissolution in EtOAc (300 cm
3
); washing with HCl 
(3 × 100 cm
3
; 0.5 M aq), Na2S2O3 (80 cm
3
; 50% sat aq), H2O (100 cm
3
) and brine 
(100 cm
3
); and recrystallisation (EtOH/H2O) gave N-Boc-4-iodopyrazole 356 as a 
colourless to pale-yellow solid (10.8 g, 92%). Rf (Hexane:EtOAc, 6:1) = 0.49; mp 
62–64 °C; IR (neat, cm
-1
) 1758 (C=O); 
1
H NMR δ (500 MHz, CDCl3) 8.17 (1H, s, 
CONCH), 7.72 (1H, s, CONNCH), 1.67 (9H, s, 3CH3); 
13
C NMR δ (125 MHz, 
CDCl3) 148.5 (CH), 146.4 (C), 135.0 (CH), 86.3 (C), 61.3 (C), 27.9 (3CH); m/z (EI) 
295 ([M]
+






N-Benzyl-4-iodopyrazole 363 was prepared according to the procedure 
described by Chaplin et al.
194
 A suspension of 4-iodopyrazole (9.70 g, 50.0 
mmol), freshly distilled BnBr (7.14 cm
3
, 60.0 mmol) and K2CO3 (13.8 g, 
100 mmol) in acetone (100 cm
3
) was heated to reflux for 3 h after which 
time the slurry was cooled to room temperature and concentrated under reduced 
pressure. H2O (300 cm
3
) was added to dissolve the residue and the aqueous layer was 
extracted with EtOAc (3 × 100 cm
3
). The combined organic layers were washed with 
NaHCO3 (100 cm
3
; sat aq), Na2S2O3 (100 cm
3





) and dried (MgSO4). The solvent was removed under reduced pressure to 





to afford N-benzyl-4-iodopyrazole 363 as a colourless solid (13.3 g, 94%). Rf 
(Hexane:EtOAc, 6:1) = 0.31; mp 64–65 °C, lit
250
 58–59 °C; IR (neat, cm
-1
) 1653 
(C=N), 1506 (C=C), 1494 (C=C), 1452 (C=C), 1433 (C=C); 
1
H NMR δ (500 MHz, 
CDCl3) 7.57 (1H, d, J = 0.3 Hz, CH2NNCH), 7.42 (1H, d, J = 0.3 Hz, CH2NCH), 
7.41–7.34 (3H, m, 3ArH), 7.26–7.24 (2H, m, 2ArH), 5.33 (2H, s, CH2); 
13
C NMR δ 
(100 MHz, CDCl3) 144.6 (CH), 135.8 (C), 133.6 (CH), 129.0 (2CH), 128.4 (CH), 
127.9 (2CH), 56.5 (CH2), 56.4 (C); m/z (EI) 285 ([M+H]
+











N-Benzyl-4-formylpyrazole 364 was prepared according to a 
modification of the procedure described by Vedsø et al.
186a
 for the 





, 39.0 mmol; 3.0 M in 2-MeTHF) was added dropwise (10 min) 
to a solution of N-benzyl-4-iodopyrazole 363 (8.52 g, 30.0 mmol) in 
THF (120 cm
3
) at 0 °C, and the light-yellow solution was stirred for 1 h. A solution 
of DMF (11.6 cm
3
, 150 mmol) in THF (60 cm
3
) was added over 5 min, and the 
bright-yellow mixture was warmed to rt and stirred for 1.75 h. NH4Cl (100 cm
3
; sat 
aq) was added to quench the reaction, and the mixture was diluted with H2O (100 
cm
3
) to dissolve residual precipitates. The aqueous layer was extracted with DCM        
(4 × 50 cm
3
), and the combined organic layers were washed with Na2S2O3 (100 cm
3
; 
50% sat aq), H2O (2 × 100 cm
3
), brine (100 cm
3
) and dried (MgSO4). The solvent 
was removed under reduced pressure to give a yellow oil that was purified by flash 
chromatography (Hexane:EtOAc, 3:2) to afford N-benzyl-4-formylpyrazole 364 as a 
light-yellow oil that solidifies to form a pale-yellow to colourless solid on cooling 
(4.76 g, 85%). Rf (Hexane:EtOAc, 3:2) = 0.39; mp 45–47 °C; IR (neat, cm
-1
) 1667 
(C=O), 1631 (C=N), 1541 (C=N), 1497 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 9.86 
(1H, s, CHO), 8.03 (1H, s, CH2NCH), 7.90 (1H, s, CH2NNCH), 7.44–7.37 (3H, m, 
3ArH), 7.31–7.29 (2H, m, 2ArH), 5.36 (2H, s, CH2); 
13
C NMR δ (125 MHz, CDCl3) 
194.0 (CH), 141.0 (CH), 134.7 (C), 132.5 (CH), 129.2 (2CH), 128.9 (CH), 128.2 
(2CH), 124.7 (C), 56.7 (CH2); m/z (EI) 187 ([M+H]
+
, 9%), 186 ([M]
+












, 100), 158 (35), 157 (52), 99 (99); HRMS (EI) [M]
+
 found 186.0782, 
C11H10N2O requires 186.0788. 
 
4-Iodo-1-(2-methoxy-ethyl)-1H-pyrazole (377d) 
In a modification of General Procedure E, 4-iodopyrazole (3.88 g, 20.0 
mmol), Cs2CO3 (13.0 g, 40.0 mmol) and tosylate ester 341 (4.61 g, 20.0 
mmol) in DMF (100 cm
3
) was reacted at 120 °C with no 1 h aging period 
prior to electrophile addition. Concentration of the solution under reduced 
pressure; HCl (200 cm
3
; 1.0 M aq) quenching; DCM (4 × 50 cm
3
) workup; and flash 
chromatography (Hexane:EtOAc, 2:1) gave N-alkylated 4-iodopyrazole 377d as a 
malodorous colourless oil (4.05 g, 80%). Rf (Hexane:EtOAc, 2:1) = 0.29; IR (neat, 
cm
-1
) 1732 (C=N); 
1
H NMR δ (500 MHz, CDCl3) 7.55 (1H, s, CH2NNCH), 7.53 
(1H, s, CH2NCH), 4.31 (2H, dd, J = 5.2, 5.0 Hz, OCH2), 3.73 (2H, dd, J = 5.2, 5.0 
Hz, NCH2), 3.36 (3H, s, CH3); 
13
C NMR δ (125 MHz, CDCl3) 144.4 (CH), 134.5 
(CH), 71.0 (CH2), 59.0 (CH3), 55.9 (C), 52.6 (CH2); m/z (EI) 252 ([M]
+
, 54%), 222 
(66), 207 (40), 194 (100); HRMS (EI) [M]
+




N-Alkylated 4-formylpyrazole 379 was prepared according to a 
modification of the procedure described by Vedsø et al.
186a
 for the 
functionalisation of an analogous N-substituted 4-iodopyrazole. To a 
solution of N-alkylated 4-iodopyrazole 377d (756 mg, 3.00 mmol) in 
THF (18 cm
3




, 3.90 mmol; 3.0 M in    2-MeTHF) at 0 
°C and the grey slurry was stirred for 1 h. DMF (1.16 cm
3
, 15.0 mmol) in THF (2 
cm
3
) was added, and the solution was warmed to rt and stirred for 2 h. The reaction 
was quenched by the addition of NH4Cl (20 cm
3
; sat aq), diluted with H2O (10 cm
3
), 
and the aqueous layer was extracted with DCM (4 × 20 cm
3
). The combined organic 
layers were washed with Na2S2O3 (40 cm
3
; 50% sat aq), brine (40 cm
3
) and dried 
(MgSO4); and the solvent was removed under reduced pressure. Flash 
chromatography (EtOAc:Hexane, 3:1) of the crude yellow oil gave N-alkylated         










Aldehyde 379 decomposes spontaneously in the presence of light and under standard 
laboratory storage conditions (–18 °C, freezer) and should be used immediately. Rf 
(EtOAc:Hexane, 3:1) = 0.38; IR (neat, cm
-1
) 1710 (C=N), 1676 (C=O), 1543 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 9.89 (1H, s, CHO), 8.05 (1H, s, CH2NCH), 8.00 (1H, 
s, CH2NNCH), 4.36 (2H, dd, J = 5.1, 5.0 Hz, OCH2), 3.78 (2H, dd, J = 5.1, 5.0 Hz, 
NCH2), 3.37 (3H, s, OCH3); 
13
C NMR δ (125 MHz, CDCl3) 184.1 (CH), 140.7 
(CH), 133.9 (CH), 124.4 (C), 70.4 (CH2), 59.0 (CH3), 52.8 (CH2); m/z (EI) 154 
([M]
+
, 6%), 124 (89), 95 (18), 58 (54), 49 (20), 45 (100). The spectroscopic data are 





In a modification of General Procedure E, 1H-pyrazole (1.37 g, 20.0 
mmol), Cs2CO3 (32.5 g, 100 mmol) and tosylate ester 341 (4.61 g, 20.0 
mmol) in DMF (100 cm
3
) was reacted at reflux with no 1 h aging period 
prior to electrophile addition. Concentration of the solution under reduced 
pressure; HCl (300 cm
3
; 1.0 M aq) quenching; DCM (5 × 100 cm
3
) workup; and 
flash chromatography (Hexane:EtOAc, 1:1 → 1:3) gave N-alkylated 1H-pyrazole 
377b as a volatile colourless oil (670 mg, 27%). Rf (Hexane:EtOAc, 1:1) = 0.37; 
1
H 
NMR δ (500 MHz, CDCl3) 7.54 (1H, d, J = 1.5 Hz, CH2NNCH), 7.49 (1H, d, J = 2.1 
Hz, CH2NCH), 6.27 (1H, t, J = 2.1 Hz, CH2NCHCH), 4.33 (2H, t, J = 5.3 Hz, 
OCH2), 3.77 (2H, t, J = 5.3 Hz, NCH2), 3.35 (3H, s, OCH3); 
13
C NMR δ (125 MHz, 
CDCl3) 139.4 (CH), 130.0 (CH), 105.5 (CH), 71.3 (CH2), 59.0 (CH3), 52.0 (CH2). 





1-Benzyl-1H-[1,2,3]triazole-4-carboxylic acid methyl ester (367) 
Triazole-4-methyl ester 367 was prepared according to a modification 
of the procedure described by Schwink et al.
197
 Sodium ascorbate (0.80 
g, 4.00 mmol, 20 mol%) was added to a solution of CuSO4•5H2O (0.50 




, 3:1) and the solution 





Stirring was continued for 15 min, and to the resulting orange-brown mixture was 




, 3:1) solutions of BnN3 
(2.83 g, 20.0 mmol) and methyl propiolate (2.19 g, 26.0 mmol) and the mixture was 
stirred overnight (~18 h) [CAUTION: blast shield required] after which time a 
yellow solution had developed. The reaction mixture was diluted with DCM (100 
cm
3
) and H2O (100 cm
3
) and the aqueous layer was extracted with DCM (3 × 50 
cm
3
). The combined organic layers were washed with NH4Cl (50 cm
3
; sat aq), brine 
(50 cm
3
) and dried (MgSO4). Removal of the solvent under reduced pressure, and 
purification of the yellow residue thus obtained by flash chromatography 
(Hexane:EtOAc, 1:1) afforded triazole-4-methyl ester 367 as a colourless solid (4.03 
g, 93%). Rf (Hexane:EtOAc, 1:1) = 0.40; mp 106–107 °C, lit
252
 115–117 °C; IR 
(neat, cm
-1
) 1722 (C=O), 1541 (C=C), 1454 (C=C), 1433 (C=C); 
1
H NMR δ (400 
MHz, CDCl3) 8.00 (1H, s, NCH), 7.46–7.41 (3H, m, 3ArH), 7.33–7.31 (2H, m, 
2ArH), 5.61 (2H, s, CH2), 3.96 (3H, s, CH3); 
13
C NMR δ (100 MHz, CDCl3) 161.1 
(C), 140.4 (C), 133.6 (C), 129.4 (2CH), 129.2 (CH), 128.4 (2CH), 127.4 (CH), 54.5 
(CH2), 52.2 (CH3); m/z (EI) 217 ([M]
+
, 4%), 174 (26), 130 (24), 91 (100). The 





4-Formyltriazole 368 was prepared according to the procedure described 
by Fray et al. for the semi-reduction of an analogous triazole-4-methyl 
ester.
198
 DIBAL (33.0 cm
3
, 33.0 mmol; 1.0 M in hexanes) was added 
dropwise (20 min) to a solution of triazole-4-methyl ester 367 (2.17 g, 
10.0 mmol) in DCM (15 cm
3
) at –78 °C. The mixture was stirred for 2.5 
h before quenching of the reaction with MeOH (10 cm
3
) followed, after 5 min, by the 
addition of sodium potassium tartrate (40 cm
3
; sat aq). The reaction mixture was 
warmed to rt, diluted with DCM (20 cm
3
) and sodium potassium tartrate (20 cm
3
; sat 
aq), and stirred vigorously until the aqueous layer had become homogenous and a 
clean phase separation was visible (~1 h). The aqueous layer was extracted with 
DCM (4 × 20 cm
3
), and the combined organic layers were washed with brine (50 
cm
3
) and dried (MgSO4). The solvent was removed under reduced pressure and the 




4-formyltriazole 368 as a colourless solid (1.38 g, 73%). Rf (Hexane:EtOAc, 1:1) = 
0.45; mp 90–92 °C, lit
253a
 89–90 °C; IR (neat, cm
-1
) 2855 (CHO), 1724 (C=N), 1692 
(C=O), 1612 (C=C), 1585 (C=C), 1533 (C=C), 1514 (C=C); 
1
H NMR δ (400 MHz, 
CDCl3) 10.16 (1H, s, CHO), 8.01 (1H, s, NCH), 7.46–7.42 (3H, m, 3ArH), 7.35–7.32 
(2H, m, 2ArH), 5.62 (2H, s, CH2); 
13
C NMR δ (100 MHz, CDCl3) 185.1 (CH), 148.1 
(C), 133.3 (C), 129.5 (2CH), 129.4 (CH), 128.4 (2CH), 125.1 (CH), 54.6 (CH2); m/z 
(EI) 187 ([M]
+
, 10%), 158 (37), 130 (22), 91 (100). The spectroscopic data are in 




7.5.2 Evans-Tishchenko Reactions 
Preparation of SmI2 
An oven- or flame-dried round bottomed flask was cooled under argon and charged 
with samarium (196 mg, 1.30 mmol), I2 (255 mg, 1.00 mmol) and THF (10 cm
3
). 
The suspension was purged with argon (balloon; ~3–5 min) and treated with 
ultrasonic vibration in the absence of light, where the colour of the solution 
progressed from brown, to orange, to yellow, to green, to green-blue. After an 
induction time of, typically, 10 min to 1 h, the deep-blue solution of SmI2 (~0.1 M in 
THF) was obtained, which was allowed to stand for ~10 min and was used 
immediately thereafter. 
N.B. Solutions were reacted for 1 h to ensure complete I2 consumption. Smaller-scale 
reactions (5.00 cm
3
, 0.50 mmol) failed, while larger-scale preparation (up to                
65.0 cm
3
, 6.50 mmol) was successful but may require a longer induction time.  
 
General Procedure F: The Evans–Tishchenko Reaction 
SmI2 (2.50 cm
3
, 0.25 mmol; 0.1 M in THF) was added to a solution of                       
β-hydroxyketone 86 (55.1 mg, 0.25 mmol) and the reactant aldehyde (6.0 eq) in THF 
(1 cm
3
) at –20 °C, and the solution was stirred for the stated time, keeping the bath 
temperature below –10 °C. The reaction was quenched by the addition of sodium 
potassium tartrate (10 cm
3
; sat aq), diluted with H2O (10 cm
3
), and the aqueous layer 
was extracted with DCM (3 × 10 cm
3
). The combined organic layers were washed 
with Na2S2O3 (10 cm
3
; sat aq), NaHSO3 (10 cm
3
; 0.1 M aq), brine (10 cm
3




(MgSO4). The solvent was removed under reduced pressure and the products of the 




Following General Procedure F with 3-pyridinecarboxaldehyde 
(0.14 cm
3
, 1.50 mmol), reaction for 4 h gave an orange-yellow 
residue after performing aqueous workup. Flash chromatography 
(Hexane:EtOAc, 3:2) gave 1,3-anti diol monoester 384a (48.0 mg, 
59%) as an orange-yellow syrup. Rf (Hexane:EtOAc, 3:2) = 0.26; 
[α]D = +72.5 (c 0.51, CHCl3); IR (neat, cm
-1
) 3374 (OH), 2220 (C≡C), 1720 (C=O), 
1670 (C=C), 1591 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 9.27 (1H, br s, COCCHN), 
8.82 (1H, br s, CHCHN), 8.33 (1H, dt, J = 7.9, 1.8 Hz, COCCHCH), 7.43 (1H, br dd, 
J = 7.9, 4.9 Hz, COCCHCH), 5.81 (1H, ddd, J = 10.6, 8.0, 6.8 Hz, C=CHCH2), 5.70 
(1H, dqd, J = Hz, 15.2, 6.5, 0.6 Hz, CH3CH), 5.58 (1H, ddq, J = 15.2, 7.3, 1.4 Hz, 
CH3C=CH), 5.47 (1H, dqt, J = 10.6, 2.3, 1.1 Hz, CHC≡CCH3), 5.39 (1H, dd,                 
J = 10.2, 2.8 Hz, CH2CHOCAr), 3.85 (1H, d, J = 7.3 Hz, CHOH), 2.87–2.80 (1H, m, 
CHAHB), 2.68–2.63 (1H, m, CHAHB), 2.47 (1H, br s, OH), 2.01 (3H, d, J = 2.3 Hz, 
C≡CCH3), 1.73 (3H, dd, J = 6.5, 1.4 Hz, C=CHCH3), 1.04 (3H, s, CCH3), 1.00 (3H, 
s, CCH3); 
13
C NMR δ (125 MHz, CDCl3) 165.7 (C), 153.5 (CH), 151.1 (CH), 137.4 
(2CH), 129.4 (CH), 129.3 (CH), 126.0 (C), 123.4 (CH), 112.5 (CH), 91.0 (C), 78.3 
(CH), 76.2 (CH), 76.1 (C), 41.9 (C), 30.6 (CH2), 18.8 (CH3), 18.4 (CH3), 17.9 (CH3), 
4.4 (CH3); m/z (ESI+, MeOH) 677 ([2M+Na]
+
, 17%), 350 ([M+Na]
+
, 100), 328 
([M+H]
+
, 9); HRMS (ESI+, MeOH) [M+H]
+















Method A: Following General Procedure F with                       
4-pyridinecarboxaldehyde (161 mg, 1.50 mmol), reaction for 1.5 h 
gave a brown residue after performing aqueous workup.
*
 Flash 
chromatography (PE 40–60:EtOAc, 1:1; dry loaded) gave 1,3-anti 
diol monoester 384b (52.8 mg, 65%) as a colourless oil. 
*
Washing 
with NaHSO3 was not performed on this run. 
Method B (Evans–Tishchenko reaction with an in situ-generated pre-catalyst):  
SmI2 (2.50 cm
3
, 0.25 mmol; 0.1 M in THF) was added to a solution of                             
4-pyridinecarboxaldehyde (26.8 mg, 0.25 mmol) in THF (1 cm
3
) and the resulting 
green-brown solution was stirred for 30 min at –10 °C. A second portion of                      
4-pyridinecarboxaldehyde (134 mg, 1.25 mmol) in THF (1 cm
3
) was added and the 
solution was stirred for 10 min before the addition of β-hydroxyketone 86 (55.1 mg, 
0.25 mmol) in THF (1 cm
3
). After stirring for 1.5 h, the reaction was quenched with 
sodium potassium tartrate (10 cm
3
; sat aq) and the mixture was warmed to rt. The 
reaction mixture was diluted with H2O (10 cm
3
) and the aqueous layer was extracted 
with DCM (3 × 10 cm
3
). The combined organic layers were washed with NaHSO3 
(10 cm
3
; sat aq), brine (10 cm
3
) and dried (MgSO4). The solvent was removed under 
reduced pressure and the residue was purified by flash chromatography 
(Hexane:EtOAc, 1:1) to give 1,3-anti diol monoester 384b as an orange-yellow syrup 
(43.0 mg, 53%). Rf (PE 40–60:EtOAc, 1:1) = 0.41; Rf (Hexane:EtOAc, 1:1) = 0.51; 
[α]D = +60.0 (c 0.45, CHCl3); IR (neat, cm
-1
) 3366 (OH), 2220 (C≡C), 1724 (C=O), 
1560 (C=C), 1512 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 8.81 (2H, br d, J = 5.8 Hz, 
2CHN), 7.89 (2H, d, J = 5.8 Hz, 2NCHCH), 5.81 (1H, ddd, J = 10.6, 8.0, 6.9 Hz, 
C=CHCH2), 5.70 (1H, dqd, J = Hz, 15.3, 6.5, 0.6 Hz, CH3CH), 5.58 (1H, ddq,                   
J = 15.3, 7.4, 1.4 Hz, CH3C=CH), 5.48 (1H, dqt, J = 10.6, 2.2, 1.1 Hz, CHC≡CCH3), 
5.39 (1H, dd, J = 10.2, 2.8 Hz, CH2CHOCAr), 3.85 (1H, d, J = 7.4 Hz, CHOH), 
2.86–2.79 (1H, m, CHAHB), 2.69–2.64 (1H, m, CHAHB), 2.34 (1H, br s, OH), 2.01 
(3H, d, J = 2.2 Hz, C≡CCH3), 1.73 (3H, dd, J = 6.5, 1.4 Hz, C=CHCH3), 1.04 (3H, s, 
CCH3), 1.00 (3H, s, CCH3); 
13
C NMR δ (125 MHz, CDCl3) 165.4 (C), 150.5 (2CH), 








78.8 (CH), 76.3 (CH), 76.2 (C), 41.9 (C), 30.6 (CH2), 18.9 (CH3), 18.5 (CH3), 17.9 
(CH3), 4.4 (CH3); m/z (ESI+, MeOH) 677 ([2M+Na]
+





, 9); HRMS (ESI+, MeOH) [M+H]
+
 found 328.1924, C20H26NO3 




Following General Procedure F with 3-nitrobenzaldehyde 
(227 mg, 1.50 mmol), reaction for 4 h gave an orange-red oil 
after aqueous workup. Flash chromatography (DCM:Hexane, 
20:1 → DCM) gave 1,3-anti diol monoester 384c as a brown oil 
(92.0 mg, 99%). 
Large-scale preparation: To a solution of β-hydroxyketone 86 (353 mg, 1.60 
mmol) and 3-nitrobenzaldehyde (1.36 g, 9.00 mmol) in THF (2 cm
3
) at –20 °C was 
added freshly prepared SmI2 (15.0 cm
3
, 1.50 mmol; 0.1 M in THF) and the solution 
was stirred for 4 h before quenching of the reaction with sodium potassium tartrate 
(20 cm
3
; sat aq). The aqueous layer was extracted with DCM (3 × 20 cm
3
) and the 
combined organic layers were washed with Na2S2O3 (20 cm
3
; 50% sat aq), brine (20 
cm
3
) and dried (MgSO4). The solvent was removed under reduced pressure and the 
brown residue thus obtained was dissolved in EtOH (20 cm
3
), NaHSO3 (4.00 cm
3
; 
4.5 M aq) was added, and the mixture was stirred for 3 h. The precipitate was 
filtered, washed with Et2O (5 × 10 cm
3
) and the solvent was removed under reduced 
pressure from the filtrate. The resulting oil was dissolved in Et2O (50 cm
3
), and the 
organic layer was washed with H2O (10 cm
3
), brine (10 cm
3
) and dried (MgSO4). 
The solvent was removed under reduced pressure and the yellow residual oil thus 
obtained was purified by flash chromatography (Hexane:EtOAc, 6:1) to give 1,3-anti 
diol monoester 384c as a yellow syrup (558 mg, 94%). Rf (Hexane:DCM, 20:1)          
= 0.27; Rf (Hexane:EtOAc, 6:1) = 0.17; [α]D = +44.0 (c 0.50, CHCl3); IR (neat,             
cm
-1
) 3528 (OH), 2218 (C≡C), 1721 (C=O), 1690 (C=O), 1616 (C=C), 1585 (C=C), 
1531 (NO); 
1
H NMR δ (500 MHz, CDCl3) 8.90 (1H, t, J = 1.8 Hz, ArH), 8.46 (1H, 
ddd, J = 8.2, 2.2, 1.1 Hz, ArH), 8.41 (1H, ddd, J = 8.2, 1.3, 1.1 Hz, ArH), 7.69 (1H, t, 







J = 15.3, 6.3 Hz, CH3CH), 5.60 (1H, ddq, J = 15.3, 7.3, 1.3 Hz, CH3C=CH), 5.46 
(1H, dqt, J = 10.6, 2.3, 1.2 Hz, CHC≡CCH3), 5.42 (1H, dd, J = 10.6, 2.7 Hz, 
CH2CHOCAr), 3.86 (1H, d, J = 7.3 Hz, CHOH), 2.93–2.87 (1H, m, CHAHB),              
2.66–2.61 (1H, m, CHAHB), 2.34 (1H, br s, OH), 2.04 (3H, d, J = 2.3 Hz, C≡CCH3), 
1.73 (3H, dd, J = 6.3, 1.3 Hz, C=CHCH3), 1.05 (3H, s, CCH3), 1.02 (3H, s, CCH3); 
13
C NMR δ (125 MHz, CDCl3) 164.9 (C), 148.3 (C), 137.2 (CH), 135.6 (CH), 131.9 
(C) 129.6 (CH), 129.5 (CH), 129.4 (CH), 127.5 (CH), 124.8 (CH), 112.8 (CH), 91.2 
(C), 78.8 (CH), 76.3 (CH), 76.1 (C), 41.9 (C), 30.6 (CH2), 18.9 (CH3), 18.5 (CH3), 
17.9 (CH3), 4.3 (CH3); m/z (EI) 371 ([M]
+
, 1%), 177 (14), 150 (100), 134 (26), 119 
(86); HRMS (EI) [M]
+




Following General Procedure F with 4-nitrobenzaldehyde (227 
mg, 1.50 mmol), reaction for 4 h gave an orange residue after 
aqueous workup. Flash chromatography (DCM:Hexane, 2:1 → 
DCM:Hexane, 5:1) gave 1,3-anti diol monoester 384d (59 mg, 
64%) as an orange-yellow syrup and β-ketoester 387 as a              
light-yellow oil (10.9 mg, 12%). Rf (DCM:Hexane, 5:1) = 0.21;               
[α]D = +96.0 (c 0.50, CHCl3); IR (neat, cm
-1
) 3537 (OH), 2216 (C≡C), 1721 (C=O), 
1607 (C=C), 1526 (NO); 
1
H NMR δ (500 MHz, CDCl3) 8.33–8.31 (2H, m, 2ArH), 
8.26–8.23 (2H, m, 2ArH), 5.81 (1H, ddd, J = 10.6, 8.5, 6.5 Hz, C=CHCH2), 5.70 
(1H, dq, J = 15.3, 6.5 Hz, CH3CH), 5.58 (1H, ddq, J = 15.3, 7.4, 1.4 Hz, CH3C=CH), 
5.47 (1H, br d, J = 10.6 Hz, CHC≡CCH3), 5.40 (1H, dd, J = 10.6, 2.8 Hz, 
CH2CHOCAr), 3.85 (1H, d, J = 7.4 Hz, CHOH), 2.89–2.82 (1H, m, CHAHB),             
2.68–2.64 (1H, m, CHAHB), 2.32 (1H, br s, OH), 2.03 (3H, d, J = 2.2 Hz, C≡CCH3), 
1.73 (3H, dd, J = 6.5, 1.4 Hz, C=CHCH3), 1.05 (3H, s, CCH3), 1.01 (3H, s, CCH3); 
13
C NMR δ (125 MHz, CDCl3) 165.0 (C), 150.6 (C), 137.3 (CH), 135.5 (C), 131.0 
(2CH), 129.5 (CH), 129.4 (CH), 123.5 (2CH), 112.6 (CH), 91.0 (C), 78.9 (CH), 76.3 
(CH), 76.2 (C), 41.9 (C), 30.6 (CH2), 18.9 (CH3), 18.5 (CH3), 17.9 (CH3), 4.4 (CH3); 
m/z (EI) 371 ([M]
+
, 1%), 151 (18), 150 (99), 134 (76), 133 (36) 119 (100), 106 (27), 
105 (26), 104 (37). HRMS (EI) [M]
+







Rf (DCM:Hexane, 5:1) = 0.50; [α]D = –36.3 (c 0.11, CHCl3); IR 
(neat, cm
-1
) 2230 (C≡C), 1726 (C=O), 1695 (C=O), 1626 (C=C), 
1608 (C=C), 1530 (NO); 
1
H NMR δ (500 MHz, CDCl3)               
8.32–8.29 (2H, m, 2ArH), 8.21–8.18 (2H, m, 2ArH), 6.99 (1H, 
dq, J = 15.1, 6.9 Hz, CH3CH), 6.61 (1H, dq, J = 15.1, 1.7 Hz, 
CH3C=CH), (1H, td, J = 10.6, 10.4 Hz, C=CHCH2), 5.64 (1H, dd, 
J = 9.9, 3.2 Hz, CH2CHOCAr), 5.48–5.45 (1H, m, CHC≡CCH3), 2.80–2.73 (1H, m, 
CHAHB), 2.59–2.54 (1H, m, CHAHB), 1.99 (3H, d, J = 2.4 Hz, C≡CCH3), 1.92 (3H, 
dd, J = 6.9, 1.7 Hz, C=CHCH3), 1.32 (3H, s, CCH3), 1.30 (3H, s, CCH3); 
13
C NMR δ 
(125 MHz, CDCl3) 200.6 (C), 164.2 (C), 150.6 (C), 144.3 (CH), 136.5 (CH), 135.6 
(C), 130.8 (2CH), 126.0 (CH), 123.5 (2CH), 112.8 (CH), 91.1 (C), 77.8 (CH), 76.0 
(C), 50.3 (C), 31.4 (CH2), 21.0 (CH3), 20.1 (CH3), 18.4 (CH3), 4.4 (CH3); m/z (ESI+, 
MeOH) 392 ([M+Na]
+
, 15%), 370 ([M+H]
+
, 2), 288 (100); HRMS (ESI+, MeOH) 
[M+H]
+
 found 370.1643, C21H24NO5 requires 370.1649. 
 
Diagnostic data for other Evans–Tishchenko products: 
(2E,4S,6S,8Z)-5,5-dimethyl-6-[(benzoyl)oxy]-dodeca-2,8-dien-10-yn-4-ol (337) 
Aldehyde substrate: benzaldehyde. 
1
H NMR δ (500 MHz, 
CDCl3) 8.09–8.07 (2H, m, 2ArH), 7.61–7.59 (1H, m, ArH),          
7.51–7.45 (2H, m, 2ArH), 5.83 (1H, dt, J = 10.5, 7.2 Hz, 
C=CHCH2), 5.69 (1H, dq, J = 15.2, 6.4 Hz, CH3CH), 5.57 (1H, 
ddq, J = 15.2, 7.2, 1.4 Hz, CH3C=CH), 5.49–5.45 (1H, m, 
CHC≡CCH3), 5.35 (1H, dd, J = 10.0, 2.5 Hz, CH2CHOCAr), 3.85 (1H, d, J = 7.2 Hz, 
CHOH), 2.82–2.75 (1H, m, CHAHB), 2.72–2.68 (1H, m, CHAHB), 2.02 (3H, d,          
J = 2.3 Hz, C≡CCH3), 1.72 (3H, dd, J = 6.4, 1.4 Hz, C=CHCH3), 1.04 (3H, s, CCH3), 











Aldehyde substrate: 3-furancarboxaldehyde. Diagnostic peaks: 
1
H NMR δ (500 MHz, CDCl3) 8.06 (1H, ddd, J = 4.5, 1.4, 0.7 Hz, 
ArH), 7.46 (1H, dt, J = 3.3, 1.7 Hz, ArH), 6.78–6.77 (1H, m, 
ArH), 5.81 (1H, dt, J = 10.7, 7.3 Hz, C=CHCH2), 5.52–5.47 (1H, 
m, CHC≡CCH3), 3.40 (1H, dt, J = 7.1, 1.5 Hz, CHOH), 2.79–2.70 
(1H, m, CHAHB), 2.66–2.59 (1H, m, CHAHB), 2.03–2.01 (3H, m, C≡CCH3), 1.74 
(3H, dt, J = 7.3, 1.5 Hz, C=CHCH3), 1.00 and 0.97 (3H, 2 × s, CCH3), 0.94 and 0.91 




Aldehyde substrate: N-benzyl-4-formyl-pyrazole 364. 
Diagnostic peaks: 
1
H NMR δ (500 MHz, CDCl3) 7.96 (1H, 
s, CH2NCH), 7.90 (1H, s, CH2NNCH), 5.79 (1H, dt, J = 10.5, 
7.3 Hz, C=CHCH2), 5.68 (1H, dq, J = 15.3, 6.4 Hz, CH3CH), 
5.55 (1H, ddq, J = 15.3, 7.2, 1.5 Hz, CH3C=CH), 5.49–5.45 
(1H, m, CHC≡CCH3), 5.33 (2H, s, CH2Ar), 5.22 (1H, dd, J = 10.3, 2.8 Hz, 
CH2CHOCAr), 3.82 (1H, d, J = 7.2 Hz, CHOH), 2.75–2.69 (1H, m, CHAHB),             
2.65–2.59 (1H, m, CHAHB), 1.99 (3H, d, J = 2.3 Hz, C≡CCH3), 1.73 (3H, dd, J = 6.4, 
1.5 Hz, C=CHCH3), 0.99 (3H, s, CCH3), 0.92 (3H, s, CCH3). 
 
7.5.3 Completion of the C(1)–C(9)/C(10′)–C(19′) Fragment (336)                                          
2,2,2-Trichloro-acetimidic acid 4-methoxybenzyl ester (394) 
PMB-TCA 394 was prepared according to the procedure 
described by Joly and Jacobsen.
213
 A solution of PMBOH (11.1 
g, 80.0 mmol) in Et2O (50 cm
3
) was added over 20 min to a 
suspension of NaH (0.32 g, 8.00 mmol, 10 mol%; 60% dispersion in mineral oil 
which was pre-rinsed with hexane, 3 × 2 cm
3
) in Et2O (10 cm
3
) and the solution was 
stirred at rt for 30 min before cooling to 0 °C. Trichloroacetonitrile (8.85 cm
3
, 88.0 






0 °C, warmed to rt and stirred for a further 1 h. The solvent was removed under 
reduced pressure and a solution of MeOH (0.40 cm
3
, 10.0 mmol) in pentane (84 cm
3
) 
and was added to the dark-orange oil. After stirring for 30 min, the mixture was 
filtered through celite and the filter cake was rinsed with pentane (5 × 20 cm
3
). 
Dilution of the filtrate with Et2O (100 cm
3
), drying (MgSO4), and removeal of the 
solvent under reduced pressure gave PMB-TCA 394 as a yellow oil (22.6 g, quant), 
which was used without further purification. Rf (Hexane:EtOAc, 3:1) = 0.53; IR 
(neat, cm
-1
) 3337 (NH), 1663 (C=N), 1612 (C=C), 1585 (C=C), 1514 (C=C), 1464 
(C=C); 
1
H NMR δ (400 MHz, CDCl3) 8.40 (1H, br s, NH), 7.43–7.39 (2H, m, ArH), 
6.96–6.93 (2H, m, ArH), 5.31 (2H, s, CH2), 3.85 (3H, s, CH3); 
13
C NMR δ (100 
MHz, CDCl3) 162.6 (C), 159.7 (C), 129.8 (2CH), 127.5 (C), 113.9 (2CH), 91.5 (C), 













155 (19), 147 (26), 145 (26), 137 (60), 121 (100). The spectroscopic data are in good 






PMB-protected 1,3-anti diol monoester 395 was prepared 
according to a modification of the O-PMB-protection procedure 
described by Rai and Basu.
214
 To a solution of 1,3-anti diol 
monoester 384c (186 mg, 0.50 mmol) and PMB-TCA (424 mg, 
1.50 mmol) in PhMe (25 cm
3
) was added Sc(OTf)3 (24.6 mg, 
0.05 mmol, 10 mol%) at 0 °C and the reaction mixture was 
warmed to rt and stirred for 1 h, after which time a yellowing of the solution had 
occurred. H2O (50 cm
3
) was added to quench the reaction, the aqueous layer was 
extracted with DCM (3 × 20 cm
3
), and the combined organic layers were washed 
with brine (20 cm
3
) and dried (MgSO4). Removal of the solvent under reduced 
pressure gave a yellow residue which was purified by flash chromatography 
(Hexane:EtOAc, 6:1) to give an inseperable mixture (~1.8:1) of PMB-protected          
1,3-anti diol monoester 395 and PMB2O 396 (242 mg, 0.39 mmol 395, 79% by 
1
H 
NMR) as a yellow syrup, which was used as a 0.05 M solution in MeOH for 




(minimum 1.8:1, maximum 6.7:1). Rf (Hexane:EtOAc, 6:1) = 0.40; [α]D = +82.0          
(c 1.00, CHCl3); IR (neat, cm
-1
) 2216 (C≡C), 1722 (C=O), 1612 (C=C), 1585 (C=C), 
1533 (C=C), 1512 (C=C); 
1
H NMR δ (500 MHz, CDCl3) 8.79 (1H, ddd, J = 2.4, 1.5, 
0.3 Hz, NO2ArH), 8.39 (1H, ddd, J = 8.2, 2.4, 1.2 Hz, NO2ArH), 8.29 (1H, ddd,              
J = 7.7, 1.5, 1.2 Hz, NO2ArH), 7.56 (1H, ddd, J = 8.2, 7.7, 0.3 Hz, NO2ArH),             
7.22–7.19 (2H, m, 2CH3OArH), 6.78–6.75 (2H, m, 2CH3OArH), 5.84 (1H, ddd,             
J = 10.6, 8.4, 6.8 Hz, C=CHCH2), 5.69 (1H, dq, J = 15.4, 6.5 Hz, CH3CH), 5.51 (1H, 
ddq, J = 15.4, 8.7, 1.7 Hz, CH3C=CH), 5.47 (1H, dd, J = 9.9, 3.2 Hz, CH2CHOCO), 
5.42 (1H, dqt, J = 10.6, 2.2, 1.2 Hz, CHC≡CCH3), 4.38 (1H, d, J = 11.0 Hz, 
CHAHBAr), 4.07 (1H, d, J = 11.0 Hz, CHAHBAr), 3.78 (3H, s, OCH3), 3.52 (1H, d,         
J = 8.7 Hz, CHOCH2Ar), 2.84–2.77 (1H, m, NO2ArCOCHCHCHD), 2.66–2.61 (1H, 
m, NO2ArCOCHCHCHD), 1.98 (3H, d, J = 2.2 Hz, C≡CCH3), 1.80 (3H, dd, J = 6.5, 
1.7 Hz, C=CHCH3), 1.07 (3H, s, CCH3), 1.04 (3H, s, CCH3); 
13
C NMR δ (125 MHz, 
CDCl3) 163.9 (C), 158.8 (C), 148.1 (C), 137.9 (CH), 135.4 (CH), 132.6 (C), 131.4 
(CH), 130.7 (C), 129.6 (2CH), 129.3 (CH), 128.0 (CH), 127.0 (CH), 124.6 (CH), 
113.4 (2CH), 112.0 (CH), 90.7 (C), 84.4 (CH), 77.8 (CH), 76.2 (C), 69.7 (CH2), 55.1 
(CH3), 41.8 (C), 31.0 (CH2), 19.8 (CH3), 19.7 (CH3), 17.9 (CH3), 4.3 (CH3); m/z (EI) 
492 ([M+H]
+
, 3%), 491 ([M]
+
, 10%), 349 (16), 348 (75), 332 (47), 228 (55), 227 
(63), 211 (39), 197 (50), 151 (100); HRMS (EI) [M]
+




PMB2O diagnostic data: Rf (Hexane:EtOAc, 6:1) = 0.40; 
1
H NMR δ (500 MHz, CDCl3) 7.32–7.30 (4H, m, 4ArH), 
6.93–6.90 (4H, m, 4ArH), 4.49 (4H, s, 2CH2), 3.84 (6H, s, 
2OCH3); 
13
C NMR δ (125 MHz, CDCl3) 159.2 (2C), 130.5 (2C), 129.4 (4CH), 113.8 











A solution of PMB-protected 1,3-anti diol monoester 395 (6.80 
cm
3
, 0.39 mmol; 0.05 M in MeOH), LiOH (196 mg, 4.68 mmol) 
and H2O (0.68 cm
3
) was heated to reflux overnight (~18 h) and 
cooled to rt. The reaction mixture was concentrated under reduced 
pressure and partitioned between Et2O (20 cm
3
) and NaOH (20 
cm
3
; 2.0 M aq), and the aqueous layer was extracted with Et2O           
(3 × 10 cm
3
). The combined organic layers were washed with NaOH (3 × 10 cm
3
; 3.0 
M aq), H2O (10 cm
3
), brine (10 cm
3
) and dried (MgSO4). The solvent was removed 
under reduced pressure to give yellow oil that was purified by flash chromatography 
(Hexane:EtOAc, 6:1) to give an inseparable mixture (~2:1) of alcohol 338 
contaminated with PMB2O 396 as a light-yellow oil (167.8 mg, 0.35 mmol 338, 91% 
by 
1
H NMR), which was used as a 0.05 to 0.1 M solution in PhMe in subsequent 
reactions without further purification. N.B. Ratios of 338:396 obtained after 
purification were variable (minimum 2:1, maximum 7.4:1). Rf (Hexane:EtOAc, 6:1) 
= 0.40; [α]D = –6.00 (c 0.50, CHCl3); IR (neat, cm
-1
) 3487 (OH), 2216 (C≡C), 1610 
(C=C), 1665 (C=C), 1585 (C=C), 1510 (C=C), 1463 (C=C), 1441 (C=C); 
1
H NMR δ 
(500 MHz, CDCl3) 7.26–7.23 (2H, m 2ArH), 6.90–6.87 (2H, m, 2ArH), 6.07 (1H, dt, 
J = 10.7, 7.2 Hz, C=CHCH2), 5.71 (1H, dq, J = 15.4, 6.4 Hz, CH3CH), 5.54–4.49 
(2H, m, CH3C=CH and CHC≡CCH3), 4.54 (1H, d, J = 11.2 Hz, CHAHBAr), 4.22 
(1H, d, J = 11.2 Hz, CHAHBAr), 3.82 (3H, s, OCH3), 3.74 (1H, br s, OH), 3.68 (1H, 
d, J = 8.6 Hz, CHOCH2Ar), 3.61 (1H, dd, J = 10.1, 2.1 Hz, CHOH), 2.57–2.52 (1H, 
m, CHCHDCHOH), 2.31–2.25 (1H, m, CHCHDCHOH), 1.98 (3H, d, J = 2.3 Hz, 
C≡CCH3), 1.82 (3H, dd, J = 6.4, 1.6 Hz, C=CHCH3), 0.94 (3H, s, CCH3), 0.92 (3H, 
s, CCH3); 
13
C NMR δ (125 MHz, CDCl3) 159.2 (C), 140.8 (CH), 131.5 (CH), 130.1 
(C), 129.5 (2CH), 127.6 (CH), 113.8 (2CH), 110.2 (CH), 90.0 (C), 87.8 (CH), 77.3 
(CH), 76.7 (C), 69.9 (CH2), 55.3 (CH3), 40.9 (C), 32.8 (CH2), 21.7 (CH3), 21.0 
(CH3), 17.9 (CH3), 4.4 (CH3); m/z (ESI+, MeOH) 707 ([2M+Na]
+
, 100%), 685 
([2M+H]
+
, 7), 381 ([M+K]
+
, 14); HRMS (ESI+) [M+H]
+








Oxazole ester 398 (and 336, below) was prepared according to a 
modification of the procedure described by Hoffmann
25
 for the 
Yamaguchi esterification
22
 of an alcohol and an oxazolyl 
carboxylic acid. Two stock solutions, the first (Solution 1) 
containing 2-methyloxazole-4-carboxylic acid (6.50 mg, 0.05 
mmol) in PhMe (1 cm
3
); and the second (Solution 2) containing 
2,4,6-TCBC (48.6 mg, 0.20 mmol) and Et3N (0.03 cm
3
, 0.29 mmol) in PhMe (1.5 
cm
3
), were prepared for the purpose of generating, portionwise, an activated ester. 
Solution 2 (0.3 cm
3
) was added to Solution 1 (0.2 cm
3
), and the mixture was stirred 
for 15 min at rt, before addition of the resulting activated ester solution (Solution 3) 
to a heated (40 °C) solution of alcohol 338 (1.00 cm
3
, 0.05 mmol; 0.05 M in PhMe) 
and DMAP (19.0 mg, 0.16 mmol); and stirring of the reaction mixture, which turned 
pale-yellow on addition, for 15 min. This procedure was repeated until all activated 
ester solutions were added to alcohol 338 (5 additions over 75 min) and stirring was 
continued for 2 h. The reaction mixture was cooled to rt, diluted with DCM (20 cm
3
), 
poured into NH4Cl (10 cm
3
; sat aq) and the aqueous layer was extracted with DCM 
(3 × 10 cm
3
). The combined organic layers were washed with HCl (10 cm
3
; 1.0 M 
aq), brine (10 cm
3
) and dried (MgSO4); and the solvent was removed under reduced 
pressure. Flash chromatography (Hexane:EtOAc, 3:1) of the resulting yellow residue 
gave oxazole ester 398 as a turbid, colourless syrup (22.0 mg, 93%). Rf 
(Hexane:EtOAc, 3:1) = 0.33; [α]D = +30.0 (c 0.50, CHCl3); IR (neat, cm
-1
) 2218 
(C≡C), 1737 (C=O), 1717 (C=N), 1668 (C=C), 1612 (C=C), 1589 (C=C), 1514 
(C=C); 
1
H NMR δ (400 MHz, CDCl3) 7.96 (1H, s, NC=CH), 7.28–7.25 (2H, m, 
2ArH), 6.86–6.83 (2H, m, 2ArH), 5.85 (1H, dt, J = 10.8, 7.2 Hz, C=CHCH2), 5.67 
(1H, dq, J = 15.1, 6.3 Hz, CH3CH), 5.48 (1H, ddq, J = 15.1, 8.6, 1.6 Hz, CH3C=CH), 
5.45–5.41 (1H, m, CHC≡CCH3), 5.41 (1H, dd, J = 9.3, 3.9 Hz, CH2CHOCO), 4.39 
(1H, d, J = 10.8 Hz, CHAHBAr), 4.12 (1H, d, J = 10.8 Hz, CHAHBAr), 3.81 (3H, s, 
OCH3), 3.51 (1H, d, J = 8.6 Hz, CHOCH2Ar), 2.73–2.59 (2H, m, OCHCH2), 2.52 
(3H, s, ArCH3), 1.98 (3H, d, J = 2.2 Hz, C≡CCH3), 1.79 (3H, dd, J = 6.3, 1.6 Hz, 
C=CHCH3), 1.00 (3H, s, CCH3), 0.97 (3H, s, CCH3); 
13




162.2 (C), 160.7 (C), 158.9 (C), 143.3 (CH), 138.4 (CH), 133.5 (C), 131.0 (CH), 
129.6 (2CH), 127.9 (CH), 113.5 (2CH), 111.5 (CH), 90.3 (C), 84.0 (CH), 77.2 (C), 
76.9 (CH), 76.5 (C), 69.8 (CH2), 55.2 (CH3), 41.8 (C), 30.9 (CH2), 19.5 (CH3), 19.3 
(CH3), 17.9 (CH3), 13.8 (CH3), 4.4 (CH3); m/z (ESI+, MeOH/DCM) 925 ([2M+Na], 
48%), 474 ([M+Na]
+
, 100); HRMS (ESI+, MeOH/DCM) [M+Na]
+
 found 474.2247, 




Two stock solutions, the first (Solution 1) containing       
C(1)–C(9) oxazole carboxylic acid 111
203b
 (11.8 mg, 0.05 
mmol) in PhMe (2 cm
3
; ultrasound assisted dissolution); and 
the second (Solution 2) containing 2,4,6-TCBC (48.6 mg, 
0.20 mmol) and Et3N (0.03 cm
3
, 0.29 mmol) in PhMe (3 
cm
3
), were prepared for the purpose of generating, 
portionwise, an activated ester. Solution 2 (0.6 cm
3
) was added to Solution 1 (0.4 
cm
3
), and the mixture was stirred for 30 min at rt, before addition of the resulting 
activated ester solution (Solution 3) to a heated (40 °C) solution of alcohol 338 (1.00 
cm
3
, 0.05 mmol; 0.05 M in PhMe) and DMAP (19.0 mg, 0.16 mmol); and stirring of 
the pale-yellow reaction mixture for 30 min. This procedure was repeated until all 
activated ester solutions were added to alcohol 338 (5 additions over 2.5 h) and 
stirring was continued overnight (~18 h). The reaction mixture was cooled to rt, 
diluted with DCM (30 cm
3
), poured into NH4Cl (10 cm
3
; sat aq) and the aqueous 
layer was extracted with DCM (3 × 10 cm
3
). The combined organic layers were 
washed with HCl (10 cm
3
; 1.0 M aq), NaHCO3 (10 cm
3
; sat aq), brine (10 cm
3
) and 
dried (MgSO4); and the solvent was removed under reduced pressure. Flash 
chromatography with gradient elution (Hexane:EtOAc, 6:1 → 3:1; dry loaded) of the 
resulting brown residue gave C(1)–C(9)/C(10′)–C(19′) oxazole ester 336 as a yellow 
syrup (20.0 mg, 71%).  
Large-scale preparation: The above procedure was repeated commencing from 
C(1)–C(9) oxazole carboxylic acid 111
203b
 (106 mg, 0.45 mmol) in PhMe (10 cm
3
) 
[Solution 1]; 2,4,6-TCBC (444 mg, 1.80 mmol) and Et3N (0.36 cm
3







) [Solution 2]; and alcohol 338 (4.50 cm
3
, 0.45 mmol; 0.1 M in PhMe) 
and DMAP (171 mg, 3.11 mmol) in PhMe (0.5 cm
3
); with Solution 3 generated 
portionwise from proportionate volumes of Solution 1 and Solution 2 [2 cm
3
 of each 
per Solution 3 preparation] and added to the alcohol 338 solution with a PhMe rinse 
(0.2 cm
3
) on each of the 5 additions. Quenching with NH4Cl (10 cm
3
, sat aq) and 
subsequent concentration of the reaction mixture under reduced pressure; workup 
with DCM (3 × 20 cm
3
), HCl (25 cm
3
, 0.2 M aq), NaHCO3 (10 cm
3
, sat aq), H2O (10 
cm
3
) and brine (10 cm
3
); and drying (MgSO4) followed by removal of the solvent 
under reduced pressure and submission of the residue thus obtained to the same 
conditions of flash chromatography gave C(1)–C(9)/C(10′)–C(19′) oxazole ester 336 
as a yellow syrup (158 mg, 63%). Rf (Hexane:EtOAc, 3:1) = 0.51; [α]D = +30.2         
(c 1.09, CHCl3); IR (neat, cm
-1
) 2224 (C≡C), 1738 (C=O), 1717 (C=N), 1667 (C=C), 
1612 (C=C), 1584 (C=C), 1514 (C=C); 
1
H NMR δ (600 MHz, CDCl3) 8.00 (1H, s, 
NC=CH), 7.28 (2H, d, J = 8.6 Hz, 2ArCH), 6.85 (2H, d, J = 8.6 Hz, 2ArCH), 5.94 
(1H, dd, J = 15.9, 7.7 Hz, CH3OCHCH=CH), 5.85 (1H, dt, J = 10.3, 7.3 Hz, 
HC=CHCH2), 5.71 (1H, br dq, J = 15.9, 2.1 Hz, CH3OCHCH=CH), 5.67 (1H, dq,              
J = 15.3, 6.4 Hz, CH3CH), 5.46 (1H, ddq, J = 15.3, 8.6, 1.3 Hz, CH3C=CH), 5.44 
(1H, br dq, J = 10.3, 2.1 Hz, HC=CHCH2), 5.40 (1H, dd, J = 9.5, 3.5 Hz, 
CH2CHOCO), 4.39 (1H, d, J = 10.8 Hz, CHAHBAr), 4.17 (1H, ddd, J = 7.7, 7.3, 5.6 
Hz, CH3OCH), 4.12 (1H, d, J = 10.8 Hz, CHAHBAr), 3.81 (3H, s, ArOCH3), 3.51 
(1H, d, J = 8.6 Hz, CHOCH2Ar), 3.29 (3H, s, CH3OCH), 3.10 (1H, dd, J = 15.1, 7.7 
Hz, CHCHDCHOCH3), 2.99 (1H, dd, J = 15.1, 5.6 Hz, CHCHDCHOCH3), 2.71–2.62 
(2H, m, HC=CHCH2), 1.98 (3H, d, J = 2.1 Hz, CH2CH=CHC≡CCH3), 1.96 (3H, d,             
J = 2.1 Hz, CH3OCHCH=CHC≡CCH3), 1.78 (3H, dd, J = 6.4, 1.3 Hz, CH3CH), 1.00 
(3H, s, CCH3), 0.97 (3H, s, CCH3); 
13
C NMR δ (150 MHz, CDCl3) 162.3 (C), 160.7 
(C), 158.9 (C), 143.5 (CH), 139.8 (CH), 138.3 (CH), 133.6 (C), 131.1 (C), 131.0 
(CH), 129.5 (2CH), 127.9 (CH), 114.0 (CH), 113.5 (2CH), 111.5 (CH), 90.4 (C), 
87.7 (C), 84.1 (CH), 79.2 (CH), 77.1 (CH), 76.5 (C), 69.8 (CH2), 56.7 (CH3), 55.2 
(CH3), 41.8 (C), 34.6 (CH2), 30.9 (CH2), 30.3 (C), 19.5 (CH3), 19.4 (CH3), 17.9 
(CH3), 4.3 (CH3), 4.2 (CH3); m/z (ESI+, MeOH) 1142 ([2M+Na]
+
, 62%), 598 
([M+K]
+
, 7), 582 ([M+Na]
+
, 100), 560 ([M+H]
+
, 17); HRMS (ESI+, MeOH) 
[M+H]
+





[*]  unspecified transformation, where * is replaced by a functional group 
  or synthetic process, e.g. [O] = oxidation 
Å   Ångstrom (10
-10
 metres) 
Ac  acetyl 
ACM  alkyne cross-metathesis 
Addt.  additive 
AM  alkyne metathesis 
Ar  unspecified aryl group 
BINAP 2,2′-bis(diphenylphosphino)-1,1′-binapthyl 
Bn  benzyl 
Boc  tert-butoxycarbonyl 
BORSM based on recovered starting material 




Bu n-butyl / tert-butyl   
CAN  ceric ammonium nitrate 
CDI  1,1′-carbonyldiimidazole 
cm  complex mixture 
CM  (olefin) cross-metathesis 
conv.  conversion 
Cp  cyclopentadienyl 
CP  cyclopropenyl 
C. R.   coupling reagent 
CSA  camphorsulfonic acid 
CuAAC copper-catalysed azide–alkyne cycloaddition 
Cy  cyclohexyl 
d  day(s) 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC  N,N′-dicyclohexylcarbodiimide 
DCM  dichloromethane 
DDQ  2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DIAD  diisopropyl azodicarboxylate 
DIBAL diisobutylaluminium hydride 
DIPEA N,N-diisopropylethylamine, Hünig’s base 
Dis. C1  disorazole C1   
DMF  N,N-dimethylformamide 
DMAP  4-dimethylaminopyridine 
DMB  3,4-dimethoxybenzyl 
DMSO  dimethylsulfoxide 
DOWEX-H
+
 cationic Dow ion-exchange resin 
DPTC  dipyridylthionocarbonate 
dr  diastereomeric ratio 
EC50  half-maximal effective concentration 
EDTA  ethylenediaminetetraacetic acid 
ee  enantiomeric excess 
ent  enantiomer 




Eq / eq  equivalent(s) 
Et  ethyl 
ET  Evans–Tishchenko 
EWG  electron withdrawing group 
h  hour(s) 
HBTU  O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium   
  hexafluorophosphate 
Het  unspecified heterocycle 
n
Hex  n-hexyl  
HMDS  hexamethyldisilazide, bis(trimethylsilyl)amide 
HMPA  hexamethylphosphoramide 
HPLC  high-performance liquid chromatography 
HRMS  high-resolution mass spectrometry 
IC50  half-maximal inhibitory concentration 
Im  imidazole 
Int  intermediate 
µL  microlitre(s) 
L  unspecified ligand 
LDA  lithium diisopropylamide 
LDBBA lithium diisobutyl-tert-butoxyaluminium hydride 
lit  literature value  
M  moles per cubic decimetre, moldm
-3
 
Me  methyl 
MEM  (2-methoxyethoxy)methyl 
Mes  mesityl, 2,4,6-trimethylphenyl 
2-MeTHF 2-methyltetrahydrofuran 
min  minute(s) 
mmHg  millimetres of mercury 
MNBA 2-methyl-6-nitrobenzoic anhydride 
mol%  mole percent 
MOM  (methoxy)methyl 
Ms  methanesulfonyl, mesyl 
MS  molecular sieves 
MTM  (methylthio)methyl 
N  sample size  
nd  not determined 
NBS  N-bromosuccinimide 
NIS  N-iodosuccinimide 
NMR  nuclear magnetic resonance
*
 
3-NOBA 3-nitrobenzyl alcohol 
NR  no reaction 
Ns  2-nitrobenzenesulfonyl, nosyl 
ox.  2,5-oxazole 
P  unspecified protecting group 
PADA  dipotassium azodicarboxylate 
PE  petroleum ether 
Ph  phenyl 





PMP  para-methoxyphenyl, 4-methoxyphenyl 
PPTS  pyridinium p-toluenesulfonate 
4-PPy  4-pyrrolidinopyridine 
i
Pr  iso-propyl 
Prod.  product 
Py  pyridine 
quant  quantitative 
R
n
  unspecified group
†
 (n = 1, 2, 3 etc.) 
RAAT  retro-aldol aldol–Tishchenko 
RCAM ring-closing alkyne metathesis 
Ref.  reference 
Rf  retention factor 
RP-HPLC reverse-phase high-performance liquid chromatography 
Rslt.  result 
Rt  retention time 
rt  room temperature 
salen  N,N′-ethylenebis(salicylimine) 
SAR(s) structure–activity relationship(s) 
SEM  [2-(trimethylsilyl)ethoxy]methyl 
Si  unspecified silicon protecting group 
Solv.  solvent 
TBAF  tetra-n-butylammonium fluoride 
TBAI  tetra-n-butylammonium iodide 
TBS  tert-butyldimethylsilyl 
TBAT  tetrabutylammonium difluorotriphenylsilicate 
TBTA  tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine 
2,4,6-TCBC 2,4,6-trichlorobenzoyl chloride, Yamaguchi reagent 
1,1,2-TCE 1,1,2-trichloroethane 
Temp  temperature 
TEMPO (2,2,6,6-tetramethyl-piperidin-1-yl)oxyl radical 
TES  triethylsilyl 
Tf  trifluoromethanesulfonate, triflate 
TFA  trifluoroacetic acid, 2,2,2-trifluoroethanoic acid 
THF  tetrahydrofuran 
TIPS  triisopropylsilyl 
TLC  thin-layer chromatography 
TMS  trimethylsilyl 
Tol  para-tolyl, 4-methylphenyl 
Ts  para-toluenesulfonyl, 4-toluenesulfonyl, tosyl 
TS  transition state 
X  unspecified leaving group 
XtalFluor (diethylamino)difluorosulfonium tetrafluoroborate 
*Abbreviations related to NMR spectroscopy and (most) abbreviations that are not used in discussion 
prior to Chapter 7: Experimental may be found in Section 7.1: General Experimental (page 174). 
†Further abbreviations for “unspecified group” include A, B, X and Y. 
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Appendix 1  
1
H NMR spectrum of the C(5)–C(9) C(6)-amino analogue mesylate 
     164 recorded at 500 MHz in DMSO-d6 at 323 K. 
 




H NMR spectrum of the C(10)–C(19) β-hydroxyketone fragment  




H NMR spectrum of the C(10)–C(19) mono-protected diol fragment 




H NMR spectrum of the C(1)–C(9)/C(10′)–C(19′) 1,3-anti diol   
     monoester bis-alkyne fragment 336 recorded at 600 MHz in CDCl3 at 
     298 K. 
 
Appendix 6 Permission letter obtained for the use of Figure 1.3. 
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